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ABSTRACT 
REGULATION OF BOTULINUM TOXIN COMPLEX FORMATION IN 
Clostridium botulinum TYPE A NCTC 2916 
by Tom 0. Davis 
Genomic DNA fragments encoding the silent type B neurotoxin gene from Clostridium 
botulinum NCTC 2916 have been cloned and the complete nucleotide sequence 
determined. The translated sequence revealed that the gene encoded a neurotoxin which 
was closely related to type B neurotoxin genes from Group I Clostridium botulinum. 
However among the nucleotide sequence differences, aG to T transition has interrupted 
the coding sequence with the formation of a stop codon. In addition the deletion of an 
adenine residue has resulted in a frame-shift mutation. 
Analysis of the DNA sequence contiguous with the silent type B neurotoxin gene 
revealed the presence of a gene encoding a Nontoxic-Nonhaemagglutinin protein which 
appears to share a bicistronic mRNA transcript with the type B neurotoxin gene. In the 
reverse orientation, the partial sequence of a gene encoding a haemagglutinin protein was 
found, typical of type A and B botulinal neurotoxin complexes. Separating the genes 
encoding the 'components of the neurotoxin complex was a gene of 178 amino acids 
which possessed features commonly associated with transcriptional factors. 
To facilitate the in vivo study of botulinal neurotoxin complex regulation, a gene transfer 
system using clostridial components has been developed. The minimal replicon of the 
cryptic plasmid pCB 102 from Clostridium butyricum NCIB 7423 was located to 1.6 kb 
DNA fragment by deletion analysis, enabling the identification of hitherto undiscovered 
putative ORFs and secondary structures, consistent with a replicative function. The 
replicon has been incorporated in to a number of Escherichia coli vectors resulting in a 
versatile series of shuttle vectors which have demonstrated high structural and 
segregational stabilities in a heterologous host Clostridium beyerinckii NCI NIB 8052. 
Gene transfer of a Group I Clostridium botulinum type A strain was demonstrated with a 
representative pCB 102-derived shuttle vector, pMTL540E. 
In addition, a 5.9 kb plasmid indigenous to C. hotulimun NCTC 2916 was cloned and 
the complete nucleotide sequence determined. Eight putative ORFs have been identified, 
including a putative replication protein and recombinase. 
xix 
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CHAPTER I 
INTRODUCTION 
1.1 Botulism 
Bacteria which prey upon the human being take many forms, but among these, 
Clostridium botulinum holds a particularly fearful reputation due to the extreme potency 
of its neurotoxins and invariably fatal consequences. There are now seven serological 
groupings of the neurotoxin (A-G) and within this framework a number of distinct sub- 
groups exist. Irrespective of the serotype, botulinal neurotoxins occur as part of a 
heterogeneous protein complex which commonly enter the body by ingestion, where 
upon they eventually effect their toxic activity in the synapses of neuromuscular 
junctions, causing flaccid paralysis and death. No single species is responsible for the 
production of these protein toxins which have been attributed to at least six lineages of 
the genus Clostridium. Whilst there is a limited understanding of the composition of the 
neurotoxin complex, information on the mechanisms by which the various components 
are regulated is virtually nonexistent. To further our understanding of neurotoxin 
complex regulation, the components must first be characterised at the genetic level. An 
essential feature of this approach is the development of a genetic system by which studies 
can be conducted in vivo. 
1.2 The Clostridia 
1.2.1 The genus 
In the latter part of the nineteenth century, the discovery of a number of anaerobic 
fermentative spore forming bacteria prompted the concept of the genus Clostridium by 
Prazmowski (1880). However it was Trecul, who in 1863 devised the term Clostridium 
which is derived from kloster, the greek word for spindle and the diminutive suffix `ium', 
thus describing a `small spindle'. It was at this time that organisms resembling many of 
the medically and biotechnologically important clostridia were first described including 
2 
Clostridium butyricum (1880), Clostridium tetani (1884), Clostridium septicum (1887), 
Clostridium perfringens (1889), Clostridium difficile (1893) and Clostridium 
pasteurianum (1895), indeed C. botulinum was described by van Ermengen in 1896 (see 
Morris, 1993). 
Clostridia are distinguished by their ability to form endospores, are generally Gram- 
positive rods and on the whole are obligate anaerobes. They are believed to metabolise a 
wide range of substances including carbohydrates, alcohols, amino acids, purines, 
steroids and other organic compounds (Cato et al., 1986). Some species fix atmospheric 
nitrogen but none are capable of dissimilatory sulfate reduction. The wide repertoire of 
metabolic capabilities of this genus underlies a very diverse spectrum of organisms which 
are collectively grouped on a rather broad basis of shared phenotypic traits. The classical 
taxonomic methods of distinguishing these organisms (i. e., Cato et al., 1986) have 
recently been superseded by DNA based studies in which the nucleotide sequence 
divergence of 16S rRNA genes is correlated with phylogenetic relationships. On this 
basis, previous groupings have been refined to produce 19 separate phylogenetic clusters 
(Collins et al., 1994). Cluster I which accommodates at least half of the currently known 
clostridia includes the C. butyricum type strain, the neurotoxigenic clostridia and C. 
perfringens, but not Cd ff cite. Members of this group retain the original `clostridial' 
status. The association of clostridial species with a variety of taxa has generated 
phylogenetic clusters containing combinations of organisms with and without the original 
`clostridial criteria, ' e. g., spore-formers and non-spore formers, Gram-negative and 
Gram-positive, aerobes and oligate anaerobes and DNA over a range of mol %G+C 
(Collins et a!., 1994). 
Three broad groups of clostridia have received disproportionate scientific attention due 
to their etiological association with a number of diseases or biotechnological potential. 
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These include pathogens and solventogens, and cellulolytic thermophiles which are 
outside the scope of this review. 
1.2.2 Solventogenic clostridia 
1.2.2.1 Clostridial solvent production 
Some species of clostridia are able to metabolise a wide range of organic compounds 
into acids, C02, H2 and a range of neutral solvents. It was the ability to produce solvents 
which gave particular species of clostridia a niche in the interests of twentieth century 
man. Fermentation of waste biomass from agriculture and industry can be transformed 
into chemical feed stocks and fuels. One such process developed on an economic scale 
termed acetone/butanol/ethanol fermentation (ABE fermentation) was economically 
viable until the 1960's (Jones & Woods, 1989). However to compete with contemporary 
chemical processes, microbial solvent production must become more efficient, 
specifically by alterations in the profile and quantities of solvents produced by the 
clostridia. To achieve this goal, the genetic basis of solventogenesis has been studied in 
detail resulting in the cloning and analysis of genes encoding many key metabolic 
enzymes (reviewed by Girbal & Soucaille, 1998). The parallel development of genetic 
systems to study and manipulate these genes has been an essential element in this field, 
which also provides useful genetic tools for work with other clostridia (reviewed by 
Minton, Young and Durre in `The Clostridia and Biotechnology' 1993). 
1.2.3 Pathogenic clostridia 
Amongst the clostridia, many species are pathogens of both animals and man, causing a 
range of conditions including specific neurological disorders, enteric infections and 
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necrotising tissue damage. Due to the large content of this subject, several principal 
clostridial pathogens will be considered with which C. botulinum can be compared. 
1.2.3.1 C tetani 
Disease caused by C. tetani is more widespread than that caused by C. botulinum, being 
endemic in 90 developing countries (Amon, 1997). Infection initiates by the introduction 
of spores into areas of tissue trauma in which a low redox potential is generated, 
typically occurring in deep wounds, umbilical cords of neonates, and post-partum, post- 
abortal or post-surgical infections (Amon, 1997). C. tetani is known to produce a 
hemolysin. However, its principal toxin is a neurotoxin which is related to the botulinal 
neurotoxins. The neurotoxin is released by autolysis at the site of infection from where it 
migrates in retrograde motion through the motor neurons to inhibitory interneurons of 
the brain stem and spinal cord. Here, tetanus neurotoxin acts as an endoprotease, 
cleaving the synaptic vesicle docking protein synaptobrevin, a substrate shared with some 
other clostridial neurotoxins (Montecucco & Schiavo, 1993). In stark contrast to the 
flaccid paralysis caused by botulism, tetanus is an acute spastic paralysis. This is because 
their respective neurotoxins act at distinct sites within the nervous system and hence the 
profoundly different pathologies are presented. 
1.2.3.2 C perfringens 
In contrast to C. bolulinum and C. tetani, which generally elaborate a single neurotoxin, 
most other clostridial pathogens elicit disease with a multifaceted assembly of toxic 
molecules. C. perfringens is such an organism. 
Different isolates of C. perfringens are essentially identical. Where strain variation does 
occur it is due to the presence or absence of a limited number of genes, particularly 
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virulence determinants which in some cases can be either genomically or 
extrachromosomally located (Cole & Canard, 1997). C. perfringens is implicated in a 
number of human and animal diseases which necessitate different virulence factors, for 
instance a form of food poisoning is mediated by a single enterotoxin (CPE), whilst gas 
gangrene requires two major cytolytic factors, phospholipase C which is a 
phospholipase-sphingomyelinase (PLC) and perfringolysin 0, a pore-forming cytotoxin. 
Other virulence factors are thought to include a collagenase, proteases, a hyaluronidase 
(nagH), neuramidase (nanH), and a so called "epsilon toxin" of unknown activity. 
Necrotic enteritis associated with type B and C C. perfringens strains is thought to be 
mediated by a `membrane active' ß-toxin and often occurs in malnourished people, 
particularly in combination with diets which are low in protein and high in trypsin 
inhibitors which may protect the protein toxin (Stevens, 1997). The large number of 
toxins produced by C. perfringens reflects the method by which this organism establishes 
its niche and subsequently exploits the potential of the host tissues. 
1.2.3.3 C septicum 
C. septicum is associated with non-traumatic or spontaneous gas gangrene. Disease is 
frequently enabled due to other predisposing factors, allowing establishment and 
subsequent access to the host blood stream. Tissues are colonised through the action of 
at least four toxins including a lethal hemolytic necrotising a-toxin, a DNase (ß-toxin), a 
hyaluronidase (y-toxin) and hemolysin (5-toxin) (Stevens, 1997). In common with C. 
perfringens, C. seplicum possess a number of virulence factors which facilitate a 
pathogenic life style. 
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1.2.3.4 C difficile 
C. difficile possess two cytotoxic proteins designated A and B. Although toxin B has the 
more potent cytotoxic activity, toxin A also has enterotoxic activity and is responsible 
for the initial intestinal damage in pseudomembranous colitis (Moncrief et al., 1997). 
Toxin A and B are the largest known bacterial toxins and share 63.1 % similarity. Both 
toxins are thought to be endocytotically internalised (Moncrief et al., 1997). Although 
enzymic in nature, C. difficile cytotoxins do not degrade host tissues but confer a subtle 
modification to their substrates, the Rho family, proteins which participate in regulating 
actin polymerization and, therefore, the integrity of the eukaryotic cytoskeleton 
(Aktories et al., 1997). 
Toxin A and B are not unique, since both Clostridium sordellii and Clostridium novyi 
possess large toxins which appear to be genetically related to the C. difficile toxins, 
indeed the two toxins found in C. sordellii roughly equate to toxin A and B of C. 
difficile. Recent evidence suggest that although these proteins may have a common 
ancestry, the range of members of the Ras superfamily which are modified is distinct for 
each toxin (Aktories et al., 1997) and the pathological effect to the host cell are, 
therefore, different. 
1.2.3.5 Distribution of clostridial toxins 
A number of toxin types occur throughout the pathogenic clostridia, these include thiol- 
activated cytolysins which occur in most pathogenic clostridia (Tweten, 1997) including 
C. perfringens (perfringolysin 0), C telani (tetanolysin) and C. botulinum 
(botulinolysin), the phospholipases C which occur in C. perfringens strains A-E, 
Clostridium hifernienlans, C novyi, C. sordellii, Clostridium parapeifringens and 
Clostridium absonum (Titball, 1997), the binary toxins of C. perfringens type E and 
Clostridium spiroforme, collagenases of C. perfringens (all types) and Clostridium 
histolyticum (Okabe & Cole, 1997) and the sialidases produced by C. perfringens, C. 
sordellii, C. septicum, Clostridium chauvoei, Clostridium tertium and particular strains 
of C. butyricum and Clostridium nexile (Roggentin & Schauer, 1997). In essence many 
of these clostridial species seem to have a similar strategy, which consists of potent 
`lethal toxins' which are required to inflict debilitating damage to the host (for example, 
C. perfringens type A cc-toxin) and a battery of synergistic `toxins' that specialise in 
degrading the host tissues and spreading infection, which in the case of C. perfringens 
could include collagenase, hyaluronidase, sialidase and proteases. 
1.3 Botulism and botulinal neurotoains 
1.3.1 Intoxication 
Botulism appears to affect vertebrate organisms through the action of the neurotoxins 
(serotypes A-G) and associated non-toxic proteins. Different mammals are intoxicated 
with varying efficiencies depending on the neurotoxin serotype (Sakaguchi et al., 1988) 
and the extent to which the neurotoxin is complexed with other proteins (Sugiyama, 
1980). The neurotoxic nature of these molecules has also been demonstrated in non- 
vertebrate organisms that contain neuronal networks (Poulain et al., 1990) indicating 
that the targets of the neurotoxins must be both ancient and highly conserved. 
1.3.1.1 Food poisoning 
Ingestion of food contaminated with growing C. botulimum is the principal method by 
which humans are intoxicated. The major source of contamination stems from the 
incorrect preparation and preservation of home prepared foods (Hatheway, 1995). 
Serotypes of C. botulinum which are most commonly associated with human poisoning 
include type A, type B and type E. The prevalence of a particular serotype can be 
attributed to the type of food, for example, strains of group I serotype A have spores 
which are resistant to thermal processing used in home canning whilst less thermally 
resilient strains from group II are frequently encountered in cured meat products 
(Hatheway, 1995). A condition known as forage poisoning occurs in herbivores such as 
horses and cattle that ingest fodder contaminated with decomposing organisms which 
contain C. botulinum types C and D, or alternatively from the growth of C. botulinum in 
the feed. Ingestion of toxic material would appear to be a major vector for botulism in 
the natural environment. The persistence of spores in animals frequently results in 
contamination of cadavers with C. botulinum. Maggots which feed on the rotting flesh 
ingest neurotoxin which does not harm the maggot and is not degraded. Wild fowl are 
then particularly prone to botulism by eating maggots from the cadavers, ingesting the 
toxin and dying, and hence potentiating the cycle. In this manner vast numbers of birds 
can die (Kalmbach, 1968). 
1.3.1.2 Wound botulism 
This form of the disease resembles infection by C. letani. Damaged tissue which is deep 
enough to generate an anaerobic environment enables clostridial spores to germinate 
(Weber et al., 1993). In contrast to tetanus, wound botulism is rare and may reflect the 
difficulty with which this group of organisms can colonise the wound environment. 
1.3.1.3 Infant botulism 
The intestine provides an ideal medium in which anaerobic bacteria can thrive. Adults are 
not readily colonised by C. botulinum. In contrast, infants between 3 and 26 weeks of 
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age are susceptible to intestinal toxico-infection caused by growth predominantly in the 
colon (Sugiyama, 1980) following the ingestion of spores. Infant botulism is principally 
caused by type A and B botulinal organisms and in rare cases toxigenic C. butylicum 
(Aureli et al., 1986) and C. baratii (Hall et al., 1985). Evidence suggests that the natural 
microflora of adults provides a barrier to C. botulinum colonisation, however, in 
instances when this is not present (such as axenic mouse models), individuals such as 
young infants become susceptible (Moberg & Sugiyama, 1979). 
1.3.2 C botulinum serotypes 
In contrast to organisms which elaborate the serologically unique tetanus neurotoxin 
(tetanospasmin), botulinal neurotoxins are produced by a range of clostridia. Neurotoxic 
molecules were initially distinguished by antibody neutralisation. In 1919 Burke isolated 
type A and B toxins from cases of human botulism, types C-G were then added in 
chronological order beginning with type C (1922) and type D (1928) which were 
isolated from cattle. Later, in 1937, type E was isolated from human botulism with a fish 
origin and, in 1958, type F was associated with poisoning from a liver paste (Hatheway, 
1995). Since this time, an additional serotype (G) was described by Gimenez, who 
isolated the organism from soil (Gimenez & Ciccarelli, 1970). 
Comparative analysis of the respective neurotoxigenic organisms using physical 
characteristics, such as growth optima, spore heat resistance and phenotypic enzyme 
analysis, has divided the bacteria into four separate lineages (group I-IV in Hatheway, 
1995). Group I are proteolytic and are able to digest casein and other complex proteins, 
a property not shared by group II organisms, which are nonproteolytic. Organisms which 
resemble group I may encode type A, B or F neurotoxins and in rare cases, organisms 
are isolated which produce more than one toxin e. g., combinations are encountered 
including A and B in various ratios or F in combination with A or B (Poumeyrol et al., 
1983; Hatheway et al., 1981; Hatheway & McCroskey, 1989; Gemenez & Ciccarelli, 
1970). Group II organisms can elaborate type E neurotoxin but not type A. Isolates also 
produce type B and type F but never together. 
C. botulinum producing type C or type D neurotoxin have a relatively high optimum 
growth temperature (37°C - 45°C) and produce a novel combination of volatile organic 
acids. Organisms which produce type G neurotoxin are distinct from groups I-III as they 
are neither lipase proficient or saccharolytic (Hatheway, 1995). 
The application of DNA technology to taxonomic classification has confirmed the 
heterogeneity observed between C. botulinum species. Sequence analysis of 16S rRNA 
genes essentially supported the separation of botulinogenic clostridia into four groups 
and also supported the previous notion that the individual groups were complemented by 
nontoxigenic counterparts (Collins et al., 1994). However, all neurotoxigenic clostridia, 
including C. tetani and neurotoxigenic forms of C. butyricum and C. baratii (producing 
type E and F neurotoxins, respectively (Aureli et al., 1986; Hall et al., 1985), are found 
within a single cluster of the diverse genus Clostridium (Collins et al., 1994). 
1.3.3 Physiology of toxin production 
A thorough investigation of toxin production by all the representative C. botulinum 
groups does not appear to have been conducted. This may in part be due to the 
difficulties associated with determining the amounts of toxin present via the mouse bio- 
assay and until recently the absence of defined media (Whitmer & Johnson, 1988). The 
relationship between the presence of toxin in culture supernatants and autolysis has been 
documented for some time (Bonventre & Kempe, 1960) and an autolytic enzyme has 
been characterised in some strains (Takumi et al., 1971; Kawata & Takumi, 1971). It 
was shown that intracellular toxin was present throughout the growth phases of batch 
cultures and its release into the growth media correlated with the extent of autolysis, 
implicating release by this mechanism. It was noted, however, that disproportionate toxin 
synthesis occurred "after the period of cell multiplication" (Kindler et al., 1956; 
Bonventre & Kempe, 1960). 
Batch fermentation studies of type A and B strains in complex media were used to assess 
the contribution of various carbohydrate sources to neurotoxicity in these strains 
(Bonventre & Kempe, 1959a). Glucose or maltose were found to induce highly 
neurotoxigenic cultures. In comparison, the presence of glycerol, pyruvate and ribose 
produced poorly toxigenic cultures. Other carbon sources, including galactose, lactose, 
xylose and inositol, did not enhance neurotoxicity. However, these results could equally 
be interpreted as a measure of the activation (proteolytic processing) of pre-existing 
neurotoxin which could account for the increased neurotoxicity. Further experiments 
were attempted by the same authors to define the effect of pH and temperature on 
neurotoxin production (Bonventre & Kempe, 1959b). Toxin was synthesised between 
pH 5.5-8.3 at a relatively unvarying rate, but at alkaline pH the toxin was unstable. In 
contrast, temperature was found to alter the toxicity of cultures. Maximum toxicity was 
detected in cultures between 28 °C and 40 °C, which correlated with both growth and 
autolysis. Siegel & Metzger (1979; 1980) conducted similar experiments on both type A 
and type B strains and obtained essentially similar results with each strain. Optimum 
toxin production was detected at 35 °C with glucose concentrations between 0.5 %-1.5 
%. Glucose concentrations above and below these levels were detrimental to toxin 
production. 
Later studies conducted with defined media using proteolytic group I strains of C. 
botulimm demonstrated that both toxin production and protease activity was `strongly 
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influenced by carbon and nitrogen nutrition' (Patterson-Curtis & Johnston, 1989). 
Arginine is thought to be a precursor of both energy producing and biosynthetic 
pathways in group I C. botulinum (Whitmer & Johnson., 1988). Indeed, the availability 
of arginine and other nitrogenous compounds appeared to inversely regulate the 
protease and neurotoxin production in these strains (Patterson-Curtis & Johnston, 1989). 
In contrast, the presence of casein counteracted this phenomenon. A similar phenomenon 
involving tryptophan was observed in a type E representative of nonproteolytic group II 
C. botulinum where the amino acid is thought to provide a nitrogen source (Leyer & 
Johnson, 1990). 
In conclusion, in the group I and II C. botulinum strains examined, the production of 
neurotoxins did not appear to directly correlate with growth but may be under regulatory 
control which is influenced by nutrient availability. 
Studies involving C. tetani concluded that this neurotoxin was also regulated by 
nutritional and environmental factors, including histidine rich peptides, nitrogen 
(glutamate) and the concentration of iron (Johnson, 1997). In summary, relatively little is 
known about the regulation of clostridial neurotoxin production, particularly at the 
genetic level. This is in part due to the absence of suitable genetic techniques. 
1.3.4 Toxin complexes 
1.3.4.1 Evidence for toxin complexes 
Initial endeavors to isolate neurotoxin from C. botulinum type A resulted in the 
crystallisation of particles of approximately 900 kDa. However work by Lamanna 
demonstrated that the preparation was heterogeneous as a haemagglutinin constituent of 
the 900 kDa moiety could be removed by absorption onto erythrocytes (cited by 
Sugiyama, 1980). Subsequently a nuip er of chromatographical approaches were then 
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able to resolve the toxic and haemagglutinin entities (DasGupta & Boroff, 1968) and 
provide further evidence that botulinal toxins were heterogeneous complexes. The 
neurotoxin complexes produced by C. botulinum strains range in size and are serotype 
specific. The toxin complexes, or `progenitor toxins', are classified into four groups. The 
smallest, at 7S (150 kDa), contained the toxic moiety and was designated `S' (for 
small). However it was not commonly observed in the extracts from any serotype. All 
serotypes, except G, did produce a progenitor toxin of 12 S (300 kDa), which was 
designated `M' (for medium). M toxin could be reversibly dissociated in alkaline 
conditions to release S toxin and a similar sized non-toxic component. With the 
exception of serotypes E and F, all other serotypes produced larger forms of progenitor 
toxin. Serotypes A, B, C and D produced a 16 S (500 kDa) complex, termed L (for 
large), whilst only serotype A formed an even larger progenitor toxin of 19 S (900 kDa), 
designated `LL' (Sakaguchi et al 1988). Serotype G progenitor toxins were only isolated 
as L progenitor complexes (Nukina et al., 1991). 
1.3.4.2 Progenitor toxin complex composition 
Haemagglutination was described for the type A toxin complex sizes M, L and LL but 
not S (DasGupta et al, 1966; DasGupta et al., 1968). A similar situation was described 
for other serotypes. In summary, progenitor toxins of 300 kDa (M) were all eventually 
found to be nonhaemagglutinating, whilst larger complexes (L and LL) were 
haemagglutinating (Sakaguchi et al, 1988). Thus, with the exception of E and F, all 
serotypes possessed haemagglutinin activity. Sackaguchi and co-workers were then able 
to demonstrate that increasing sizes of progenitor toxin complexes correlated with 
enhanced oral toxicity (Sakaguchi et al., 1988). Indeed, in comparison to intraperitoneal 
administration, it was considered that approximately 10 million times more S toxin was 
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required to cause toxicity by the oral route. In contrast, a mere 1,500-12,000 fold 
increase was required for L toxin. 
The larger progenitor complexes afford protection to the S toxin in environments which 
resemble those encountered in the intestine. For example, M or L complexes remain 
largely recalcitrant to the action of acidic environments at pH 3-4 and by the action of 
gastric proteases and juices (Sugiyama, 1980). In addition large toxin complexes 
facilitate the entry of S toxin into the lymph (Sugii et al., 1977). 
1.3.4.3 Antigenic cross-reactivity of toxin complexes 
The similarity observed between botulinogenic neurotoxins in their clinical symptoms and 
molecular sizes is to some extent reflected in a number of common antigenic motifs. 
Monoclonal antibodies raised against the light chain of type E neurotoxin are also able to 
cross react with type B, C, D and tetanus neurotoxin (TeNT) (Tsuzuki et al., 1988). A 
reciprocal experiment using synthetic peptides of TeNT provided a similar result 
(Halpern et al., 1989). More recently, monoclonals have been found which recognise all 
botulinal neurotoxin serotypes (Dertzbaugh & West, 1996), indicating some sequence 
homology between all toxins. 
The nontoxic components of specific progenitor toxins also appear to be similar. 
Lamanna noted immunological cross reactivity between the nontoxic component of type 
A and type B progenitor toxins which were later shown to be of a similar size (cited in 
Somers & DasGupta, 1991). Likewise, haemagglutinin components of type C and type 
D progenitor toxins were also immunologically related (Miyazaki et al., 1977). Thus, it 
appeared that clostridial neurotoxins were related. Furthermore, the non-toxic proteins 
associated with serologically distinct botulinogenic neurotoxins were also related. Similar 
methodology has demonstrated that neurotoxins of the same serotype are not identical, 
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for example, type B neurotoxins from proteolytic and nonproteolytic strains (Shimizu & 
Kondo, 1973), type F strains (Gimenez & Ciccarelli, 1972) and type C strains (Ochanda 
et al., 1984) are immunologically variable. 
1.3.4.4 Neurotoxin 
DEAE-Sephadex chromotography of progenitor toxins of serotype A-F at slightly 
alkaline pH dissociated the complexes into constituent proteins, among these was the 7S 
neurotoxin (Sakaguchi et al., 1988). However, by whatever method used, a 150 kDa 
protein was attributed with neurotoxic activity in all known clostridial neurotoxin 
complexes. Analysis of this protein from proteolytic strains A, B and F under reduced 
denaturing conditions demonstrated the presence of two bands of approximately 50 kDa 
and 100 kDa (DasGupta & Sugiyama, 1972). However, polypeptides of equivalent size 
were only obtained from non-proteolytic strains (which do not possess endogenous 
proteases) following trypsination. 
1.4 Structure - function analysis of clostridial neurotoxins 
1.4.1 Functions of the neurQtoxin 
In an effort to determine the mechanism by which botulinal neurotoxins poison 
vertebrates, a plethora of structural and pharmacological investigations have been 
performed. During the post war period the neurotoxins were shown to block synaptic 
transmission of cholinergic neurons by preventing acetylcholine release from nerve 
terminals (Harris & Miledi, 1971). To equate this mode of action with the neurotoxins 
structure, - experiments were conducted to detect cell receptor binding and cell membrane 
interaction potential as well as an intracellular site of action. 
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1.4.2 Neurotoxin structure 
The analysis of type A neurotoxin revealed that the 150 kDa protein was initially 
synthesized as a single polypeptide chain. Although it subsequently cleaved into a 50 kDa 
N-terminal light chain fragment and 100 kDa C-terminal heavy chain fragment, the two 
chains remained linked by a disulfide bridge (Krieglstein et al., 1994) which was essential 
for toxicity in vertebrates (Maisey et al., 1988). Among the remaining 7 cysteine 
residues, a further pair were involved in intra-chain disulphide bridge formation near the 
C-terminus of the heavy chain (Krieglstein et al., 1994). Peptide sequence analysis of the 
light chain-heavy chain junction has revealed that in the type A serotype, 10 amino acids 
which are thought to correspond to a surface exposed loop are excised by endogenous 
proteases (Krieglstein et al., 1994). The similarities observed between the gross features 
of the different clostridial neurotoxins are surprisingly well reflected in the high degree 
of conserved secondary structure motifs predicted along the length of the proteins 
(Lebeda & Olson, 1994). Indeed, regions which do diverge are typically variable loop 
structures (Lebeda & Olson, 1994), including the respective sites for light chain cleavage 
which are all closely flanked by cysteine residues (Krieglstein et al., 1994). 
1.4.3 Neuron binding 
Botulinal neurotoxins pass from the intestinal lumen to the lymphatic or vascular 
systems, possibly by a pinocytotic mechanism (Bonventre, 1979). The toxins are then 
considered to target cell surface receptors of peripheral cholinergic motor neurons which 
innervate the musculature. 
Experiments to define the receptive molecule(s) to which the neurotoxins bind have 
suggested a number of possibilities. Early reports indicated that several neurotoxin 
serotypes would preferentially bind to presynaptic membranes in synaptosomal fractions 
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and could be inhibited by specific ganglioside molecules found naturally in neuronal 
membranes (Kitamura et al., 1980). Type A neurotoxin interacts most strongly with 
ganglioside Grlb and with synaptosomes in a temperature dependent manner (Kitamura 
et al., 1980). The region of toxin binding was tentatively attributed to the extreme C- 
terminus of the heavy chain (Shone et al., 1985). More recent evidence suggests that at 
least two receptor types may mediate toxin adherence to presynaptic terminals. One class 
is thought to be more prevalent, and of low affinity, whilst a second has a higher affinity, 
is less numerous and may be `productive' in the intoxicating process (Daniels-Holgate & 
Dolly, 1996). The identity of a human, high affinity receptor for the type A neurotoxin 
has not been determined, although a 140 kDa presynaptic membrane glycoprotein with 
toxin affinity has been isolated from the Torpedo electric organ (Blasi et al., 1992). 
However, multiple affinity receptors have been reported for the type B neurotoxin 
(Evans et al., 1986), including gangliosides GTIb, GDI, and a protease-sensitive acceptor, 
possibly synaptotagamin (Ogasawara et al., 1991; Nishiki et al., 1994). 
Tetanus neurotoxin, which binds to all peripheral and central neurons (Montecucco, 
1986), may also bind to proteinaceous and ganglioside receptors (Halpern & Loftus, 
1993). The ganglioside receptors bind to the 34 C-terminal amino acids of tetanus 
neurotoxin in a region which is conserved in other clostridial neurotoxins (Shapiro et al., 
1997). Thus, it seems that the C -terminus (Hc fragment) of the clostridial neurotoxins 
have a significant role in cell targeting and receptor docking, a prerequisite to 
endocytotic internalisation of the neurotoxin, and that a unique combination of 
ganglioside and protein receptors may be required for each toxin. 
It is intriguing that synaptotagamin may form a neurotoxin receptor due to its 
involvement in Ca2rdependant neurotransmitter release. This protein may be participating 
in both exocytosis and endocytosis at the presynaptic membrane (Geppert et al., 1994) 
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as it is present on synaptic vesicles and also binds to the clathrin adaptor protein complex 
AP-2 (Chapman et al., 1996). 
1.4.4 Internalisation 
Clostridial neurotoxins are thought to enter neuronal cells by an energy dependent 
receptor-mediated endocytotic mechanism, possibly involving clathrin-coated vesicles 
(Black & Dolly, 1986a, b). Having entered the neuron, the neurotoxins have been located 
to small transport vesicles which are then sorted (Black & Dolly, 1986b). Differences in 
the 'sorting process is believed to account for the dissimilar pathologies exhibited by 
tetanus and botulinal toxins. In contrast to botulinal toxins, vesicles containing tetanus 
toxin assume a retrograde mode of transport which directs it across synaptic clefts until 
the toxin has ascended to the Renshaw cells of the spinal cord. In contrast, botulinal 
toxin-containing vesicles may be recycled locally. (Ahnert-Hilger & Bigalke, 1995). The 
disparity in vesicle transport is dependent on the neurotoxin heavy chain. However, 
whilst it is presently unclear as to whether specific vesicles are selected or if the heavy 
chain directs vesicle transport is unknown, the N-terminus of the heavy chain fragment 
(Hn) is known to interact with lipid membranes (Shone et al., 1987). 
1.4.5 Vesicle membrane translocation 
The precise mechanism by which the neurotoxic moiety of clostridial neurotoxins escapes 
from vesicles has not been determined. Strong evidence implicates the 50 kDa Hn 
fragment in this process (Boquet & Duflot, 1982; Mochida et al., 1989; Hoch et al., 
1895; Montal et a!., 1992; Blaustein et al., 1987). This domain forms channels in vesicle 
membranes which are stimulated by a reduction in pH of the vesicle lumen. The channel 
forming activity may be concomitant with pH-induced conformational changes and is 
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purported to involve a transmembrane domain composed of 4 amphipathic a-helices 
(Montal et a!., 1992; Lebeda & Olson, 1995). It is not clear whether a channel is formed 
per se, or if the membrane integrated proteins have a chaperone role, however, it is likely 
that multiple Hn fragments may aggregate to translocate the pharmocologically active 
entity (Donovan & Middlebrook, 1986). 
1.4.6 Intracellular activity 
Studies which by passed the neurotoxin binding and internalisation steps demonstrated 
that separation of the disulphide bridge connecting the light chain and heavy chain was 
necessary for intoxication (Stecher et al., 1989), and that light chain alone was 
responsible for inhibiting exocytosis (Bittner et al., 1989; Dolly et al., 1990). The 
requirement of both chains in the Aplysia model appeared to be a characteristic of that 
particular non-vertebrate system (Maisey et al., 1988). 
Deletion mapping of the tetanus and botulinum light chain domains demonstrated that 8 
amino acid N-terminal deletions or 65 and 32 C-terminal deletions (respectively) were 
still toxic, and a common motif remained which was characteristic of metalloproteases 
(Kurazono et al., 1992). In agreement with these deductions an affinity site for Zn2+ 
was mapped to the putative metal binding site (Wright et al., 1992) which complemented 
earlier findings that clostridial neurotoxins could be inactivated by divalent metal ion 
chelators (Bhattacharyya & Sugiyama, 1989). Thus, it appeared that the 
pharmocologically active component of clostridial neurotoxins could be an enzyme, 
which shared limited similarity with other Zn2+'dependent metalloendopeptidases 
(Schiavo et al., 1992). 
Attempts by Schiavo and colleages to discover a substrate for the clostridial neurotoxins 
in the subcellular fractions of neuronal cells identified a 13 kDa integral membrane 
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protein, termed vesicle associated membrane protein (VAMP) (also called 
synaptobrevin). Found on small synaptic vesicles (Montecucco & Schiavo, 1993), 
VAMP participates in the docking of these vesicles through an interaction with a 
presynaptic membrane protein called syntaxin (Sollner et al., 1993). Vamp is 
proteolytically cleaved by tetanus neurotoxin and serotype B, D, F and G botulinal 
neurotoxins (Niemann et al., 1994). It is interesting to note that only tetanus and type B 
neurotoxins have a common cleavage site in VAMP. Type A and E neurotoxins do not 
cleave VAMP at all, but are specific to another component of the synaptic vesicle 
docking apparatus, SNAP-25 (Schiavo et al, 1993; Blasi et a!., 1993). Type C 
neurotoxin cleaves another member of the vesicle snare complex, syntaxin (Blasi et al., 
1993). 
In retrospect, the distinct substrates of the neurotoxins complement earlier reports that 
particular neurotoxins exhibit `quantitative and qualitative differences in their effects on 
neuromuscular transmission' (Sellin et al., 1983). However, the specific activities of 
toxins involving proteinaceous components of the synaptic vesicle docking complex do 
not necessarily agree with other reported activities involving the activation of a 
transglutaminase (Facchiano et al., 1993). This theory suggests that tetanus toxin is able 
to activate transglutaminase, which is then able to cross-link synapsin-vesicle complexes 
to actin filaments and prevent exocytosis. Current conjecture, however, suggests that 
tetanus toxin light chain is unable to reach ä suitable concentration in vivo to activate 
transglutaminase (Ahnert-Nilger & Bigalke, 1995). 
1.4.7 Functions of the non-toxic/haemagglutinin components 
Although a great deal of data has been generated to describe the structure-function 
attributes of the 150 kDa 7S neurotoxin, and to some extent the role of the 300 kDa 12 
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S complex in evading the hostile acidic and proteolytic environment of the stomach, little 
attention has been directed towards the haemagglutinin components of the larger 16 S 
and 19 S complex. Initial studies observed that a higher proportion of 7S toxin was 
absorbed in the lymph when larger 16 S complexes were used instead of 12 S complex 
(Sugii et al., 1977). This phenomenon was attributed to the higher stability afforded by 
the haemagglutinin components. However more recent evidence suggests that the 
haemagglutinin components have an active -role in specific binding to the epithelium of 
the small intestine (Fujinaga et al., 1997). The binding of the haemagglutinin 
components is thought to be with undefined glycolipids or glycoproteins which 
consequently mediate efficient absorption. This evidence could explain why 12 S toxins 
such as type E and F are comparatively less toxic by the oral route (Fujinaga et al., 
1997). 
1.5 Genetics of neurotoxin production 
1.5.1 Location of neurotoxin genes 
One definition of virulence factors are those components of an organism whose loss 
specifically impairs pathogenicity but not viability (cited in Johnson, 1997). It is 
therefore, of no great surprise to find virulence factors associated with various mobile 
genetic elements, as the relative ease with which they are acquired and lost may offer a 
selective advantage. An association between mobile/extrachromosomal elements and 
neurotoxicity has been'investigated in all known serotypes of C. botulinum and C. tetani. 
Not only are the neurotoxins dispensible, but in some cases show traits of genetic 
instability. 
A link between phage and neurotoxicity was first demonstrated in a neurotoxin minus 
strain of C. boluliinim type C, which could be converted back to a neurotoxic phenotype 
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by exposure to a lysate from a toxin producing strain (Inoue & lida, 1970; Eklund et al., 
1971). Phage conversion was then demonstrated for C. botulinum type D, and, like type 
C, was considered to be pseudolysogenic (Eklund ei al., 1972). Strains cured of either 
toxigenic phage were then shown to be converted to neurotoxicity by either the `type C' 
or `type D' phages, indicating that the original host of either phage was a common 
clostridial strain (Eklund & Poysky, 1974). Phages encoding type C or type D 
neurotoxins are thought to be composed of a heterologous assemblage (Fujii et al., 1988; 
Sunagawa & Inoue, 1991). Even though other serotypes of C. botulinum contained 
phage (Inoue & lida, 1968) no other examples of phage-mediated toxin conversion were 
unequivocally demonstrated. 
The production of a neurotoxin by C. tetani was correlated with the presence of a 75 kb 
plasmid. Furthermore, the spontaneous loss of which resulted in a toxin minus 
phenotype (Laird et al., 1980). Oligonucleotide probes designed from the tetanus 
neurotoxin N-terminal amino acid sequence were then used to map the structural gene to 
a 16.5 kb EcoRI restriction fragment of this plasmid (Finn et al., 1884). A similar 
scenario exists in C. botulinum type G strains, where a 114 kb plasmid is lost in non- 
toxigenic derivative strains (Eklund et al., 1988). The genetic association between 
plasmid and neurotoxin complex were subsequently unequivocally derrgpstrated by 
Zhou et al (1995). 
An extrachromosomal location for neurotoxin gene serotypes A, B, E and F has not been 
conclusively established. Type A strains possess both phages (Kinouchi et al., 1981) and 
plasmids (Scott & Duncan, 1978; Strom et al., 1984; Weickert et al., 1986; Ferreira et 
al., 1987), however, their presence has not been correlated with neurotoxicity. 
PFGE studies of a type A C. botulinum strain were able to demonstrate that the 
neurotoxin gene was chromosomally located, but its loss was consistently the result of 
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the deletion of 70 kb (Lin & Johnson, 1995), specifically associated with the 
`experimental' insertion of the conjugative transposon Tn916 (Johnson et al., 1997). As 
the authors point out, an induced deletion of this nature may insinuate the presence of an 
unstable mobile genetic element, such as a prophage, insertion sequence or transposon. 
Variations of a type B neurotoxin are produced by both proteolytic and nonproteolytic 
strains of clostridia which are not closely related (Collins et al., 1994). This indicates that 
some type of horizontal gene transfer has occurred, but the genetic location of type B 
neurotoxins has not been established. Likewise, type F neurotoxins are found in more 
than one species of clostridia including proteolytic type F strains which can also be found 
in combination with either type A or type B neurotoxins (Gemenez & Ciccarelli, 1970; 
Hatheway & McCroskey, 1989), as well as non-proteolytic F strains and strains closely 
resembling C. baratii (Hall et al., 1985). Again, there is no direct evidence that confirms 
the existence of a vehicle for this interspecies transfer. 
Serotype E neurotoxin is produced by two distinct non-proteolytic clostridia, one 
resembles the clostridial type strain C. butyricum (McCroskey et a1., 1986; Collins et al., 
1994) whilst the more common strain resembles group II C. botulinum strains which 
produce type B and type F neurotoxins. Some evidence suggests that neurotoxigenic 
strains of C. butyricum contain a plasmid encoding the type E neurotoxin (Hauser et al., 
1992). However, the evidence obtained was indirect and is certainly less convincing 
compared to C. tetani and C. botulinum type G. 
A separate study implicated a common prophage in toxigenic type E organisms, 
irrespective of species. Under the conditions used, the prophage could not directly infect 
non-toxigenic strains or hybridise with a type E neurotoxin-specific probe. Interspecies 
transfer was possible via the use of a second non-toxigenic helper strain (Zhou et al., 
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1993). The precise genetic context of type E neurotoxin genes as well as those of other 
group I and II neurotoxin serotypes remains unclear. 
1.5.2 Neurotoxin gene sequences 
The first data obtained for botulinal neurotoxins was derived from N-terminal sequencing 
of the light chain, heavy chain and full length toxin of serotypes A, B and E (Schmidt et 
al., 1984; Schmidt et al., 1985; Sathyamoorthy & DasGupta, 1985). This data provided 
evidence that the neurotoxin was synthesised as a single polypeptide chain which was 
cleaved approximately one third from the N-terminus to yield anterior light chain and 
posterior heavy chain fragments. Furthermore the sequence data provided direct 
evidence that the botulinal neurotoxins A, B and E formed a homologous group which 
were related to tetanus neurotoxin (Robinson & Hash, 1982). 
N-terminal sequence data was then to prove a decisive factor in the cloning and 
subsequent sequencing of the tetanus (Fairweather & Lyness, 1986; Eisel et al., 1986), 
type A (Thompson et al., 1990; Binz et al., 1990), type C (Hauser et al., 1990) type D 
(Binz et al., 1990) and type E neurotoxins (Poulet et al., 1992) whilst the remaining 
representatives were cloned using hybridisation and PCR strategies based on published 
neurotoxin serotypes (Elmore et al., 1995). 
Comparative alignment of the clostridial neurotoxin sequences revealed that each toxin 
was composed of a single ORF of approximately the same size (1251-1315 amino acids). 
Toxin genes had related light chains linked to related heavy chains coupled by conserved 
cysteine residues typical of the AB class of toxins. Each neurotoxin has a conserved zinc 
binding motif (HELxHxxHxLYG) centrally located in the light chain domain consistent 
with a metalloprotease activity. The primary sequences show blocks of conserved residue 
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groups occurring throughout the protein interspersed with variable regions thought to 
form loops in the native protein (Lebeda & Olson, 1994). 
Variable regions are more conspicuous in the light chain domain and in the He fragment 
of the heavy chain consistent with the altered specificities of the neurotoxins substrates 
and ecto-receptors. Among the 153 conserved amino acids, only 4 amino acids 
corresponding to the zinc binding motif were conserved in the thermolysin sequence 
suggests that even though regions of predicted secondary structure were conserved, the 
evolutionary link predicted with the light chain was relatively distant (Lebeda & Olson, 
1994). Regions of the high conservation appeared to correlate with four domains 
predicted to form transmembrane helices (Lebeda & Olson, 1995). 
1.5.3 Genetic location of components from the neurotoxin complex 
The progenitor neurotoxin complexes from a number of botulinal serotypes are known to 
contain proteins with haemagglutinin activity, whilst the 150 kDa neurotoxin or 300 kDa 
complex do not. The haemagglutinin components of some neurotoxin complexes are 
immunologically cross reactive (e. g., cross reaction is seen between types A and B or 
types C and D) suggesting that in addition to the neurotoxins, the haemagglutinin 
proteins may also be related (Somers & DasGupta, 1991). Moreover, in some instances 
the production of both neurotoxin and haemagglutinin were found to be associated with 
bacteriophage conversion in type C and D strains of C. botulinum (Oguma et al., 1976). 
It has subsequently been shown that the type C neurotoxin gene is closely associated 
with at least one haemagglutinin component of the type C neurotoxin complex and the 
genes are divergently transcribed (Tsuzuki et al., 1990). Further sequence analysis has 
detected a third gene whose N-terminal sequence and size correlate with a `non-toxic- 
nonhaemagglutinin' protein thought to form the 300 Wa complex with type C 
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neurotoxin gene (Tsuzuki et al., 1992). Inspection of the region 5' to the neurotoxin 
gene of other serotypes suggests that the C-terminus of a similar gene may also reside 
next to other botulinal neurotoxins (Thompson et al., 1990; Whelan et al., 1992) but is 
not present in front of the tetanus neurotoxin gene (Fairweather & Lyness, 1986). 
Consequently, some evidence exists to postulate that components of some neurotoxin 
complexes may occur in close association with the respective neurotoxin gene such as in 
operons or regulons. 
1.6 Detection of C botulinum. 
Botulism poses a serious risk to both producers and consumers of food. Current 
methods of detecting and diagnosing this condition include demonstrating the presence 
of vegatative/spores of neuropathogenic clostridia in the food samples, through selective 
culture, and via detection of neurotoxin using the toxin neutralisation/mouse bioassay, a 
slow, expensive and ethically unacceptable test. To improve this situation, advances in 
our knowledge of the toxins have allowed alternative strategies to detect either the 
organism or toxin directly. Two main approaches using either immunological or DNA 
hybridisation strategies have been used. 
1.6.1 Immunological based detection methods 
Early attempts to detect C. botulinum neurotoxins were principally based on 
immunological techniques, including radioimmunoassays, electroimmunodiffusion, 
ELISAs and immunodiffusion assays (Ferreira et al., 1981). However, unless monoclonal 
antibodies were used, cross reactivity between neurotoxins or their progenitor complex 
components could contribute to confusion. To improve on the sensitivity of the ELISA 
assay approach, modifications have been made including the use of an enzyme-linked 
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coagulation assay which claims a sensitivity of <10 pg/ml which is comparable with the 
mouse bioassay (Doellgast et al., 1994). This methodology offers advantages over 
alternatives, including colony immunoblotting (Goodnough et al., 1993) and the use of a 
fiber optic-based sensor (Ogert et al., 1992), in that it is both fast and does not require 
specialised equipment. 
1.6.2 DNA hybridisation detection methods 
Hydridisation forms the basis of a number of techniques by which specific DNA 
sequences are detected and has become particularly useful since the delineation of 
neurotoxin gene sequences. - Among these, the combination of PCR and Southern 
hybridisation is of particular utility and sensitivity. A number of approaches have 
involved amplification of a specific region common to all botulinal neurotoxin genes of 
interest, followed by hybridisation of the PCR product to serotype specific fragments 
(Fach et al., 1995; Campbell et al., 1993). Although this technique offers a high degree 
of certainty, it is slow. 
A more sophisticated method employs the amplification of serotype-specific sized PCR 
products which can be quickly analysed by gel electrophoresis (Whelan, S. M. Ph. D thesis 
1993; Ferreira & Hamdy, 1995). Although this approach is possibly the most efficient, it 
is unable to distinguish between functional and silent genes (Franciosa et al., 1994) and 
may not detect a small percentage of subtype or hybrid genes which do not hydridise 
with probe DNA. An alternative method of detecting group I C. botulinum strains is 
based on hybridisation of a DNA fragment specific to these neurotoxigenic organisms 
(McKinney ei al., 1993). This method does not appear to offer a selective advantage 
over PCR methods and is not thought to hybridize to elements of the neurotoxin 
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complex. It must, however, be of scientific interest as it is likely to represent some part 
of a mobile genetic element associated with neurotoxin genes in these organisms. 
The most reliable detection methods are likely to be a combination of PCR and ELISA 
strategies which allows rapid detection and evaluation of the presence of a toxin 
molecule. 
1.7 Clinical applications of neurotoxins 
1.7.1 Clinical applications of neurotoxins 
Botulinal neurotoxins are generally considered to possess a specific activity, the cleavage 
of vesicle associated proteins within synapses at the neuromuscular junction, which 
inhibits neurotransmitter release and hence inactivates muscular contraction. This 
property was recognised as a potential therapeutic agent in the treatment of movement 
disorders where paralysis of a particular muscle was desirable (Scott, 1980). In this 
respect the LL type A progenitor neurotoxin complex has principally been used. Due to 
its relatively large size, it does not diffuse extensively, so the region of muscular paralysis 
does not spread beyond the point of injection. A number of treatments for over active 
muscle disorders have become established including Blepharospasm (spasm of the 
orbicularis oculi muscle), Hemifacial spasm (a disorder of the facial nerve resulting in 
involuntary movements of facial muscles), Torticollis (deformity of the neck caused by 
contraction of cervical muscles and sternocleidomastoid muscles) and cosmetic 
applications such as removing wrinkles (Montecucco et al., 1996). However the therapy 
is not permanent and must be periodically repeated. An immunological response 
attributed to the haemagglutinin moieties of the type A progenitor toxin complex can 
occur which impedes its further use. This could be circumvented by the use of serotypes 
(Montecucco et a!., 1996). 
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1.8 Clostridial genetics 
1.8.1 Transcriptional factors 
Those elements of the transcriptional machinery of clostridia that have been characterised 
to date share common features with the equivalent components of other eubacteria. The 
RNA polymerase holoenzyme of C. perfringens (Gamier & Cole, 1988) and C. 
acetobutylicum (Pich & Bahl, 1991), a basic unit of transcription, has been found to 
contain a, ß and ß' components. In addition, a number of a factors have also been 
detected. A protein analogous to the E. coli a7° /B. subtilis aA, which recognises 
vegetative/house keeping gene promoters, was detected in C. acetobutylicum by 
immunological cross reactivity. .A similar preparation 
has been isolated from 
exponentially growing C. perfringens (Rood & Cole, 1991) and used to characterise 
promoter elements in vitro. In common with B. subtilis, clostridia have the ability to 
sporulate. Indeed, many of the a factors which participate in the sporulation process of 
B. subtilis have homologs in C. acetobutylicum, including, aE, a, a°, e, aK, SpoOA 
and SpoDII. This indicates that sporulation is a conserved process in the separate genera 
(Wilkinson et al., 1995). Furthermore, some clostridial genes appear to be under 
sporulation-specific control (including CPE, an enterotoxin produced by type A strains 
of C. perfringens (Melville et al., 1997)) and under & control, a a-factor generally 
involved in the control of gene expression during late exponential- phase (Sauer et al., 
1995). 
Nucleotide sequence analysis of regions. of DNA contiguous with cloned genes in 
solventogenic clostridia has revealed the presence of a number of transcriptional factors. 
In C. bvijerhnckii NCJMB 8052 a {iorfiolog of the LysR family was found adjacent to a 
thiolase gene (T. Davis, unpublished data), whilst MaIR, a homolog of the E. coil LacI 
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repressor, has been found associated with an operon putatively involved in maltose 
metabolism (Dr N. P. Minton, pers. comm. ). In C. acetobutylicum ATCC 824, a TetR 
homolog was discovered next to another thiolase gene, whilst in C. acetobutylicum P262 
homologs of a two component response-regulator and the LacI repressor have been 
discovered (Woods & Reid, 1995). AC F54 was also identified in Clostridium 
kluyveri (Sohling & Gottschalk, 1996). This transcriptional factor, which has been 
associated with nitrogen assimilation, pilin formation, motility and pathogenicity in 
Gram-negative bacteria, has also been implicated in the control of gene expression in the 
levanase operon of B. subtilis (Klier et al., 1992). Thus, the limited sequencing 
undertaken has identified a variety of transcriptional factors. This situation resembles B. 
subtilis where there is, in addition to promoter-specific a-factors, a range of 
transcriptional activators and repressors which have homologs throughout the bacterial 
kingdom, but which do not necessarily control the expression of equivalent operons and 
regulons present in other organisms (Moran, 1993). 
1.8.2 Transcriptional signals 
In keeping with the discovery of homologs of RNA polymerase and &° (also known as 
c) in clostridia, a number of promoters have been characterized in vitro which resemble 
the target of the RNA-o' holoenzyme complex in E. coli and B. subtilis. The studies 
which were conducted, using 14 separate mapped promoters and the RNA-ßA 
holoenzyme from C. perfringens, demonstrated that the derived consensus [5'-TTGAcA- 
14-TG-1-TATAAT-3'] was similar to the vegetative promoters of E. coli and like B. 
`- subtilis, in that it frequently had a -10 sequence preceded by a TG motif (Rood & Cole, 
1991).. Subsequent cloning of the ßA gene from C. acetobzrtyliczmi has demonstrated that 
the regions of ß`' which are predicted to interact with the vegetative promoter regions 
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exhibit significant similarity to the equivalent regions of are E. coil and B. subtilis a, 
further indicating that the consenus vegetative promoters are also common to the 
clostridia (Sauer et al., 1995). However, there are some examples of clostridial 
promoters which are not recognised by E. coli (including the UV responsive promoters 
of C. perfringens (Gamier & Cole, 1988a), and the P2 promoter of the sol operon 
transcript from C. acetobutylicum ATCC 824 (Fischer et al., 1993)) suggesting that 
transcriptional factors with altered specificities are likely to be required in clostridia. 
1.8.3 Translational signals 
In contrast to E. coli, Shine-Dalgarno (SD) sequences preceding most clostridial genes 
have in general, a high level of complimentarity to the 3' terminus of 16S rRNA 
(reviewed by Young et al., 1989). Indeed, this phenomenon appears to be shared with B. 
subtilis, a paradigm of Gram-positive bacteria. The relationship between a `strong' SD 
interaction and the efficiency of translation has been determined and has shown that in 
contrast to the Gram-negative E. coli, `significant' complimentarity is necessary for 
efficient translation initiation in B. subtilis (Vellanoweth, 1993). In the majority of cases, 
the initiation codon of clostridial genes is AUG, but as in B. subtilis, UUG and GUG also 
occurs (Young et al., 1989). 
1.9 Genetic manipulation of clostridia 
The ability to genetically manipulate micro-organisms, particularly to generate defined 
mutants and complement the disrupted genotype via in vivo recombinant DNA 
techniques, has been an important goal in the study of bacteria. Within the clostridia, 
these have been developed predominantly in pathogenic or solventogenic species as they 
respectively command medical and industrial attention. Recent advances, such as the 
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construction of gene knockouts in C. perfringens (Rood, 1997), demonstrate the 
potential for genetic manipulation in these organisms, but currently, most clostridial 
species remain relatively recalcitrant to these techniques. However, this developing field 
employs an array of genetic tools. 
1.9.1 Genetic elements 
1.9.1.1 Indigenous plasmids 
Several studies have established the widespread nature of plasmids in various species and 
strains of the clostridia (Minton & Morris, 1981; Truffant & Sebald; 1983; Urano et al., 
1983; Squires et al., 1984; Popoff & Truffant, 1985; Lee et al., 1987; Kurose et al., 
1989; Brehm et al., 1992). Although plasmids with a wide range of molecular weights 
occur, research has focused on small plasmids (<10 kb) as a prelude to shuttle vector 
construction. Small plasmids are commonly found to encode replicons of the rolling 
circle type (Gruss & Ehrlich, 1989). In the clostridia these include pCB 101 (Brehm et 
al., 1992) and pNB2 (Delver et al., 1996). Other cryptic clostridial plasmids which are 
not extensively characterised have been used as components of shuttle vectors. However, 
they do not necessarily form-stable replicons (Yoshino et al., 1990). 
Unlike the solventogenic clostridia, where the indigenous plasmids have no selectable 
traits, genetic elements derived from C. perfringens commonly encode antibiotic 
resistance determinants and are consequently the basis of genetic systems in this 
organism (Heefner et al., 1984; Squires et al., 1984). A plasmid which has been well 
characterized, and is not thought to replicate via a rolling circle mechanism, is pIP404 
(Garnier & Cole, 1988c). Vectors incorporating this clostridial replicon are a popular 
choice, particularly in the natural host C. perfringens (Shimizu et al., 1997), as a 
replication mechanism which does not generate single stranded DNA intermediates is 
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more likely to be stable (Janniere ei al., 1990). Another plasmid of clostridial origin 
which has had its entire nucleotide sequence determined is the C. butyricum NCIB 7423 
plasmid pCB 102. This does not appear to possess a replicon resembling any other 
known plasmid (Minton et al., 1993) and has not been developed into a shuttle vector. 
1.9.1.2 Heterologous plasmids 
Many bacterial plasmids are inherently promiscuous in nature and frequently encode 
various elements which promote inter-species transfer (Wallets et al., 1993). This 
observation has promoted the concept that these plasmid replicons may possess a wide 
host range. Thus, the initial transfer of plasmids into the solventogenic clostridia utilised 
genetic elements which originated from other Gram-positive bacteria (Reysset et al., 
1988). 
In general, plasmids which are not of clostridial origin do not seem to form the basis for 
stable clostridial genetic systems (Truffaut et al., 1989; Lin & Blaschek, 1984). Although 
many heterologous plasmid replicons are able to persist in the clostridia, they may be 
inefficiently maintained due to the incomplete recognition of all elements required for 
replication (del Solar et al., 1996). Indeed, an undefined host mutation has been the basis 
by which one heterologous plasmid has attained stable inheritance in a clostridial host 
(Azeddoug et al., 1992). However, recombinant plasmids which are derived from the E. 
faecalis conjugative plasmid pAMß 1 (Leblanc & Lee, 1984) are reported to possess 
traits of segregational stability and structural stability in solventogenic clostridia. This 
may be partly attributed to the theta mechanism of replication which does not generate 
highly recombinogenic single stranded DNA replication intermediates (Bruand et al., 
1991). However, there is still a requirement for well characterised, stable vector systems 
for the clostridia, particularly for thermophilic species. 
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1.9.1.3 Conjugative plasmids 
This class of genetic element is defined by their ability to replicate autonomously as an 
extrachromosomal element and transfer between bacteria. Indeed, the host range for 
conjugative plasmids is typically broad and is complimented by a promiscuous replicative 
apparatus. Consequently, representatives of this type of plasmid are widespread 
throughout bacteria and are implicated in the `horizontal' transfer of genetic information. 
Although conjugative plasmids such as pCW3, PIP401, PJ R25 and PJIR27 have been 
recently identified within the clostridia (Lyras & Rood, 1997), the utility of conjugative 
gene transfer to the clostridia was demonstrated with heterologous conjugative plasmids 
of Gram-positive origin, including the MLSR pAMß1, pIP501 and derivatives (Young et 
at., 1993). In addition to self-transmissibility, these plasmids have several interesting 
properties. Firstly, transfer between bacteria is mediated via the transfer of a single DNA 
strand which is not a substrate for many host restriction systems. Secondly, some non- 
conjugative plasmids can be co-mobilised from the donor, to the recipient bacterium. 
They are also a source of useful broad host range antibiotic resistance genes and stable 
replicons. However, the drawbacks for use in gene transfer include their large size, a 
degree of instability due to internal insertion sequences/transposons, and the introduction 
of self-transmissible elements into pathogens. Gene transfer by conjugation has been 
largely superseded by electrotransfer techniques. 
1.9.2 Transposons 
1.9.2.1 Conjugative transposons 
In addition to the tetracycline resistance determinants tetA(P) and tetB(P) which are 
found linked on the C. perfriirgens conjugative plasmids homologous to pCW3, two 
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further unlinked tetracycline resistance genes are found in C. perfringens strains. One of 
these cross-hybridised with leaf and flanking regions of Tn916 indicating that this 
resistance determinant may be associated with a similar conjugative transposon (Lyras & 
Rood, 1997). A transmissible conjugative transposon designated Tn5397 is also thought 
to harbour a tetracycline resistance determinant in some strains of C. difficile (Lyras & 
Rood 1997). Nucleotide sequence analysis and hybridisation studies indicate a mosaic 
relationship between Tn916 and Tn5397 where some segments are virtually identical and 
some are unrelated (cited in Lyras & Rood, 1997). Erythromycin resistance can also be 
located on the conjugative transposon Tn5398 in C. dijficile strain 630. 
Heterologous conjugative transposons have been effectively used to generate mutants in 
both pathogenic and solventogenic clostridia. Although insertions have been reported in 
organisms such as C. perfringens (Rood et al., 1997), C. acetobutylicum (Woolley et al., 
1989) and C. botulinum (Lin & Johnson, 1991), the occurrence of multiple insertions 
reduces the attraction of this technique. 
The low number of transposable elements that have been detected in the clostridia may 
reflect that the majority of this large genera are not pathogenic and, therefore, have not 
benefited by obtaining antibiotic resistance determinants in this fashion. Transposable 
elements may be widely disseminated which encode cryptic functions not including 
antibiotic resistance; a parallel situation has already been exposed for plasmids in 
nonpathogenic clostridia. 
1.9.2.2 Non-conjugative Transposons 
Chloramphenicol resistance in C. perfringens is either encoded on a transposon, within a 
conjugative plasmid (i. e. pIP401 or pJIR25), or chromosomally. In either case, it is 
encoded by distinct chloramphenicol acetyl-transferase (CAT) genes. A homolog of the 
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plasmid encoded CAT gene of C. perfringens is found in multiple copies in the C. 
difficile genome. The transposon encoding CAT in pIP401 has been sequenced. In 
addition to encoding members of the resolvasel nvertase and integrase proteins, a 
Pre/Mob type gene is present, indicating the potential for interspecies transmission by 
cointegrate formation or co-mobilisation. Again, the discovery of this transposon is 
related to its association with a selective phenotype. 
1.9.3 Insertion sequences 
An insertion sequence IS1151 has been found next to the epsilon-toxin gene and/or 
enterotoxin gene in C. perfringens when these genes are present on a plasmid (Lyras & 
Rood, 1997). The association of this class of element with virulence factors is not 
uncommon and would thus seem a feasible means to facilitate toxin gene transfer. It has 
been postulated that the `chromosomally' located botulinual neurotoxin type A gene may 
reside on a mobile genetic element (Johnson, 1997). 
1.10 Gene transfer techniques in clostridia 
1.10.1 Natural transformation 
A number of bacterial species are able to absorb DNA from the surrounding milieu and 
incorporate it into their own genome (Stewart & Carlson, 1986). This process is 
facilitated if the DNA is both homologous and genomic, however, such `natural 
competence' has not been documented in a Clostridium. 
1.10.2 Transformation by chemical permeabilisation 
A technique developed for the transformation of a Bacillus brevis strain, which was 
recalcitrant to natural transformation procedures, involved stripping the surface protein 
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layer with an alkaline Tris solution, followed by PEG-induced permeabilisation 
(Takahashi et al., 1983). With minor modifications, this process was successfully applied 
to a mesophilic C. acetobutylicum strain (Yoshino et al., 1990) and a thermophilic C. 
thermohydrosufricum strain (Soutschek-Bauer et al., 1985). 
1.10.3 Protoplast transformation 
This approach to transformation- relies on the natural competence of cell wall-less 
bacteria and thus protocols were developed to both generate cell wall-less protoplasts 
and subsequently to regenerate vegetative cells following transformation. Broadly 
speaking, many clostridial species were converted to protoplasts. However, efficient 
regeneration to vegetative cells proved problematical. In some cases regeneration 
appeared to correlate with the autolytic activity of the host (Heefner et al., 1984; Reysett 
et al., 1987). The most efficient protoplast transformation frequencies (103 
transformants/gg of DNA) were achieved using an autolytic mutant of C. acetobutylicum 
N1-4080 (designated Ni 4081), in combination with the addition of an autolytic 
inhibitor choline (Reysett et al., 1988). The application of this technique to non-mutant 
strains of other clostridia was less successful. 
1.10.4 Conjugative transfer 
Conjugative methodology has had a number of applications in gene transfer to and 
between clostridial species. Unsuccessful attempts to simulate interspecies transfer of C. 
perfringens tetracycline resistance plasmids to C. acetobutylicum was successfully 
repeated with MLSR plasmids from other Gram-positive bacteria (Oultram & Young, 
1985; Reysett & Sebald, 1985). Having established a mode of gene transfer, 
complementation experiments were devised where a cloned gene was incorporated into 
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the wild type conjugal plasmid pAM(31 by homologous cointegrate formation (Oultram 
et al., 1988). Transfer from B. subtilis to C. acetobutylicum by conjugation 
demonstrated the utility of this approach. However, the application of a simpler 
technique, electrotransformation, superseded conjugation. 
The success of conjugation prompted attempts to mobilise recombinant plasmids with 
only the origin of transfer (or/I) to clostridia. (Williams et al., 1990). Transfer of shuttle 
vectors with the RK2 oriT were mobilised from an E. coif strain harbouring an IncP 
group helper plasmid. Although this technique is more `cumbersome' than 
electrotransformation, entry of plasmid DNA via conjugative pili is in single stranded 
form and has the advantage of evading many host restriction systems. 
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1.10.5 Electrotransformation 
The study of pore formation in cell membranes began with eucaryotic systems in which 
the application of an externally applied high-intensity electric field could induce 
membrane breakdown and cellular lysis (for a more recent review see Weaver & 
Chizadzhev, 1996). Modulation of the electric field strength and duration produced 
conditions in which re-sealable pores could be formed and through which molecules 
could be introduced. The basic electroporation technique has now become an 
established tool by which molecules can be introduced into living cells representing most 
phyla of biology, not least the bacteria. Here, electroporation allows the introduction of 
genetic elements in the absence of natural competence or bypasses less amenable 
procedures, such as conjugation and protoplast transformation. The late eighties saw a 
plethora of both Gram-negative and positive bacteria successfully transformed using this 
technique (Trevors et a!., 1992), including two clostridial species C. aceroburylicum 
(Oultram et a!., 1988) and C. perfringens (Allen & Blaschek, 1988). Since this time, the 
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number of clostridial species and strains compliant with this technique has increased and 
includes members of group I C. botulinum (Zhou & Johnson, 1993). 
Electrotransformation is rapid, inexpensive and reproducible, and can yield a high 
transformation efficiency. However, the introduction of heterologous DNA can still be 
subject to challenge by host barriers, including non-specific and site-specific nuclease 
activities (Mermelstein & Papoutsakis, 1993; Chen et al., 1996). 
1.11 Pathogenic bacteria 
Bacteria survive and multiply by utilising the compounds available in their surroundings. 
Those bacteria which find a niche in, or on tissues, to the detriment of a host, are 
considered pathogenic. The factors which contribute towards the colonisation of a 
specific host environment, but otherwise are not vital to the microorganism's survival, 
are considered virulence factors. C. botulinum would appear to be an unusual pathogen 
because, in general, it does not invade host cells or tissues but acts remotely through the 
action of a potent neurotoxin. However, a survey of features which contribute towards 
pathogenicity in other bacteria may form a useful basis to compare the `virulence 
factor(s)' and strategy of C. botulinum. 
1.11.1 Virulence determinants 
1.11.1.1 Toxins 
Although toxic molecules derived from bacteria are relatively diverse, an initial 
classification can be imposed depending on whether the toxic molecule is a secreted 
protein (exotoxin), which are commonly produced by both Gram-positive and Gram- 
negative bacteria, or an endotoxin, which are lipopolysaccharides specifically derived 
from Gram-negative cell walls. 
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In this brief survey, exotoxins will be considered because, like clostridial neurotoxins, 
they are all proteinaceous molecules. Although isolated exotoxins can often elicit most 
symptoms of the respective disease, additional factors, such as the secretory apparatus, 
adherence factors and regulatory genetic circuits, are required to potentiate the action of 
the toxin (Finlay & Falkow, 1997). 
Clostridial neurotoxins are examples of A-B toxins. This class of exotoxin is defined by 
the presence of a toxic entity (A), frequently an enzyme that modifies a molecule within 
the host, in combination with a second protein molecule(s) (B), which comprises a host 
specific binding domain which promotes delivery of (A) to a specific location of the host. 
Thus, exotoxins are combinations of enzymes and binding domains whose particular 
specificities directly contribute to the unique pathogenesis of an individual disease. In 
addition to clostridial neurotoxins, examples of A-B toxins include diphtheria and cholera 
toxins, whose A subunits possess ADP-ribosylating activity with distinct substrate 
specificities (London, 1992; Spangler, 1992), and shiga toxin, whose A subunit has a 
rRNase activity (Tesh & O'Brien, 1991). 
A second class of unrelated enzymic toxins which modify strategic eucaryotic protein 
messengers include the C. difficile A and B toxin monoglucosyltransferases, C. 
botulinum exoenzyme C3 ADP-ribosyltransferase and E. coli cytotoxic necrotising 
factor type 1. These toxins modify members of the Rho family which mediate actin 
polymerisation (Aktories et al., 1997) and consist of a single polypeptide chain. 
A number of toxins target the host cell plasma membrane. Those which insert into the 
membrane to form pores include E. coli hemolysin, a member of the RTX hemolysins 
found in some Gram-negative pathogens (Finlay & Falkow, 1997), and lysteriolysin 0, 
produced by Listeria monocylogenes, an example of a sulfhydryl-activated cytolysin 
found in Gram-positive pathogens (Farber & Peterkin, 1991). Plasma membranes are 
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also targeted via enzymic degradation. Phospholipase C is a major lethal factor 
produced by C. perfringens which has a number of roles in disease, particularly as a 
cytolytic factor (Titball, 1993) and is related to a number of other Gram-positive 
phospholipases. 
A group of related toxins, that support their own secretion, are found in a range of 
Gram-negative pathogens and are represented by IgA proteases characterised from 
Neisseria spp. and Haemophilus influenzae (Finlay & Falkow, 1997). However their 
precise roles in pathogenesis remain largely undefined. 
Unlike many of the exotoxins mentioned, two types of toxins, the heat stabile toxins and 
superantigens, do not possess a catalytic function but mimic complex molecular 
interactions of the host. Heat stable toxins are similar to guanylin, a host activator of 
intestinal guanylate cyclase (Currie et al., 1992), whilst superantigens, produced mainly 
by staphylococci, dramatically increase the indiscriminate interaction between antigen 
presenting cells and T cells, ultimately causing the elevated release of cytokines into the 
bloodstream where they induce fever and shock. 
1.11.1.2 Adherence factors 
Pathogens such as C. botulinum, Staphylococcus aureus and to some extent C. 
perfringens produce toxin(s) in food substances which interact with humans after 
ingestion. In contrast, the majority of pathogenic bacteria interact with or invade host 
cells and consequently are equipped with a variety of non-toxic adherence and invasion 
factors. 
Adherence to specific host receptors is mediated by bacterial adhesins which commonly 
fall into two classes; fimbrial or afimbrial adhesins (Finlay & Falkow, 1997). Fimbrial 
adhesin (alternatively known as pili) genes are frequently heterogeneous and occur in 
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operons that may also encode protein chaperones which mediate fimbrial assembly 
(Hultgren et al., 1991). The host ligand targeted by the fimbrial adhesin consequently 
determines tissue specificity during host colonisation. Afimbrial adhesins interact more 
closely with host cells and, in some cases, contain host binding motifs which mimic host 
factor molecules (Sandros et al., 1993). Both Gram-positive and Gram-negative 
pathogens frequently possess adhesins which bind to the extracellular matrix (Patti et al., 
1994). 
1.11.1.3 Invasive factors 
A variety of pathogenic bacteria persist by entering a host cell and exploiting an 
intracellular niche. Not all bacteria share the same strategy, for example, Salmonella, 
Mycobacterium and Legionella gain access to intracellular vacuoles and remain there by 
altering the natural course of vacuole destruction, whilst Listeria monocytogenes and 
Shigella flexneri destroy the vacuole and occupy the cytoplasm (Finlay & Falkow, 
1997). However, each micro-organism requires an invasive strategy to initially cross the 
host cell membrane. These mechanisms are typically complex and frequently involve 
interaction with host cell messengers. Yersinia spp. possess an outer membrane 
adherence factor, `invasin', which binds to a host receptor. This interaction promotes 
bacterial engulfment in the host membrane and internalisation as a vacuole (Isberg & 
Leong, 1990). When other bacteria, such as Salmonella typhimurium, contact a host cell, 
a modulation of the host cytoskeleton is initiated, resulting in membrane ruffling and 
macropinocytosis of the bacterium (Francis et al., 1993). In this instance, cytoskeletal 
rearrangement results from a bacterial factor interacting with a member of the host's Ras 
superfamily, Cdc42, one of many such factors involved in actin regulation (Nobes & 
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Hall, 1995; Chen et a!., 1996). Parallel mechanisms of host entry are also used by other 
Gram-negative intracelluar pathogens (Finlay & Falkow, 1997). 
Clearly, the methods by which different pathogens enter and survive in host cell 
environment depend on specialised virulence factors. Whatever the role a protein has in 
pathogenesis, e. g., toxin, adhesin, secretory protein, intracellular survival, immune 
evasion or host signal interaction, the regulation of these factors is of immense 
importance. 
1.11.1.4 Regulation of virulence factors 
A major form of protein regulation is exerted at the level of transcription. Bacteria have 
a number of factors which associate with RNA polymerase during the initiation of 
transcription. The success of transcription initiation depends largely upon the cumulative 
effect of the promoter/operator elements present and prevalence of transcriptional 
factors which interact with them. Genes which are vital to basic survival, with a `house 
keeping' function, are controlled in this manner. Evidence suggests that specific 
virulence determinants from some organisms are to some extent also modulated by 
factors similar to those which participate in `housekeeping' regulation. For example, 
homologs of the AraC family participate in virulence regulation activation in Yersinia 
spp. (Skurnik & Toivanen, 1992), Shigella flexneri (Sakai et al., 1988) and Vibrio 
cholerae (Higgins & DiRita, 1996). Likewise, members of the LysR regulatory family 
have been identified in co-ordinate regulation of some virulence genes in Salmonella 
spp. (Caldwell & Gulig, 1991). 
In contrast to AraC and LysR type regulatory factors which modulate transcription by 
binding to operators which facilitate RNA polymerase binding, some virulence gene 
promoters have activators which replace the sigma entity of the RNA polymerase and 
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thus exert promoter specificity. However genes which are regulated by `alternative sigma 
factors' are not all involved in pathogenicity per se, but in general could be classified as 
factors which promote survival. For instance, `extracytoplasmic function' factors (ECF) 
are a group of small sigma type proteins which appear to participate in the regulation of 
specific operons (Lonetto et al., 1994) in both Gram-positive and Gram-negative 
bacteria. Members of this group have been implicated in controlling pathogenic 
determinants (Schurr et al., 1995) as well as a variety of stress responses (Huang et al., 
1997). The specific mechanism by which ECF factors are activated or transcribed is as 
yet unclear. However, transcriptional control can in some cases be subject to `regulatory 
cascades' of environmental response messengers and intermediate transcriptional factors, 
capable of interacting with disparate genetic loci and thus co-ordinating an environmental 
response. Such mechanisms often involve two component regulators which were initially 
found to be responsive to environmental conditions, such as osmolarity or nitrogen, 
phosphate and carbon source concentrations (Russo & Silhavy, 1993). These systems are 
also known to promote a large number of virulence responses (Dziejman & Mekalanos, 
1995) and have been characterised in Gram-positive bacteria, including C. perfringens 
(Shimizu ei al., 1997). 
Recent evidence has demonstrated that a distinct system of intercellular communication 
exists between Gram-negative bacteria. This system is comprised of a diffusible 
messenger (N-acyl homoserine lactone (N-AHL), a N-AHL synthase and [N-AHL] 
dependent transcriptional activator (Salmond et al., 1995). The prevalence of such 
`quorum sensing' systems appears wide spread among Gram-negative bacteria and is 
intimately linked with the production of virulence determinants by some Gram-negative 
pathogens (Salmond ei al., 1995). Although Gram-positive bacteria do not seem to 
possess N-AHL-dependent quorum sensing potential, a number of cell density dependent 
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systems have been described which appear to be mediated by pheromone peptides 
(Kleerebezem et al., 1997), and include the virulence response of S. aureus. 
There is tentative evidence to suggest that an intercellular signal molecule participates in 
the regulation of some C. perfringens virulence genes, but it is not established whether 
this is a cell density sensing mechanism (Shimizu et al., 1997). 
In conclusion, as regulation by promoter activity can be influenced at a number of levels 
through the action of regulatory cascades, the potential for modulation via intercellular 
and intracellular signals is immense and reflects the complex and coordinated nature of 
bacterial responses. 
1.11.1.5 Pathogenicity islands - inheritance and dissemination of virulence 
`Pathogenicity island' is a term coined to describe a defined region of a genome in which 
are encoded a number of virulence determinants often with associated functions (Lee, 
1996). Analysis of these features has revealed that they are commonly associated with 
some type of mobile genetic element which is either extrachromosomal, for example a 
phage or plasmid (e. g., in Yersinia and Shigella human pathogens, (Rosqvist et al., 
1995)) or a similar structure which has integrated into the pathogens genome (e. g., 
retronphages in E. coli enteric pathogens (Inouye et a1., 1991)). It is unlikely that 
inheritance of genetic information in this manner is entirely associated with virulence as 
large cryptic plasmids are widespread, but rather that virulence factors are one facet of 
the bacterial kingdom's array of tools which are employed to gain a selective advantage 
by colonising a new environment. For a non-pathogenic example, essential genes 
required for solventogenesis (a metabolic response to unfavourable environmental 
conditions) are plasmid borne in some clostridial species (Girbal & Soucaille, 1998). The 
association of multiple virulence factors on a single `island' would be logical when they 
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are interdependent i. e., operons containing toxin genes and respective secretion 
apparatus, or two synergistic toxins. The acquisition of pathogenicity islands may 
therefore be a common route by which non-pathogenic bacteria become virulent. 
It is known that regulation of certain genes encoded within pathogenicity islands are 
influenced by regulatory factors which are also found in the pathogenicity island, which 
may in turn be controlled by chromosomally encoded mechanisms (Johnston et al., 
1996). Furthermore, cross-talk between elements of distinct pathogenicity islands may 
also contribute to virulence regulation (Morschhauser et al., 1994). 
1.12 Research aims 
This project will attempt to determine the genetic basis of neurotoxin complex 
production in C. botulinum NCTC 2916, with a specific focus on the genetic context of 
the silent type B neurotoxin gene in this strain. To complement these studies, a novel 
plasmid-based gene transfer system will be sought for use in C. botuhhum (group I), 
providing a vehicle by which the regulation of neurotoxin complex production can be 
studied in vivo. 
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CHAPTER TWO 
MATERIALS AND METHODS 
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2.1 MATERIALS 
2.1.1 Chemicals and kits. 
Amersham International, Buckinghamshire, U. K. 
Hybond N+ Nylon membrane, megaprime DNA labelling kit. 
Life Technologies Ltd. (GibcoBRL), Paisley, UK 
Agarose, ammonium persulphate, caesium chloride, calcium chloride, DNA 
kilobase ladder, ethylenediaminetetraacetic acid (EDTA), ethidium bromide, 
formamide (37 % v/v), formaldehyde, glycine, Lambda DNA HinduI fragments, 
magnesium chloride, mineral oil, phenol, phenol: chloroform: isoamyl alcohol 
25: 24: 1, pre-prepared dialysis tubing, sodium acetate, sodium hydroxide, 
sucrose, tetra-methylethylenediamine (TEMED), T4 Polynucleotide 
kinase/buffer. 
Biorad laboratories, Watford, U. K 
Acrylamide, methylene-bis acrylamide. 
Boehringer Mannheim (BCL), East Sussex, U. K 
AMV reverse transcriptase, deoxynucleotide triphosphates, calf intestinal 
alkaline phosphatase, Klenow DNA polymerase I fragment, restriction 
endonucleases/buffers, and T4 DNA ligase. 
CP Laboratories, Herts, U. K 
RNase A. 
Du Pont (U. K. ) Ltd. Hertfordshire, U. K. 
a-[32P]dATP (aqueous), y-[32P]rATP (aqueous) and a-[35S]dATP (aqueous). 
iGi (Immungen International Ltd) Tyne & Wear, U. K. 
Deoxynucleotide triphosphates. 
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Original TA Cloning' Kit. 
Northumbria Biochemicals Ltd. 
Restriction endonucleases/buffers. 
New England Biolabs (U. K), Ltd. Herts, U. K. 
Restriction endonucleases/buffers. 
Perkin Elmer, Cheshire, U. K. 
Amplitaq® DNA polymerase, IN PCR buffer, 25 mM MgC12 solution and 10 
mm dNTP kit. 
Pharmacia Biotech Ltd Herts, U. K 
SequenaseT"" version H. 
Sigma Aldrich Company Ltd, Dorset, U. K 
Absolute ethanol, ampicillin, dimethylformamide, erythromycin, guanidinium 
thiocyanate, isoamyl alcohol, kanamycin, lysozyme (chicken egg white), 
polyethylene glycol (PEG 8000), polyoxyethylene 20 cetyl ether (Brij 58), (3- 
isopropyl-thio-ß-galactosidase (IPTG), propan-2-ol, sodium dodecyl sulphate 
(SDS) and 5-bromo--chloro-3-indolyl-(3-D-galacto-pyranoside (X-gal). 
Stratagene Ltd, Cambridge, U. K 
RNase block. 
2.1.2 Nucleic Acids. 
Oligonucleotide primers were synthesised on an Applied Biosystems 380A 
DNA synthesiser and were kindly supplied by Mr R. Hartwell and Dr M. 
Duffield, (Division of Structural Sciences, CAMR, U. K). 
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VECTOR SOURCE OF SELECTION FEATURES REFERENCE 
REPLICON 
pMTL20 Col E1 Amp Cloning vector Chambers et al., 
1988 
pMTL22 Col E1 AMPK Cloning vector Chambers et al., 
1988 
pMTL20E Col EI Amp /Erm Replicon probe Minton et al., 
vector 1993 
pCB4 Col E 1/pCB102 Amp /Erm pCB102 replicon Minton et al., 
clone 1993 
pMTL500E Col E 1/pAMß 1 Amp /Erm Broad-host range Minton et al., 
shuttle vector 1993 
pMTL500F Col E 1/pAM 31 Amp /Erm Broad-host range Brehm et al., 
expression vector 1987 
pFD Col E1 Amp Ferredoxin clone Graves et al., 
1985 
pGK12 pWV01 Erm /Cm Broad-host range Kok et al., 1984 
lactococcal vector 
pXem I Col E1 Amp /Kan PCR cloning Cha et al., 1993 
vector 
pCR2.1 Col E1 Amp/Kan PCR cloning 
vector Invitrogen Inc 
Tablc 2.1 Plasmids used in this study 
2.1.3 Bacterial strains. 
STRAIN GENOTYPE REFERENCE 
F supE44 &(IacZYA- 
argF), U169 (480lacZAM15) 
E coli DH5aTM hsdR17 (r m) recAl endAl Woodcock et al., 1989. 
deoR gyrA96 ?. thi-1 re/AI phoA. 
F'endAl recAl hsdR17(rr, mr ) 
supE44 thi-1 gyrA96 rel41 
E colt InvaF' 480lacZcAMl5 A(1acZYA-argF) Invitrogen 0. 
U169. 
F' ara-14 leuB6 thi-1 jhuA31 
lacYl tsx-78 galK2 gal T22 
E. coli GM2163 supE44 hisG4 rpsL136 (Stf) xyl- Palmer & Marinas, 1994. 
5 mt1-1 dam 13:: Tn9 (Cam) don- 
6 mcrBl hsdR2(rk, mk`) mcrA. 
F A(gpt proA)62 leuB6 supE44 
E. coli HB101 ara-14 galK2 lacYl A(mcrC- Boyer & Roulland- 
mrr) rpsl2O(Stf) xyl-S. mtl-1 Dussoix, 1969. 
recA13. 
F'traD36 lacI° A(lacZ) MIS 
E. coli TG1 proA+B+ l supE A(hs&f-mcrB)5 Gibson, 1984 
(rk mr mcrH) thl A(lac-proAB). 
Clostridium beijerinckii wild type C. beijerinckii 
NCIMB 8052 (Solventogenic). NCIMB 
Clostridium botulinum type A wild type C. botulinum encoding 
NCTC 2916 type A and silent B neurotoxin NCTC 
genes 
Clostridium botulinum type A wild type C. botulinum encoding 
NCTC 7272 / ATCC 19397 type A neurotoxin gene. NCTC 
Clostridium botulinum type A wild type C. botulinum encoding 
ATCC 3502 type A neurotoxin gene. ATCC 
Clostridium botulinum type B wild type C. botulinum encoding Danish Serum Institute 
`Danish' type B neurotoxin gene. 
Clostridium botulinum type B wild type C. botulinum encoding 
ATCC 25765 (17B) type B neurotoxin gene. ATCC 
Table 2.1 Bacterial strains 
The list of strains is accompanied with a genotype reference where possible, however, 
the clostridial strains are unpublished wild type isolates which can be traced to the 
respective culture collection. 
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2.2 METHODS 
2.2.1 Storage and maintenance of bacterial strains 
Strains of E. coli were stored at -70°C using the MicrobankTu system (Prolab 
Diagnostics). Stocks were revived by plating onto M9 minimal media (Appendix II) 
supplemented with the appropriate metabolic requirements and incubated at 37°C for 
16 h. Cells were maintained at 4°C on LB agar plates for 4 weeks. 
Culture and manipulation of anaerobic bacteria was conducted when ever possible in a 
Mk 3 anaerobic work station (Don Whitely Scientific Ltd, West Yorks, U. K. ) The 
atmosphere, N2: C02: H2, was maintained at ratios of 87: 9: 4 respectively and at a 
temperature of 37 °C. Clostridial strains were inoculated into 20 ml of CMC broth 
(Appendix II) incubated for 24 h and stored. Single colonies were obtained by spreading 
10 µl of storage broth on to a blood-agar plate (Appendix II) and incubated for 16-24 h. 
2.2.2 Purification of DNA 
2.2.2.1 Small scale plasmid isolation from E coli 
Small quantities of plasmid DNA were routinely isolated by a modification to the 
`Rapid Boiling' method of Holmes and Quigley (1981). A single colony was used to 
inoculate 2 ml of L-broth (Appendix II), supplemented with the appropriate antibiotic. 
Cultures were incubated aerobically for 5-16 h at 37°C with shaking (225 r. p. m). Cells 
were harvested by centrifugation (6000 x g, 3 min) and the supernatant completely 
removed. The cell pellet was resuspended in 100 gI of STET buffer (Appendix I) 
containing 10 mg/ml lysozyme and placed on ice for 2 min. Cells were lysed in a boiling 
water bath for 40 sec. and the cellular debris pelleted by centrifugation (13000 x g, 15 
min). The pellet was removed and plasmid DNA precipitated at -70°C for 20 min by 
the addition of 160 gl of propan-2-ol. Plasmid DNA was recovered by centrifugation 
(13000 x g, 10 min, 4°C) and the supernatant completely removed. The pellet was air 
dried and resuspended in 50 Rl of IxTE buffer (Appendix I). RNA contamination was 
removed by adding I µl of RNase A (10 mg/ml) per sample to the STET buffer. 
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2.2.2.2 Medium scale plasmid isolation from K coll. 
Superior quality plasmid DNA was isolated using the `Plasmid Midi Kit' (Qiagen Ltd. 
Surrey, U. K. ) according to the manufactures instructions. The system is based on the 
alkaline lysis procedure of Birnboim & Doly (1979). 
2.2.2.3 Large scale plasmid isolation 
To obtain large quantities of plasmid DNA, a procedure was adapted from the method of 
Clewell and Helinski (1969). Typically 11 of broth was inoculated with a single fresh 
colony and incubated at 37°C for 16 h with shaking (225 r. p. m). Those transformed with 
the pWVO1 plasmid replicon (Kok et al., 1984) were inoculated with 2 ml of a late 
exponential culture. Cells were harvested by centrifugation (6000 xg for 20 min, 4 °C) 
and the supernatant completely removed. The cell pellet was resuspended in 5 ml of Tris- 
sucrose solution (Appendix I) and placed on ice for 2 min. Lysozyme was added to 2 ml 
of 0.25 M EDTA and 1 ml of 0.025 M Tris-HCI (pH 8.0) at a final concentration of 10 
mg/ml. This solution was added to the cells, mixed by gentle inversion and incubated on 
ice for a further 5 min. Lysis was induced by the addition of 8 ml of Brij/DOC solution 
(Appendix I). Cellular debris was pelleted by centrifugation (30,000 x g, 40 min, 4°C). 
Plasmid DNA was isolated from the cleared lysate by isopycnic centrifugation (Section 
2.2.2.4). 
2.2.2.4 Isopycnic centrifugation 
Plasmid DNA from crude lysates was purified from chromosomal DNA, RNA and 
protein contaminants by isopycnic centrifugation in a continuous gradient of caesium 
chloride (Sambrook et al., 1989). Crude lysates containing 1.25 g/ml caesium chloride 
and 80 pg/ml ethidium bromide were centrifuged at 160,000 xg for 48 h in a T12-70 
rotor at 19°C. The plasmid band was removed by aspiration and ethidium bromide 
extracted from the sample three times with caesium chloride-saturated isopropanol, 
before dialysis against 51 volumes of Ix TE buffer (4°C) at 1 h, 4h and 16 h intervals 
(Sambrook et al., 1989). DNA samples were stored at - 20°C. 
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2.2.2.5 Small scale bacteriophage isolation 
Single plaques were inoculated into 3 ml of 2x YT broth and incubated with shaking (225 
r. p. m) for 16 h at 37°C. Cells were pelleted by centrifugation (13,000 xg for 5 min) and 
the supernatant added to a clean tube. To this, 250 µl of precipitation was added (20 % 
(w/v) PEG MW 8000,2.5 M NaCI in sterile H2O) and the mixture incubated at room 
temperature for 15 min. Precipitate was collected by centrifugation (13,000 x g, 5 min) 
and the supernatant completely removed by aspiration. The pellet was resuspended in 
150 gl of lx TE and extracted with 50 µl of phenol: 100 x TE buffer solution (1: 0.4). 
The mixture was centrifuged (13,000 x g, 2 min) and 140 µl of the aqueous layer 
removed to a fresh tube containing 280 gl of chilled absolute ethanol and 14 µl of 3M 
sodium acetate. DNA was precipitated at -70°C for 20 min and harvested by 
centrifugation (13,000 x g, 2 min). The pellet was washed with 70 % (v/v) ethanol and 
air dried before being dissolved in 40 pl of lx TE. 
Double stranded bacteriophage DNA could be isolated from the cell pellet by the 
method described in section 2.2.2.1. 
2.2.2.6 Large scale bacteriophage DNA isolation 
A single plaque and an uninfected E cola strain (TG1) were individually inoculated into 
10 ml of 2xYT broth prior to 16 h incubation at 37°C. The 10 ml of uninfected culture 
was inoculated into 11 of 2x YT broth pre-warmed to 37°C and incubated until mid- 
exponential growth phase (O. D600 = 0.6). The infected 10 ml of culture was centrifuged 
(13000 x g, 10 min) and the supernatant added to the 11 culture of exponentially 
growing E. coll. Incubation was continued for a further 4h before a cleared lysate was 
obtained by the method described in section 2.2.2.3 and purified replicative form (RF) 
bacteriophage obtained by the method described in section 2.2.2.4. 
2.2.2.7 Isolation of DNA from clostridial strains. 
Plasmids were purified from clostridial species by a variation of the alkaline lysis 
method (Birnboim & Doly, 1979) as described by Ish-Horowicz and Burke (1981). 
Cells from 1.5 ml of culture, grown to late exponential phase (O. D60o = 0.8-1.2) were 
pelleted by centrifugation (13,000 x g, 5 min). The supernatant was completely 
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removed, the cells gently resuspended in 100 µl of GTEL buffer (Appendix I) and the 
mixture incubated at 37°C for 15 min. A further 200 Itl of lysis solution (Appendix I) 
was added and after brief mixing by vortexing, the lysing cells were placed on ice for 
exactly 5 min. Cellular debris was precipitated by the addition of 150 µl of chilled 3M 
potassium acetate solution (pH 4.8) and incubated on ice for 30 min. The precipitate 
was pelleted by centrifugation (13,000 x g, 20 min, 4°C). The supernatant fraction was 
extracted with an equal volume of phenol: chloroform: isoamyl alcohol (25: 24: 1) and 
nucleic acids precipitated by the addition of 2.5 vol. of absolute ethanol and 0.1 vol. of 
3M sodium acetate solution (pH 4.8). The pellet was collected by centrifugation 
(13,000 x g, 20 min 4°C), washed briefly with 70 % (v/v) ethanol and then resuspended 
in 100 µl of 1xTE buffer. RNase A was added to a final concentration of 10 µg/ml and 
the mixture was incubated for 30 min at 37°C. After further phenol: chloroform 
extraction, the plasmid DNA pellet was resuspended in IxTE buffer. To obtain larger 
quantities of plasmid, the ratio of cell culture volumes to volume of buffers was kept 
constant. In addition, an isopycnic centrifugation step (see section 2.2.2.4) was 
introduced after RNase treatment to remove contaminating chromosomal DNA and 
proteins. 
2.2.2.8 Phenol Extraction 
DNA and RNA samples were routinely purified by phenol extraction. An equal volume 
of phenol equilibriated with 100 x TE buffer, or a phenol: chloroform: isoamyl alcohol 
(25: 24: 1) solution was added to the sample and mixed by shaking for 20 sec. After 1 
min the sample was again shaken for 20 sec and centrifuged (13,000 x g, 5 min). The 
upper aqueous layer was promptly removed for further manipulations. 
2.2.2.9 Column Purification 
DNA samples were routinely purified and concentrated using the Wizard clean up 
column, Promega Ltd. Southampton, U. K. or the Qiagen® column systems, Qiagen Ltd, 
Surrey, U. K and used according to the manufacturers instructions. 
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2.2.2.10 Ethanol precipitation 
Nucleic acids were precipitated from solution by the addition of 2.5 vol. of chilled 
absolute ethanol and 0.1 vol. of 3M sodium acetate (pH 4.8). Precipitation was 
enhanced by placing the samples at -70°C for 20 min. Nucleic acids were recovered by 
centrifugation (13,000 x g, 20 min 4°C), the supernatant completely removed, and the 
pellet washed in 70 % (v/v) ethanol before being air dried. The sample was finally 
resuspended in 1x TE buffer and stored at -20 °C. 
2.2.2.11 Analysis of DNA. 
DNA was quantified at 260 nm using quartz cuvettes with a1 an path length and I ml 
volume (Sambrook et al., 1989). An O. D260 of 1.0 equated to concentrations of 50 tg/ml 
of double stranded DNA, 40 tg/ml of single stranded DNA and 20 µg/ml of synthetic 
oligonucleotide respectively. 
Contamination of DNA with protein or phenol was estimated by determining the ratio 
for a sample at both O. D260 and O. D280. A ratio (O. D26onso) below 1.8 indicated 
contamination. The structural integrity of nucleic acid was also judged visually on 
agarose gels. 
2.2.3 Transformation of bacteria. 
2.2.3.1 Preparation of competent E. coli. 
Competent cells were prepared by a modification of the method of Cohen (1972). A 
single colony was inoculated into 50 ml of L-broth and grown with shaking (225 r. p. m) 
at 37°C to an O. D600 of 0.8. The culture was cooled on ice for 10 min and harvested by 
centrifugation (6000 x g, 10 min). After removal of the supernatant, the cells 
resuspended in 30 ml of ice cold 0.1 M MgCl2 solution, the cells were pelleted (6000 x 
g, 5 min) and finally resuspended in 2.5 ml of ice cold 0.1 M CaCl2 solution. 
Competency was induced by incubation on ice for a minimum of 2 h. Cells could be 
stored at +4 °C for 24 h without loss of transformation efficiency. 
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2.2.3.2 Transformation of competent E. coli cells with plasmid DNA. 
Cells were transformed by the addition of 0.1 volumes of DNA (typically 1-10 µl) to an 
aliquot of competent cells, the mixture was placed on ice for 20 min and heated at 42 °C 
for 2 min before replacing on ice for 20 min. A period of expression was included when 
using bacteriocidal selection before plating the transformed cells. 300 µl of L-broth was 
added to the cells and incubated at 37 °C for 20 min. 
2.2.3.3 Transfection of competent E coli with bacteriophage DNA. 
Competent cells were prepared by the method presented in section 2.2.3.1 using a strain 
with aF episome, commonly strain TGl . 
Phage DNA was mixed with competent cells 
and placed on ice for 20 min prior to a `heat shock' step of 42°C for 2 min, the cell 
suspension was then placed on ice for 5 min and added to 3 ml of molten H-top agar 
(Appendix II) at 45°C with 200 gl of an exponentially growing culture of E coli 
(O. D600-0.6-0.8). The mixture was poured on to a 2x YT agar plate (Appendix II) and 
allowed to set before incubation at 37°C for 16 h. 
2.2.3.4 Transformation of C beijerinckii strains. 
C. beijerinckii NCIMB 8052 was transformed using a variation of the method described 
by Oultram et al., (1988). A single colony was used to inoculate 10 ml of YTG media 
(Appendix II). This was serially diluted (10''-10-4) to give 5 cultures, which were grown 
for 16 h at 37°C. The culture which had not reached stationary phase was used to 
inoculate a 100 ml volume of YTG broth and grown to an O. D600 = 0.8. The culture was 
cooled on ice, harvested by centrifugation (6000 x g, 10 min) and washed once in ice cold 
S. E. B electroporation buffer (Appendix I) before resuspension in 5 ml of the same 
buffer. Electroporation was conducted using 0.3 ml of cell suspension in a 0.2 cm 
electroporation cuvettes, applying a 1.25 kv pulse, 200 Q, 25 p. F in a Bio-Rad gene 
PulserTM, The mixture was then incubated at 37°C in 3 ml of YTG broth for 3h and then 
collected by centrifugation (13,000 x g, 5 min). The cells were resuspended in 100 gl of 
YTG broth and plated onto dry YTG plates supplemented with erythromycin (20 
µg/ml). Manipulations were performed in an anaerobic environment whenever feasible 
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using an Anaerobic Workstation Mark III (Don Whitley Scientific Ltd, West Yorkshire, 
U. K). 
2.2.4 Determination of plasmid stability 
2.2.4.1 Structural stability in C botulinumIC beijerinckii. 
Plasmid DNA was isolated from the transformed organism and re-transformed into an E. 
coli strain. Larger quantities of plasmid were isolated from E. coil and then subjected to 
restriction enzyme analysis, using an equivalent control whenever applicable. 
2.2.4.2 Segregational stability in C beijerinckii. 
The stable inheritance of plasmids by daughter cells was estimated by a method described 
by Swinfield (1987). A single transformed colony was inoculated into 10 ml of YTG 
broth supplemented with erythromycin (20 µg/ml). The culture was incubated for 8h 
where upon an aliquot of 50 µl was used to inoculate a further 10 ml of YTG. This 
culture was also grown for 8h and the sub-culturing step repeated, finally after a third 8 
h of growth, serial dilutions were spread on to non-selective YTG agar plates. The 
resulting colonies were replica plated onto both selective (erythromycin, 20 pg/ml) and 
non-selective YTG plates. The segregational stability of a plasmid was deduced by the 
percentage of colonies still retaining an antibiotic resistant phenotype. 
2.2.5 Electrophoresis of Nucleic Acids 
2.2.5.1 Horizontal slab gel electrophoresis of DNA. 
DNA was analysed by horizontal electrophoresis using 0.7-2.0 % (w/v) agarose gels. 
casting trays (5 x8 cm, 11 x14 cm and 20 x 21cm) by These were cast in portable' 
melting agarose in the appropriate buffer (Appendix I) using a microwave oven. Loading 
wells were created by immersing combs in the molten agarose. Samples were loaded 
using DNA tracking dye (Appendix I) and separated by electrophoresis at a voltage of 
between 25 - 100 V/cm. DNA was stained using ethidium bromide and illuminated using 
short wave u. v. (254 nm). Photographic records were taken with a Polaroid MP4 land 
camera with a red filter, using Polaroid 667 film. Visualisation of DNA for preparative 
purposes was done using long wave length u. v. (366 nm). 
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2.2.5.2 Horizontal slab gel electrophoresis of RNA. 
RNA molecules were analysed on agarose gels according to the method of Goda & 
Minton (1995). Apparatus was pre-soaked in aqueous 1% (w/v) SDS solution and 
rinsed with sterile H2O prior to use. Electrophoresis was performed according to section 
2.2.5.1 except that gels were composed of 1.2 % (w/v) agarose, and that before pouring, 
gaunidinium thiocyanate was added to the molten agarose at a final concentration of 20 
mM. Agarose solutions and electrophoresis buffers comprised of double autoclaved lx 
TBE buffer (Appendix I). Prior to loading, 10 µl of RNA (section 2.2.10.2) was added 
to 5 µl of formaldehyde (38 % v/v) and 10 µl formamide and boiled for 2 min, before the 
addition of 3 pl of IOx RNA tracking dye (Appendix I). Electrophoresis was performed 
at 15 V/cm. 
2.2.5.3 Recovery of DNA from agarose gels. 
DNA fragments were recovered from an agarose matrix by an adaptation to the 
`electrophoretic elution method' of McDonell (1977). Narrow slices of agarose were 
inserted within 1/4 " washed dialysis tubing with a small volume of lx TBE buffer (pH 
8.0). DNA was electroeluted out of the gel slice into the dialysis bag by electrophoresis 
at 100 V/cm. The solution in the dialysis bag was transferred to a clean tube and the 
DNA purified according to section 2.2.2.9. 
2.2.5.4 Denaturing polyacrylamide gel electrophoresis. 
Single stranded linear nucleic acids were separated through denaturing polyacrylamide 
gels based on a system described by Sanger (1980). Polyacrylamide was cast and run 
between two glass plates (20 x 50 cm), which were thoroughly cleaned and rinsed with 
absolute ethanol. The `notch plate' was coated with a gel repellent (2 % (v/v) dimethyl- 
dichlorosilane in 1,1,1-trichloroethane in absolute ethanol whilst the `back' plate was 
coated with a gel adherent (75 µl of y-(methyl-acryloxy)-propyltrimethoxysilane and 750 
µl of 10 % (v/v) glacial acetic acid in 25 ml absolute ethanol). The dried plates were 
separated by a narrow 1 mm spacer and sealed. A gradient gel was made with 40 ml of 
0.5 x TBE gel mix and 7 ml of 5x TBE gel mix (gel mixes A and B respectively, 
Appendix I). Polymerisation was initiated by the addition of 5 [il/ml 25 .% (w/v) 
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ammonium sulphate and I tl/ml TEMED. Approximately 4 ml of mix B and 7 ml of 
mix A were poured between the glass plates. The remaining volume of mix A was added 
in such a manner as to create a regular vertical gradient with mix B. Shark tooth or square 
tooth combs were inserted to create sample wells and the polymerisation allowed to 
continue for a further hour. Gel rigs were run with upper and lower reservoirs of lx 
TBE running buffer at 1500 V/ 25 mA. The gel sandwich was parted and the plate with 
the adhered gel was fixed in 10 % (v/v) glacial acetic acid containing 10 % (v/v) methanol 
for 15 min. DNA sequencing gels were dried at 80°C before autoradiography. 
2.2.6 Modification of DNA with enzymes 
2.2.6.1 Restriction endonucleases. 
Double stranded DNA was cleaved with restriction endonucleases in the specified 
buffers provided by the enzyme's manufacturers. No more than 1/10 of the final digest 
volume consisted of the restriction endonuclease's storage solution. Digests were 
incubated at the temperature suggested by the manufacturer. Digests using more than 
one enzyme were conducted in a mutually compatible buffer. Restriction enzymes were 
heat inactivated at 70°C for 10 min before further manipulation of the DNA. 
2.2.6.2 Klenow Fragment. 
The large fragment of E. coli DNA polymerase I (Klenow fragment) was used for 
creating `blunt' ends on ds DNA from 3' recessed termini. The reaction was conducted 
at 37°C in lx TM buffer (Appendix I) using 5 units of enzyme and dNTPs at a final 
concentration of 25 pM. DNA fragments were then purified according to section 2.2.2.8 
and 2.2.2.9. 
2.2.6.3 Calf Intestinal Alkaline Phoshatase. 
Calf intestinal alkaline phosphatase (CIP) was used to remove the 5' phosphates from 
linear plasmid DNA to prevent subsequent re-ligation. 20 U of CIP were used in a 
reaction containing 1-10 pg of DNA in lx phosphatase buffer (Appendix I). The 
mixture was incubated at 37°C for 20 min and the enzyme inactivated at 70°C for a 
further 10 min. Plasmid DNA was then purified according to either section 2.2.2.8 or 
2.2.2.9. 
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2.2.6.4 T4 polynucleotide ligase. 
Purified DNA fragments with compatible termini were covalently joined in vitro using 
T4 DNA ligase. Varying ratios of the candidate DNA fragments of approximately 50 
ng/µl were incubated at 14°C for 4-16 h with 0.5 units of ligase in lx ligase buffer 
(Appendix I). 
2.2.7 Immobilisation of nucleic acids on Nylon membranes 
2.2.7.1 Southern blotting. 
Double stranded DNA was transferred from agarose gels to charged nylon membranes 
using a variation of the method of ' Southern (1975). DNA was first separated by 
electrophoresis and then partially depurinated by soaking the gel in 0.25 M HCl for 45 
min with gentle agitation. After brief rinsing in sterile H2O, the DNA in the gel was 
denatured by soaking in 1.5 M NaCl, 0.5 M NaOH for 45 min. After a further wash in 
sterile water, the alkaline solution was' neutralised with 0.5 M Tris-HCI, 1.5 M NaCl 
(pH 7.5) for 30 min. Denatured DNA was then transferred to a positively charged nylon 
membrane (Hybond N+, Amersham International, Bucks, U. K. ) via capillary blotting, 
using 400 ml of sterile 20 x SSC as transfer buffer (Appendix I) and Quick DrawTM 
blotting paper (Sigma, Poole, U. K). Following a 4-16 h blotting period, the membrane 
was laid upon a pad of 3 MM Whatman filter paper pre-soaked in 0.4 M NaOH for 20 
min to covalently fix the DNA to the membrane. The membrane was briefly washed in 
5x SSC and either probed for DNA sequences or stored at 4°C. 
2.2.7.2 Northern Blotting. 
RNA gels were blotted by capillary action in sterile 20x SSC transfer buffer as 
previously described (Section 2.2.7.1), to positively charged nylon membranes. The 
RNA was then attached to the membrane covalently by heating at 80°C in vacuo for 2h 
and probed for mRNA species. 
2.2.7.3 In-situ colony hybridisation. 
Individual plasmid clones were isolated from a genomic library by a variation of the 
method of Grunstein and Hogness (1975). E. coli transformants were replica plated on 
to llybond N' nylon membrane which was in contact with L-agar (Appendix II) 
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membrane was carefully peeled off the agar and laid on several layers of 3MM 
Whatman filter paper soaked in 0.4 M NaOH. Cell lysis and attachment of the plasmid 
DNA to the membrane occurred during the next 20 min, the membrane was washed 
briefly in 5x SSC and then immersed in GOOP pre-hybridisation solution (Appendix I) 
at 56°C. Residual cellular debris was reduced by replacing the pre-hybridisation solution 
after Ih of rotation in a hybridisation oven. 
2.2.8 Preparation of DNA Probes 
2.2.8.1 Radio-labelling of DNA probes. 
Double stranded DNA fragments to be labeled were isolated by gel electrophoresis in a 
low melting point agarose gel (Section 2.2.5.1) The required fragment (50-100 ng) was 
prepared and labeled with a-[32P]dATP using the Megaprime m kit (Amersham 
International, Bucks, U. K. ) according to the manufacturers instructions. Briefly, a . pool 
of random hexamer nucleotides were annealed to the DNA probe and extended with 
Klenow fragment in the presence of a-[32P]dATP and BdNTP nucleotides. Radio- 
labeled probes were added directly to the pre-hybridised membrane without further 
purification. 
2.2.8.2 Radio-labelling of DNA size markers. 
DNA kilobase ladder or lambda DNA-HindlII fragments were radio-labeled by filling in 
their terminal recesses with a-[32P]dATP. DNA polymerase `Klenow fragment', 
dGTP, dCTP, dTTP and lx TM buffer (Appendix I) were supplied by Boehringer 
Mannheim (BCL), East Sussex, U. K. The labeling reaction was incubated for 30 min at 
37°C. A volume of I µl was loaded per well of an agarose gel. 
2.2.9 Hybridisation. 
2.2.9.1 Hybridisation of probes to nucleic acids. 
Membranes were prehybridised in `GOOP' pre-hybridisation solution (Appendix I), 
typically for 15 min. Radio-labelled probe was added and the incubation continued at 
the appropriate hybridisation temperature for 16 h. Unbound probe was removed by 
washing 3 times using 2x SSC, 0.1% (w/v) SDS. The membrane was then air dried, 
wrapped in SaranTM Wrap and auto-radiographed against Kodak X-OMAT AR film. To 
enable the repeated probing of membranes for different sequences, the previous probe 
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was removed using one of two methods; membranes containing DNA were immersed in 
stripping solution containing 0.4 M NaOH at 50°C for 30 min. This solution was 
replaced with strip neutralisation buffer (Appendix I) and gently agitated for a further 
15 min. Finally the membrane was rinsed in 2x SSC and the efficiency of probe removal 
qualified by autoradiography. Alternatively, membranes containing immobilised RNA 
were stripped by immersion in a boiling solution of 1% (w/v) SDS. This was continued 
until the SDS solution had cooled to 40°C, The membrane was then washed in 2x SSC 
and residual probe detected by autoradiography. 
2.2.9.2 Autoradiography. 
Kodak X-OMAT AR film was routinely used for the detection of 35S and 32P 
radioactive isotopes. Film was placed next to a dried sequencing plate or Nylon 
membrane in an X-ray film cassette. Calcium tungstate-phosphor intensifying screens 
were employed to improve sensitivity. * The sealed cassette was stored at -80°C for 16- 
72 h before developing the film in a Kodak X-OMAT automatic developing machine. 
2.2.10 Purification and Analysis of RNA. 
2.2.10.1 Culture of strains. 
Preparation of cells for harvesting RNA was adapted from the method of Henderson et 
al., (1996). A fresh 20 ml volume of CMC broth (Appendix II) was inoculated with 1.5 
ml of CMC storage culture of the appropriate clostridial strain and incubated at 37°C 
for 24 h. An aliquot of this culture, typically I ml, was used to inoculate 20 ml of USA 
II broth (Appendix II) supplemented with 1% (w/v) glucose. This culture was 
incubated for 16 h and used as an inoculum for a further 80' ml of USA II broth 
containing 1% (w/v) glucose. Incubation was continued for a further 5 h. 
2.2.10.2 Extraction of total RNA from C. botulinum strains. 
During all procedures solutions, glassware, tubes and disposables were `double 
autoclaved' at 121°C for 15 min to eliminate RNase contamination. Cells from 10 ml of 
C. bolulinum culture were harvested by centrifugation (6000 x g, 5 min at 4 °C), the 
supernatant completely removed and the cell pellet was then resuspended in 500 µl of 
chilled sterile AE buffer (Appendix I). To this, 50 µl of 10 % (w/v) SDS was added and 
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then mixed thoroughly by vortexing. An equal volume of phenol, previously 
equilibriated with lx AE buffer, was added and the cells mixed again by vortexing. The 
mixture was incubated in a 65°C water bath for 5 min and then frozen in a dry ice- 
ethanol water bath for 2 min. The sample was then centrifuged (13,000 x g, 4 min), the 
aqueous layer extracted with phenol chloroform (section 2.2.2.8) and then the RNA was 
precipitated. DNA was removed by resuspending the RNA pellet in 50 t1 of lx DNase 
buffer (Appendix I) containing 20 units of DNase I and incubation at 37°C for I h. The 
RNA was then extracted once more using phenol: chloroform and finally precipitated 
with ethanol. RNA was stored under the ethanol supernatant at -70°C until required. 
2.2.10.3 Analysis by Primer Extension. 
The 5' nucleotide of a mRNA species was determined by the method of Faulkner 
(1992). Approximately 30 nM of oligonucleotide primer was phosphorylated at the 5' 
terminus with ? -[32P]rATP in the following reaction: 1 µl of primer solution was mixed 
with 5 µl of y-[32P]rATP, 3 gl of lOx kinase buffer (Appendix I), 2 µl of T4 
polynucleotide kinase and 19 µl of H20. The mixture was incubated at 37°C for I h. 
The volume was subsequently made up to 130 pl with lx TE, phenol extracted (section 
2.2.2.8) and ethanol precipitated (section 2.2.2.10) with the inclusion of 1 µl of 
glycogen to aid formation and visualisation of the precipitated oligonucleotide pellet. 
End-labeled primer was then resuspended in 10 gl of 3x PEB buffer (Appendix I), to 
which 5 µl of total RNA was added and 15 µ1 of double autoclaved water. Primer was 
annealed to the target mRNA (Section 2.2.10.2) using a MJ-Research thermal cycler, 
programmed for an initial denaturing step at 80°C for 10 min followed by annealing for 3 
h at 55°C. The oligonucleotide-mRNA hybrid was precipitated in 60 gl of chilled 
absolute ethanol, air dried and resuspended in a mixture lx reverse transcriptase buffer 
(Appendix I), 1mM of each dNTP, actinomycin (25 µg/ml) and 1 µl of placental RNase 
inhibitor. The extension reaction was initiated by the addition of 9U of AMV reverse 
transcriptase and incubated at 42°C for 1 h. Extension products were precipitated by 
the addition of 50 µl of chilled absolute ethanol and 2 µ1 of sterile 3M sodium acetate 
and incubated at -20°C for lh. The precipitate was collected by centrifugation (13,000 x 
g, 10 min) and air dried. The DNA was resuspended in denaturing running buffer 
(Appendix I), heated at 85°C for 2 min and then loaded along side control sequencing 
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reactions, generated from the same oligonucleotide and template onto a6% denaturing 
polyacrylamide gel (Section 2.2.5.4). 
2.2.19.4 4pglysis by Primer Extension-Blotting. 
This method is identical to primer extension except that the oligonucleotide used was 
non-radioactive. After running the polyacrylamide gel, extension products were blotted 
on to Hybond N+ membrane using 20 x SSC as transfer buffer. The ss DNA was then 
fixed to the membrane with 0.4 M NaOH for 20 min, concomitantly hydrolysing the 
alkali labile RNA. A PCR fragment was generated which was complementary to the 
putative primer extension product, this probe was radioactively labeled (section 2.2.8.1) 
and used to probe for specific primer extension products (Section 2.2.9.1). 
2.2.11 DNA Sequence Analysis 
2.2.11.1 Primers. 
Oligonucleotide primers of between 17-20 bases were designed from known DNA 
sequence and synthesised (section 2.1.2). Palindromes, inverted repeats and compatible 
ends were avoided whilst the G+C content was maximised to increase the annealing 
temperature. Oligonucleotide stock solutions were quantitatively determined (section 
2.2.2.11) using a 1/200 fold dilution in H20. The concentration was calculated in . tg/ml 
and adjusted to the working concentration of 30 p. M/ml for ds plasmid sequencing and 2 
µMJml for ss M13 sequencing. 
2.2.11.2 Plasmid template. 
Double stranded DNA plasmid template was prepared using commercially available 
column based procedures (section 2.2.2.9). Between 1-3 gg was used for each sequence 
reaction. 
2.2.11.3 M13 bacteriophage template. 
Superior quality template was obtained by cloning DNA fragments into RF M 13 
bacteriophage vectors M13mp18 and M13mp19 (Messing el a!., 1986). Single stranded 
DNA template was purified according to the method described in section 2.2.2.5. 
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2.2.11.4 Manual sequencing reactions. 
DNA was sequenced `manually' using the chain terminating method described by Sanger 
(1977). Thermal denaturation was used to prepare the template for sequencing 
(Andersen et al., 1992). Briefly, 8 µl of plasmid DNA and 1 . tl of oligonucleotide 
primer solution were annealed by heating to 97°C for 5 min and cooled to the annealing 
temperature of 37°C. Immediately 1 µl of IOx TM buffer was added and annealing 
continued for a further 20 min. The primer was extended at room temperature with 5.5 
µl of labeling mixture (Appendix I) for 5 min. The sample was then split into four equal 
fractions and individually mixed with 3.5 . tl of a dideoxy-nucleotide termination mix 
(Appendix I) and incubated at 37°C for 10 min. The chain termination reaction was 
stopped with the addition of 4 gl of formamide stop dye (Appendix I) and either stored 
at -20°C or denatured for 2 min at 70°C before loading on to a polyacrylamide gel for 
electrophoretic separation (section 2.2.5.4). Ss M13 templates/primer solutions were 
denatured in a water bath at 80°C and allowed to anneal slowly in the cooling water bath 
reservoir, an appropriate volume of 10 x TM buffer was added and the sample was then 
sequenced as described for ds plasmid DNA. 
2.2.11.5 Automated DNA sequencing reactions 
Double stranded plasmid DNA was sequenced with an automated robotic catalyst using 
approximately 25 gg of plasmid DNA prepared using the Qiagen midi system (section 
2.2.2.2) and 4.5 pmol of oligonucleotide primer. Sequence reactions were extended by 
the cycle sequencing method using Amplitaq FS dye terminator chemistry. Samples were 
separated and recorded using an AB1377 DNA sequencer. 
2.2.11.6 Analysis of data. 
DNA sequence data was collated and processed using the `DNASTAR' program 
`LASERGENE', DNASTAR Inc. London U. K. 
2.2.12 Polymerase Chain Reaction (PCR) 
2.2.12.1 Oligonucleotide primers. 
Oligonucleotide primers were designed to achieve several objectives, to amplify DNA 
fragments with an elucidated DNA sequence, to amplify DNA fragments whose 
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sequence was predicted and to amplify known sequences, but in addition to engineer 
specific base changes in the primer sequence to create, for example, convenient 
restriction endonuclease sites. Whilst designing primer pairs, several factors were 
considered, complementarity between regions within a single primer and between two 
primers was avoided, especially at the 3' end. Mesophilic clostridia have a high A+T 
DNA base bias particularly in the intergenic regions, so, where possible, primers were 
designed with a high percentage G+C DNA base content, thus increasing the 
temperature and specificity of annealing. The length of primers was generally between 
30-36 base pairs. This enhanced specificity, and helped overcome . steric repulsion 
between the template and mutagenic primers. 
2.2.12.2 Template preparation. 
Purified chromosomal and plasmid DNA samples were diluted 1/1000 using sterile 
H20. Small scale preparations of genomic DNA were also obtained from single colonies 
using the Gene ReleaserlM system (Cambio, Cambridge, U. K). 
2.2.12.3 Reagents and conditions. 
A thermostable DNA polymerase was used in the amplification reaction (Saild et al., 
1988). Biotaq® (Bioline Ltd. ) and Amplitaq® (Perkin Elmer) DNA polymerases were 
chosen as they possess a non-template directed polymerisation activity, often resulting 
in the addition of a dATP residue and consequently facilitating the cloning of the 
amplified fragment in `T' vectors. Reaction volumes were 100 µl, comprising of 10 µl of 
template, 10 tl of each primer at lOx working concentration (0.2 µM), 70 tl of `PCR 
reaction master mix', typically containing 2.5 units of polymerase, 10 tl of lox PCR 
buffer (Appendix I) and dNTP's at a final concentration of 0.2 mM. A 50 mM MgC12 
stock solution was added to give a final concentration of MgC12 between 1.5 - 3.0 mM. 
PCR amplification was attempted using a number of thermal programs, typically an 
initial template denaturation step was conducted at 94°C for 1 min, followed by 
multiple cycles of three steps starting with a denaturation step of 94°C for 1 min, a 
primer-template annealing step at a temperature between 37°C and 60°C depending on 
the primers, and finally an incubation step at 72°C, where the polymerase extends the 
primer to complement the template strand. This cycle was repeated 25-30 times and 
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followed with a further extension step at 72°C to complete the synthesis of the amplified 
products. Products were analysed by agarose gel electrophoresis.. 
2.2.12.4 Cloning PCR products. 
DNA fragments amplified by certain DNA polymerases commonly have a single non- 
template directed nucleotide, often a dATP residue polymerised to the 3' end (Hu, 
1993). These fortuitous overhangs can be used to clone PCR fragments into 
complementary `T' vectors. Two such vectors were used. The `TA' Cloning@ kit vector 
pCR2000 (Invitrogen BY, Leek, the Netherlands) was used according to the 
manufacturers instructions. An alternative `T' vector, pXcm I was kindly supplied by Dr 
S. Chandrasegaran (Cha et al., 1993). Double stranded plasmid DNA was isolated and 
digested with the endonuclease Xcm I whose recognition sequence is 
5'... CCANNNNNUNNNNTGG... 3'. Two of these sites flank a kanamycin resistance 
gene and possess dTTP residues at the appropriate position to create compatible ends for 
PCR products. Ligated PCR products were transformed into competent E. cola, selected 
on ampicillin agar plates and then replica plated onto kanamycin agar plates. Plasmid was 
isolated from transformants not possessing a kanamycin resistant phenotype and analysed 
for a cloned insert by restriction mapping. 
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CHAPTER 3 
GENETIC CEIARACTERISATION OF A SILENT TYPE B 
NEUROTOXIN GENE FROM C botulinum NCTC 2916. 
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3.1 Introduction. 
During the course of a previous project in this laboratory, a method of detecting 
clostridial neurotoxin genes was developed using PCR and neurotoxin serotype specific 
oligonucleotide primers. The amplified products were indicative of the type of 
neurotoxin gene present (Dr S. M. Whelan. Ph. D thesis, 1993). In general, the results 
could reproducibly determine the presence of a specific neurotoxin gene in a particular 
strain but did not amplify DNA fragments from any other organism tested. However, 
the type A strain of C. botulinum NCTC 2916 consistently produced results indicating 
the presence of both type A and type B neurotoxin genes. Successive isolation of clonal 
colonies and screening with serotype specific primers, including. primers derived from 
the type B strain Danish, indicated the presence of an entire type B gene. In contrast, 
antibody neutralising tests indicated that only serotype A toxin was expressed in the 
strain, suggesting that the gene encoding the type B gene was silent (Dr S. M. Whelan, 
Ph. D thesis, 1993). 
The concept of a clostridial strain containing two copies of neurotoxin genes is not new. 
Several examples of strains expressing dual neurotoxin combinations of serotypes A, B 
and F have been documented (section 1.3.2). However, in these cases, both neurotoxins 
were detectable. The aim of this study was, therefore, to genetically characterise the 
type B neurotoxin gene and determine the genetic basis of why the type B neurotoxin 
gene in C. botulinum NCTC 2916 was not expressed. 
3.2 Strategy. 
In order to manipulate genomic clones from C. botulinum in a rational and safe manner, a 
high resolution restriction map of the silent neurotoxin locus was required. To achieve 
this, a number of DNA probes likely to hybridise to the target gene were required. 
Fortunately, a representative serotype B neurotoxin gene had been sequenced (Whelan et 
a!., 1992) and was an obvious candidate as a source of DNA sequence data and probes. 
Having established a restriction map, specific DNA fragments were then targeted for 
cloning which, for safety reasons, were theoretically incapable of encoding a neurotoxic 
peptide. 
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3.3 Cloning of the neurotoain locus. 
3.3.1 Cloning of a DNA fragment 5' to the silent neurotozin gene. 
Data accrued from the type A neurotoxin and proteolytic type B neurotoxin DNA 
sequencing projects (Thompson et al., 1990; Whelan et al., 1992) were used to design 
two oligonucleotide primers. These were anticipated to selectively amplify a 622 bp 
DNA fragment encompassing the 3' extremity of an ORF preceding the silent neurotoxin 
gene, a short intergenic section and the 5' end of the silent neurotoxin gene itself (figure 
3.1). The 5' oligonucleotide, designated B2676, was 22 bases in length and homologous 
with the extreme 5' sequence known for the proteolytic type B neurotoxin locus 
(Whelan et al., 1992). In comparison to the equivalent region in the type A locus, nine 
base mis-matches occurred, six of which were at the 3' end. It was, therefore, unlikely 
that B2676 would anneal with the type A sequence. The oligonucleotide primer 
designated B2677 was homologous with the proteolytic type B neurotoxin coding 
sequence in a region where only 10 of 23 bases were in common with the type A 
neurotoxin. PCR amplification with B2676, B2677 and C. botulinum NCTC 2916 
genomic DNA produced a DNA fragment of the expected size. The DNA was recovered 
from the agarose matrix by electroelution and purified by phenol extraction. The DNA 
fragment was then cloned into pCRII and designated pSB06. 
3.3.2 Investigation of the 5' coding sequence. 
The insert of pSB06 was sequenced with forward and reverse universal primers and the 
oligonucleotides B2676 and B2677 (figure 3.1). Comparison of the sequence data with 
the equivalent region of the published proteolytic type B sequence (Whelan et a1., 1992) 
revealed a fragment of identical length with 7 nucleotide substitutions, 6 of these 
occurred in the coding region of an upstream ORF resulting in 2 conserved amino acid 
changes and 4 non-conserved amino acid substitutions. A further nucleotide substitution 
occurred in the intergenic region. No obvious discrepancy could account for the 
proposed transcription or translational dysfunction of the neurotoxin gene. Both the 
coding sequence of the upstream ORF and the putative neurotoxin gene remained in 
frame, whilst the proposed ribosome binding site and initiation codon were homologous 
to the published sequence. A possibility existed that one or more of the nucleotide 
substitutions may have disrupted a promoter element, however, no data currently 
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B2709 
5' ATTCTCCGGTGGATAATAAGAATG 
B2708 
5' TTTTTTAGATCAATGGTGGAC 3' 
B2676 
5' GTAAAT AATTATTTTTCTTATT 
TR 'FT'AT F 9I"I"I 
5' TT , T1'AA'I'TATTTTPAGGTTC 
s' soar/B 
3' BoNT/A 
NTNH GENE BoNT/B 
B2677........................ 
3' CTACCTCGGAGGTAAACGCTCTC 5' BoNT/B 
TT AGGT AC C 
3' ATATTTTTAAGGTTTACAT C 5' B0NT/A 
0.6 Kb (pSB06) 
1.7 Kb (pSB17) 
4.0 Kb 
0 2.0 4.0 6.0 8.0 
Scale (Kb) 
Figure 3.1 Selective PCR amplification from the silent type B neurotoxin locus. 
Three separate DNA fragments were amplified from the type B neurotoxin locus in strain 
NCTC 2916 (tan boxes). Structural genes are represented by green boxes. Oligonucleotide 
primers used in the PCR are shown below their designated name and where pertinent, are 
compared to the equivalent region in the type A locus. Primers 2676 and 2677 were 
designed in regions where the type A and type B neurotoxin and NTNH gene sequences 
varied, whilst primers B2708 and B2709 were designed where conserved motifs occurred in 
the type A and type C NTNH genes 
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documents promoter(s) for this gene. Another consideration is that the nucleotide 
substitutions observed may have been artifacts of the amplification process (Tindall & 
Kunkel, 1988). 
Having identified the 5' end of a putative gene encoding a serotype B neurotoxin, as well 
as the existence of the 3' end of an ORF preceding the type B neurotoxin, the region 5' 
to the neurotoxin gene was further characterised. An oligonucleotide primer, B2708 
(figure 3.1) was designed whose sequence was complementary to a region of similarity 
detected between equivalent NTNH genes from clostridia expressing the type C 
(Tsuzuki et al., 1992) and type A neurotoxins. A pilot PCR experiment using primers 
B2708, B2677 and proteolytic type B clostridial DNA successfully amplified a 
fragment of the expected size (1.7 kb), suggesting that the primer B2708 shared enough 
similarity with the type B upstream sequence to anneal in a PCR reaction. The 
experiment was repeated using genomic DNA from C. botulinum NCTC 2916. A unique 
DNA product was amplified of the predicted size and cloned into the pCRII vector and 
designated pSB17. Initial sequence data obtained with forward and reverse universal 
primers gave unexpected results. The 3' end of the PCR clone was identical to pSB06, 
however, the 5' end was identical to the equivalent region in the `type A' NTNH gene 
(Henderson et al., 1996). The insert of pSB17 was sub-cloned into M13mp18 and 
M13mp19 bacteriophage vectors using the flanking EcoRI restriction sites of the pCRII 
plasmid. Further sequence data obtained with primers designed to the type A sequence 
demonstrated that the majority of the insert of pSB17 was homologous to the type A 
NTNH gene and that the 5' end of pSB06 was very close to the end of this homologous 
tract (see figure 4.1). 
One explanation for this observation could be that a chimeric PCR product (Bhavsar et 
al., 1994) may have been formed between the type A and type B upstream genes in the 
PCR reaction, possibly due to inefficient primer annealing at the 5' end of the type B 
upstream gene or because B2708 efficiently annealed to both type A and B upstream 
genes. 
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3.3.3 Creation of a genomic restriction map of the silent neurotozin gene N- 
terminal coding region. 
Nucleotide sequence data derived from pSB 17 illuminated the requirement for a genomic 
restriction map to encompass the silent neurotoxin gene and a considerable 5' region. To 
ensure that an `upstream' clone had originated from the silent B locus and not a type A 
locus, it would have to be selected for and be contiguous with a type B sequence. 
A 395 bp Bgll-StuI restriction fragment was isolated from pSB17. This fragment was 
essentially homologous with the proteolytic type B neurotoxin upstream sequence and 
did not contain tracts of DNA identical to the type A upstream sequence (figure 3.2). 
The choice of this restriction fragment in combination with Bgll double digests and 
Haeff double digests (HaeIII is within the Slid palindrome) allowed the precise 
delineation of restriction sites 5' and 3' to this probe's region (figure 3.2). Samples of C. 
botulinum NCTC 2916 genomic DNA. were digested with a number of restriction 
enzymes and the region 5' to the putative serotype B gene was mapped using the BgIH- 
StuI probe by Southern blotting (figure 4.7a and 4.7b). A 6.5 kb XbaI fragment identified 
in the map was targeted for cloning the N-terminal coding region of the silent neurotoxin 
gene and at least 4 kb of upstream DNA (figure 3.2). 
3.3.4 Creation of a genomic restriction map of the silent neurotoxin gene. 
Due to the large size of a clostridial neurotoxin gene, a more extensive area was mapped, 
encompassing all of the neurotoxin coding region. Probing of double digests of C. 
botulinum NCTC 2916 genomic DNA, generated with combinations of either HaeIII or 
HindIIl enzymes using a ScaI- Xbal DNA restriction fragment derived from a 
proteolytic type B neurotoxin clone BINV3 (Whelan et al., 1992), extended and 
improved the existing restriction map (figure 3.2). However a comparison of the 
restriction profile with the published proteolytic type B neurotoxin sequence 
highlighted some variation, specifically the HindII1 maps did not correlate. A restriction 
enzyme site which did appear to occur at a convenient spacing was Xbal. Verification of 
the Xhal sites in relation to the other mapped restriction sites was achieved by probing a 
variety of Xbal double digests with a flindI. ll-Xbal probe, which was also obtained 
from the BINV3 clone (Whelan -el a!., 1992). Thus a further two contiguous Xbal 
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fragments of 1.6 and 1.9 kb were targeted for cloning which were potentially capable of 
encoding the entire silent neurotoxin gene and adjacent areas. 
3.3.5 Cloning the silent neurotoxin gene. 
Approximately 500 tg of C. botulinum NCTC 2916 genomic DNA was digested with 
400 units of Xbal for 5 h. The sample was separated in a 0.8 % (w/v) agarose gel before 
sections of the gel were excised which corresponded approximately to 6.5,1.9 and 1.6 
kb. The DNA was recovered from the gel by electroelution, purified by phenol 
extraction and ligated into the E coli cloning vector pMTL22 (Chambers et al., 1988). In 
total, 960 transformant colonies from each respective fragment population were probed 
for the presence of an insert which hybridised with either the BgIII-StuI restriction 
fragment or a Hindul restriction fragment which bridged the 3' XbaI site in the 
proteolytic type B neurotoxin (figure 3.2). Representative clones for each potential 
fragment were isolated and restriction analyses of purified plasmid DNA with XbaI 
revealed the presence of inserts of the predicted size. It was interesting to note that 
clones containing the two larger inserts were blue in the presence of X-gal and IPTG. 
Clones were designated pSBI, pSB2 and pSB3 according to their relative position 
(figure 3.2). 
3.3.6 Nucleotide sequence analysis of silent neurotoxin gene in C botulinum 
NCTC 2916. 
Preliminary sequence data obtained for pSB 1 using a reverse universal primer confirmed 
the presence of a type B-like neurotoxin sequence, whose reading frame read in an 
opposite direction to the lacZ a gene into which it was cloned. The sequence data using 
a forward universal primer suggested the presence of another component of the 
neurotoxin complex (section 4.2.1.6). The entire insert was subcloned as an XbaI 
restriction fragment into the M13mpl8 bacteriophage vector to facilitate nucleotide 
sequencing. Sequence data from the distal ends of the pSB2 insert also suggested the 
presence of a type B-like neurotoxin gene. Both Xbal sites appeared to correspond to 
those present in the published proteolytic type B neurotoxin sequence suggesting that 
the inserts of pSB l and pSB2 were contiguous. In a similar vein, the sequence obtained 
from pSB3 with forward universal primer appeared to correlate with the sequence 
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adjacent to the 3' XbaI site in the published proteolytic type B neurotoxin sequence. In 
conclusion, the three contiguous clones were predicted to contain the equivalent coding 
region of the entire silent neurotoxin gene. 
pSB3 was cloned into the M13mp18 bacteriophage vector as a XbaI fragment. All three 
clones were sequenced on both strands using the manual dideoxy chain termination 
method with custom made oligonucleotide primers. Primers were designed from the 
published proteolytic type B neurotoxin sequence (Whelan et al., 1992). However 
when a deviation in the silent neurotoxin sequence affected primer annealing, primers 
were designed from the raw sequence data. Data was analysed and assembled using 
DNASTAR giving a single contig. The greatest problem in generating over 4 kb of 
sequence data by the `manual' dideoxy-Sanger method was in determining a reliable 
method to prevent the acrylamide gel from adhering to both glass plates during 
electrophoresis. 
3.3.7 Comparison of the silent neurotoxin gene in C botulinum NCTC 2916 with 
the published proteolytic and non-proteolytic type B neurotoxin sequences. 
3.3.7.1 Nucleotide sequence. 
An initial comparison of the complete nucleotide sequence obtained from clones pSB 1, 
pSB2 and pSB3 with the published proteolytic type B neurotoxin gene (Whelan et al., 
1992) suggested that a complete neurotoxin gene was present (figure 3.3). The A+T 
DNA content for the `coding' region was 74.78 % which was marginally higher than that 
for both of the other type B genes which shared an A+T DNA content of 74.51 %. 
Alignment of the sequence with both type B genes using the Martinez/Needleman- 
Wunch method (MEGALIGN programme, DNASTAR Inc. ) demonstrated identity of 
97.5 % and 94.8 % with the proteolytic and nonproteolytic genes respectively. This 
indicated that over approximately 3.9 kb, significant, but not dramatic, variations 
occurred between the genes and that overall, the silent gene appeared to be most similar 
to the proteolytic type B neurotoxin sequence. 
A close inspection of the silent gene showed that 6 contiguous nucleotides were missing, 
starting at nucleotide position 983 (figure 3.3). This deletion removed 2 codons 
encoding lysine and tyrosine, and is not present in either of the type B neurotoxin genes. 
BOTB' TGCGCATTTATGGGCATTAAAAGGGATATAAACTTAAAATAAGGAGGAGAATATTT CCAGTTACAATAAATAATTTT 80 
BOTB° ---A---------------------------------------------------- --------------------- 
BOTB" ---A--------- A------------------------------------------ --------------------- 
BOTB' AATTATAATGATCCTATTGATAATAATAATATTATTATGATGGAGCCTCCATTTGCGAGAGGTACGGGGAGATATTATAA 160 
BOTB° -------------------------------------------- A------------------- T--------------- 
BOTB" ------------------------G-C-----------------A-----------A--G-------------------- 
BOTB' AGCTTTTAAAATCACAGATCGTATTTGGATAATACCGGAAAGATATACTTTTGGATATAAACCTGAGGATTTTAATAAAA 240 
BOTB° -----------------------------------T-------------------------------------------- 
BOTBN ------------------------------------C------------------------------------------- 
BOTB" GTTCCGGTATTTTTAATAGAGATGTTTGTGAATATTATGATCCAGATTACTTAAATACTAATGATAAAAAGAATATATTT 320 
BOTB° ----------------------------G--------------------------- 
BOTBN ---------------------------------------------------------- C--------------------- 
BOTB' TTACAAACAATGATCAAGTTATTTAATAGAATCAAATCAAAACCATTGGGTGAAAAGTTATTAGAGATGATTATAAATGG 400 
BOT13° -------------------------------------°°-------------------°°--------°°---- 
BOTB' --C------T---------------------------------------------------------------------- 
BOTB' TATACCTTATCTTGGAGATAGACGTGTTCCACTCGAAGAGTTTAACACAAACATTGCTAGTGTAACTGTTAATAAATTAA 480 
BOTB° ------------------------------------- T------------------------------------------ 
BOTB" -------------------------------------------------------------------------------- 
BOTB' TCAGTAATCCAGGAGAAGTGGAGCGAAAAAAAGGTATTTTCGCAAATTTAATAATATTTGGACCTGGGCCAGTTTTAAAT 560 
BOTB° ------------------------------------------------- G-----------------°°°------- 
BOTBN -T------------------------------------------------------------------------------ 
BOT B° GAAAATGAGACTATAGATATAGGTATACAAAATCATTTTGCATCAAGGGAAGGCTTCGGGGGTATAATGCAAATGAAGTT 640 
BOT13° ---------------- C--------------------------------------------------------------- 
BOTB" --------------------------------------------------------T--------------------A-- 
BOT B' TTGCCCAGAATATGTAAGCGTATTTAATAATGTTCAAGAAAACAAAGGCGCAAGTATATTTAATAGACGTGGATATTTTT 720 
BOTB° -------------------------------------------------------------------------------- 
BOTB" ---T---------------------------------------------------------------------------- 
BOTB' CAGATCCAGCCTTGATATTAATGCATGAACTTATACATGTTTTACATGGATTATATGGCATTAAAGTAGATGATTTACCA 800 
BOTB° -----------------C--------------------------------------------- T---- A----------- 
BOTB" -------------------------------------------G------------------------------------ 
BOTB' ATTGTACCAAATGAAAAAAAATTTTTTATGCAATCTACAGATGCTATACAGGCAGAAGAACTATATACATTTGGAGGACA 880 
BOTB° ----- G----------------------------------------------------------------------- G-- 
BOTBN ------------------------------------------A---------------------- --------------- 
BOTB' AGATCCCAGCATCATAACTCCTTCTACGGATAAAAGTATCTATGATAAAGTTTTGCAAAATTTTAGAGGGATAGTTGATA 960 
BOTB° -----------------G-------------------------------------------------------------- 
BOTBN ----------------T----------A--------------------------------------G------------- 
BOTB' GACTTAACAAGGTTTTAGTTTGCATATCAGATCCTAACATTAATATTAATATATATAAAAATAAATTTAAAGATAAATAT1040 
BOTB° ------------------------------------------------------------------------------M 
BOTEN ------------------------------------------- C------------------------------------ 
BOTB' AAATTCGTTGAAGATTCTGAGGGAAAATATAGTATAGATGTAGAAAGTTTTGATAAATTATATAAAAGCTTAATGTTTGG1120 
BOTB° AAA---------------- A----------------------------- C----------------------------- 
BOTB" -------------------- A----------------------------- C-------------------------- A-- 
BOTB' TTTTACAGAAACTAATATAGCAGAAAATTATAAAATAAAAACTAGAGCTTCTTATTTTAGTGATTCCTTACCACCAGTAA1200 
BOTB° -------------------------------------------------------------------------------- 
BOTB" -----------T-------------------------------------------------------------------- 
BOTB' AAATAAAAAATTTATTAGATAATGAAATCTATACTATAGAGGAAGGGTTTAATATATCTGATAAAGATATGGAAAAAGAA1280 
BOTB° -----------------------------------------------------------------A-------------- 
BOTB" -----------------------°°--------------------------------------A------G------- 
BOTE' TATAGAGGTCAGAATAAAGCTATAAATAAACAAGCTTATGAAGAAATTAGCAAGGAGCATTTGGCTGTATATAAGATACA1360 
BOTB° ----------------------------------------------- C------------------ A------------- 
BOTB" ----- G----------------------------------------- C-------------------------------- 
BOTB' AATGTGTAAAAGTGTTAAAGCTCCAGGAATATGTATTGATGTTGATAATGAAGATTTGTTCTTTATAGCTGATAAAAATA1440 
BOTB° ---------------------------------------------------G---------------------------- 
BOTBN --------------------T---------------------C---------A--------------------------- 
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BOTB' GTTTTTCAGATGATTTATCTAAAAACGAAAGAATAGAATATAATACACAGAGTAATTATATAGAAAATGACTTCCCTATA1520 
BOTB° ------------------------------------ C-------------- A------------------ T---T----- 
BOTB" -------------------------T------G------------------A-----------G---------T------ 
BOTB' AATGAATTAATTTTAGATACTGATTTAATAAGTAAAATAGAATTACCAAGTGAAAATACAGAATCACTTACTGATTTTAA1600 
BOTB° -------------------------------------------------------------------------------- 
BOTB" ------------------------------------------------- ------------------------------- 
BOTB° TGTAGATGTTCCAGTATATGAAAAACAACCCGCTATAAAAAAAATTTTTACAGATGAAAATACCATCTTTCAATATTTAT1680 
BOTB° ----T---------A----A---------T-------------------------------------------------- 
BOTBN ------------------------------------------- G---°°----------------- 
BOTB" ACTCTCAGACATTTCCTCTAGATATAAGAGATATAAGTTTAACATCTTCATTTGATGATGCATTATTATTTTCTAACAAA1760 
BOTB* -T ----------------------------------------- 
BOTBN -------------------- A----------------------------------------------- G------ G---- 
BOTB° GTTTATTCATTTTTTTCTATGGATTATATTAAAACTGCTAATAAAGTGGTAGAAGCAGGATTATTTGCAGGTTGGGTGAA1840 
BOTB* --------------------------------------------------------------------------------- 
BOTBN A --------- 
BOTB' ACAGATAGTAAATGATTTTGTAATCGAAGCTAATAAAAGCAATACTATGGATAAAATTGCAGATATATCTCTAATTGTTC1920 
BOTB° ----------G------------------------------G-------------------------------------- 
BOTBN ---------- G------------------------------ G-------------------------------------- 
BOTBP CTTATATAGGATTAGCTTTAAATGTAGGAAATGAAACAGCTAAAGGAAATTTTGAAAATGCTTTTGAGATTGCAGGAGCC2000 
BOTB° -------------------------------------------------------------------------------- 
BOTBN ----------------------------- G--------------------------- G------------------- T-- 
BOTB' AGTATTCTACTAGAATTTATACCAGAACTTTTAATACCTGTAGTTGGAGCCTTTTTATTAGAATCATATATTGACAATAA2080 
BOTB° --------------------------------------------------T------------- ---------------- 
BOTBN ...... T------------------------------------------ T------------------------------ 
BOTB° AAATAAAATTATTAAAACAATAGATAATGCTTTAACTAAAAGAAATGAAAAATGGAGTGATATGTACGGATTAATAGTAG2160 
BOTB° -------------G--------A---G----------------G------------T----------------------- 
BOTBN ------------------------------------------- GTG---------- T----------------------- 
BOTB° CGCAATGGCTCTCAACAGTTAATACTCAATTTTATACAATAAAAGAGGGAATGTATAAGGCTTTAAATTATCAAGCACAA2240 
BOTB° -------------------------------------------------- ------------------------------ 
BOTB" -------------------------------------------------------------------------------- 
BOTB' GCATTGGAAGAAATAATAAAATACAGATATAATATATATTCTGAAAAAGAAAAGTCAAATATTAACATCGATTTTAATGA2320 
BOTB° -------------------------A------------------ G-------G--------------------------- 
BOTBN ------------------------- A------------------- G-G--------------------- A---------- 
BOTB° TATAAATTCTAAACTTAATGAGGGTATTAACCAAGCTATAGATAATATAAATAATTTTATAAATGGATGTTCTGTATCAT2400 
BOTB° -G---------------------------------------------------------------A-------------- 
BOTBN --------------------- T----------------- G------------ G------------ A-------------- 
BOTBP ATTTAATGAAAAAAATGATTCCATTAGCTGTAGAAAAATTACTAGACTTTGATAATACTCTCAAAAAAAATTTGTTAAAT2580 
BOTB° ------------------------------------------------- C------------- G--------- A------ 
BOTB -------------------------------- A----------------------------------------A------ 
BOTB' TATATAGATGAAAATAAATTATATTTGATTGGAAGTGCAGAATATGAAAAATCAAAAGTAAATAAATACTTGAAAACCAT2660 
BOTB° ------------------------------------------------------------G--------- G 
BOTBN -------------------------- A---------- T---- G----------------- G------------------- 
BOTBP TATGCCGTTTGATCTTTCAATATATACCAATGATACAATACTAATAGAAATGTTTAATAAATATAATAGCGAAATTTTAA2740 
BOTB° ---A-----------------G-----T---A-------------------A--------------------T------- 
BOTBN ---A-A--------------CG---T-T---AT-GA----------A----A---------------------------- 
BOTB' ATAATATTATCTTAAATTTAAGATATAAGGATAATAATTTAATAGATTTATCAGGATATGGGGCAAAGGTAGAGGTATAT2820 
BOTB° --------------------------- G--------- G------------------------------------------ 
BOTB"---------------------------- GA-------------------------------- A------------------ 
BOTB' GATGGAGTCGAGCTTAATGATAAAAATCAATTTAAATTAACTAGTTCAGCAAATAGTAAGATTAGAGTGACTCAAAATCA2900 
BOTB° -----G---A------------------------------------------------------ T--------- 
BOTBr ----- G---A----------------------------------------- G----------------C----------- 
BOTB' GAATATCATATTTAATAGTGTGTTCCTTGATTTTAGCGTTAGCTTTTGGATAAGAATACCTAAATATAAGAATGATGGTA2980 
BOTB° -------------------A---------------------- T--------- ---------------------------- 
BOTBN ------T------------A--------------------- 
80 
BOTE' TACAAAATTATATTCATAATGAATATACAATAATTAATTGTATGAAAAATAATTCGGGCTGGAAAATATCTATTAGGGGT3060 
BOTB° ------------------------------------------------------- T--A---A----------------- 
BOTBN ----------------------------G--------------------------A------------------------ 
BOTB' AATAGGATAATATGGACTTTAATTGATATAAATGGAAAAACCAAATCGGTATTTTTTGAATATAACATAAGAGAAGATAT3140 
BOTB° ---- T----------------------------------- T------ A---------------- G----- A--------- 
BOTB" -----------------C-----------------------------A-------------------------------- 
BOTB' ATCAGAGTATATAAATAGATGGTTTTTTGTAACTATTACTAATAATTTGAATAACGCTAAAATTTATATTAATGGTAAGC3220 
BOTB° ------C-G------------------------------ 
BOTBN -------------------------------------------------G----T--------------------C-C-T 
BOTBP TAGAATCAAATACAGATATTAAAGATATAAGAGAAGTTATTGCTAATGGTGAAATAATATTTAAATTAGATGGTGATATA3300 
BOTB° --------C---T--------G--------------------------A-------------------------A----- 
BOTBN ------------ TG--------------- G------------ T-------------- C------------------- G-- 
BOTB' GATAGAACACAATTTATTTGGATGAAATATTTCAGTATTTTTAATACGGAATTAAGTCAATCAAATATTGAAGAAAGATA3380 
BOTB° --------------C---------------------G------------------------------------------- 
BOTBN -------------------------------- T--------------- C------ A------------- A---- G-T--- 
BOTB' TAAAATTCAATCATATAGCGAATATTTAAAAGATTTTTGGGGAAATCCTTTAATGTACAATAAAGAATATTATATGTTTA3460 
BOTB° -------------------------------------------------------------------------------- 
BOTBN ------------------------C--------------------------------T---------------------- 
BOTE' ATGCGGGGAATAAAAATTCATATATTAAACTAAAGAAAGATTCACCTGTAGGTGAAATTTTAACACGTAGCAAATATAAT3540 
BOTB° -----------------------------------------------------A-T------------------------ 
BOTBN --------------------------------GT----------T-------------A----T---------------- 
BOT B' CAAAATTCTAAATATATAAATTATAGAGATTTATATATTGGAGAAAAATTTATTATAAGAAGAAAGTCAAATTCTCAATC3620 
BOTB° --------C----------------------------------------------------------------------- 
BOTBN --G-----C-T----------------A-----------------------------------G---------------- 
BOTB' TATAAATGATGATATAGTTAGAAAAGAAGATTATATATATCTAGATTTTTTTAATTTAAATCAAGAGTGGAGAGTATATA3100 
BOTB° -------------------------------------------------------------------------------- 
BOTBN -------------------------------------C----------GG-ACT-CACC-G------------------G 
BOT B' CCTATAAATATTTTAAGAAAGAGGAAGAAAAATTGTTTTTAGCTCCTATAAGTGATTCTGATGAGTTTTACAATACTATA3780 
BOTB° T--------------------------------------------------------------- T--------------- 
BOTB" ----------------- G--C-------------------- T--AT-------------A----A-----T--G------ 
BOTB' CAAATAAAAGAATATGATGAACAGCCAACATATAGTTGTCAGTTGCTTTTTAAAAAAGATGAAGAAAGTACTGATGAGAT3860 
BOTB° -------------------------------------------------------------------------------- 
BOTBN G--------------------------T------------------------------------- T-- 
BOTB' AGGATTGATTGGTATTCATCGTTTCTACGAATCTGGAATTGTATTTGAAGAGTATAAAGATTATTTTTGTATAAGTAAAT3940 
BOTB° -------------TA-------------------------------A--------------------------------- 
BOTBN ------------------------------------- G--T--CG-A----------------°°------------- 
BOTB' GGTACTTAAAAGAGGTAAAAAGGAAACCATATAATTTAAAATTGGGATGTAATTGGCAGTTTATTCCTAAAGATGAAGGG4020 
BOTB° ------------------------------------ C------------------- A----------------------- 
BOTB1° ----------------------------------G-C---T--------------------------------------- 
BOT Be TGGACTGAATAATATAACTATATGCTCAGCAAACCTATTTTATATAAGAAAAGTTTAAGTTTATAAAATCTTAAGTTTAA4100 
BOTB° ------------ 
BOTBN ............ 
BOTB' GGATGTAGCTAAATTTTGAATATTAGATAAACTACATGTTT 4141 
Figure 3.3 Comparitive alignment of the silent BoNT/B gene. 
The silent type B neurotoxin gene BOTB°, is aligned with the published proteolytic type B 
neurotoxin gene BOTBP (Whelan et al., 1992) and the non-proteolytic type B neurotoxin 
gene BOTBN (Hutson et al., 1994). Conserved nucleotides are marked with (-) whilst 
deleted residues are marked with (A). Nucleotide numbering is relative to BoNT/B . The thymine residue which creates a nonsense stop codon is shown in magenta, ribosome 
binding site in red and initiation codon in yellow. 
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A second single base pair deletion occurs at position 2881. Here there are only 3 adenine 
residues instead of a run of four. Of the remaining 86 base substitutions, 26 produce 
conservative mutations, 24 produce semi-conservative amino acid substitutions, 37 
produce non-conservative amino acid changes using the groupings (ILV, ST, EDNQ, 
WYF, KR, P, A, C, H, M and G) and one causes the formation of an amber stop codon 
(UAG) from a glutamic acid codon (GAG) at position 383 or codon 128 (figure 3.4). 
Among these base changes, the stop codon at position 128 of the silent neurotoxin gene 
would, in then absence of any other changes, entirely account for the observed `silent' 
type B neurotoxin phenotype. Similarly, the frame-shift alone would produce a 
truncated protein with a nonsense C-terminal sequence. However, characterisation of all 
the amino acid changes may also reveal more subtle influences on the structure of this 
silent gene. If the stop codon and frame shift in the silent neurotoxin gene were 
`corrected', the light chain would contain 8 conservative codon changes, 4 semi- 
conservative amino acid changes and 5 non-conservative amino acid changes, using the 
amino acid groupings above, whereas the heavy chain would contain 18 conservative 
changes, 18 semi-conservative changes and 32 non-conservative changes. The deviations 
in both nucleic acid and amino acid sequence appear to have a disproportional bias 
towards the heavy chain, whilst changes in the light chain are proportionally under 
represented by 50 %. 
Determination of the position of the nucleotide substitutions within each codon between 
the silent gene and proteolytic type B neurotoxin gene demonstrates that overall, no 
particular position has a greater frequency of substitution, indeed the distribution 
appears to be particularly constant (table 3.1). To test whether this seemingly random 
substitution was associated with the silent gene or if it were a common feature of other 
closely related genes, the exact position of nucleotide substitutions was determined in 
two other closely related pairs of clostridial neurotoxins, for which a complete 
nucleotide sequence has been determined (table 3.1). 
PROB MPVTINNFNYNDPIDNNNIIMMEPPFARGTGRYYKAFKITDRIWIIPERYTFGYKPEDFNKSSGIFNRDV 70 
SILB -----------------------------M----------------L----------------------- 
NPRB ----------------D----------------------------------------------------- 
PROB CEYYDPDYLNTNDKKNIFLQTMIKLFNRIKSKPLGEKLLEMIINGIPYLGDRRVPLEEFNTNIASVTVNK 140 
SILB W--------------------------------------------------------*------------ 
NPRB ------------------F--L------------------------------------------------ 
PROB LISNPGEVERKKGIFANLIIFGPGPVLNENETIDIGIQNHFASREGFGGIMQMKFCPEYVSVFNNVQENK 210 
SILB --------------------A------------------------------------- 
NPRB ---------------------------------------------------------------------- 
PROB GASIFNRRGYFSDPALILMHELIHVLHGLYGIKVDDLPIVPNEKKFFMQSTDAIQAEELYTFGGQDPSII 280 
SILB --------------------------------I-N----------------------------------- 
NPRB ----------------------------------------------------T----------------- 
PROB TPSTDKSIYDKVLQNFRGIVDRLNKVLVCISDPNININIYKNKFKDKYKFVEDSEGKYSIDVESFDKLYK 350 
SILB 7 ------------------------------------ AA---------------------- S-------- 
NPRB - S----------------------------------------------------------------N---- 
PROB SLMFGFTETNIAENYKIKTRASYFSDSLPPVKIKNLLDNEIYTIEEGFNISDKDMEKEYRGQNKAINKQA 420 
SILB -----------------------------------------------------N---------------- 
NPRB ---L----I--------------------------------------------N-G-------------- 
PROB YEEISKEHLAVYKIQMCKSVKAPGICIDVDNEDLFFIADKNSFSDDLSKNERIEYNTQSNYIENDFPINE 490 
SILB ----------I------------------------------------------A----N-------S-- 
NPRB ---------------------V----------N-------------------V-----N---G------- 
PROB LILDTDLISKIELPSENTESLTDFNVDVPVYEKQPAIKKIFTDENTIFQYLYSQTFPLDIRDISLTSSFD 560 
SILB --------------------------Y--E-K-L------------------------------------ 
NPRB ---------------------------------------V------------------N----------- 
PROB DALLFSNKVYSFFSMDYIKTANKVVEAGLFAGWVKQIVNDFVIEANKSNTMDKIADISLIVPYIGLALNV 630 
SILB --------------------------------------D---------S--------------------- 
NPRB ----V-S-------------------------------D---------S--------------------- 
PROB GNETAKGNFENAFEIAGASILLEFIPELLIPVVGAFLLESYIDNKNKIIKTIDNALTKRNEKWSDMYGLI 700 
SILB ------------------------------------------------- E--NS----- D---I------ 
NPRB -D--------S------S----------------V------------------------V---I------ 
PROB VAQWLSTVNTQFYTIKEGMYKALNYQAQALEEIIKYRYNIYSEKEKSNINIDFNDINSKLNEGINQAIDN 770 
SILB ------------------------------------K--------R---------V-------------- 
NPRB ------------------------------------K------E-------N---------D-----M-- 
PROB INNFINGCSVSYLMKKMIPLAVEKLLDFDNTLKKNLLNYIDENKLYLIGSAEYEKSKVNKYLKTIMPFDL 840 
SILB ------ E------------------------- R------------------------- D----- SI---- 
NPRB --D---E---------------K---------------------------V-D-----D------I---- 
PROB SIYTNDTILIEMFNKYNSEILNNIILNLRYKDNNLIDLSGYGAKVEVYDGVELNDKNQFKLTSSANSKIR 910 
SILB -M---N-----I------D-----------R--K-----------------K------------------ 
NPRB -T-S-IE---KI------------------ R-------------------- K------------- D---- 
PROB VTQNQNIIFNSVFLDFSVSFWIRIPKYKNDGIQNYIHNEYTIINCMKNNSGWKISIRGNRIIWTLIDING 980 
SILB -I---------M-----------------------------------------A-----M---------- 
NPRB -----------M---------------R--D--------------------------------------- 
PROB KTKSVFFEYNIREDISEYINRWFFVTITNNLNNAKIYINGKLESNTDIKDIREVIANGEIIFKLDGDIDR 1050 
SILB -I------- S-K------------------ SD------------ HI-R-------- D-------- N--- 
NPRB -------------------------------D--------T----M----- G---V----T------V-- 
PROB TQFIWMKYFSIFNTELSQSNIEERYKIQSYSEYLKDFWGNPLMYNKEYYMFNAGNKNSYIKLKKDSPVGE 1120 
SILB V----------------------------------------------------------N 
NPRB --------------Q-N----K-I-------------------------------------V---S---- 
PROB ILTRSKYNQNSKYINYRDLYIGEKFIIRRKSNSQSINDDIVRKEDYIYLDFFNLNQEWRVYTYKYFKKEE 1190 
SILB -------------------------------------------------------------I-------- 
NPRB --I--------N-----N-----------E-----------------H-LVLHHE------A-----EQ- 
PROB EKLFLAPISDSDEFYNTIQIKEYDEQPTYSCQLLFKKDEESTDEIGLIGIHRFYESGIVFEEYKDYFCIS 1260 
SILB ------------D------------------------------------Y----------K--------- 
NPRB -----SI----N---K--E--------S---------------D-------------VLRKK-------- 
PROB KWYLKEVKRKPYNLKLGCNWQFIPKDEGWTE 
SILB -------------S------K---------- 
NPRB ------------KSN---------------- 
1291 
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Figure 3.4 Comparative alignment of the type B neurotoxin amino acid 
sequences. 
The amino acid sequences for the proteolytic type B neurotoxin (PROB), (Whelan et al., 
1992) and non-proteolytic type B neurotoxin (NPRB), (Hutson et al, 1994) are 
compared. Amino acids are indicated by the single letter code. Dashes (-) represent 
amino acids with identity. The silent neurotoxin gene (SILB) is altered by replacing the 
nonsense stop codon with a *, whole codon deletions with aA and single nucleotide 
deletion which would otherwise disrupt the amino acid reading frame with a A. The 
amino acid positions indicated on the right correspond to the proteolytic type B 
sequence. Features of particular interest including the proposed active site region; 
HELIHVLHGLYG (aa 230-241), light chain-heavy chain junction; VK (aa 440-44 1) and 
cysteine residues implicated in the light chain-heavy chain disulphide bond (aa 437 and 
446) are shown in cyan. 
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NEUROTOXIN CODON CODON CODON 
GENE PAIR POSITION I POSITION II POSITION III 
Silent B 
vs. 30.2 % 33.8% 36.0 % 
Proteolytic B 
Non-proteolytic B 
vs. 36.8 % 20.6 % 42.6 % 
Proteolytic B 
C. botulinum E 
vs. 39.5 % 44.7 % 15.8 % 
C. bu icum E 
Table 3.1 Distribution of nucleotide substitutions within the codons of three 
pairs of neurotoxin genes. 
The neurotoxin genes are the silent neurotoxin gene, (this study), the proteolytic type 
B neurotoxin, (Whelan et al., 1992), the non-proteolytic type B neurotoxin, (Hutson et 
al., 1994) and the type E neurotoxins from C. botulinum and C. butyricum (Poulet et al., 
1992). The comparisons show that, for this limited number of genes, the distribution of 
nucleotide substitutions within codons alters between the toxin gene serotypes 
examined. 
3.3.7.2 Amino acid sequence. 
Alignment of the stop codon-corrected amino acid sequence of the silent B neurotoxin 
with examples of all known serotypes of botulinal neurotoxins and tetanus neurotoxin 
(Elmore et al., 1995) allowed a rational speculation as to the nature of the amino acid 
changes found between the silent neurotoxin primary sequence, the type B sequences 
and the other serotypes. Amino acid changes appeared to fall into four groups. Firstly, 
there were two changes which occurred in regions which were absolutely conserved in 
all other clostridial neurotoxins. Both of these occurred in the light chain region. The 
non-conservative replacement of a proline for a leucine residue at position 47 occurs in a 
highly conserved motif containing two other conserved residues. A second change where 
contiguous lysine and tyrosine residues are deleted occurs at positions 327-8, removing 
this short motif which is also found in all other clostridial neurotoxins (figure 3.5). 
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YKNKFKD--KFVEDSE G(329) BoNT/B (SILENT) 
MKNVFKEKYLLSEDTSG 329 
MKNVFKEKYLLSEDTSG 329 
YKNKFKDKYKFVEDSEG 336 
YKNKFKDKYKFVEDSEG 336 
YKQKLIRKYRFVVESSG 338 
YKKYFSEKYNFDKDNTG 338 
Y KDV FEAKYGLDKDASG 315 
YKDVFEAKYGLDKDASG 315 
YKDYFQWKYGLDKNADG 332 
YKDYFQWKYGLDKNADG 332 
YKNFFQWKYGLDQDSNG 324 
YKQIYKNKYDFVEDPNG 335 
YKQIYQQKYQFDKDSNG 338 
BoNT/A 
BoNT/A(Inf) 
BoNT/B(GpI) 
BoNT/B(GpII) 
BoNT/C 
BoNT/D 
BoNT/E 
BoNT/E (Buty) 
BoNT/F(GpI) 
BoNT/F(GpII) 
BoNT/F(Barat) 
BoNT/G 
TeNT 
Figure 3.5 Comparative alignment of a clostridial neurotoxin motif absent 
in BoNTB (silent) 
Alignment of all known clostridial neurotoxins demonstrates that a number of 
amino acids are totally conserved (Elmore et al., 1995). The comparison above 
shows that a Lysine-Tyrosine two amino acid motif is found in all of the 
neurotoxin primary amino acid sequences, but is deleted in the silent type B 
neurotoxin's `coding sequence'. This type of aberation may render any 
pharmacological potential of the silent type B neurotoxin redundant. 
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A second class of amino acid substitutions can be grouped on the basis that these 
differences only occur between the proteolytic type B neurotoxin and silent neurotoxin, 
but there is no equivalent difference between the non-proteolytic type B neurotoxin and 
silent neurotoxin. These substitutions would logically be formed by changes to the 
proteolytic type B sequence after the evolutionary separation of these two genes. 
Fourteen such changes exist and may reflect the duration that these sequences have 
been independent. 
The third group is composed of amino acid changes which are different from both 
proteolytic and non-proteolytic type B neurotoxins, but are widely used at that 
position by most of the other toxin serotypes (Elmore et al., 1995). Although only 3 of 
these are semi-conservative, the other 8 could be considered as semi-conservative as 
they may fulfill a similar biological role in the other toxin serotypes. A fourth group 
exists which falls into neither of the 3 previously described categories and seems to be 
composed of residue changes, which based on neurotoxin sequence similarities (Elmore 
et al., 1995), occur in between conserved motifs or rather in the `variable' regions of the 
neurotoxin sequences. This group contains both semi-conserved and non-conserved 
residues. 
3.3.8 Comparison of the 5 prime region 
Analysis of the nucleotide sequence 5' of the predicted initiation codon suggested that 
the silent gene was preceded by another coding region, separated by a 25 bp intergenic 
region similar to the proteolytic and non-proteolytic type B neurotoxin genes (Whelan et 
al., 1992; Hutson et a!., 1994). The intergenic region in front of the silent neurotoxin 
gene was identical to both type B sequences and contained the polypurine sequence 
previously proposed for the ribosome binding site (Whelan et al., 1992). 
3.4 Transcriptional mapping of the silent B gene using Northern blotting and 
primer transcript analysis 
Total RNA was isolated from C. botulinum NCTC 2916, C. botulitrum NCTC 7272 (a 
type A positive control) and C. hotulinum type B strain Danish, the proteolytic 
neurotoxin which has its nucleotide sequence determined (Whelan et a!., 1992). 
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3.4.1 Northern analysis 
RNA was analysed by agarose gel electrophoreses and blotted onto a Nylon membrane 
and probed with a type A neurotoxin and type B neurotoxin specific DNA sequence 
(figure 3.6a and 3.6b). The blots clearly demonstrate that C. bolulinum NCTC 2916 
contains both a type A and a type B neurotoxin transcript, whilst the C. botulinum 
NCTC 7272 only contains a type A transcript and C. botulinum Danish only contains a 
type B neurotoxin transcript. 
Inspection of the blots (figure 3.6a and 3.6b) suggested that the strongest signal 
originated from a point immediately below the 23S rRNA band at a size of about 2.6 
kb. However, the ribosomal RNA bands appeared to interfere with the binding of the 
probe to the mRNA transcript, presumably at high concentration, possibly by 
competing for ligands when binding to the Nylon membrane. In light of this supposition, 
the transcript could be deemed to be somewhat larger. Indeed, most of the neurotoxin 
transcripts in these blots appear to form a smear which initiates from a quite faint but 
distinct band of at least 7.4 kb, most clearly seen on figure 3.6b. This appears to be the 
case for type A, type B and the `silent' neurotoxin transcript. A similar artifact was 
previously noticed in Northern blots for the type A neurotoxin of C. botulinum type A 
(Dr I. Henderson, pers. comm. ) and can be seen in blots ofC. difficileRNA (Hammond et 
al., 1997). 
3.4.2 Primer transcript analysis. 
Attempts were made to map a transcription initiation site for the silent type B gene by 
primer extension using primer 3237 (Appendix 5) from both C. botulinum NCTC 2916 
total RNA and C. botulinum type B Danish total RNA. A number of bands were 
produced. However, the majority of the bands did not appear in the same position in 
both strains (figure 3.7), some bands appeared in the neurotoxin coding region whilst 
only 2 bands coincided in both strains. These two bands occurred close to the start of 
the neurotoxin genes and the strongest were positioned 5 bp in front of the ribosome 
binding site of the neurotoxin gene. This result did not give a satisfactory basis from 
which a conclusion could be drawn. It was not clear if the multiple bands represented 
separate initiation points of an mRNA species or if a degree of false priming with other 
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123456789 
a. 
23S rRNA E 
2.8 OIL 
16S rRNA 0 
Figure 3.6a Northern blot of C botulinum total RNA probed with a type A neurotoxin 
specific probe 
Total RNA isolated from C. hots/inum strains was analysed by Northern blotting (section 
3.4). Lane 1) RNA molecular weight markers (Boehringer Manheim) 2) type A DNA 
positive control 3) Strain B Danish 4) NCTC 2916 (A/B°) 5) NCTC 7272 (A) 6) Strain B 
Danish 7) NCTC 2916 (A/B°) H) NCTC 7272 (A) 9) type B positive DNA control. 
Probing the fixed RNA samples with a type A neurotoxin specific radiolabeled DNA 
fragment generated using type A neurotoxin serotype specific PCR primers (Whelan, S. M. 
1993) detected a type A transcript in C. holulinum NCTC 7272, a strain only known to 
contain a type A neurotoxin gene, and C. hoiuliunum NCTC 2916 a type A neurotoxin strain 
harbouring a type B neurotoxin gene. RNA from the type B strain did not hybridise 
significantly with the type A neurotoxin probe. 
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Figure 3.7 Detection of 5' mRNA transcripts by primer extension 
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Figure 3.7 Detection of 5'mRNA transcript ends by primer extension 
Transcripts were mapped by generating cDNA from radiolabeled 
oligonucleotide primers using the method detailed in section 3.4.2. Total 
RNA samples from C. botulinum NCTC 2916 and the proteolytic type B 
strain (Danish) were both extended with primer 3273 (Appendix V). Primer 
extension products were separated by denaturing gradient polyacrylamide gel 
electrophoresis beside the respective plasmid sequencing reaction (lanes 
AGCT). Lane 1 was cDNA products generated from NCTC 2916 whilst lane 
2 was the cDNA product generated from strain Danish. The accompanying 
sequence is of the intergenic gap between the NTNH gene and the silent 
BoNT/B where the stop codon of the NTNH gene is blue, the base 
corresponding to the primer extension products in both standard and primer 
extension-blotting is tan, the ribosome binding site in red and the initiation 
codon of the silent type B neurotoxin gene in green. 
92 
transcripts had occurred. To produce an answer to these questions an alternative 
strategy was devised. 
3.4.3 A novel modification for primer transcript analysis. 
To avoid the possibility of generating radio-labeled primer transcripts from mRNA 
other than the type B neurotoxins, the primer extension reactions (section 2.2.10.3) 
were conducted with unlabeled oligonucleotides 3237 and 2677 (Appendix 5). The 
cDNA products were then separated on a polyacrylamide gel (section 2.2.5.4) next to a 
non-radiolabeled dideoxy-sequencing reaction using primers 3237,2677 and a plasmid 
clone encoding the 5' region of the neurotoxin gene. The nucleic acids were then 
transferred to a positively charged Nylon membrane via Southern blotting. Alkali fixing 
of the cDNA to the membrane concomitantly removed the template RNA. The blot 
was prehybridised for 15 min in GOOP buffer (Appendix 1) and then probed with a 
radiolabeled PCR fragment which was complementary to the neurotoxin region under 
study (figure 3.8). 
Reactions using either 3237 and 2677 oligonucleotide primers, with total RNA from C. 
botulinum NCTC 2916 or C. botulinum type B Danish produced virtually identical 
bands which occurred close to the ribosome binding site of the type B neurotoxin 
sequence (figure 3.9). The position of the one of these bands was approximately 5 bp in 
front of the proposed ribosome binding site which directly coincided with the result 
obtained with the standard primer extension method (figure 3.7). 
3.5 Discussion. 
3.5.1 A silent neurotoxin gene. 
On the basis of nucleotide and predicted amino acid sequence similarities, C. botulinum 
NCTC 2916 would appear to possess the remnants of a neurotoxin gene which is most 
closely related to the proteolytic type B neurotoxin gene (Whelan et al., 1992), classified 
as a silent type B neurotoxin gene (BoNTB°) in this study. This gene is in addition to 
the type A neurotoxin gene which had been previously characterised in this strain 
(Thompson et a!., 1990). 
Although clostridia have been isolated that produce dual combinations of neurotoxin 
serotypes AT (Gimenez et a!., 1970), B: f (Hatheway et a!., 1989) and A: B (Poumeyrol 
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Figure 3.8 Development of a primer extension blotting technique. 
To aid the identification of authentic primer extension products, an adaption to the primer 
extension method was made (section 3.4.3). In essence, primer extension products were 
radio-labeled after in vitro synthesis and electrophoretic seperation, instead of starting 
with a radiolabeled primer in the cDNA synthesis reaction. 1) A primer extension reaction 
was performed with an unlabeled oligonucleotide primer. 2) The primer extension product 
(in red) were separated on a polyacrylamide gel, beside a control sequencing reaction 
(black). 3) The cDNA primer extension product and DNA control fragments were 
transferred to a Nylon membrane using a standard Southern blotting technique. 4) The 
membrane was then probed with a radiolabeled DNA fragment in a hybridisation solution 
which anneals to both primer extension products and DNA sequencing control. 5) The 
results were detected by conventional autoradiography. 
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Figure 3.9 Detection of 5' mRNA ends by primer extension-blotting 
Transcripts were mapped by generating cDNA from unlabeled oligonucleotide primers 
using the method detailed in section 3.4.3. mRNA samples from C. botulinum NCTC 
2916 and a proteolytic type B strain (Danish) were both extended with two separate 
primers 3237 and 2677 (Appendix V). Primer extension products were separated by 
denaturing gradient polyacrylamide gel electrophoresis beside the respective plasmid 
sequencing reaction (lanes AGCT). L1 and L3 are cDNA products generated from C. 
botulinum NCTC 2916 with primers 3237 and 2677 respectively whilst L2 and IA are 
cDNA products generated from C. botulinum type B (strain Danish). The accompanying 
sequence is of the intergenic gap between the NTNH gene and the silent BoNT/ß where 
the stop codon of the NTNH gene is blue, the base corresponding to the primer extension 
products in both standard and primer extension-blotting is tan, the ribosome binding site 
in red and the initiation codon ofthe silent type B neurotoxin gene in green. 
96 
et al., 1983, Gimenez et al., 1984), the recent discovery of silent neurotoxin genes has 
added a new dimension to the genetics of this group of organisms. Indeed, the prevalence 
of silent type B genes within serotype A organisms has been reported to be relatively 
common (Franciosa et al., 1994). This implies that the methods currently used to detect 
neurotoxins and their encoding genes are unsatisfactory. A protein detection approach 
will not detect a silent gene (irrespective of the reasons why the gene or part of the 
genettoxin complex is not expressed) and a DNA based assay will not distinguish if the 
toxin gene(s) detected will be expressed. An additional concern with the presence of the 
silent toxin gene is that in theory the first 127 amino acids should be expressed and 
although the peptide may be degraded, it may equally persist in the cell. In light of the 
current pharmaceutical applications of clostridial neurotoxins, particularly type A, the 
presence of such peptides and associated components of the silent type B neurotoxin 
complex must be undesirable. 
3.5.2 Genetic anomalies of the silent type B neurotoxin gene. 
An interesting problem is posed when one considers the order in which sequence 
changes to the type B neurotoxin gene may have occurred. When comparing several 
neurotoxin genes (Elmore et al., 1995) the deletion of several codons is not unusual. 
However, if the lysine and tyrosine residues were vital to the function of the neurotoxin, 
the organism would contain a particularly large protein which would be entirely 
redundant but still demand a lot of cellular resources to be expressed. This would also 
. 
be the case with the C-terminal deletion mutation. A practical solution from the 
bacteria's point of view would be to minimise this futile energy loss by introducing a 
translational stop codon near the beginning of the gene and avoiding translating the large 
protein. Conversely the translational stop codon may have occurred first and the other 
mutations may simply be due to the lack of selective pressure for maintenance of the 
sequence. 
During the course of this study another group published a partial sequence of a similar 
silent type B neurotoxin gene from the type A C. bolulinum strain 667 (Hutson et al., 
1996). In addition to the genetic alterations described above an additional single base 
pair deletion was found (figure 3.10). This could suggest that the second frame-shift 
deletion in strain 667 was due to genetic drift within this sequence. 
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3.5.3 Interpretation of the Northern blotting 
The Northern blots in figure 3.6a and 3.6b demonstrate that the silent type B neurotoxin 
gene in C. botulinum strain NCTC 2916 does have a mRNA transcript and that under 
the conditions isolated, the distribution of the toxin transcript appears to be virtually 
identical to the transcript detected in the proteolytic type B control organism, C. 
botulinum strain Danish. In fact, the distribution of the transcripts probed with type B 
genes appeared to resemble those of type A genes. In general, this appears to conform 
to a faint high molecular size transcript of at least 7.4 kb, which becomes more intense at 
approximately 1-3 kb. In between these sizes, a `smear' can be observed. These 
observations may be explained by the physiological production of the neurotoxins. 
Studies by Bonventre & Kempe (1960), demonstrated that toxin production gradually 
increased, reaching a peak after approximately 24 h. In effect, toxin was being produced 
during exponential growth at a steadily increasing rate (section 1.3.3). The preparation 
of the clostridial cultures for purification of total RNA was designed to complement this 
phenomenon and this method had been successfully used to study the mRNA 
transcripts from the type A neurotoxin complex in strain NCTC 2916 (Henderson et al., 
1996). Thus, at the time of total RNA purification, full length transcript and partially 
degraded transcripts would have been present in all viable cells. The ratio of these 
transcripts would depend on the relative stability (half life) of the full length transcript. 
The deductions from the Northern blots could therefore be explained as a small amount 
of large full length transcript with shorter disintegrating transcripts increasing in number 
at 1-3 kb. The proposed size of the `full length' mRNA suggested that the neurotoxin 
gene may be part of a polycistronic operon, possibly a bicistronic operon in 
combination with the preceding NTNH gene (section 4.2.1.4). Attempts to detect 
neurotoxin specific transcripts from `younger' cultures were unsuccessful which could 
be due to the low level of transcripts present. The toxin titer of the culture was not 
determined and, therefore, some degeneracy of toxin production can not be ruled out. 
3.5.4 Interpretation of primer transcript analysis. 
Studies on a number of other botulinal neurotoxin serotype transcripts have identified 
possible mRNA start points (Binz et al., 1990; Hauser et u!., 1994; 1lenderson et a!., 
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Figure 3.10 Nucleotide sequence discrepency in the silent BoN1'/B neurotoxin 
sequence 
Comparison of the nucleotide sequences determined for the silent BoNT/B pseudogene in 
C. holulinum NCTC 2916 (this study) and the partial silent BoNT/B pseudogene in C. 
hotu/m um strain 667 (Hutson el al., 1996) revealed a single discrepency. In the sequence of 
Hutson (1996) a single thymidine base was deleted at position 2391. Autoradiographs of 
the equivalent region of sequence from this study were analysed (above) and the sequence 
determined in either direction (P-) was shown to contain a thymidine residue (in red) 
as was previously determined for the proteolytic type B (Whelan et al., 1992) and non- 
proteolytic type B neurotoxin gene sequences (Hutson el al., 1994). 
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1996). Through a combination of studying the length of the intergenic region between 
the NTNH genes and neurotoxin, the position of the proposed transcripts and 
attempting to map a start point in front of the type B neurotoxin, it became evident that 
it was unlikely that a separate transcript did exist for the neurotoxin genes per se. In the 
first instance several of the NTNH genes among the botulinal serotypes appeared to be 
fused with the ribosome binding site of the following neurotoxin gene or were separated 
by relatively few bases (figure 3.11). This organisation suggests that translation and, 
therefore, transcription, could be linked. A more theoretical argument supporting the 
tight linkage of the two genes on the same transcript stems from the observation that 
neurotoxin complexes contain neurotoxin and NTNH proteins in the M and L complex 
forms at an equal ratio (Sugiyama, 1980). One mechanism to ensure that this ratio is 
maintained could be by linking the expression. Indeed, the relative organisation of these 
two genes is maintained in all botulinal neurotoxin complex operons characterised. 
The view point that the NTNH gene and 'neurotoxin gene could be linked would appear 
to be mutually exclusive with the occurrence of transcripts starting near the intergenic 
region. With this in mind, the attempts to map mRNA transcripts in this region would 
not be successful but could possibly detect artifacts of the primer extension process or 
mRNA degradation intermediates. An examination of a 500 bp section of sequence 
spanning the type B NTNH-neurotoxin intergenic region did not appear to reveal an 
obvious secondary structure motif which could have been capable of prematurely 
terminating the reverse transcriptase. This suggests that if the bands which were 
obtained were not due to (multiple) promoters, they could be due to degradation 
products of a larger transcript. 
A comparison of the transcripts mapped for the type A neurotoxin gene (Henderson et 
al., 1996)with those determined for the silent and proteolytic type B neurotoxin genes 
(this study) revealed that a `transcript' start point was detected 5' of the neurotoxin 
genes, which in both cases occurred at 5-6 bases in front of the respective gene's 
ribosome binding site. The positioning of a promoter so close to a gene is uncommon 
and was not found in the study of Binz (1990) who mapped a transcript start site for 
the type A neurotoxin to 118 bases upstream from the initiation codon. however, in 
that study the oligonucleotide primer bridged the type A neurotoxin ribosome binding 
site and would consequently have produced an equivalent transcript which was too 
too 
NTNH/A 5'-TGGTCATTTAAA -29-AAGAGG--8-ATG-3' BoNT/A 
NTNH/B 5'-TTAAAAGGGATA -10-AGGAGG--9-ATG-3' BoNT/B 
NTNH/C 5'-ATATTAGAAAGT ------GAGA-10-ATG-3' BoNT/C 
NTNH/D 5'-ATATTAGAAAGT ------GAGA-10-ATG-3' BoNT/D 
NTNH/E 5'-TTAAAAAATATA -10-AGGAGA--8-ATG-3' BoNT/E 
NTNH/F 5'-TTGAAAGAAGTA ------ GGGG--8-ATG-3' BoNT/F 
NTNH/G 5'-TTAAAAAAGATA -70-AGGAGG--8-ATG-3' BoNT/G 
Figure 3.11 Alignment of the intergenic regions between botulinal neurotoxin 
serotypes 
The intergenic region between the NTNH gene and neurotoxin gene are aligned for the 
different neurotoxin serotypes so a rational prediction of translational coupling can be 
made. The last four codons of the NTNH gene are shown, followed by the stop codon 
(green), ribosome binding site (red) and initiation codon of the neurotoxin. Nucleotide 
spacings are depicted by numbering and nucleotides shared between the stop codon and 
ribosome binding site are in blue. The sequence evidence suggests that the NTNH gene 
and neurotoxin gene of serotypes C, D and F have tight translational coupling, those of B 
and E would also appear to be coupled whereas the sequence evidence appears to be less 
obvious for A and G. However, due to the conflicting evidence supporting the 5' 
positioning of mRNA transcripts (Henderson et al., 1996, Binz et al., 1990, Hauser et al., 
1994) the existence of a promoter positioned within the NTNH coding sequence cannot 
be ruled out. On the other hand, the requirement of a BoNT-specific promoter would not 
be logical if the NTNH and neurotoxin gene were transcriptionally and translationally 
coupled. 
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small to detect. A survey of the literature did describe a phenomenon where short 
polypurine tracts of mRNA were capable of attenuating mRNA degradation (Hue et 
al., 1995; Agaisse & Lereclus, 1996). These sequences, which closely resemble ribosome 
binding sites, are thought to protect the transcript from 5'-+3' riboexonucleolytic 
degradation via binding of a ribosome to produce a pseudo-transcriptional start site a 
few bases in front of the polypurine tract (Agaisse & Lereclus, 1996). An obstacle to 
this hypothesis is that little evidence for a 5'--+3' ribonuclease exists, at least in E. coll. 
However, recent studies in B. subtilis suggest that this activity may exist (DiMari & 
Bechhofer., 1993) and that 5'-proximal structures which sequester the 5' terminus of an 
mRNA can increase a transcripts half life. The explanation proposed is that 
ribonucleases require either a 5' or 3' end from which to initiate degradation (figure 3.12). 
Among the mechanisms which appear to protect the 5' end of a transcript from 
ribonucleolytic degradation, ribosome binding sites appear to feature prominently (table 
3.2). Studies on E. coli lacZ transcripts provide evidence that the efficiency of the SD is 
a strong determinant of transcript stability and that the SD sequence may effect this role 
independent of its role in the initiation of translation (Agaisse & Lereclus, 1996; Wagner 
eta!., 1994). 
The prevalence of `false' transcripts due to the proposed phenomenon is not widely 
reported, possibly due to the heterogeneous nature of DNA sequences to which 
promoter elements can be assigned. A survey by Agaisse & Lereclus (1996) did detect a 
number of transcripts which appeared to initiate shortly before a `SD type sequence'. In 
addition the SD sequence of the B. subtilis SP82 bacteriophage early RNA has been 
demonstrated to perpetuate transcript half life (Hue et al., 1995). 
Assuming that this transcript interpretation is correct, what purpose could such a 
stabilising element serve in the inter-cistronic space between NTNH and BoNT genes? 
Without further practical experimentation, this question cannot be answered. However, 
several plausible ideas can be. suggested. Ehretsmann (1992) noted that in general, 
mRNA degradation is rapid, where the majority of transcripts in procaryotes such as E 
coli have a half life of 2-3 minutes. Thus, in a long polycistronic transcript, mRNA 
degradation is sufficiently rapid that the 5' end begins to be degraded before the 3' end is 
synthesised. Thus, differences in the stability of separate genes of a polycistronic 
transcript may be required to maintain proper co-ordination of the expressed proteins 
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Figure 3.12 Hypothetical mechanism of NTNH-Neurotoxin transcript 
degradation 
Ribonucleolytic degradation of the NTNH-neurotoxin transcript may occur by the 
action of a 5'-3' ribonuclease or by the 5' binding of a 3'-5' ribonuclease 
(section 3.5.4). The 3' end of the transcript is probably protected from 
degradation by an inverted repeat which may also act as a Rho-independent 
transcriptional terminator. Degradation which has initiated at the 5' end would be 
blocked by a ribosome pausing at the ribosome binding site of the neurtoxin 
transcript. As the half life of the neurotoxin transcript would be longer than that 
of the preceding NTNH section, the new 5' end of the neurotoxin transcript 
would be preferentially detected by techniques such as primer extension analysis 
(adapted from Bechofer, 1991) 
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Assuming that an 8 kb transcript of this nature is relatively long, protection from 5' 
binding endoribonucleases may be of particular relevance. Another hypothesis could be 
that translation of the NTNH and BoNTB genes by a ribosomal complex are intimately 
linked in such a manner that the two newly synthesised peptides are able to efficiently 
bind during toxin complex assembly (figure 3.13). If this were the case, a brief pause 
between the genes may be necessary to enable a post translational modification step 
such as peptidase processing of the NTNH protein to occur. Theoretical justification of 
this idea is supported by the observation that NTNH and BoNT proteins are naturally 
found processed and complexed. The sequestration of the neurotoxin may be vital to 
avoid a deleterious intracellular action of the neurotoxin which could be similar to the 
activity observed with transaminases in eucaryotic cells. 
ORGANISM LOCUS MECHANISM COMMENT REFERENCE 
B. thuringiensis cryllIA toxin gene Shine-Dalgarno interaction of a S-D Agaisse & Lereclus 
sequence sequence in the mRNA (1996) 
leader sequence with a 
ribosome protects from 
5'-º3' nbonucleolytic 
degradation. 
B. thuringlensts cryIIIB toxin gene Shine-Dalgarno suggested by Agaisse & Donavon et al. (1992) 
sequence Lereclus. (1996) 
B. thuHriglensls cryIUB2 toxin gene Shine-Dalgatno suggested by Agaisse & Donavon et al. (1992) 
sequence Lereclus. (1996) 
B. brevls cwp Shine-Dalgamo suggested by Agaisse & Adachi et al. (1989) 
sequence Lereclus. (1996) 
L. monocytogenes MIAB Shine-Dalgacno suggested by Agaisse & Dramsi et al. (1993) 
sequence Lereclus. (1996) 
B. subnlis early RNA of Shine-Dalgamo proposed interaction laue et al. (1995) 
bacteriophage SP82 like sequence with the 3' end of 16 S 
rRNA 
B. subtls ermC ribosome interaction erythromycin induced 13echhofer & Zen (1989) 
with mRNA stalling of a ribosome 
Saurens ermA nbosome interaction erythromycin induced Sandier & Weisblum, 
with mRNA stalling of a ribosome (1989) 
Table 3.2 Examples of mRNA stability influenced by Shine-Ualgarno type 
scqucnccs 
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Ribosome Bicistronic NTNH-neurotoxin mRNAtranscript 
NTNH peptide 
Processing/Conformational change 
Neurotoxin peptide 
Figure 3.13 Hypothetical function of the stalled ribosome. 
A possible function of the ribosome stalling at the neurotoxin's SD sequence 
could be that a short delay may be required between the translation of the 
NTNH gene and the neurotoxin gene. This could be essential if precise 
sequestration of the neurotoxin by the NTNH protein was important to protect the 
cells from proteolysis or the formation of transmembrane pores by the neurotoxin 
(section 3.5.4). 
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3.5.5 Translational coupling of the NTNH and BONTB transcripts? 
The efficiency of translational initiation is partly determined by the sequences preceding 
the initiation codon. Either initiation is termed We novo', if a ribosome binding site 
precedes the initiation codon, or `re-initiation' if no ribosome binding site exists, but the 
initiation codon is often intimately linked with a 5' gene (Sprengel et al., 1985). As the 
BoNT/B gene is accompanied by a ribosome binding site (figure 3.11), initiation is 
presumed to be We novo'. However, the termination codon of the NTNH gene is 
separated from the BoNTB ribosome binding site by only 10 bases suggesting that the 
ribosomes may pass efficiently from the 5' ORF to the BoNTB ribosome binding site. 
This provides a possible mechanism of translational coupling which negates the 
requirement of an independent promoter and mRNA transcript for the neurotoxin gene 
whilst providing a co-ordinated expression system. 
3.5.6 Function of the silent BoNT/B `pseudogene' 
Genes classified as `silent' have been described in a variety of organisms including 
pathogenic bacteria. Examples include an enterotoxin gene from S. aureus (Solds et al., 
1990), recA from the mycoplasma Acholeplasma laidlawii (Dybvig & Woodard 1992), 
ilvG genes from E. coil K12 and Salmonella typhimurium LT2 (Burns et al., 1995) and 
pilin genes from Neisseria gonorrhoeae (Gibbs et al., 1989). However, interpreting the 
biological significance of such `silent' genes is complex. The most simple scenario is 
proposed for the ilvG haemolysin of E. coil K12 and S. typhimurium LT2. Here the 
nonsense mutations are thought to have been acquired since entering the laboratory, a 
phenomenon also proposed for other laboratory isolates (Burns et al., 1995). Such an 
explanation is unlikely for the mutations occurring in the BoNT/B genes in group I C. 
botulinum strains as their occurrence appears to be widespread in a number of separate 
isolates (Franciosa et al., 1994). An alternative hypothesis could be that the pseudo- 
gene sequences have an important role in the pathogenesis of neurotoxigenic clostridia, 
which may be maintained as a transiently redundant gene pool. This type of explanation 
is illustrated in N. gonorrhoeae where novel pilin genes are assembled from a larger 
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repertoire of partial gene sequences (Gibbs et al 1989). This type of mechanism is a 
versatile method of increasing or maintaining virulence, which is used by a number of 
pathogens, including trypanosomes (Roth et al., 1989). A neurotoxin gene has been 
isolated which appears to consist of a type C and type D chimera (Moriishi et al., 
1996). Although the process by which this gene evolved is unknown, it must be noted 
that the majority of neurotoxigenic clostridia have been isolated from clinical cases. 
Thus, only functional genes would be isolated, and therefore we may only see a fraction 
of the clostridia which do possess active neurotoxins and not those which maintain a 
library of `transiently redundant' neurotoxin sequences from which chimeras could be 
constructed. 
3.5.7 Reversion to an active neurotoxin? 
From an analysis of the nucleotide sequence of this BoNTB silent gene, two principle 
mutations appear responsible for the discontinuity of the coding sequence; a 
substitution at nucleotide 381 to form a translational stop codon and a single nucleotide 
deletion at 2881. Assuming that rectification of only these defects would be necessary 
to produce a viable neurotoxin, the possibility of this gene returning to an active form 
must be feasible. This, however, does not seem to have been the case for the partially 
characterised AB strain I. P. 7212 (Fujinaga et at., 1995) which is virtually identical to 
the type B neurotoxin from strain Danish. 
In some instances a translational stop codon does not present a total barrier to 
translation (Gozalbo & Hohmann, 1989). Indeed, the identity of the bases which reside 
next to a stop codon can to some extent modulate the efficiency to which the stop codon 
can be suppressed (Feinstein & Altman, 1978). In E. coli, the effect of `codon context' 
was shown to be due to the 5' and 3' codons surrounding the stop codon (Bjornsson & 
Isaksson, 1993). Purine bases which are under represented at `true' termination codons 
(Brown el a/., 1990) were able to enhance leaky translational readthrough which was 
further increased by mutations in specific ribosomal proteins If translational 
readthrough is also feasible in clostridia, a possibility exists that a low level of 
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expression, or base changes which lead to a conducive codon context around the 
fortuitous stop codon will enable a low level of expression of the BoNT/B gene. As 
clostridial neurotoxins are particularly potent, this level of expression may be 
significant. 
3.5.8 Why do type A group IC botulinum strains commonly contain type B 
pseudogenes? 
A number of biologically important proteins depend on the aberrant suppression of 
stop codon translational termination to create a greater protein repertoire (Ryoji et al., 
1983) but this does not seem to be likely in this example. Instead, a rational explanation 
could be that other components of the neurotoxin complex which are encoded at the 
silent BoNTB locus do provide an advantage to the organism,. e. g., the NTNH or 
haemagglutinin proteins. If this were the case, the BoNT/B neurotoxin may have become 
an unnecessary burden to an organism which already contained an efficient neurotoxin. 
Expression of the NTNH gene may depend on the stability afforded by the 3' BONTB 
transcript, thus a nonsense stop codon near the 5' end of the BONTB would avoid 
expression of the BoNT/B neurotoxin but still maintain NTNH gene expression. 
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CHAPTER 4 
MOLECULAR CHARACTERISATION OF THE 
NEUROTOXIN OPERON FOUND IN ASSOCIATION WITH 
THE TYPE B NEUROTOXIN GENE IN C botulinum NCTC 
2916. 
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4.1 Introduction 
Genetic evidence accumulated whilst cloning and characterising the botulinal neurotoxins 
serotypes A-G (Elmore et al., 1995) demonstrated that at least one additional 
component of the neurotoxin complex was consistently found to reside 5' to neurotoxin 
genes. Initially, an ORF was found in the same orientation and in close proximity to the 
neurotoxin genes of serotypes A, C, D and E (Binz et al., 1990a; Kimura et al., 1990; 
Binz et al., 1990b; Fujii et al., 1990). Alignment of the predicted C-terminal sequence of 
the ORF from the different serotypes demonstrated a high degree of similarity. A 
further report established that the ORF which was predicted upstream of the type C 
neurotoxin gene was indeed a component of the neurotoxin complex (Tsuzuki et al., 
1992). In addition, a clone whose gene product possessed haemagglutinin activity was 
also located 5' to the type C neurotoxin locus (Tsuzuki et al., 1990). This suggested that 
the haemagglutinin activity associated with other neurotoxin complex serotypes (Somers 
& DasGupta, 1991) could also be genetically linked to the respective neurotoxin gene. 
With these facts in mind, a strategy was devised to identify additional genetic 
components associated with the silent type B neurotoxin gene from C. botulinum NCTC 
2916. 
4.2 Results 
4.2.1 Characterisation of the silent type B neurotoxin complex locus 
4.2.1.1 Evidence of neurotoxin complex genes accompanying the silent type B 
neurotoxin gene. 
Initial data supporting the existence of additional genes 5' to the silent type B 
neurotoxin gene surfaced whilst characterising the silent neurotoxin gene (section 3.3.2). 
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Southern blotting with DNA fragments from the NTNH/A gene generated data 
incompatible with the type A neurotoxin locus alone (Dr S. M. Whelan pers. comm. ) In 
addition, the preliminary sequence data from clone pSBI supported this view (section 
3.3.2), but also confirmed previous reports that the components of type A and B 
neurotoxin complexes were closely related (Somers & DasGupta, 1991). Attempts to 
clone DNA fragments 5' to the silent type B neurotoxin were complicated by the 
prediction that the type A and type B NTNH and haemagglutinin genes were very 
similar (Somers & DasGupta, 1991). Type B specific NTNH and haemagglutinin genes 
were reliably cloned by targeting a DNA fragment contiguous with part of the type B 
neurotoxin gene (section 3.3.5). 
4.2.1.2 Cloning strategy 
A PCR fragment of the type B NTNH gene (section 3.3.3) which differed from the type 
A NTNH gene (Henderson et al., 1996) was excised as a Bg1II Stul restriction fragment 
This was radio-labeled and used in Southern blotting experiments to create a restriction 
map of the contiguous sequence (figure 4.1 and figures 4.7a, 4.7b). Accordingly, a 6.5 kb 
XbaI restriction fragment was targeted for cloning into an E coli vector pMTL22 
(Chambers et aI., 1988). The entire nucleotide sequence of the cloned fragment, pSB 1 was 
determined on both strands by the method of Sanger (section 2.2.11.4). Forward 
universal and reverse universal oligonucleotide primers were used to obtain initial 
sequence data, from which successive oligonucleotides were designed to `walk' through 
the clones. Individual sequences were compiled into a single contig using the DNASTAR 
software package `Seaman'. The complete nucleotide sequence was translated in all six 
$ lkhý 
M* 
pp, 
ORF's of type A locus (correct) 
Haemaggludmin operon -1 
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<==ýý 
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p933 DCBA4 
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Genomic clones (A) 
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Genomic restriction map (A. ) 
Genomic restriction map (B) 
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4.0 kb (uncloned) 
HAST/21.5 ýl J Bom ORF's of Silent type B neuro- 
toxin locus 
Haemagglutinin operon 
0123456789 10 11 12 
Scale (kbp) 
Figure 4.1 Cloning strategy for the type A and type B neurotoxin loci from 
C. botulinum NCTC 2916. 
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Figure 4.1 Cloning strategy for the type A and type B neurotoxin loci from C. 
botulinum NCTC 2916. 
The type A locus was initially cloned (central ORF's) from overlapping genomic 
DNA fragments, targeted by Southern blotting experiments (Henderson et al., 1996; 
Thompson et al., 1990). The type B locus (lower ORF's) was then cloned as 
contiguous Xbal genomic fragments also characterised by Southern blotting 
experiments (this study). Blue shading indicates 100 % sequence identity, brown 
shading indicates ORF's originating from the silent type B locus (B°), yellow 
hatching represents uncloned ORF's from the type B sequence, purple shading 
represents type A ORF's, purple hatching indicates uncloned ORF's of the type A 
locus. Some restriction sites are omitted for clarity. The organisation deduced from a 
different A(B°) strain (Hutson et al., 1996) is shown at the top (ORF'S of type A 
locus (correct)) and differs significantly from the organisation originally suggested for 
the type A locus for C. botulinum strain NCTC 2916. Analysis of the strategy 
employed to clone the type A locus from C. botulinum NCTC 2916 reveals that 
clones pNTNH, p933, p544 and p257 almost certainly originate from the type B° 
locus. Unfortunately, the 3' oligonucleotide primer used to generate pNTNIVA was 
designed in a region of the NTNH gene which was identical in both the type A and B 
NTNH genes. Furthermore, the entire overlap of pCBA4 and p933 was identical in 
sequence to the equivalent region of the NTNH/B gene. This error could have been 
avoided if the restriction profile predicted earlier (Thompson et al., 1990) had been 
closely observed. . 
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possible reading frames. Two complete ORF's and two partial ORF's were detected 
(figure 4.1). 
4.2.1.3 ORF 1 
The 5' end of a gene previously characterised as the silent type B neurotoxin was found 
at the end of this genomic fragment (section 3.3.6). This verified that the genes which are 
contiguous within the 6.5 kb XbaI clone are naturally associated with the silent type B 
neurotoxin gene. 
4.2.1.4 ORF 2 
ORF 2 coded for a protein of 1197 amino acids starting with a methionine initiation 
codon and ending with a ochre termination codon (Appendix III). The primary amino 
acid sequence of ORF 2 showed similarity with the N-terminal sequence data 
determined by protein micro-sequencing for the `nontoxic-nonhaemagglutinin' protein 
(NTNH) isolated from type C (Tsuzuki et al., 1992) and type E (Somers & DasGupta, 
1991) botulinal neurotoxin complexes. This strongly indicated that ORF 2 coded for a 
nontoxic-nonhaemagglutinin gene (NTNH/B°). Comparative alignment of the predicted 
amino acid sequence with the putative NTNH protein from the type A neurotoxin locus 
from the same strain (Henderson et al., 1996) demonstrated that these proteins were 
closely related, sharing 93.7 % amino acid identity. On closer examination, the 
alignment of the putative type A and B NTNH genes appeared to show regions of 
almost perfect identity, particularly in the N-terminal 1021 amino acids where only a 
single base change was detected. However, the 177 C-terminal amino acids differed 
significantly from the corresponding NTNH/A gene and were virtually identical to the 
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C-terminal region of the NTNHB gene from the proteolytic type B neurotoxin locus 
(Whelan et al., 1992). In an attempt to judge if the putative NTNHB° was " 
representative of a typen B neurotoxic strain, the sequence of another NTNH/B gene 
was aligned with the NTNH genes from C. botulinum NCTC 2916 (Appendix IV). The 
comparison demonstrated that NTNH/B° possessed greater similarity with the N- 
terminal 1021 amino acids of NTNH/A from the same strain and not with the published 
type B strain. However, in general it appeared that the degree of similarity among 
NTNH genes from various serotypes appeared to alternate inconsistently along the 
length of the genes. 
Contemporary studies have demonstrated that a representative NTNH gene is present 
in all other botulinal serotypes investigated and that its genetic orientation is conserved 
with respect to the accompanying neurotoxin gene (East et al., 1994). A comparative 
alignment of the predicted primary amino acid sequences available for serotypes A-F 
(Appendix IV) demonstrates that these proteins are well conserved. In addition, they 
contain a number of N -terminal amino acid motifs which are also present in the N- 
terminus of all currently characterised clostridial neurotoxins (Elmore et al., 1995). Both 
the composition and spatial orientation of these genes with their respective neurotoxin 
adds further weight to the assumption that they are homologs. 
4.2.1.5 ORF 3 
In a region spanning 925 bp 5' to NTNH/13°, a second ORF of 178 amino acids was 
identified. This was encoded on the same strand as NTNHB° and would be predicted to 
be transcribed in the same orientation as both the NTNfl/B° and neurotoxin gene. The 
putative methionine initiation codon was preceded by a polypurine sequence resembling 
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a Shine-Dalgamo sequence (Shine & Dalgarno, 1974). Although the mass of this 
predicted protein (21.65 kDa) was close in size to components of the type A 
neurotoxin protein complex (Somers & DasGupta, 1991), no sequence similarities could 
be detected. ORF 3 did not appear to encode a protein encountered in the neurotoxin 
complex. A search of the entire Swiss-Prot data base (release 100) revealed a low degree 
of amino acid similarity with a number of proteins. A 29 % identity over a 61 amino 
acid overlap occurred between the ORF 3 polypeptide and MsmR, a positive 
regulatory effector controlling the multiple sugar metabolism (msm) system in 
Streptococcus mutans (Russell et al., 1992). From a critical examination of this 
alignment, the majority of the similarity was centered in a section which was described 
as a helix-turn-helix motif in MsmR (Russell et a1., 1992). The equivalent section of the 
ORF 3 polypeptide was evaluated for helix-turn-helix potential using the method of 
Dodd & Egan (1990) and was predicted to contain this motif (figure 4.2). 
Application of this technique to other proteins retrieved in the database search included 
UviA, (a protein implicated in the UV-irradiation response of C. perfringens; Gamier & 
Cole, 1988), and ORFtxel (present on the C. dif cile toxigenic element; Hammond & 
Johnson, 1995), also detected helix-turn helix motifs (figure 4.2). However, unlike 
MsmR, both UviA and ORFtxel were of similar length to the ORF 3 protein and shared 
similarity along their entire length (figure 4.3). 
Among the other proteins which were identified in the database search were a variety of 
transcriptional factors, however, the alignments did not provide compelling evidence of 
an evolutionary or functional link. Several sigma factors displayed a low level of 
sequence similarity with the ORF 3 polypeptide, UviA and the ORFtxel polypeptide. 
Amon; these were, SigG (12.1 %) from C. acetohnlt'licum (Sauer e! ('/., 1994), SigG 
116 
Prediction of helix-turn-helix motifs In ORF 3141-163, uvlA1u-176 and txeR145167. 
ORF3 IKEIDIAKKLNISRQSVYKNKI 
[75] [-31] t-171][451 [109] [116] [238] [94] [70] (132] [128] [128] [174] [129] (65] [-26] [1691 (162] [38] [-137][-9][-155] 
UviA KSEVEIAEIMGTSRQWINRIKN 
[-31] [961 [-1711[-177] [1561[116][2381 [107] [651 [1221 [2021 1-81 1174) 11291 [651J-261 [1881 [21 [1791 [531 1-9111041 
TxeR YSDREISVKLKISRQAVNKAKN 
[-401 [961 1-156][651 [1561 [1161 [-81 [-1781 [70] [1321 [-91 [1281 [174] [1291 1651 [771 11691 [2] [381 [46] [-9][104] 
(H-T-H) CUMULATIVE SCORE SCORE CLASS H-T-H PROBABILITY 
ORF3 1253 35 71 % 
UviA 1574 4.5 100% 
TxeR 1167 3.2 >50 % 
Table 4.2 Calculation of helix-turn-helix probability. 
Figure 4.2 Prediction of H-T-H motifs 
The probability of 11-1-II potential as estimated by the Weight ntattiy method of I)odd K, I pan i It), )()) 
Individual amino acid scores relating to their position in the I I- I -I l (table -13 I) \\ etc calculated to give it 
cumulative score (es) and entered into an equation to derive it -score class ligure (I )odd &. I: }an I'))(I) 1c Ics- 
23K 11/293.01- score class, lion which aII -I'- Il probability vvas derived 
Prediction of the 11-1 -11 M this method relies on the iek rencc set of 11 -1 -11 sequence, to accitialch iepiescnt all 
such motifs. therefore sequences which are not predicted to loan this mutti mav do so but may not he tauly 
rchtcscntcd in the master telercnce set. un example is 111)k (I )add & I-ran. I990) 1 Iii, method 001st be unk used 
, is u ho; itivc disaiintnatou 
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AMINO ACID POSITION IN PUTATIVE H-T-H 
1I -LFL: r`IKML--KNDNEEFQEIFKHFE---KT IFTRKY---N ORF3 
1 M-SELY <NIVLCQNGDKKAIEYIINRFE---IL KYKMSFLý EI UviA 
1 MQiSFY`LIVLARNNSVDDLQEILFMFK. ---PL. XLS---- RVL TxeR 
1 NEETF---QLLYDTYHQDLYQFLFYMV: H"DKNQTEDLLQEVYIRVL SigX 
region 2.1 region 2.2 
38 IYDNYN------ DILYHLWYTLKKVDLSNFNTQND--LERYISRT ORF3 
42 HFNSYDIEDNKQDLIVSLINIVNKIPIDNPQFENEGCLVNYIYKS UviA 
39 HY-----EEGETDLIIFFIELIKNIKLSSFSEKSDAIIVKYIHKS TxeR 
43 --NSYHTFEGRSSEKTWLLSIARHVAIDWFRKQQ----------- SigX 
0, A b- 
4 
region 2.3 region 2.4 
75 LKRYCLDIti NKRKIDKK--IIYNSEIADKNLS-LI71J'ýSYSSYSE- ORF3 
88 ILNSR DMYIN1 IKRY-FIE--: =- Y>SLSSMVE -FKDKPLVKYIES UviA 
79 LL "KTFELSRRYSKMFFNFVEFLEN ILNMKNN-YQSKSV--FEED TxeR 
75 ------------TIRQRILGTFDWDTQDVRDQQLLPDELAVQHEN SigX 
region 3.1 region 3.2 
116 -FEFNDLISILPDDQKKIIYMKFVEDIKEIDIAKKLNISRQSVYK ORF3 
128 NIA' IEDMLKCLTEKEQKVIKYKFLNDKSEVEIAEIMGTSRQWINR UviA 
122 ICFFEYILKELSGIQRKVIFYKYLKGYSDREISVKLKISRQAVNK TxeR 
118 VREISCALDQCTIDQR. AVIILRFIQGYSIQETAKALRFSESKVKT SigX 
region 4.1 'on 
T 
160 NKIMALERLEPIL X LI HM ORF3 
173 IKNTALKKLKENI UviA 
166 AT<NRAFKKIKKDYENYFNL TxeR 
153 TQHRGLKVLRK HMELLREELMDDEVRMERRTDKGVVKSTSGS SigX 
Figure 4.3 Alignment of ORF 3 polypeptide homologues with SigX 
Alignment of the ORF 3 polypeptide, UvIA and TxeR with SigX was performed using the DNASTAR software 
program Megalign by the Clustal method (Higgins & Sharp, 1988). Amino acids were grouped on a `structural' 
basis where green implies external residues (DEHKNQR), red implies internal residues (FILMV) and blue 
implies ambivalent residues (ACGPSTWY). Residue groups are only shown in colour when the majority group 
is present. Asterices denote residue groups occuring in the a70 family and the ORF 3 protein. UviA and TxeR, 
whilst arrows indicate functional domains which are conserved in the the a70 related group with specific 
reference to SigX, residues 1-117 (Lonetto et al., 1994) and residues 118-195, (Lonetto et al., 1992). 
(13.9 %) from B. subtilis (Yudkin et al., 1987) and SigX from B. subtilis (Lonetto et a!., 
1994). This suggested that the ORF 3 protein and its putative homologues (UviA and 
ORFtxel) could contain domains similar to sigma factors. Using the sigma factors 
mentioned above, the ORF 3 protein and its putative homologues were aligned with a 
wide selection of other sigma factors for which structure-function relationships have 
been partially determined (Lonetto et al., 1992). The helix-turn-helix motif of the ORF 3 
protein and its putative homologues, determined by the method of Dodd & Egan 
(1990), appeared to precisely match the helix-turn-helix ascribed to region 4.2 found in 
the sigma factor group. Furthermore, additional conserved residue groups were found 
outside of the helix-turn-helix motif (figure 4.3). 
4.2.1.6 ORF 4 
On the reverse DNA strand, a third ORF was discovered 225 bases 5' to the putative 
ORF 3 and was preceded by a ribosome binding sequence which closely complimented 
the 3' end of B. subtilis and C perfringens 16S rRNA (Gamier et al., 1991). The gene 
coded for a protein of 263 amino acid residues and appeared truncated by the end of the 
clone. This partial sequence was identical to the N-terminal 291 amino acid residues of 
the HA34 protein found at the type A locus (Henderson et al., 1996). A comparative 
analysis of the predicted amino acid sequence with N-terminal sequences determined by 
Somers & DasGupta, (1991) demonstrated that this gene encoded a haemagglutinin 
component identical to the type A neurotoxin complex described as the 35 kDa 
haemagglutinin protein (Somers & DasGupta, '1991) with 10 of 10 N-terminal amino 
acid residues matching. Comparison of HA34/B° with a 33 kDa haemagglutinin cloned 
and sequenced from C. botulinum type C (Tsuzuki ei u!,, 1990) demonstrated that the 
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gene products shared 33.0 % amino acid identity and were of a similar length (figure 
4.4). In addition, the type A and type C HA33/4 genes were found in a similar 
orientation to the putative NTNH and neurotoxin genes. They were thus deemed to be 
homologous. Comparison of HA34B° with the current Swiss-Prot database (release 
100) identified a region of 32.4 % similarity over a 93 amino acid overlap with the 
HA17/C gene (Figure 4.4) in the type C operon (Fujinaga et at., 1994). A marginally 
lower percentage similarity was found with HA17B° (section 4.2.1.8), a possible 
homologue of HA17/C. The conserved residues matching HA34B° were essentially 
identical in both the type B and type C HA17 proteins (figure 4.4). 
A second protein also showed a low percentage similarity with HA34B°, the 100 kDa 
mosquitocidal toxin from Bacillus sphaericus (Thanabalu et al., 1992), exhibiting a 28 % 
identity over a 245 amino acid overlap. Intriguingly, many residues which appeared to 
correlate between HA34/B° and HA17 found in type B and C, also were found to align 
with the mosquitocidal toxin (figure 4.4). 
4.2.1.7 Origin of the neurotoxin complex sequences 5' to BoNT/A 
A total of 7.996 kb of DNA were characterised in the region 5' to the start codon of the 
type A neurotoxin gene (Henderson et al., 1996). The A+T content of the DNA was 
75.1 % suggesting a clostridial origin. Within this sequence a total of five ORFs were 
identified by the similarity of their encoded proteins to other published proteins and N- 
terminal sequences, which may encode at least seven separate polypeptides. The 
putative genes appeared to be organised in three separate operons (figure 4.1), When 
analysing this data, a discrepancy was found between the theoretical position and actual 
position of Xbal and BgIll restriction sites which were predicted by the Southern 
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MEHY VI. SLNDKIVTI: CKADTNLFFYQVA-GNVSLFQQTRNYLF; RWRLIYIISNKA YKIKSMPIHNTN HA34/A 
MSQTNA':: LRNNEVFFI. PSNNITNKVLDKISQS 'VKLW'UKLSGA', 2KWRLIY, )TNKQ YKIKVM: --NT HA33/C 
MSVERTFLPNGNYNIKSIF--SG. HA17/A 
MSSERTFLPNGNYKIK: SLF--SD HA17/C 
ýIFGFENQKWNIKYISKKN YKIYNRF, --TP. Mtx 
SDKEINIQVWNLIYPILK YKIK: 'LK--YPN Mtx rep2 
NYSS DKNNR Y FN --HP. ü Mtx rep3 
-VL: W---- NAPTHNI TQQ. NA , 
YPJL:. LK I-GNNSFIIASYK,.. V: -IA. T ARN- KL LN HA34/A 
LILTW---- NAPLSSV. VKTi'. NG7'IN; QYWYLLQI, IY-I. RNVIIRNYMtN1 NLVLQY--NIPDT-LMV. :; T HA33/C 
LYLNP---- VSKSLTF. '--Ni:. SA JQKWNVEYMA-ENRCFKISI'IVAE 1IKYLSYDNIFGFIS-LDSL ': RC HA17/A 
LYLTY---- SSGALSF; --NT ýSLý'tNNQKWKLEYIS-S. 'NGFRFSN, VAE NKYLAYNPYGFIY-LSS.. 'UN1: ' HA17/C 
`, LL''WNSNS $NGEQVIRGYTiI', GS'; '1('YWTIEKNVNGFYKFRNLSDPSKILDLKDGt? TLIIKTPLVV.;. "F'I1 Mtx 
YS AUDSNNTRTIVAA, 'GDY---- L R''EDN, YIIRNYP, NRKIVLDLSNGSTTf)GNGI, Mtx rep2 
S AIIDSNNDKIFGATGDY---- IPILTDG. FIFRNYKNPNKIFGTN-G, PI' DIP Mtx rep3 
-' NYIKFIIFDYI ISDJJIt]FTCKISPI_L1 RNNIKVVc, QV'I ! MTNLN`. 'NLYTWDYGR': ,, 
KWT i RY'; EEKA YQFF 
-: SNQFFKFSNCIYEALii? IRNCKLQTQL ISDRFLSK-i, ILNSQITVLWQWF' I. SR KWI LEY: ETKS YTL- 
YWFPIKIAVIdTYIML. 3LNKVNELDYAWDIYPTNENNNILSQPLLLLPNF: IY? d. "1:; MFKLEKI 
LWNPIKIAINSYIICTLSIVNVTDYAWTIYI, NNNNIT))QPILNT_, PNFI)INN: ý1NIQILKI, EKL 
-: SSQEWL; F: KTNYQ . 
'K, GTYQ''SSK-:; E' KV''. Q STNK`. H --FSNS KI. V'%N I PILK KIK 
NTILS'IGV' TWIFSNG?: TVRVSSSVDQNNDAYWL : PVS TDETYT; T: JLR: TTKA - : Y:; SQTA:. GTAI 
KCQEN RY T IQNSNIJYVETYQSTD--SLI N YLD' DASKYILYNLQDTNRVI, IDVYNSQIANNIGTHV 
SLKYP YS A ---DS': NTRTIVAATGDYND L R-- EDNTYITR'IYE'IRKIV', ýlLS'IGSTT: GNG 
QVFNY DDL: L; KWN! RNP HA33/A 
IVDSY NT' QI NLI HA33/C 
LGFEF GI RIK Mtx 
Figure 4.4 Comparitive alignments of the HA34 haemagglutinin component of C. botulinum NC FC 2916. 
HA34/A 
HA33/C 
HA17/A 
HA17/C 
Mtx 
HA34/A 
HA33/C 
Mtn: 
Proteins which were similar to the 34 kDa haemagglutinin from C. botulinum NCTC 2916 were found using the DNASTAR software programs to 
scan the Swiss-Prot database (release 100). Homologues of approximately the same molecular weight were detected in other botulinal neurotoxin 
regulons including type A NCTC 7272 (98.6 % identity) nonproteolytic type B (89.7% identity), (East et a!., 1994) and types C and D (identical 
proteins with 33 % identity), (Tsuzuki et at., 1990; Ohyama et al., 1995). A lower degree of similarity was found between type C HA17 protein (34 % 
identity over a 95 amino acid overlapXFujinaga et al., 1994) and to a slightly lesser degree with the type A HAI 7 protein (this study). The 100 kDa 
mosquitocidal protein (Mtx) from B. sphaericus SSII-1 also displayed a significant degree of similarity (29.79 % identity over a 245 amino acid 
overlap). Alignment of the type A 34 kDa haemagglutinin (HA34/A) and type C 33 kDa haemagglutinin (HA33/C) with the type A and type C 17 
kDa haemagglutinins (HA17/A and HAI7/C) and partial Mtx coding sequence demonstrates a number of similar motif's and conserved residues 
which appear to occur in all 5 proteins. The sequences described as motif I and motif 2 appear to occur in multiple copies in the Mtx and HA33-34 
kDa proteins and form part of a consensus motif occuring in the multiple internal repeat sequences (Mtx rep 1,2 and 3) of Mtx (Thanabalu et al.. 
1992). Amino acid groupings are (E, D, N, I (Vs', Y, F), (' and (R and K), ( ), (C), (M) and ((i). Amino acids were grouped 
when the majority was at least three. 
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blotting data of Thompson et al (1990). The analysis of this data suggested that these two 
sites occurred in the DNA sequence 5' to type A neurotoxin, but were never actually 
found (Henderson et al., 1996). Examination of the DNA sequence 5' to the BoNT/A 
gene of other strains (discussed in section 4.3.6) demonstrated that both the Xba I and Bgl 
II restriction sites are present at the predicted positions. It is concluded that sequences 5' 
to the NTNH/A gene presented by Henderson (1996) were actually derived from the 
BoNTB° locus and the NTNH/A gene sequence described is actually an artefactual 
chimera which is fused at a 500 bp region identical in both the NTNH/A and N TNH/B° 
genes. It therefore appears that members of the haemagglutinin operon which were 
thought to be located in the BoNT/A locus are actually from the BoNT/B° locus and 
should therefore be considered here (figure 4.1). 
4.2.1.8ORF5 
A fifth ORF was identified, on the same strand as ORF 4 separated by an intergenic 
distance of 68 nucleotides. The ORF codes for a protein of 147 amino acids (17 kDa) 
and was preceded by 8 bases with a Shine-Dalgarno sequence (figure 4.6). Comparison 
of this protein sequence of ORF 5 with the results of Somers & DasGupta (1991) also 
suggested that this protein was an individual component of type A and B neurotoxin 
complexes (HA17). A search of the Swiss-Prot database (release 100) found a putative 
homologue of HA17 in the type C botulinal neurotoxin complex locus (Fujinaga et a1., 
1994). The type C HA17 was of identical length and shared 63 % amino acid identity 
with HA17B°. HA34 and HA17 also shared a similar organisation to their counterparts 
at the type C locus (Fujinaga ef (il., 1994) and were separated by virtually identical 
intergenic gaps however, the 17 kDa proteins of the BoNT/ß° and type C progenitor 
122 
neurotoxin complexes contained a higher degree of amino acid sequence identity in 
comparison to the larger 34 kDa and 33 kDa proteins of the BoNTB° and type C 
progenitor neurotoxin loci. 
4.2.1.9 ORF 6 
A sixth ORF was discovered closely associated with ORF 5, which coded for a protein 
of 625 amino acids (71.14 kDa). The initiation codon was separated from a Shine- 
Dalgamo-like sequence by seven nucleotides, which in turn was adjacent ' to the 
termination codon of ORF 5 (Appendix III). An initial comparison of the predicted 
sequence of this ORF with the N-terminal sequence data of Somers & DasGupta (1991) 
indicated that the remaining two peptide sequences corresponding to proteins of 57 kDa 
and 21.5 kDa in the neurotoxin complex. Both appeared to originate from within the 
coding sequence of ORF 6. However, both occurred at internal sites which did not 
correlate with translational signals and therefore were possibly due to multiple 
proteolytic processing. Indeed, the predicted cleavage sites both occurred between a 
lysine and valine residue. 
A search of the Swiss-Prot database (issue 100) revealed that the ORF 6 polypeptide 
had a homologue in the type C neurotoxin complex which shared 67.7 % amino acid 
identity. The corresponding ORF found in the type C locus (Fujinaga et al., 1994) was 
orientated in an identical manner to ORF 6 and was separated from the HA17 gene by 
16 bp, an identical intergenic distance was found between ORF 5 and ORF 6. Both 
proteins also appeared to result from post translational modification where up to 15 
hydrophilic amino acids were removed at the amino terminal ends, whilst a second 
cleavage created a 21.5 kDa and 53 kDa moiety. ORF 6 was also found to share 20 % 
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amino acid identity with the C. perfringens type A enterotoxin (CPE) (Czeczulin et al., 
1993) over a 202 amino acid overlap (figure 4.5). 
4.2.2 Repetitive sequences 
Haemagglutinins and other lectins are commonly found to contain repetitive domains 
(Romeo et al., 1986). Repeating motifs were searched for using the `Dot-Matrix' 
algorithm method (DNASTAR inc. ). Self alignment of the 3 genes occurring in the 
putative haemagglutinin operon exposed a number of possible repetitive sequences. The 
21.5 kDa component of the HA70 protein appeared to share sequence identity with the 
contiguous 53 kDa component (figure 4.5). Elements of this similarity were also shared 
with CPE. This relationship was previously shown to occur in the C. botulinum type C 
HA70 protein (Fujinaga et al., 1994). 
A repeating motif was discovered in the coding sequence of the HA 34 protein (figure 
4.4). This occurred 4 times, and in two cases was preceded by a similar repeat (figure 
4.4), and intriguingly, the double repeat also occurred in the HA 17 protein. Alignment 
of HA 34 and HA17 indicate that these two sequences could share an evolutionary 
relationship (figure 4.4). Motifs similar to these also occur in the 3 regions of internal 
homology found in the B. sphaericus mosquitocidal toxin (Thanabalu et al., 1992). 
4.2.3 Transcripts 
Northern blotting data generated by Dr I. Henderson (Henderson et al., 1996) 
demonstrated that radio-labeled DNA probes derived from either the HA70, HA17 or 
HA34 genes detected a single 3.2 kb transcript. Transcription of the putative 
haemagglutinin genes therefore, appeared to be linked 
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1 MNSSIKKIY---NDIQEKVINYSDTIDLADGNYWRRGDGWILSRQNQILGGS'. 'ISN' (ý HA22/A 
1 MSLSIKELY---YTKDKST---- NNVNLADGNYVVNRGDGWILSRQNQNLGGNISNNGC: A HA22/C 
194 TNNIF---NS---KVSSTQRVLPYSNGLYVINKGDGYIRTNDKDLIGTLL_EA= HA53/A 
191 KNSNN---NI---NFNT. "QTILPYPNGLYVINKGDGYMR'TNDKDLIGTLLIESS HA53/C 
1 MLSNNLNPMVFENAKE', IFLISEDLKTPINI'NSNSNLSDGLY`'IDKGDGWTTG-EPSVVSSQILNPNET', CPE 
CPE (A) CPE (B) 
K- X---X------ . -- .. ---X-X-XGL '.: >: Gý DGi. rL -I-XXXGX-XXX-G'1; G CONSENSUS 
58 IVGDLRVNDNAI YYYP''--PSFNEEYIKNNIQTVFTN--F: EANQIPIGFEF. KT' . ýNKNLYMY:. QY HA22/A 
54 IVGDLRIRET-'AT YYYPT--ASFNEEYTKNNVQNVFAN--F': EA: EIPIGFEF K: ' : 'NKSLYMT: QY HA22/C 
246 : IIQPRLRN: TR LFTTSNDTKFSQQYTEERLKDAFN'JQLFNTS'_'SL---F'KFVEE DKNICIKAIN. HA53/A 
242 :'I IQPRLRN ý'TR L, FNT: NPTI F $QEYTEARLNDAFN i QLFNTS ITL FKFVEE NKN 1 SMK'TYNT' HA53/C 
69 TFSQSLTKSKEVSi-NVNFSVGFTSEFIQAS`JEYGFG; ---' IGEQNTTERSV. T: ' GPNEYVYYK`. 'YA' CPE 
1: -X-R: x, RXT--P: -:: --: '----F: ": XXXI-X-: -XX-F-: >: ---T-- -:: -I-F-FS-TAP;: XKXYY-K Y-T CONSENSUS 
124 YIRYEIIKVLQHEIIER VLYV SLGYVKSIEFNPGEKINKDFYFLTNDKCILNEQFI, YKKILET-: KNI HA22/A 
120 YIRYEIIKVLQNTVTER VLYV: -SLGYVKSIEFN EEQIDKNFYFTSQDKCILNEKFIYKKIDDTI. VKE HA22/C 
312 YEKYELIDYQNGSIVNK EYYL SLGYCEV, 'N PSPESEVVKMQVAEDGFIQNGPEEEIVVGVIDP: 'ýENI HA53/A 
309 YEKYELINYQNGNIDDK EYYL; SLGKCEVD PSPQAPVVETPVDQDGFIQTGPNENIIVGVINPEN; HA53/C 
135 YRKYQAIRISHGNISDSGSIYKLTGIWLMK'['S DSLGN------ IDQGSLIETGERCVLTVPSTDIEKE: CPE 
Y-XYXXIXX-XGXX-XX--XYXPXLGXX--: XA-S-X----X----XX--IX-GXX-:::: -V---X-: '-XI CONSENSUS 
193 P HA22/A 
192 SK HA22/C 
383 QEINTAISDNYTYNIPGIVNNNPFYILFTVN'1'? 'GIYKINTQNNLPPLKIYEAICSGNRNLQAGNLCNNNI HA53/A 
380 EEISTPIPDDYTYNIPTSIQNNACYVLFKVN'I"I'GVYKITTKNNLPPLIIYEAIGSSNRNMNSNNLSNDNI HA53/C 
199 LDLAAATER---LNLTDALNSNPAGNLYDWR. NSYPWTQKLNLH-LTI-TATGQKYRILASKIVDFNIY CPE 
-X:: ----------NX---XX-N---- LX---.: --Y------ NL--L-I---- G---R------ X. --X-- CONSENSUS 
453 KAINYITGVDDPNTKSYLVVLLNKDKNYYIRVPQTSPNIENQIKFKREEGDLRNLMNSSVNIIDNLNSTG HA53/A 
450 KAIKYITGLNRSDAKSYLIVSLFKDKNYYIRIPQISSSTTSQLIFKRELGNISDLADSTVNILDNLNTSG HA53/C 
264 SNNFNNLVKLEQSLGDG'J'KDHYVDISLDAGQYVLVMKANSSYSGNYPYSILFQKF CPE 
CPE (C) 
522 AHYYTRQSPDVGNYISYEFTVPGNFNNKDTSNIRLYTSNNQGIGTLFRVIETIDGYKLIGIRQNLHLLNN HA53/A 
519 THYYTRQSPDVGNYISYQLTIPGDFNNIASSIFSFRTRNNQGIGTLYRLTESINGYNLITINNYSDLLNN HA53/C 
593 TNSIRLLNGAIYILKVEVTELNNYNIRLHIDITN HA53/A 
590 VEPISLLNGATYIFRVKVTELNNYNIIFDAYRNS HA53/C 
Figure 4.5 Alignment of HA70 derivatives with the C perfringens CPE enterotoxin 
The HA70 `Haemagglutinin' protein sequence from C botulinum NCTC 2916 shares a 67.7 % amino acid identity 
with a homologue in the type C neurotoxin locus (Fujinaga et al., 1994). Evidence suggests that both proteins under go 
proteolytic cleavage into 53 kDa and 22 kDa entities (Fujinaga et al., 1994; Inoue et a!., 1996). The cleavage product 
of type A may be further processed (blue arrow indicates HA53 cleavage and red arrow indicates HA22 cleavage 
(Inoue et al., 1996). Alignment of the 53 kDa and 22 kDa moieties from both type A and type C proteins demonstrates 
that a degree of sequence conservation exists. At the N terminus of all peptides exists a conserved motif surrounding 
the tri-peptide sequence GDG; this region (CPE(B)) is considered essential for the toxic action of cpe whilst 
proteolytic removal of region CPEA enhances activity (Kokai-Kun & McClane, 1997). The C-terminal region of CPE 
(CPE(C) encodes the enteric receptor domain (Kokai-Kun & McClane, 1997) and does not appear to resemble the C- 
terminus of the botulinal 53 kDa fragments. Amino acid groupings are (E, D, N, Q), (I, I., \'), (W, Y, F), (- and I), (R 
and K), ( ), (C), ( ), (H), (M) and (G). Amino acids were grouped when the majority was atleast three. 
ACUUGAAAAAAUAUAAAGGAGAAAAGUGU------ AUG HA70 
UAUCAUCUAAUUUAUAAAGAGGUGAAUUAU ----- AUG HA17 
AUUAAUUCUUAAAUAAAGGAGGAAUCAUA------AUG HA34 
AAUAAUAUGUAUAUUAUGGAGGGAUAGUGGUAAAUAUG ORF 3 
GCGUUGAAAUAAAUUUAGGAGAGUGGUUAGAU---AUG NTNH/B 
UAAUUUUAAAUAUUAUAAGAGGUGUUAAAU-----AUG BONT/A 
AUAUAAACUUAAAAUAAGGAGGAGAAUAUUU----AUG BONT/B° 
1-----789---13 
3'-UCUUUCCUCC-16S B. subtilis rRNA 
Figure 4.6 Translational signals from neurotoxin locus genes from C. botulinum NCTC 
2916 
Sequences resembling ribosome binding sites (Shine & Dalgarno, 1974) are aligned with the 
complementary 16 S sequence from the Gram-positive Bacillus subtilis (blue). The putative 
initiation codon of the respective genes are shown in green. Gram-positive organisms such as 
clostridia are believed to require extensive complementarity with the 3' end of the 16 S rRNA 
to participate in protein synthesis initiation (Vellanoweth, 1993). Other features which 
facilitated synthesis in Gram-positives, such as B. subtilis were the choice of initiation codon 
(AUG>UUG>GTG) and an SD-initiation codon spacing of between 6-10 nucleotides. Thus, 
with the exception of ORF 3, the ribosome binging sites are all within I base of the consensus 
sequence 5'-AGGAGG-3' and are between 7-10 nucleotides from an optimal initiation 
codon. 
The non-conformist nature of the putative transcriptional factor's translational signals may 
suggest a lower degree of translation in comparison to the neurotoxin complex structural 
genes. 
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ORF 3 appears to form a monocistronic operon. The gene is divergently transcribed 
from the putative haemagglutinin operon and is 5' to the proposed NTNH-neurotoxin 
operon promoter. Therefore, it is unlikely to be under the direction of either of these 
promoters. Although a transcript of ORF 3 was not detected by Northern blotting (Dr I. 
Henderson pers. comm. ) a cDNA product was detected, which mapped 64 bases 5' to 
the ORF 3 initiation codon and from which -35 (TGGATA) and -10 (TATTAA) boxes 
could be tentatively ascribed (Henderson et a1., 1996). 
ORF 3 is closely followed by the putative promoter regions regulating the expression of 
the NTNH gene (Appendix III). However, transcriptional read through from ORF 3 into 
the following operon does not seem to contribute significantly, as Northern blotting of 
total RNA from C. botulinum NCTC 2916, using ORF 3 derived DNA as a probe, did 
not detect the larger 7.5 kb NTNH-neurotoxin transcript. 
4.2.4 Transcriptional signals 
The divergent nature of the genes encoding the neurotoxin complex components implied 
that a minimum of two promoters must be present. Comparative alignment of the 
intergenic sequences preceding the NTNH gene and putative HA 34 gene identified a 
common sequence of 23 bp which was followed by a second conserved element of 10 
bp separated by 7 bp (see figure 4.8 and Appendix III). The larger sequence contained a 
motif `TTTACA' which is virtually identical to the -35 promoter element recognised by 
the major form of RNA polymerase (Young et al., 1989). Subsequent primer extension 
analysis by Dr I. Henderson located mRNA initiation sites 3' to the putative promoter 
sequences in front of both the NTNH and putative HA 34 kDa genes. 
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Figure 4.7a Generating a genomic restriction map of the type It neurotoxin locus in 
C botulinum NCTC 2916 
Genomic digests of chromosomal DNA isolated from C. hotu/inunr NC1'C 2916 were 
separated in an agarose gel and transfered to a Nylon membrane. The membrane was 
probed with probe 3, a radiolabeled Bg/ll-Surf DNA restriction fragment isolated from a 
PCR clone of the type B NTNH gene from the same strain (see figure 4 1). The probe was 
hybridised at 56 °C for 16 h in `GOOF hybridisation solution Minor bands typically 
observed near 4.4 kb probably result from weak interaction with the type A NTNI I gene. 
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Figure 4.7b Generating a genomic restriction map of the type B neurotoxin locus 
in C botulinum NCTC 2916 
Genomic digests of chromosomal DNA isolated from C. ha/u/rnum NC'I'C 2916 were 
separated in an agarose gel and transfered to a Nylon membrane. The membrane was 
probed with probe 3, a radiolabeled Bg/Il- , ti'/ul DNA restriction fragment 
isolated from a 
PCR clone of the type B NTNH gene from the same strain (see figure 4.1). The probe 
was hybridised at 56 °C for 16 h in `GOOF' hybridisation solution. 
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Figure 4.7a Generating a genomic restriction map of the type B neurotoxin locus in 
C. botulinum NCTC 2916 
Genomic digests of chromosomal DNA isolated from C. holultnum NCTC 2916 were 
separated in an agarose gel and transfered to a Nylon membrane. The membrane was 
probed with probe 3, a radiolabeled Bg/ll-Slid DNA restriction fragment isolated from a 
PCR clone of the type B NTNH gene from the same strain (see figure 4.1). Positive NTNH 
type A and type B controls were pCBA4 and pSB 17 respectively (see pl 12, figure 4.1). The 
probe was hybridised at 56 °C for 16 h in `GOOF' hybridisation solution. Minor bands 
typically observed near 4.4 kb probably result from weak interaction with the type A 
NTNH gene. 
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Figure 4.7b Generating a genomic restriction map of the type B neurotoxin locus 
in C botulinum NCTC 2916 
Genomic digests of chromosomal DNA isolated from C. ho/u/m um NCTC 2916 were 
separated in an agarose gel and transfered to a Nylon membrane. The membrane was 
probed with probe 3, a radiolabeled BgIll- Shil DNA restriction fragment isolated from a 
PCR clone of the type B NTNH gene from the same strain (see figure 4.1). Positive 
NTNH type A and type B controls were pCBA4 and pSB 17 respectively (see p 112, 
figure 4.1). The probe was hybridised at 56 °C for 16 h in `GOOF' hybridisation 
solution. 
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TTATATTTTTAAAAA AT. 'AAAA AATAGTGTGGCT A :; AT - 84nt-AGGAGA- Ent-ATG-N'1'NH/A Allgn. l 
ATTTGATATATTTAA AT: CAAAA AATAACTTGATT A TAT- 21nt-AGGAGG- 7nt-ATG-HA34/A 
TTTATATATTTTTAT ATTTTAGA1'1TACAAAA GACGATGAAGAA !..,,,.,,. A1'AA GTG- 82nt-AGGAGA-10nt-ATG-NTNH/C1 
AATAGATATATTATA ATTTTAGGTTTACAAAA TTTGGCTTAAAT ; _. TTATATGTAP, GTG- 20nt-GGGAGG- 6nt-ATG-HA33/C 
TTTTTAAAAATTTAA ATTTTCAGTTTACAAAA AATAACCTGATT ;.. 3 TATATGT _`. TTG-110nt-AGGAGA- 
Bnt-ATG-TeNT 
TATATCAAATTTTTA TTAGTATGTTTACATAA TTGATTATGGAT ATTTCGTAAAAAT GGC- 62nt-TGGAGG-13nt-ATG-ORF 3 Align. 2 
TAAATAATATTATAG AGAATTAGTTTACATAT TATTACATGTAA GTTATAATAATGT AAA- 5nt-AGGGGA- 7nt-ATG-ORF22/C 11 
AAATAAAAAAATTAT AAATTTAGTTTACAAAA TTGAAGTCAAAT TA T AT,; - 74nt-GAGAGG- 8nt-ATG-Bcn5 P1 Align. 3 
TATCGGCTTTTTTAA TTTTTAGGTTTACATTT TTAAAACTAAA CT T TTA-156nt-GAGAGG- Bnt-ATG-Bcn5 P3 
TAGATTTTTATAAAA AATAGATATTTACAAAA TAGACTAAAAAA AG . 
N11T-152nt-AGGGGT- 9nt-ATG-uviA P5 
ACATTAAAAAAATAT AAGATATGTTTACAAAT TACTATCAGACA ATCTCCTTATCTA N4A-222nt-AGGAGG-5nt-ATG-ToxA Align. 4 
TTTATATTTTATATA GAACAAAGTTTACATAT TTATTTCAGAAA AAGTCTTTATTCA ATc-15lnt-AGGAGA-7nt-ATG-ToxB 11 
TATTTATTGACTAAA TTATAAAGTTTACATAA TTATTTAATAAT TATGTAATTGTTA CTT-333nt-AGAGGG-7nt-ATG-TxeR A1[gn. 5 
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CONSWSUS PR TLR SLQULNRS Oi B. +ubtilis a FACTORS 
-35 SPACZA -10 SIGMA FUNCTION in B. subtilii 
TTGACA--- ------------ --TATART (aA) 
RGGXTTRA- ------------ - GGGTAT (a`) 
AAATC---- -----------T AXTGYTTZTA (a`) 
TAAA----- ----------GC CGATAT (aý) 
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House keeping/early sporulation. 
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Post exponential gene expression. 
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Post exponential gene expression, 
competence and early sporulation. 
Degradative enzyme gene expression. 
Early mother cell gene expression. 
Early forespore gene expression. 
Late forespore gene expression. 
Late mother cell gene expression. 
TGGCAC--- --TTGCANNN (aL) 
ZHATAXX-- ------------ CATACAHT (as) 
GCATR---- -----------G GHRARHTX (a') 
GHATR---- ------------ --CATXHTA (a°) 
AC------- ----------CA TANNNTA (a') 
Figure 4.8 Clostridial neurotoxin promoters and other cognate promoters 
Alignment 1 consists of mapped clostidial neurotoxin operon promoters (adapted from I lenderson et a!., 1996) 
which consist of the promoter regions directing expression of the haemagglutinin operon in type A; I IA33/A and 
type C; HA34/C, the NTNH-neurotoxin operon from type A; NTNH/A and type C; NN H/C and for the C. tetani 
neurotoxin; TeNT. 
Alignment 3 and 4 show mapped promoters from the C. perfringens BCN5 regulon (Gamier & Cole, 1988) and C. 
dijcile toxigenic element (Hammond et a!., 1997), respectively, where promoters P1 and P3 direct expression of 
the bacteriocin 5, P5 directs expression for the putative transcriptional factor uviA, and toxA and toxB direct the 
expression of the C. difficile type A and B entero/cytotoxin and cytotoxins, respectively. 
Alignment 2 shows unmapped sequences preceding ORF3 and its homologue in the type C neurotoxin locus ORF 
22 (Hauser et al., 1994), whilst alignment 5 shows a similar unmapped sequence in front of the putative positive 
transcriptional regulator TxeR of the C. difficile toxigenic element (Hammond et a!., 1997; Moncrief et a!., 1997). 
The comparisons appear to show that an extended -35 type sequence exists in the clostridia] neurotoxin operons 
surrounding a core sequence TTTACA, which is similar to the -35 
e consensus promoter element. Features of this 
extended promoter (RRRTTTACAAXX) appear to be present in the BCN5 and C. diJcile cytotoxin regulons 
(alignments 3,4 and 5) which also possess putative homologues of ORF3. However the highly conserved -10 box 
found in the clostridial neurotoxin regulons may be replaced with alternative `specific' -10 analogues in the other 
operons. It is interesting to note that sequences resembling the -35 box occur in front of ORF 3, ORF22 (alignment 
2), uviA (alignment 3; P5) and TxeR (alignment 5). These could participate in some type of autoregulation. 
Other characterised sigma factor consensus sequences are shown below (adapted from Haldenwang, 1995) 
Ambiguous bases are coded; H: A or C, N: A, G, C or T, R: A or G, W: A, G or C, X: A or T, Y: C or T, Z: Tor G. 
Transcriptional start sites are shown in magenta. 
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4.3 Discussion 
4.3.1 Haemagglutinin genes 
ORFs 4,5 and 6 appear to form an operon encoding haemagglutinin proteins. A similar 
operon has been characterised in the type C neurotoxin locus (Fujinaga et al., 1994; 
Hauser et al., 1994) and by analogy has also been characterised to varying degrees in 
representatives of serotypes A and B (East et al., 1994), B (Yang et al., 1996), 
(Bhandari et al., 1997), A(B°) (Hutson et, al., 1996), D (Ohyama et al., 1995) and G 
(Bhandari et al., 1997). Serotypes E, F and some sub-types of serotype A described as 
A2 do not appear to possess a haemagglutinin operon closely associated with the 
respective neurotoxin locus (East et al., 1996). The existence of haemagglutinins in C. 
botulinum serotypes and their association with the neurotoxin complex is a well 
established phenomenon (Lowenthal & Lamanna, 1952; Oguma et al., 1976). 
Consequently, the genetic alliance of genes encoding the neurotoxin and haemagglutinins 
ties in well with these earlier observations. However, haemagglutination has not been 
directly established for each individual component. The HA 34 gene would appear to 
encode a haemagglutinin. Tsuzuki was able to demonstrate that deletions in the HA 33/C 
gene cloned in E cola eliminated the haemagglutinating activity which had been 
demonstrated for the intact gene (Tsuzuki et al., 1990). Haemagglutinin activity was 
attributed to the type G neurotoxin complex (Nukina et al., 1991) which does not 
appear to encode a homologue of the HA 33 gene (Bhandari et al., 1997). Thus, on the 
basis of a `simple' comparison, it could be deduced that the HA 33 homologues were 
not entirely responsible for all haemagglutinating activities of the neurotoxin complex. In 
the report of Somers & DasGupta (1991), individual elements of the type A or B 
neurotoxin complex corresponding to the 53 kDa, 35 kDa, 21.5 kDa and 17 kDa 
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components could not demonstrate haemagglutination of RBC. This was attributed 
either to the presence of SDS, or to the fact that heterologous haemagglutinins were 
required containing multiple ligand binding sites to effect haemagglutination. However, 
with the observations of Tsuzuki (1990) in mind, this could not be a logical explanation 
of why the HA 34 did not function. 
Close inspection of the HA 34 coding sequence revealed a number of repeating features, 
characterised by a tryptophan residue preceded by residues with polar side chains and 
followed by another hydrophobic residue (figure 4.4). Two of these repeats appear to 
be preceded by a second motif also containing a -tryptophan residue (figure 4.4). These 
motifs form a significant proportion of residues common between the HA 34 and HA 17 
homologues from other botulinal neurotoxin complexes and the 3 repeating domains of 
the mosquitocidal toxin from B. sphaericus (Thanabalu et al., 1992). As these motifs 
appear to occur in multiples, it is tempting to speculate that they may contribute to the 
binding capacity of the clostridial haemagglutinins and mosquitocidal toxin. Furthermore, 
the sequence similarity detected between the HA 34 and HA 17 proteins indicate that 
they may have common ancestry, where the HA 34 gene might have arisen by a 
duplication of the HA 17 gene. Domain duplication has been. implicated in the formation 
of other haemagglutinins (Romeo et al., 1986). Analysis of the predicted secondary 
structures of the haemagglutinin proteins and the mosquitocidal toxin demonstrate that 
they are all mainly composed of ß-pleated sheets punctuated by a large number of turns 
and coils. The structures are predicted to contain flexible regions along their entire 
length. A similar secondary structure has been described for the M-agglutinin of E. coil 
and certain lectins (Rhen e[ u!., 1986). 
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Comparison of the HA 70 coding sequence failed to detect motifs found in the HA 34 
protein. However, Fujinaga first reported a primary sequence similarity between the 
proteolytic cleavage products of the HA 70 protein of the type C neurotoxin complex 
and the C. perfringens type A enterotoxin (CPE) (Fujinaga et al., 1994). A similar 
relationship is also evident from this study. Several interesting parallels exist between 
these proteins. Firstly, post-translational modification of HA 70 produces HA 21.5 
and HA 53 proteins. The HA 21.5 kDa protein is then further processed from the N- 
terminus in C. botulinum type A (Fujita et al., 1995) and type C (Fujinaga et al., 1994). 
The CPE enterotoxin can also be modified by peptidases endogenous to the human 
digestive system, removing up to 44 N-terminal amino acids and concomitantly 
increasing cytotoxicity (Kokai-Kun & McClane, 1997). They are all predicted to 
comprise ß-pleated sheets, interspersed with turns and coils, and are flexible. In 
addition, the CPE enterotoxin, HA 21.5 and HA 53 proteins at some point all 
specifically interact with other proteins (Kokai-Kun & McClane, 1997). 
Details of the structure-function relationship of CPE enterotoxin are emerging. The 30 
C-terminal amino acids are thought to determine initial receptor binding to a 50 kDa 
protein, the initial intestinal target of the enterotoxin (Kokai-Kun & McClane, 1997). At 
the N-terminal end, residues 45-53 are essential for cytotoxicity (Kokai-Kun & 
McClane, 1997). The N-terminal 45-53 residues of the enterotoxin also form part of a 
well conserved motif common to the type A and C HA 53 and HA 21.5 proteins (figure 
4.5). At the center of the motif, a RGD sequence present in both HA 21.5 proteins (but 
replaced by KGD in the HA 53 and CPE proteins) was suggested as a cell attachment 
site (Fujinaga el a!., 1994). 
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Pairwise alignment of the C-terminal end of the CPE enterotoxin with the C-terminal 
end of the HA 53 protein show negligible similarity. In conclusion, the similarity 
between CPE and the HA 53 and HA 21.5 appears to indicate a distant but common 
ancestry, however the extrapolation of functions to the botulinum proteins would be 
naively ambitious. 
The HA 70 gene may have been formed by a duplication event. However, although the 
exact function of the resultant proteins from this gene appears obscure, but logically 
would in some way facilitate the delivery of the neurotoxin to the site of intestinal 
absorption. Whether it also has a lectin-like activity or binds to -other (protein? ) 
elements of the intestinal membrane, as well as the neurotoxin complex, remains a 
mystery. 
4.3.2 ORF 3-A putative transcriptional factor? 
4.3.2.1 Similarity to the a7° family of proteins? 
Sigma factors are unified by their ability to confer promoter-specific transcription 
initiation on RNA polymerase. The a70 related proteins are composed of specific 
domains for which some structure-function relationships have been determined (Lonetto 
et al., 1992). However, the degree to which these domains are present and the extent of 
sequence conservation varies. This variation is thought to reflect the role served in their 
respective hosts (Lonetto et al., 1992). Among the domains which have been described, 
region 2.1 is thought to mediate core polymerase binding, region 2.3 is involved in the 
interaction with the -10 promoter sequence and region 4.2 forms a helix-turn-helix motif 
which specifically recognises the -35 box of a promoter (Lonetto e[ u!., 1992). 
134 
The most convincing similarity between the ORF 3 polypeptide, UviA, the ORFtxel 
polypeptide and a compilation of sigma's presented by Lonetto (1992) is found in 
regions 4.1 and 4.2. Not only are a number of highly conserved residues present, but 
other features resemble sigma factors, including a basic charge consistent with DNA 
binding, a predominately a-helical secondary structure and a C-terminal helix-turn-helix 
motif. 
Beyond region 4, the extrapolation of domain motifs to recognised regions of the sigma 
factors is obscure, so the contribution of approximately the first 140 amino acids of the 
ORF 3 protein is difficult to predict. 
4.3.2.2 The helix-turn-helix motif 
This motif was predicted using the method of Dodd & Egan (1990), (figure 4.2). 
Promoter specificity has been demonstrated to be particularly influenced by amino acid 
residues at positions +3, +4, and +7 relative to the center of the H-T-H motif (Lonetto 
et al., 1992) and it is interesting to note that in the ORF 3 protein, UviA and the 
ORFtxel protein, an identical motif, SRQ, is found at positions +2 to +4 in the H-T-H. 
4.3.2.3 Parallels with the UviA and ORFtael loci 
UviA and the ORFtxel protein represent the closest homologues of the ORF 3 protein 
outside of the putative clostridial neurotoxin 21 kDa transcriptional factor group. As the 
promoters of this group seem to be extremely well conserved among the clostridial 
neurotoxin operons, the promoter regions of genes associated with uviA and ORFtxel 
were examined. Both regulons contained mapped transcriptional start sites with 
potential -35 elements which have considerable identity to the clostridial neurotoxin 
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operon promoters (Gamier & Cole, 1988; Hammond et al., 1997). For uviA, the 
promoter occurs in front of the ben gene encoding the bacteriocin BCN5, and, for 
ORFtxel, the promoters are in front of the C. difcile cytotoxin A and cytotoxin B 
genes (toxA and toxB genes, respectively). 
Extrapolation of mutagenesis experiments on the sigma factor group (Lonetto et al., 
1992) would suggest that the amino acid sequence SRQ found in the H-T-H motifs of 
UviA, ORFtxel and ORF 3 proteins could contribute towards this promoter specificity. 
Intriguingly, a very similar -35 element has been mapped in front of uviA and, on 
examination of the nucleotide sequence, could also be present in front of ORFtxeI, ORF 
3 and its homologues from type A, B and C neurotoxin complex operons. This raises 
the possibility that these putative transcriptional factors may participate in some type 
of autoregulation. Recently, the product of ORFtxel (TxeR) was shown to positively 
regulate C. docile toxA and toxB promoters in E coli (Moncrief et al., 1997). 
4.3.2.4 A member of the FixJ family? 
Several authors have grouped homologues of ORF 3 in the FixJ family on the basis that 
the ORF 3 botulinum homologues are similar to UviA which in turn has been grouped in 
the FixJ family (Lonetto et al., 1992). At the present moment, this categorisation does 
not appear to be valid due to several observations. A report which separates the FixJ 
family from the a factors documents the unique features found in the FixJ sequences 
(Kahn & Ditta, 1991). Features which were purported to define the FixJ response 
regulators were not generally observed in the ORF 3 polypeptide and UviA. In 
particular, a conserved glycine residue at position 156 of the FixJ family (Kahn & Ditta, 
1991) was not present in the ORF 3 protein or UviA (although it is present in a number 
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of group 3 sigmas; Lonetto et al., 1992), a conserved threonine was not found at the 
equivalent position 172 (Kahn & Ditta, 1991), neither the ORF 3 protein or UviA were 
of sufficient size to contain the 191-200 region of FixJ members, did not possess an 
aromatic residue at 'FixJ position' 176 or a hydrophobic residue at 'FixJ position' 186 
(Khan & Ditta, 1991). The inference that ORF 3 encoded a FixJ member would have 
insinuated that the N-terminal portion was specifically an acceptor module, typically 
modulated by a kinase sensor (Khan & Ditta, 1991). 
An interesting tangent originating from the FixJ question is how much of the ORF 3 
protein is required for its putative transcriptional function? FixJ was bisected into 
FixJN(1,126) and FiXJC(131-204)" The 73 amino acid moiety FixJC was capable of directing 
promoter specific expression. Thus, the relatively limited section surrounding the helix- 
turn-helix motif must be capable of interacting with the core RNA polymerase (Khan & 
Ditta, 1991). 
4.3.2.5 A member of the ECF a family? 
A number of transcriptional factors have been grouped on the basis that they exert 
transcriptional control on a regulon whose protein product(s) have an extracytoplasmic 
function (ECF) (Lonetto et at., 1994). Although this name probably does not strictly 
apply to all of the members (Huang et al., 1997), the concept of a disparate group of 
small sigma's effecting control on a contiguous regulon seems to be useful. 
The ECF group is characterised at the structural level by conserved regions and 
deletions when compared to the larger sigma factors (Lonetto et al., 1994). Alignment of 
SigX, a member of the ECF group, with UviA and the ORF 3 and ORFtxel proteins, 
using amino acid groupings devised either on a structural, chemical, charge or functional 
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basis, produced virtually identical alignments which revealed a number of conserved 
residue groups. This may indicate that regions equivalent to 2.1,2.2,2.3 and 2.4 present 
in SigX (Lonetto et a1., 1994) may exist in the ORF 3 protein sub-family. However, the 
inherently low sequence conservation between these types of transcriptional factors 
underlies the tenuous nature of these deductions (figure 4.3). 
Region 2.1 of sigma factors is thought to participate in core polymerase binding. Here, 
high primary amino acid sequence identity is not expected as different sigma factors are 
thought to interact with varying affinities with the core RNA polymerase, and, 
therefore, have non-identical core binding sites (Gross et al., 1992). Region 2.1 and 2.3 
function in DNA strand melting (Lonetto et al., 1992). Amino acid residue groups occur 
in the ORF 3 group which are highly conserved in the ECF family in these two regions. 
A similar situation occurs in the region equivalent to 2.4 in the ECF family, implicated in 
sequence specific contacts with the -10 promoter region. Again, a very high sequence 
conservation would also not be expected if different -10 promoter elements were 
recognised. 
A region equivalent to 4.1 and 4.2 appeared to be well conserved with the ECF and 
other classes of sigma factors, but the ORF 3 sub-family did not extend in the C- 
terminal direction beyond the H-T-H motif, as seen in members of the ECF and a7° 
family. 
Significant differences between ECF, a7° and the ORF 3 sub-family were found in region 
3.1 and region 3.2. This is a region which has little sequence conservation among 
different classes of sigma factors and is tentatively implicated in core RNA polymerase 
interactions. 
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On the basis of a comparison between the ORF 3 protein and SigX, both are not 
predicted to contain a 1.2 domain. When 1.2 is present, it is thought to obstruct the 
sigma factor from binding to promoter sequences in the absence of the core RNA 
polymerase (Lonetto et al., 1994, Dombroski et al., 1992). Thus, the ORF 3 protein 
may bind to its promoter autonomously. 
In conclusion, the ORF 3 protein, UviA and the TxeR could not be easily confined to an 
existing transcriptional sub-family and could form the basis of a novel group. Although 
H-T-H motifs are found in a variety of transcriptional regulators, including both 
transcriptional repressors and activators (Pabo & Sauer, 1992), the C-terminal location 
of the H-T-H and appropriately positioned conserved residues suggests that the ORF 3 
protein, UviA and TxeR are comparable to group 3 of the a7° family (Lonetto et al., 
1992). - These proteins typically act as positive transcriptional factors of individual 
regulons. Interestingly, the encoded 21.6kDa, product an ORF which is spatially 
associated with. the adc operon of C. acetobutylicum appears to bear a low degree of 
similarity with this group (Gerischer & Durre, 1990). 
4.3.3 Promoter structure 
Primer-extension studies by Dr I. Henderson were able to positively identify promoter 
structures corresponding to the divergently orientated operons coding for structural 
genes of the type A neurotoxin locus (Henderson et al., 1996). The conserved features 
`box 1' and `box 2' appeared to represent -35 and -10 elements of a promoter (Hawley 
& McClure, 1983). At the core of the -35 element, a sequence (TTTACA) was noted 
that closely resembled the vegetative promoter (TTGACA) recognised by a7° in J 
co/i and (Y" in B. subtilis. In front of either operon, box 1 was composed of a highly 
139 
conserved sequence of 17 nucleotides. Intriquingly, box I was almost perfectly 
conserved in front of both structural neurotoxin gene operons from C. botulinum type C 
(Fujinaga et al., 1984), proteolytic and non-proteolytic type B C. botulinum strains 
(East et al., 1994) and in front of the C. tetani neurotoxin gene (Eisel et al., 1986). In all 
examples where box 1 was found, a second conserved sequence box 2, was separated by 
exactly 12 nucleotides. Box 2 was well represented with A and T residues typically 
found at -10 promoter sites consistent with a role in DNA strand melting (Lonetto et al., 
1992), but did not contain the motif (TATAAT) proposed as the consensus -10 
vegetative promoter. Box 2 initiates with the sequence ATG; recent-evidence suggests 
that a `TG' sequence positioned one base `upstream' of the a70 -10 hexamer is an 
essential motif required for transcription and can circumvent the requirement of a -35 
element in E cola (Barne et al., 1997). 
An over-riding feature of these promoter elements seems to be the extended nature of 
the -35 and -10 elements. The -35 box is 17 bp in length while and the -10 box extends 
for 13 bp. If these are the promoters of the neurotoxin operons, the extended lengths 
recognised may explain the poor H-T-H prediction of their respective transcriptional 
factors, which may be based on H-T-H motifs recognising shorter DNA sequences 
(Dodd & Egan, 1990). 
The spacing of 12 bp between the promoter elements box 1 and box 2 is 
uncharacteristic of the ß70 family. However, if the sequence `TTTACA' is used as the 
core a70 -35 sequence, the distance between this sequence and the -10 box is 15 bp. If 
the base 3' to the `TG' motif is used, there is a distance of 19 bp, which exceeds the 
consensus spacing (17 bp) of a a"' type promoter (Mulligan el a!., 1985). As the class 
of sigma subunit may be largely responsible for -35 to -10 promoter spacing 
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(Dombroski et a1., 1996), the association of an alternative type of sigma factor may 
suggest that the proposed non-optimal spacing is indeed sigma factor specific. 
The spatial association of ORF 3 homologues with the promoter elements box 1 and box 
2 in distinct clostridial neurotoxin operons would seem to suggest that their functions 
are linked. When the H-T-H motif SRQ and possible -35 promoter similarities of the 
ORF 3 protein, UviA and TxeR are taken together, a convincing hypothesis emerges, 
relating a group of transcriptional factors to a conserved promoter sequence. However, 
the -10/box 2 sequences linked to the respective -35/box 1 sequences of the different 
systems do not appear to correlate (figure 4.8). Examination of the C. perfringens 
pIP404 UV-responsive promoters associated with uviA show a striking feature in that 
the -10 elements associated with promoter sequences TTTACA are unusual 
(CTTTTTAT) and conserved (Gamier & Cole, 1988). Thus, an attractive explanation 
could be that this class of transcriptional factor recognises specific -35 and -10 
elements, thus conferring a high degree of specific control to an operon or regulon. 
Indeed, the P1, P3 and P5 promoters mapped at the uviA locus were not found to be 
activated in vitro by RNA polymerases isolated from C. perfringens or B. subtilis during 
vegetative growth (Gamier & Cole, 1988). Furthermore, during an in vivo reporter 
experiment conducted in C. botulinum type A strain, ATCC 3502 (Dr I. Henderson, 
pers comm. ). the promoters which were proposed for NTNH-BoNT/A operon and 
haemagglutinin operon (Henderson et al., 1996) were not active until the stationary 
phase of growth. 
The contribution of additional transcriptional factors such as SpoOA are unknown, as are 
the contribution of the -35 to -10 spacer region which are virtually conserved in the 
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promoters of the haemaggluttinin operon of C. botulinum NCTC 2916 and the C. tetani 
neurotoxin. 
4.3.4 The NTNH proteins 
In C. botulinum NCTC 2916, the gene encoding a NTNH protein is found 5' to the 
respective type A neurotoxin and type B neurotoxin pseudogene. NTNH proteins are 
found naturally complexed to all known botulinal neurotoxins by non-covalent 
attractions, resulting in the formation of a 12 S NTNH/neurotoxin complex. C. 
botulinum strains which possess haemagglutinin operons can form larger neurotoxin 
complexes of 19 S (type Al) and 16 S (typeA1, B, C, D and G), whilst 12 S complexes 
are formed by serotypes Al-D, G and neurotoxic C. botulinum strains which do not 
appear to possess a contiguous haemagglutinin operon (types E, F and A2). 
The molecular dissection of the NTNH genes from various C. botulinum serotypes, in 
combination with a detailed study of the interaction between the components of the 
neurotoxin complex (Inoue et al., 1996), has improved the understanding of the NTNH 
gene structure. Alignment of NTNH genes from serotypes Al, AZ, B, C/D, E and F 
show that the genes can be sub-divided into two groups, based on those with or without 
a N-terminal deletion. NTNH genes with an N-terminal deletion belong to serotypes A2, 
E and F, and correspond to strains which do not posses contiguous haemagglutinin 
operons and in which the toxins are only found as a 12 S complex. 
Strains without the N-terminal deletion in the NTNH gene, produce either the 12 S or 16 
S complex. Inoue has suggested that a protease cleavage site exists in the N-terminus of 
NTNH proteins which do not have the deletion (A,, B, C and D), (Inoue el al., 1996). 
Cleavage at this site destroys a putative haemagglutinin binding site (Fujita et at, 1995) 
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which blocks further binding of the haemagglutinin components to the 12 S complex, 
thereby inhibiting the formation of 16 S complex. A 19 S complex is formed by two 16 S 
complexes, cross-linked by a single haemagglutinin protein (Inoue et al., 1996). 
A striking feature of the NTNH genes from C. botulinum NCTC 2916 is the non- 
uniform distribution of sequence anomalies. Virtually all the differences occur in the 3' 
516 bp. This phenomenon seems to occur between other representative NTNH genes 
(Kubota et al., 1996; East et al., 1996) and could have arisen by a recombination 
mechanism. The generally very high relatedness of these genes could facilitate these 
events. 
4.3.5 Recombination 
What could be gained through recombination? It must first be noted that the NTNH gene 
is not the only site of recombination. The type C and D neurotoxins are preceded by 
virtually identical NTNH genes and haemagglutinin operons (Ohyama et al., 1995), 
which were most likely created from a recombination event involving the entire HA- 
NTNH. Hybrid neurotoxin genes also exist which appear to be chimeras of type C and 
D neurotoxins (Moriishi et al., 1996a and b). Thus, a situation exists where neurotoxin 
genes, or functional domains of neurotoxin genes, are found in combinations with a 
variety of nontoxic components. This increased `repertoire' may be able to increase or 
alter the environments in which the neurotoxin complex can endure or alter the site of 
intestinal absorption and so alter pathogenicity. In this light, the NTNH gene could be a 
common site at which ancillary operons are matched with different neurotoxins, so 
called `module shuffling' (Chateau & Bjorck, 1994). 
143 
The mosaic nature of genes and regulons in bacteria is a recurring feature, which is 
particularly evident in pathogenic organisms, including the vacuolating cytotoxins of 
Helicobacter pylori (Atherton et al., 1995), S-endotoxins of Bacillus thuringiensis spp. 
(Bravo, 1997) and streptokinase from Streptococcus pyogenes (Kapur et al., 1995). This 
phenomenon probably reflects the importance of horizontal gene transfer and 
recombination in the evolution of bacterial function and could imply that the neurotoxin 
complexes of C. botulinum are under a degree of selective pressure. 
4.3.6 What advantage does a silent neurotoxin gene confer to C botulinum NCTC 
2916? 
C. botulinum NCTC 2916 had appeared to contain an active type A neurotoxin, a 
dysfunctional type B neurotoxin and two sets of virtually identical NTNH and 
haemagglutinin proteins. There would appear to be little advantage in duplicating these 
genes. This poses the question, why does this duplication occur? Analysis of the 
neurotoxin operons from C botulinum 667 (A/B°) (Hutson et al., 1996) revealed that 
the silent type B neurotoxin gene was preceded by a NTNH gene and HA34 gene which 
were identical to the corresponding locus in C. botulinum NCTC 2916. However, the 
type A neurotoxin gene was accompanied by a NTNH gene and contiguous operon 
which resembled the genes found in front of type A2, E and F strains which did not 
contain the haemagglutinin operon. Inspection of the NTNH/A gene from strain 667 
reveals two restriction sites (Xbal and Bg1II) which were predicted to occur 5' to the 
type A neurotoxin gene in C. bolulinum NCTC 2916 (Thompson el al., 1990). This 
would indicate that the clones 5' to the type A neurotoxin were incorrect and were 
actually derived from the silent type B locus. Furthermore, the PCR cloning strategy 
used to derive probes for'the type A upstream region was designed in an area of the type 
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A NTNH gene (clone p933, Henderson et al., 1995) which was essentially identical in 
both the type A and silent type B loci. The second 5' oligonucleotide primer would have 
bound to a haemagglutinin derived sequence present only in the silent B neurotoxin locus 
and not to the p47-like sequence 5' to the type A neurotoxin. 
Evidence supporting this hypothesis is presented by East (1996) who demonstrated that 
PCR oligonucleotide primers which specifically amplified a DNA fragment from NTNH 
genes with a N-terminal deletion (typically found in A2, E or F like NTNH genes) 
produced a positive DNA fragment in C. botulinum NCTC 2916 and other type A1/B° 
strains. This mistake would have been circumvented if the restriction profile generated 
for the type A neurotoxin (Thompson et al., 1990) had not been overlooked. 
Elements of this chapter describing the sequence analysis and mRNA transcripts, 
therefore, apply only to the silent type B neurotoxin locus and would suggest that the 
regulon is transcriptionally active. In this light, strains containing both type A and silent 
type B loci would benefit from two sets of nontoxic components, those derived from the 
type A locus, including NTNH, and p47 type proteins, similar to the type strain Kyoto F 
(East et al., 1996), plus the NTNH and haemagglutinin genes derived from the silent 
type B locus. This `choice' may be advantageous to the clostridium in different 
environments and mechanisms of action (i. e., ingestion of preformed toxin vs. intestinal 
colonisation) or against different potential victims. 
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CHAPTER 5 
DEVELOPMENT OF A NOVEL SHUTTLE VECTOR 
CAPABLE OF REPLICATION IN CLOSTRIDIA AND 
Escherichia coli. 
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5.1 Introduction 
5.1.1 Why develop another vector system? 
The objective was to develop a means of monitoring gene expression at the neurotoxin 
locus of C. botulinum type A using a suitable reporter vector. This genetic system could 
be achieved by either fusing the reporter gene to the neurotoxin genes of interest, and 
maintaining the construct on an autonomously replicating plasmid, or by integrating the 
reporter gene into the gene of interest ' in the host chromosome. To achieve either 
strategy, the development of a gene transfer system for C. botulinum type A was 
necessary. 
Amongst the clostridia a number of gene transfer systems already exist, principally 
conjugative plasmids, conjugative transposons, transposons and plasmids. Several 
features preclude the use of conjugative elements. Firstly the introduction of genes into 
an organism which may facilitate the inter-species transfer of a virulence factor creates 
an element of risk and should be avoided. In the same vein, the inclusion of a conjugative 
origin of transfer i. e, oriT from the IncP plasmid RK2 may complement host conjugative 
systems and facilitate the spread of virulence genes. Furthermore, conjugative elements 
are generally rather large and possess few unique restriction sites, which makes them 
less than ideal for molecular manipulations. Transposons are normally maintained within 
the chromosome and may, therefore, disrupt essential features of the system under 
study, again making them unsuitable. 
Plasmids are relatively small and can be easily engineered to contain unique restriction 
sites, and thus, they offer a number of practical advantages. Recombinant vectors for 
use in clostridia have been developed from a number of plasmids of Gram-positive 
origin including pIM l3 from B. suhti/is, pJU 122 from C. perfrhigens and pUB 110 from 
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S. aureus (reviewed by Minton et al., 1993), but on closer inspection, do not necessarily 
meet the criteria of this project. The majority of these plasmids replicate via the rolling 
circle mechanism using a single stranded DNA intermediate (Gruss & Ehrlich, 1989). 
These single stranded intermediates are highly recombinogenic and, therefore, make this 
type of plasmid intrinsically unstable (Janniere et al., 1990) and would not be expected 
to efficiently maintain portions of the vector that are not under direct selection. Two 
vectors which replicate by the unidirectional theta mechanism are derived from the 
plasmid pAMßl (Bruand et al., 1993) and possibly pIP404 (Gamier & Cole, 1988). 
Plasmids replicating via this method are considered to be more stable. However, when 
the replicons are isolated from their natural plasmid environments a degree of 
segregational instability occurs (reviewed by Minton et al., 1993). In summary, no 
vector currently available completely satisfies the requirements of this project. 
5.1.2 Important features in vector design 
The ideal K coli-clostridial shuttle vector should comprise a replicon which functions in 
E coif, a replicon which functions in the clostridial host(s) and markers for selection in 
both hosts. Group I C. botulinum are sensitive to erythromycin (Cato et al., 1986), as 
are a number of other Gram-positive bacteria. Thus, the erm gene from the plasmid 
pAMßl was chosen as a selection marker for clostridia (Brehm et al., 1986). The Tn3- 
derived ß-lactamase was chosen as a selectable marker in E. coil (Uhlin & Nordstrom, 
1977). The E coli replicon most widely used is that derived from the E. coil plasmid 
ColEI (Staudenbauer, 1978), because it is stable and can be manipulated to give a range 
of useful plasmid copy numbers. One such derivative of the ColEI replicon is found in 
the pMTL series of vectors (Chambers el a!., 1988). 
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Plasmids which are not shuttle vectors but are designed to only replicate in E coil and 
serve as a template for homologous recombination in a target host (such as clostridia), 
are termed "suicide vectors". Accordingly only an E. coli replicon and resistance marker 
are present on the suicide vector, whilst a second Gram-positive resistance marker is 
frequently integral to the homologous integration cassette. Irrespective of the use of a 
vector, plasmid constructs must be genetically manipulated. To achieve this, the 
necessary restriction endonuclease sites required must be preferably both unique and 
concentrated in a polylinker which is distinct from functional elements of the plasmid. 
In some instances, instability of a vector is thought to be caused by poor recognition of 
vector replication signals by a heterologous host, for example, the inefficient use of 
lagging strand conversion signals to convert single stranded plasmid intermediates into 
double stranded plasmids (Minton et al., 1993). In light of this fact, the ideal choice of 
vector should be a plasmid isolated from the strain under study. However, cloning and 
sequence analysis of novel plasmids is demanding on resources and may not yield a 
suitable replicon. 
The solution in this study was to choose the cryptic plasmid pCB102, from another 
mesophilic clostridium, Clostridium butyricum NCIB 7423 (Minton & Morris, 1981, 
Minton et al., 1993). Although pCB102 has been cloned for some time, very little is 
currently known about its novel replicon. However, it does function in heterologous 
clostridial hosts, including C. beijerinckii, and has the advantage of being fully sequenced 
(Dr N. P. Minton, Pers. comm. ). 
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5.2 Analysis of pCB102 
5.2.1 Nucleotide sequence analysis 
In silico nucleotide sequence analysis of pCB 102 reveals the presence of nine potential 
ORFs (A-I) each potentially encoding proteins of greater than 70 amino acids (figure 
5.1), which appear to constitute at least four operons (Minton et al., 1993). 
Comparisons of the primary amino acid sequence of each predicted encoded protein 
with the entire SWISSPROT data base (issue 100) revealed significant similarities with 
other proteins for only the products of ORF A and ORF I (figure 5.2 and 5.3). 
Polypeptide A, the product of ORF A, exhibits 22.1 % similarity with MobC, a 
polypeptide of 94 residues encoded by the E coli IncQ incompatibility group plasmid 
RSF1010. The mobC gene forms part of a divergent operon whose function is to 
provide a mobilisation mechanism for RSF1010 (Scherzinger et al., 1993). MobS, also 
thought to have a role in the conjugative mobilisation of another plasmid pTF1 from 
Thiobacillusferrooxidans, forms a third member of this group. Both MobS and MobC 
have been shown to be essential in the mobilisation process of their respective plasmids 
(Drolet et al., 1990 and Scherzinger et al., 1992). In RSF1010, MobC has been shown 
to bind to a larger mobilisation protein MobA, when MobA is found complexed to the 
substrate oriT site. MobC then induces DNA strand melting allowing MobA to effect a 
single strand cleavage activity, initiating the plasmid mobilisation process (Scherzinger et 
al., 1992). 
Proteins which are similar to the predicted product of ORF I (polypeptide I) are also 
exclusively of plasmid origin and form an indispensable part of mobilisation machinery. 
The most closely related of these is ORFI (for clarity referred to as ORF st-1) from the 
streptoccocal conjugative plasmid pIP501 (Wang & Macrina, 1995) which shares 58.8 
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AccI 
EcoRV 
EcoRU orf D 
orf C 
Hpal 
HindIIl 
orf B 
forf 
A pCB102 
8.07 kb 
orfHý 
//--- Hind III 
Hpal 
EcoRI 
EcoRV 
orf E 
orf F 
orf G 
RI 
Pstl 
Ppu 101 
Figure 5.1 Schematic map of pCB102 
pCB102 was isolated from Clostridium butyricum NCIB 7423 where it was 
found to be co-resident with a second plasmid pCB 101 (Minton & Morris, 
1981). (Adapted from Minton et al., 1993). 
151 
CL) 
H 
"G aý 
ca. 
N 'v, - V "TJ Ö 
c4 0 C, 
U 
vi 
' fý4 
~ý" ö- c' 
p 
cd 
QUvý QUvý äi 
cý .o .a tom, ý .o vfsý, " `ý aai 
', 3 
Oýý 
c0ýýý 
Cý4 a tw 
c> p4 >t >t -e w 
Cd . 4avi a 4x el -rn. -. H ®z AA o a'~ ýä 
aa Gq 
ö 'v 
wwxM., ' Ur 
aaa , 
0. ö -«4 c 
.ö9.. ri 4 04 014 
cqj *ä e Haw Iaw 
a» ,ý0aa 0 
NAa0 
° aA CD _1 m94 
fi UH^ 
xHa aH p .wß. 
ß. b 
0 . - oýwx i 30) 
öö 
< . 25 azx 
gj 
cnA aZ "xi a r. aHaw una <Uvn -A Iri ö 
^"' 
aOzwýöö Ile p. " 
x<x H> 1 x: Oa ýt ö 
Ha> V1 x ', ý', 
ýÖ 
0 
xa ýc ýAo Acs U' E&. Nwwx -w as O_ waV aý 
AWH H> 
H 
v) WÖAV 
aa 94 1xa ww xC Ei ei iV 
xxwaaaHxw°0ý 
,ýa cý caxaw ,uE 
11 - 
tom, 
1 a0: 4 H> > >aa O výg-6 
as was zaH [' ^1 
Ax H>H waa °u 
a4 
iI 
, 
1aaaz0Ir.. 
wC0Ö 
HHH Es O2 
91 .- 10 v 
wzw" m* 
r. 
x v, waaaýxAý "ý 
N 
o°ý, 
zOwwwaA 
rO, ý 
N~ 
A aG vý i c9 a4 º+a > cV 
t)n 
t+l Iý -1 M Vrl 
L i3"ý 'ý ý r+ 
r-1 e-i '-1 MM Vý t0 Ir OD 
e +-u°ebel 
152 
10 20 30 40 
1ORF RFIa 
1MTIAK ------- RENGKRLI AMA SYRSGEKLYSELYEKT 
ORF1h 
1M AMY HFQN-KFVSKANGQ :ATAKSAYNSASRIKDFKEEF ORF 1c 
1MAIAHFSA-SIVSRGSGRVVLSAAYRHCAKMEYEREART ORF 11 
1A[3 MOB L 
50 60 70 
i 
41 HDYTRKGVVFSEVMLPENAKDEWKNRQ I--- 
34 NLYNHRT-VKPEAFI L---- KPDYVPNEFL FD R 
40 KDYSNKQC D- YSEILLPNNADDKFKDRE Y--- 
40 I jD YTP. KQGLLHEEQVLPADAPK-WVP. SLIADR 
40 HDYTP. KGGVLHSELILPGGG T-------- ADR 
90 
70 LWNEVEKIEK Sr 
63 LWNKMELAEKSP 
68 LWNKVHDVENRK 
79 FWNKVEAFEKRA 
66 FWNGVEAHHKRG 
10 
130 
100 
VSQLAF. SFEVGI. 
NAQL ©F EVNVAL 
NE 
]Q 
VAPE InII I[G I, 
DA ýL AFDLTIAI, 
VILIVIR EIE IIS 
140 
110 
1 
TEFTLE 
IELNNS 
NE FL DPN 
LELSAE 
TELTAE 
150 
110 VV KDNFIDKGMCADICMHDK 
IS 
DGNPHAHVMLTMKIDn EGG 
103 VKDNFVNEGMIADVAIHRDDENNPHAHIMLTMREVDSEG 
108 A-ESLSNEGMI V] DLNIHKINEENPHAHLLCTLRGLDKNN 
119 Vý NH 
WA 
LAKGMVADWVYHENP-GNPHIHLMTTLRPLSDES 
106 ------ ARALA 
MD 
RYGVAADV-A ------ LHAP R' TVTDRE 
170 
150 FLPK-AEKY L--- 
143 ILNKSHRIPKLDEN 
147 FEPKRKGNDYIR D- 
157 -FGS-KKVAVIGED 
132 -LE K- HPDYHETD 
180 190 200 
---CRNDKGD---- -EKY- ---- --- ORF la 
GNQIFNEKGRVTV SIKTN D W- G RKS ORF 1n 
----WNTKEKH--- ----N EW -- --- ORF 1c 
GQPV RT KSG K---- E -ILYE LWAG STD ORF 11 
PKTGRRHNGN---- ----- -W-- --- MOB L 
210 220 230 240 
1 
170 ---------------- - -LNSN DLK -DDR D FGK --- - -- ORFIa 
182 LVSEIRKDWA KVNQY L KDRNI DQQ ITEK S HAE LGK K ELP ORF lb 
170 -----RK RWE VýN KH 
[ 
L EKNGF SVR VSAD S YKN QNI D LEP ORF 1c 
190 DFNVLRDGWFLNHH ER L ALGGI DLK IDGR S YEK QGI N LEP ORF 11 
155 ------------- HAH I LLSAC HVQ PDG T LGK KAV E LDP MOB L 
Figure 5.3 Alignment of ORF I from pCB102 with site-specific single strand endonucleases. 
80 
1 
-------- ORFIa 
QT ORF lb 
____--_- 
ORF 1c 
SVSGASEAORF 
A------E MOB L 
120 
FN IKfIKEY ORF la 
j QRM IIED Fl ORF lb 
NIEiAKEF ORF 1c 
QNIAI, VRDF ORF 11 
QRK 
IA JA 
VGY MOB L 
160 
1 
K ORF la 
N ORF 111 
i] E ORF Ic 
-ORF11 
MOB L 
153 
Figure 5.3 Alignment of ORF I from pCB102 with site-specific single strand 
endonucleases. 
The Clustal alignment above compares the N-terminal amino acid sequences of four 
proteins found to possess significant similarity with ORF Ia. Percentage identities with 
ORF Ia along the entire length of each protein were; pIP501: ORF lb (Wang & Macrina, 
1995) 58.8 %, pGOl: ORF 1c (Climo et al., 1996) 30.3 %, pTiC58: ORF 11(Alt-Morbe 
et al., 1996) 27.2 % and pTF1: Mob L (Drolet et al., 1990) 23.2 %. A similarity of 19.6 
% was found with Mob A from RSF1010 (not shown) (Scholz et al., 1989). Conserved 
amino acid residues are highlighted in red, whilst tyrosine residues in an equivalent 
position to that suggested as part of the active site of MobA from RSF1010 
(Scherzinger et al., 1993) are shown in green. Residue groupings are (ST), (WYF), 
(EDNQ), (ILV), (KR), (C), (P)(H), (A), (G) and (M). 
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% similarity. Polypeptide I and ORF st-I appear to be members of a much larger group 
of proteins which include MobA from RSFIO10 and whose common function is a site 
specific DNA cleaving joining activity associated with plasmid mobilisation. Greatest 
similarity exists in the N-terminal region, extending for the first 160 amino acids (figure 
5.3). This region is thought to contain the site specific cleavage activity, involving a 
tyrosine residue mapped in MobA to position 24. This residue is conserved in 
polypeptide I. However, MobA of RSF1010 possess a C-terminal domain with a 
separate function (Scherzinger et al., 1993), which may reflect the poor sequence 
conservation between these proteins in this region. 
Intriguingly the relative orientation of ORF A/ORF I and their homologs in RSF1010 
and pTF1 are conserved in all three examples. Examination of the intergenic nucleotide 
sequence between ORF A and ORF I revealed the presence of a conserved motif 3' to an 
inverted repeat, previously identified as an oriT in RSF1010 (Scherzinger et al., 1993) 
and which conforms to the origin of transfer found in the IncQ group of plasmids 
(Waters et al., 1993). However, polypeptide A homologues are not found in all other 
mobilisation operons identified in this search (Wang & Macrina, 1995; Scholz et a1., 
1988). Proteins which are similar to polypeptide I also occur in a 52 kb staphylococcal 
plasmid pGOI (Climo et al., 1996), in the conjugative region of plasmid pTiC58 from 
Agrobacterium tumefaciens (Farrand et al., 1996) and with the single stranded 
endonuclease encoded on plasmid pSC101 (Drolet et al., 1990). All members of this 
group occur in close proximity to an IncQ type origin of transfer (figure 5.4) (Climo el 
al., 1996). 
155 
pCB102 G G G G T A T A A G T G C GC C C T T C 
RSF1010 A A C C G G T A A A T G C G* C C C T C C 
R1162 A A C C G G T A A G T G C CC C C T C C 
pTF1 T T A C T C T A A G T G CG GC C C T T G 
pTiC58oriT C G A G T A T A A T T G C GC C C T T G 
pSC101 A A A G T C T A A G T G C GC C C T G A 
pIP501 T G C G T A T A A G T G C G C8 C C T T A 
pGO1 T T C G C A T A A G A G C GC C8C T T A 
Figure 5.4 Alignment of the putative origin of transfer from 
pCB102 
Alignment of the sequence located between ORF A and ORF I on 
pCB102 with the oriT regions of other IncQ compatible plasmids 
(adapted from Climo et al., 1996). Blue letters indicate conserved 
nucleotides and red letters indicate virtually conserved nucleotides. 
Vertical arrows indicate mapped cleavage points of the origin of 
transfer. 
5.2.2 Analysis of the pCB102 clone pCB4. 
A previous report suggested that a derivative of pCB 102, pCB4 (see figure 5.7) is 
capable of autonomous replication in clostridia (Minton et al., 1993). Inspection of the 
translated nucleotide sequence of this clone reveals the presence of 2 major ORFs 
previously assigned H and I. As described in section 5.2.1, the product of ORF I is 
likely to contain a single stranded endonuclease activity within its N-terminal domain. 
However the C-terminus bears little similarity to other proteins listed in current data 
bases, a feature of the other representatives of this group. The C-termini do encode 
functional domains, for example, a helicase activity is proposed for TraA of pTiC58 
(Climo et al., 1996) and a DNA primase activity specific to oriV in MobA of RSF1010 
and possibly in ORF 1-st of pIP501 (Wang et al., 1995). Thus it is possible that the 
replication function may (partially) reside in the C-terminus of ORF I. Alternatively the 
replicative process may be attributed to the product of ORF H and/or hither to 
unrecognised mechanisms. Therefore, it was necessary to determine the minimal replicon 
of pCB102 before using it to construct a shuttle vector. 
5.3 Determination of the minimal replicon of pCB102 
5.3.1 Deletion analysis of pCB4. 
The fragment of DNA encoding the essential replication mechanism of pCB 102 was 
established by deletion analysis of pCB4. A series of nested deletions were created in 
pCB4 (figure 5.7). A deletion from the unique StO and HpaI sites was created by 
digesting pCB4 and re-ligating the blunt-ended DNA strands (figure 5.7), removing 196 
N-terminal amino acids from ORF I. A second larger deletion, SYul to /. spl, was made by 
digesting and modifying the recessed termini created by Ls p[ with Klenow fragment, 
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Figure 5.5 Comparative alignment of hydrophilicity profiles for ORF D of 
pCB102 and putative homologues. 
Comparison of the hydropathic profile (Kyte & Doolittle, 1982) for ORF D of pCB102 
with ORF 2 from the proposed conjugative operon of pIP501 (Wang & Macrina, 1995) 
and with TrsB, another member of a Gram-positive conjugative operon (Morton et al., 
1993). The pattern of alternating hydrophobic and hydrophilic regions is striking and 
could suggest that the three proteins may be similar. Hydropathic profiles were 
predicted using the PROTEAN software package, DNASTAR Inc. with a window of 9 
residues. The average hydropathy within this window is represented on a scale where 
negative values indicate a hydrophobic nature and positive values indicate a 
hydrophilic nature. 
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Figure 5.6 Alignment of ORF D (pCB102) with putative homologues 
Comparison of the primary amino acid sequence of ORF D from pCB 102 with ORF 2 from the 
broad-host range conjugative plasmid pIP501 (Wang & Macrina, 1995) and TrsB from the 
conjugative staphylococcal plasmid pGOl (Morton et al., 1993). Alignment was by the clustal 
method (Higgins & Sharp, 1986) using the MEGALIGN software package, DNASTAR Inc. 
with the residue groupings of (ST), (ILV), (KR), (EDNQ), (WYF), (A), (G), (M), (H), (C) and 
(P). Both ORF 2 and TrsB are found in operons whose protein products are implicated in 
conjugative mobilisation. In addition all three proteins possess a similar hydrophobicity profile 
(figure 5.5) suggesting a possible functional and evolutionary relationship. 
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removing ORF I as well as a further 106 bp of non-coding DNA. The pCB4 derivative 
plasmids were called pCB4ASH and pCB4ASL respectively (figure 5.7). A third 
deletion mutant was created by digestion of pCB4 with EcoRI, removing ORF I and the 
native promoter of ORF H. This derivative was named pCB4ARI. Finally, an ORF H 
frameshift mutant was created by digesting pCB4 with Ppu101 (figure 5.7). This 
restriction site is unusual because when the 3' overhangs created by digestion with 
PpulOI are filled with Klenow fragment and ligated, two partially overlapping Ppu10l 
sites are recreated. Although Ppu10I could not be used to select for frame-shifted sites, 
the manipulation should have created a new Sph I site, However no SphI sites were 
detected. Mutant versions were isolated which were refractory to digestion with either 
enzyme. Subsequent DNA sequencing across the modified site revealed a small 4 bp 
deletion, not typically associated with the activities of Klenow fragment, but still 
generating a frame-shift mutation (figure 5.8). This mutant of pCB4 was called 
pCB4AP. 
5.3.2 Functional analysis of pCB4 and its deletion derivatives 
The plasmid pCB4 and its deletion derivatives were introduced into C. beUerinckii 
NCIMB 8052 by electrotransformation. Putative transformants were selected on 
2xYTG agar supplemented with erythromycin at a concentration of 20 µg/ml. 
Transformants were scored after 48 h incubation. Colonies were obtained for pCB4, 
pCB4ASH, pCB40SL and pCB4AP; no colonies were obtained with pCB4bRI. It was 
noted that the number of transformants achieved with pCB40P was considerably lower 
(10/µg DNA) when compared to that obtained with pCB4, pCB4ASI1, pCB4ASL 
(103/µg DNA each). Plasmid DNA was isolated from clostridial cultures transformed 
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pCB4 contains a 3.6 kb HindIII fragment encoding the replicon from a clostridial 
plasmid pCB102 cloned into a ColEl based E. coli vector pMTL20E (Minton et al., 
1993). Putative ORFs are shown as green arrows. Deletion derivatives (pCB4ASH, 
pCB40SL and pCB4AR I) are indicated with purple lines and the frame-shift 
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The sequence above illustrates a section of ORF 11 encoded by p('11102 in which a 
frame-shift mutation was introduced at the P )n lO I site (highlighted in red). Wild type 
sequence is shown in black whereas two separate mutant versions are shown in blue and 
green. The translated amino acid sequences are shown on the extreme right, 
corresponding to the central base of the respective codon. A white arrow indicates the 
position at which the sequence annotation begins. 
167 
with pCB4, pCB4ASH, pCB4ASL and pCB4AP. The samples were then introduced 
into E coif TGI and a larger quantity of plasmid DNA prepared. Restriction enzyme 
analysis of these plasmid samples revealed that all constructs appeared to be identical to 
those used for transformation and were assumed to be structurally stable under the 
conditions used. This data suggests that ORF H is required for plasmid replication. 
5.3.3 Segregational stability. 
The segregational stability of each deleted vector construct was estimated in C. 
beßjerinckii NUMB 8052 and compared with pCB4 and pMTL500E, a relatively stable 
pAM(31 derivative plasmid (Minton et al., 1993) which replicates via a theta mechanism 
(Bruand et at., 1993). A method of estimating plasmid maintenance in the multiplying 
bacterial population (segregational stability) was employed (section 2.2.4). The eight 
hour time course chosen for inoculating fresh media was strictly adhered to, avoiding the 
clostridial cells entering a persistent stationary phase. The results are presented in 
Table 5.1. The data indicates that under the conditions of this experiment, the 
segregational stability of pCB4 exceeded that of pMTL500E. Indeed, 10 % of the final 
population had lost pCB4 whilst between 28-74 % had lost pMTLS00E. This feature 
of the isolated pCB 102 replicon was extended to the deletion derivatives pCB4tSH and 
pCB4ASH. In contrast, pCB4AP demonstrated particularly poor segregational stability 
with 84 % of the population having lost the antibiotic phenotype. It was observed that 
the degree of segregational stability of a particular plasmid was proportional to the 
relative electro-transformation frequency among the plasmids tested. The structural 
integrity of the plasmid constructs was investigated at the end of' the stability 
experiment Plasmid DNA was purified from replica plated colonies with an 
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erythromycin resistant phenotype and passaged through E coli, strain TGI. Restriction 
enzyme analysis of the plasmid DNA revealed no obvious structural alterations in any 
of the constructs (data not presented). 
VECTOR PCB4 PCB4ASII PCB4ASL PMTL540E PMTL541E PMTISOOE PCB4AP 
Exp. 1 92.0 98.0 100.0 92.0 100.0 74.0 - 
Ex .2 
88.0 98.0 98.0 92.0 100.0 72.0 - 
Ex .3 88.0 92.0 96.0 100.0 
98.0 34.0 - 
Exp. 4 84.0 98.0 94.0 100.0 100.0 26.0 16.0 
Ex .5 92.0 100.0 98.0 100.0 
98.0 26.0 21.0 
Exp. 6 96.0 100.0 98.0 100.0 100.0 28.0 11.0 
Mean 90.0 97.7 97.3 97.3 99.3 43.6 16.0 
Table 5.1 Estimation of plasmid segregational stability 
Data was obtained by the method described in section 2.2.4. Results are expressed as 
the percentage of C. beyerinckii NCIMB 8052 cells retaining an erythromycin resistant 
phenotype after 16 h of growth with out antibiotic selection. (-) not done. For plasmids 
pMTL540E and pMTL541E see section 5.4. 
5.4 Construction of an E. coli-Clostridial shuttle vector system. 
5.4.1 Vector construction 
The 1.627 kb (IspI HindIll) restriction fragment was isolated from pCB4 and the ends 
filled in using the Klenow fragment. pMTL21E (see figure 5.11) encoding ampicillin 
resistance (ß-lactamase), an E coif ColE1 replicon and lacZa, was linearised at the 
unique NheI site and the ends filled using Klenow DNA polymerase. The two fragments 
were ligated to give either pMTL540E or pMTL541E, depending on the orientation of 
the 1.627 kb of pCB4. The Nhel sites were recreated at the fusion between the modified 
NheI and LspI sites. 
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5.4.2 Functional analysis of pMTL540E and pMTL541E 
In E coli, the plasmid vectors pMTL540E and pMTL54IE possessed an ampicillin and 
erythromycin resistant phenotype, suggesting that both the bla and erm genes were 
fully functional. In addition, growth on solid media containing X-Gal and IPTG 
produced blue colonies, indicating that the lacZa component and multiple cloning sites 
were intact. Electroporation of C. beijerinckii NCIMB 8052 with both plasmids resulted 
in erythromycin resistant colonies. Subsequent passage of plasmid DNA isolated from 
these colonies through E coli TG1 produced DNA which was indistinguishable from 
that originally introduced in to C. beyerinckii NCIMB 8052. Furthermore, in C. 
beyerinckii NCI MB 8052 the estimation of segregational stability of these constructs in 
comparison with pCB4 and pMTL500E, demonstrated that pMTL540E and 
pMTL541E had inherited a degree of segregational stability comparable to pCB4 (table 
5.1). 
5.5 Construction of a Clostridial in-vivo expression system 
To develop the range of capabilities for this vector series an expression cassette was 
incorporated. A simple strategy was employed to replace the lacZa component of 
pMTL540E and pMTL541 E with a derivative of the same gene under the 
transcriptional control of a constitutive Gram-positive promoter. An expression cassette 
combined with a plasmid encoding the pAMß1 replicon, termed pMTL500F, had 
already been constructed (Brehm et al., 1988). This employed the transcriptional 
machinery of the ferredoxin gene (fd) from Clostridium pasteurianum (Graves et al., 
1985). A Pvul restriction fragment encoding the expression cässette was chosen to 
substitute the original lacZa gene of pMTL540E and pMTL541E. Dephosphorylation 
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was not employed as each fragment involved in the ligation reaction was incapable of 
autonomous replication. All attempts at this experiment were unsuccessful. A similar 
approach using the restriction endonuclease Bg1I instead of Pvul resulted in the cloning 
of the correct vectors, designated pMTL540F and pMTL54IF (figure 5.12). However, 
over a number of attempts, only pMTL541F could be introduced successfully into C. 
beyerinckii NCIMB 8052 by electroporation. The presence of a Gram-positive 
promoter controlling lacZa gene expression was the most significant difference between 
pMTL540E and pMTL540F. Deletion of the promoter element was achieved by 
digesting pMTL540F plasmid DNA with EcoRV and Stuf. This DNA could be used to 
transform C. beyerinckii NCIMB 8052. A number of colonies with an erythromycin 
resistant phenotype were obtained. The restriction profile of plasmids isolated from 
these colonies matched the pMTL540F deletion mutant exactly. This experiment 
suggested that the EcoRV-Stul restriction fragment contained a determinant which 
completely subverted the replicative mechanism encoded by the 1.627 kb pCB 102 
DNA fragment, in an orientation specific manner. 
To test this hypothesis the fd transcriptional terminator was inserted between the 
expression cassette and the replicon. The terminator was amplified by PCR from a 
genomic clone, pATFdu (Dr J. K. Brehm, Pers. comm). XbaI and NheI restriction 
endonuclease sites were incorporated into the PCR oligonucleotide primer sequences to 
facilitate subcloning of the terminator into the unique NheI site of pMTL540F (figure 
5.12). A PCR amplified fragment was initially cloned into a T-tailed vector (section 
2.2.12.4) and the nucleotide sequence determined. The terminator fragment was then 
isolated by digestion with Xhal and NheI restriction endonucleases before ligation into 
the Nhel site of pMTL540F . 
Recombinant plasmids were obtained in F,. coli with a 
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single copy of the terminator fragment orientated in either direction. The clone with the 
terminator in the `natural' direction was designated pMTL540FT, whereas the clone 
with the alternative arrangement was called pMTL540TR. 
Electroporation of C. beyerinckii NUMB 8052 in the presence of either pMTL540T or 
pMTL540TR resulted in erythromycin resistant colonies. Subsequent analysis of their 
plasmid content revealed the presence of either vector. 
5.6 Discussion 
5.6.1 Inspection of the minimal replicon 
5.6.1.1 Analysis of ORFs 
Deletion analysis of pCB102 revealed-that a DNA fragment of 1.627 kb was capable of 
sustaining replication of plasmid DNA in a clostridial host. This region did not encode 
ORF I, but was only reported to contain a single ORF, designated H (Minton et al., 
1993). When translated, the product of ORF H did not appear to resemble any other 
protein in the available databases, suggesting that the replicon is novel. The observation 
that a short deletion near the C-terminus of ORF H (pCB4EtP) appeared to reduce the 
plasmids segregational stability seems to implicate this protein in some aspect of 
replication. A close inspection of the amino acid sequence of ORF H revealed the 
occurrence of 10 cysteine and 4 histidine residues within a protein of only 98 amino 
acids. Database analysis of ORF H revealed a low level of similarity with non-structural 
proteins encoded in rotaviral genomes. Intriguingly, the basis of similarity is with the 
high content of cysteine and histidine residues (Hua & Patton, 1994). Although no 
evolutionary relationship is inferred, the function of the rotaviral proteins is thought to 
be in single stranded nucleic acid binding, associated with viral RNA replication 
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intermediates. The cysteine rich motifs of rotaviral proteins are thought to form zinc 
fingers, a motif which also occurs in some transcriptional factors and replication 
proteins (Coleman, 1992). 
An analysis of the DNA sequence between the 5' end of the minimal replicon and ORF 
H, by translating all six possible reading frames revealed several ORFs greater than 40 
amino acid residues, however none appeared to be correlated with convincing initiation 
codons (ATG, GTG or TTG) or ribosome binding sites (Shine & Dalgamo, 1975). At a 
distance of 480 bp downstream of the 5' end of the minimal replicon, the DNA sequence 
was distinguished by the frequent punctuation of all six reading frames with translational 
termination codons. However, in the first 270 bp directly before ORF H, a short coding 
sequence of 34 residues is present on the same strand. This feature, named ORF J, 
begins with a GTG codon and is preceded by a putative ribosome binding site (figure 
5.8). Prediction of the secondary structure for this protein revealed a hydrophobic 
region which could possibly interact with lipid structures such as the cell membrane. In 
the N-terminal section, a hydrophilic region is attached to the hydrophobic domain with 
a predicted turn motif (figure 5.13). A second potential ORF (K) exists on the reverse 
strand overlapping the N-terminus of ORF-H. This 44 amino acid peptide starts with a 
methionine codon and is predicted to encode three hydrophilic domains interspersed by 
two hydrohobic domains. Both ORF J and K are reminiscent of small ORFs which are 
commonly found in the complex control of plasmid replication (Hardy, 1988). 
5.6.1.2 Analysis of secondary structure 
Computational folding of the entire minimal replication region using the Squiggle program 
(Zuker, 1989) predicted a number of inverted repeats capable of secondary structure 
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formation (figure 5.9). A 10 bp inverted repeat was found immediately 5' of the 
predicted ribosome binding site of ORF H, whilst a second inverted repeat of 8 bp was 
found 35 bp 5' to the same point. Further upstream, a region of imperfect dyad 
symmetry was found immediately in front of the putative ORF J. An interesting feature 
was that the inverted repeat in front of both ORF J and ORF H are nearly identical 
suggesting that this region could form a much larger secondary structure motif (figure 
5.10). This opinion is substantiated by the presence of weaker regions of dyad 
symmetry in the intervening regions which may form `lateral appendages' in a larger 
`club' structure. It was noted that one short inverted repeat bridged the stop codon of 
ORF K, a further region of weak dyad symmetry was found 3' to ORF H. 
5.6.1.3 Mechanism of replication encoded by pCB102 
A previous report has inferred the existence of a single ORF in the replicating region of 
pCB102 (Minton et al., 1993). Closer inspection has revealed the possibility of a 
further two significantly shorter ORFs, J and K (Figure 5.9). The existence of short 
ORFs of 5-11 kDa in close proximity to a replication protein has been documented in 
plasmids of diverse origins (del Solar et al., 1993; Byeon & Weisblum, 1990; Brantl et 
al., 1994, Riise & Molin, 1986; Gamier & Cole, 1988). Evidence suggests that several of 
the proteins have a role in plasmid copy number control. The targets of many of these 
proteins are nucleic acids, where they recognise inverted repeats. Typically inverted 
repeats encompass the replication proteins -35 promoter element and therefore exert 
negative control via transcriptional repression (Brantl ei al., 1994). Such copy number 
control proteins are seldom the only regulatory mechanism. For example, the plasmid 
replicon of CoWEI, which does not encode a `replication protein, ' also possess a small 
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CAGTACGCAAAGGCTTTTTTATTTGATAAAAATTAGAAGTATATTTATTTTTTCATAATTAATTTATGAAAATGAAA(jc; G!;, ýTGAGCAAA 
GTCATGCGTTTCCGAAAAAATAAACTATTTTTAATCTTCATATAAATAAAAAAGTATTAATTAAATACTTTTACTTTCCCCCACTCGTTT 
ORF J» 
4--------------- ---- 
GTGACAGAGGAAAGCAGTATCTTATCAAATAACAAGGTATTAGCAATATCATTATTGACTTTAGCAGTAAACATTATGACTTTTATAGTG 
---------------------------------------------------------------------------180 
CACTGTCTCCTTTCGTCATAGAATAGTTTATTGTTCCATAATCGTTATAGTAATAACTGAAATCGTCATTTGTAATACTGAAAATATCAC 
VTEESSILSNNKVLAISLLTLAVNIMTFTV 
1 
CTTGTAGCTAAGTAGTACGAAAGGGGGAGCTTTAAAAAGCTCCTTGGAATACATA ATAAATTAATTTATGAAAA«; iAGGGCGTA 
---------------------------------------------------------------------------270 
GAACATCGATTCATCATGCTTTCCCCCTCGAAATTTTTCGAGGAACCTTATGTAT TATTTAATTAAATACTTTTCTTCCCGCA 
LVnK ORF H 
GQ ti' Y11, F: HfR1 
TATGAAAACTTGTAAAAATTGCAAAGAGTTTATTAAAGATACTGAAATATGCAAAATACATTCGTTGATGATTCATGATAAAACAGTAGC 
---------------------------------------------------------------------------360 
ATACTTTTGAACATTTTTAACGTTTCTCAAATAATTTCTATGACTTTATACGTTTTATGTAAGCAACTACTAAGTACTATTTTGTCATC'S 
MKTCKNCKEFIKDTEICKIH[, MI II VA 
HFSTFIAFLKNFISFYAFYMRQHNM« ORF K 
AACCTATTGCAGTAAATACAATGAGTCAAGATGTTTACATAAAGGGAAAGTCCAATGTATTAATTGTTCAAAGATGAACCGATATGGATG 
---------------------------------------------------------------------------450 
TTGGATAACGTCATTTATGTTACTCAGTTCTACAAATGTATTTCCCTTTCAGGTTACATAATTAACAAGTTTCTACTTGGCTATACCTAC 
TYCSKYNNSRCL, il KG FN VQCINCSKMNRYGW 
GTGTGCCATAAAAATGAGATGTTTTACAGAGGAAGAACAGAAAAAAGAACGTAC 'I'AAATATTATGCAAGGAGCTTTAAAAAAGC 
-----------------------------------------"-------------------------------"-540 
CACACGGTATTTTTACTCTACAAAATGTCTCCTTCTTGTCTTTTTTCTTGCATG AT'I'TATAATACGTTCCTCGAAATTTTTTCG 
CAIKMRCFT FE F, QFKKKYYAk! KKA 
TCATGTAAAGAAGAGTAAAAAGAAAAAATAATTTATTTATTAATTTAATATTGAGAGTGCCGACACAGTATGCACTAAAAAATATATCTG 
---------------------------------------------------------------------------630 
AGTACATTTCTTCTCATTTTTCTTTTTTATTAAATAAATAATTAAATTATAACTCTCACGGCTGTGTCATACGTGATTTTTTATATAGAC 
HVKKSKKKK. 
TGGTGTAGTGAGCCGATACAAAAGGATAGTCACTCGCATTTTCATAATACATCTTATGTTATGATTATGTGTCGGTGGGACTTCACGACG 
-------------------------. _----------------. _---- - ------. -. _. --_. _---_-_--720 
ACCACATCACTCGGCTATGTTTTCCTATCAGTGAGCGTAAAAGTATTATGTAGAATACAATACTAATACACAGCCACCCTGAAGTGCTGC 
AAAACCCACAATAAAAAAAGAGTTCGGGGTAGGGTTAAGCATAGTTGAGGCAACTAAACAATCAAGCTAGGATATGCAGTAGCAGACCGT 
---------------------------------------------------------------------------810 
TTTTGGGTGTTATTTTTTTCTCAAGCCCCATCCCAATTCGTATCAACTCCGTTGATTTGTTAGTTCGATCCTATACGTCATCGTCTGGCA 
Figure 5.9 Putative regulatory structures within the minimal replicon of pCB102. 
Open reading frames are shown below the corresponding DNA sequence. Ribosome 
binding sites are in magenta. Inverted repeats are indicated with dotted blue arrows, Solid 
tan arrows denote direct repeats potentially capable of forming a kissing complex. 
Restriction endonuclease sites, EcoR I (GAATTC) and Ppu10 I (ATGCAT) are in tan. Note 
the high occurrence of cysteine and histidine residues in ORF H. 
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Figure 5.10 Secondary structure of pCB102 replicon RNA species 
A possible stem-loop structure which could be formed by a mRNA species, 
sequestering the ribosome binding sites (red letters) of ORF J and ORF H from 
the replicon of pCB102. Intra-molecular phosphodiester bond are solid red 
circles, inter-molecular hydrogen bonds are depicted as green bands. Neutral 
base pairings are purple bands. Regions of symmetry involved in the formation 
of a putative kissing complex are marked as solid tan arrows. Initiation codons 
are boxed. Numbering correlates with figure 5.9. 
protein of 63 amino acids, `Rom', which stabilises the interaction of two RNA 
molecules. A database search did not reveal a close homologue of ORF J, which appears 
to contain a hydrophilic N-terminal domain followed by a hydrophobic C-terminal 
domain (Figure 5.13). An analysis of ORF K, revealed the presence of three alternating 
hydrophilic and hydrophobic domains (Figure 5.13). A database search with ORF K did 
not reveal similarity to a particular evolutionary group, but did show similarity to a 
variety of proteins with transmembrane domains. Among these was the protein thought 
to determine copy number control in the C. perfringens plasmid pIP404 (Gamier & 
Cole, 1988b). The concept that plasmid DNA is associated with the bacterial membrane 
would suggest the localisation of proteins involved in aspects of plasmid maintenance to 
be located in the membrane (Firshein & Kim, 1997, Gamier & Cole, 1988b). The Cop 
proteins of pIP501, pIP404, pLS1 and pE194 all appear to contain at least one 
hydrophobic region. The gross functional similarities with other Cop proteins and 
spatial organisation with the proposed replication protein ORF H would make ORFs J 
and K good candidates as Cop proteins. 
The presence of inverted repeats within the minimal replicating DNA fragment is 
particularly interesting. Areas of complex dyad symmetry are frequently found in a 
number of diverse replicons. They may function independently, or in combination with, 
copy number and replication proteins to promote and control plasmid replication 
(Eguchi, 1991, Brantl et al., 1993, Wagner & Simons, 1994). Regions of complex 
symmetry may interact at the RNA level. Indeed, pairs of naturally occurring 
complementary RNA transcripts composing of a sense and antisense strand have been 
shown to contain sequences capable of forming stem-loop type structures (Wagner & 
Simons, 1994). Among the potential stem loop structures found in the pCB 102 
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replicon, two appear to occur directly in front of the ribosome binding sites of ORFs H 
and J (figure 5.9). This relationship of secondary structure and ribosome binding site is 
encountered in the antisense regulatory mechanism of pIP501 and related plasmids 
(Brantl, 1993) and the ' IncFII-like plasmid group (Wagner & Simons, 1994). The 
nucleotide sequence found in the inverted repeats present in front of the putative RBS 
of ORF H and ORF J of pCB 102 are very similar, sharing 21 bp of homology, 
interrupted only on one strand by a single. base pair insertion. This is reminiscent of 
structures forming `kissing complexes' between two complementary stem loop 
structures. This phenomenon was first characterized in the ColE1 replicon (Tomizawa, 
1990) and subsequently in other antisense RNA replicon control mechanisms, e. g., as 
described by Brand et al., 1993; Paillart et al., 1996; Eguchi, 1991. An important aspect 
of the formation of a kissing complex (figure 5.10) is the complementarity between the 
respective stem structures and the loops. Both requirements are fulfilled by this 
putative example in pCB102. It is interesting to note that three copies of the stem loop 
structures could exist, two encoded on a sense strand, as previously mentioned, and one 
on the antisense strand encoded near the 3' end of the putative ORF K mRNA. At least 
two further regions of symmetry can be found between the ribosome binding sites of 
ORF J and ORF H. It is tempting to speculate that they might form part of a larger 
mRNA secondary structure (figure 5.10) whose formation may also alter the level of 
translation from ORF H and ORF K ribosome binding sites. The occurrence of an eight 
base pair inverted repeat overlapping the 3' end of the ORF K coding region could 
protect this transcript from 3'--*5' ribonucleolytic degradation. The half life of a 
transcript which possibly functions as an antisense RNA would be an important factor 
in determining copy number control (Brand &Wagner, 1996). 
VA 
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ORF H would seem to be the candidate replication protein. The evidence in favour is the 
reduced segregational stability of the Ppu10I mutant and that removal of the 
transcriptional signals of ORF H eliminates the plasmids ability to function. However 
the matter is complicated by the absence of a designated origin of replication (oriP). The 
replication deficient derivative of pCB4, pCB4AR1, which has a deletion of DNA 5' to 
ORF H, could be due to the loss of a putative oriV. Previous work has indicated that a 
deletion from the PpulOI site to the 3' end of the clostridial DNA results in the total 
loss of plasmid function. There are two possible explanations, firstly that the Ppu10I- 
HindIIl fusion (Minton et al., 1993) created a C-terminus which may have been 
incompatible with the function of ORF H, or that oriV was also deleted. oriV can occur 
within the replicating proteins coding region or at either end (Novick, 1989; Gamier & 
Cole, 1988). Secondary structure predictions for ORF H reveal four alpha helices 
interrupted by turns. A large proportion of ORF H appears to have the potential to 
interact with hydrophobic environments, possibly a feature of plasmid maintenance 
proteins (Firshein & Kim, 1997). The basic nature of the ORF H peptide (pI 9.85) and 
charge (+17.05) would be consistent with a nucleic acid binding function (Lonetto et al., 
1992). Whatever the mode of replication, vectors which are based on the pCB102 
replicon would appear to be both segregationally and structurally stable. This would 
suggest that a single stranded DNA intermediate is unlikely due to the poor stabilities 
observed in this class of plasmid (Janniere et al., 1990). 
The method used to estimate the segregational stability for each plasmid construct was 
relatively crude. A more. accurate experiment should take into account factors such as 
the relative growth rates of plasmid and non-plasmid containing cells under non-selective 
conditions or whether the plasmid is conjugative (Boe & Rasmussen, 1996). The data 
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suggested that very little plasmid loss occurred from generation to generation with 
vectors based on the pCB 102 replicon, whereas a more significant loss occurred using 
vectors based on the pAMßl replicon. However, weight cannot be placed on the degree 
of segregational stability between vector replicon types, as the relative rate growth rates 
of plasmid free cells is not known. This fact must also be considered in relation to the 
pCB40P stability data. A possible explanation for a plasmid with very low 
segregational instability could be the consequence of a post segregational killing system. 
This will not be known until the replicon of pCB 102 is analysed in greater detail. 
The stability data indicates that pCB4 is marginally less stable than its deletion 
derivatives pCB4iSH and pCB4ASL. Analysis of the DNA sequence between ORF I 
and the proposed - replicon did not. reveal features typical of a Rho-independant 
transcriptional terminator. Therefore, transcriptional read through from ORF I would 
seem possible. Transcriptional read through into the replicon could form a natural 
mechanism of temporary replication attenuation, possibly whilst ORF I and the plasmid 
are involved in conjugation. This could explain why constitutive expression from the 
ferredoxin promoter in pMTL540F (figure 5.12 ) may interfere with plasmid replication. 
5.7 Functional deductions for pCB102 
5.7.1 Evidence for a Conjugal operon? 
pCB102 could be viewed as encoding three separate units, consisting of regulon 1, 
including ORFs A, B, C, D and I, a second operon encoding ORFs G, F and E, and 
finally operon 3, encoding ORF H. There is considerable sequence evidence suggesting 
that regulon 1 may contain features associated with either a conjugal or mobilisable 
function. Homologues of ORF I and ORF A, in combination with a conserved IncQ 
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consensus nic site, are found in a number of mobilisable plasmids (RSF I OI O and pTF 1; 
Drolet et al., 1990) and conjugative plasmids (e. g., Climo et al., 1996). However 
mobilisable plasmids are distinguished from conjugative plasmids, as they require 
additional factors donated in trans from a truly conjugative plasmid. Intriguingly, a third 
member of operon 1, ORF D, also appears to belong to a small group of proteins 
represented in the Gram-positive conjugal systems of pIP501 (Wang & Macrina, 1995) 
and pGOl (Morton et al., 1993). A computer aided prediction of the hydrophilicity 
profile of ORFs B-D suggested that all three proteins exhibited hydrophilic and 
hydrophobic domains, the latter commonly required in cell membrane complexes. In 
particular, ORF D displayed an alternating pattern of hydrophilic and lypophilic regions 
typically encountered in transmembrane proteins (Wang et al., 1995). Similar 
predictions for ORFs occurring in operons whose proteins are part of a conjugative 
system demonstrated that two separate Gram-positive plasmids did indeed appear to 
contain a protein with a similar profile (figure 5.5). All three proteins were close to 11 
kDa, had an overall positive charge and a pI of approximately 9. Alignment of their 
primary amino acid sequence revealed a number of conserved residue groups (figure 5.6), 
possibly indicating an evolutionary relationship. Spatial linkage of genes with a related 
function is a common phenomenon, which is frequently observed in other conjugal 
systems (Wang & Macrina, 1995; Alt-Morbe et al., 1996; Winans, 1996). Inspection of 
the putative operon I structure reveals that ORF B and C form a tightly linked 
transcriptional unit where the coding regions are separated by a single nucleotide and the 
putative ribosome binding site of ORF C is located in the coding region of ORF B. At 
the 3' end of ORF C, a region of dyad symmetry is found. As this occurs in the coding 
region, it may well confer resistance to 3'-*5' ribonucleolytic degradation of the B-C 
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transcript as this is a feature frequently associated with enhanced gene expression via 
improved mRNA stability (Belasco & Higgins, 1988). ORFs A, B, D and I are preceded 
by short intergenic regions which are capable of containing individual promoter 
sequences, but do not appear to contain regions of dyad symmetry typical of Rho- 
independent transcriptional terminators. In perspective, the organisation of ORFs A, B, 
C, D and I may form a divergent operon, and could be designed to produce proteins for 
the conjugal mechanism at specific ratios. In a comparison with characterised conjugal 
operons (Wang & Macrina, 1995, Winans et al., 1996, Morton et al., 1993) regulon I of 
pCB102 would contain the least number of genes. This may reflect a narrower host 
range, or a different membrane complex through which the DNA is transferred. 
It is interesting to note that among the large number of single-stranded DNA plasmids 
characterised, a conjugal system does not appear to have been found. Single-stranded 
DNA plasmids are thought to mobilise by forming co-integrates with other plasmids 
using either the RSA-Pre or RSB systems (Novick, 1989). Several examples of single- 
stranded DNA plasmids with a mobilisation system have been investigated (Thomas et 
al., 1992, Projan et al., 1988). The systems have two trans-acting mobilisation proteins 
and an oriT, Transfer must be mediated by the conjugal plasmid pGO1. However no 
similarities with the oriT (IncQ type) specific single-stranded endonucleases were 
found. A degree of similarity was found with a single-stranded plasmid encoded ORF 
and an ORF in one of the pGOI transfer regions (Morton et al., 1993). It would be 
tempting to speculate that IncQ type oriT sites, in combination with their 
complementary mobilisation proteins and conjugal proteins which may appear to occur 
in pCB102, were only found in non-single stranded replicating plasmids. 
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The precise deliniation of this conjugal transfer system is important in pCB102 so the 
construction of a non-conjugal recombinant vector can be rationally achieved. In 
addition it seems that plasmids with a full conjugal system are a likely source of a non- 
single stranded /rolling circle replicating replicon (Bruand et al., 1993). An important 
factor in vector design. 
In summary, the minimal replicon of pCB102 has been mapped to a 1.627 kb DNA 
fragment which has formed the basis of. novel shuttle vectors for members of the 
clostridia. These plasmids appear to be stably maintained in a heterologous host C. 
beyerinckii, advocating their assessment in other clostridia including C. botulinum. 
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A versatile pair of vectors encoding both E. coli and clostridial replicons were constructed. A blunt ended Lspl-HindI1l 
restriction fragment originally derived from pCB 102 (Minton & Morris, 1981) was inserted in both orientations into the 
modified NheI restriction site of pMTL21E (Minton et al., 1993). Vectors pMTL540E and pMTL541E both possess 
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A Gram-positive expression cassette based on the C. pasteurianum transcriptional 
machinery (Minton et al., 1993) was inserted into pMTL540E by substituting a Bgll 
fragment from pMTL500F. An identical strategy was used to create an expression 
version of pMTL541E, called pMTL541F. The insertion of a transcriptional terminator 
into the NheI site of pMTL540F restored the replicative function of the derivative 
plasmid (pMTL540T) in the clostridia] host. Both PMTL540T and pMTL541 F contain 
a convenient array of restriction endonuclease sites in which gene fusions can be made. 
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Figure 5.13 Secondary structure and hydrophobicity profiles for putative ORF J 
and ORF K of pCB102. 
Secondary structure predictions of ORF J and ORF K were generated with a number 
of predictive algorythms created using the Protean' programme, DNA STAR Inc. 
(Gamier et al., 1978; Chou & Fashman, 1978; Kyte & Dolittle, 1982; Eisenberg et al., 
1984; Karplus & Shultz; 1985 and Emini et al., 1985). The hydropathicity profiles 
determined for each putative ORF contain large sections of hydrophilic residues. The 
primary amino acid sequence of ORF K shares a short motif with a wide range of 
transmembrane proteins, however this putative ORF appears to reside as a 
countertranscript to the proposed replicon protein ORF H. The function of these 
putative proteins could be intimately linked with plasmid replication such as in copy 
number control, as a membrane associated mechanism of equipartion in plasmid 
maintenance or as a killer system, forming lethal pores in the cell membrane. 
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CHAPTER 6 
GENE TRANSFER STUDIES IN C botulinum TYPE A 
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6.1 Introduction 0 
6.1.1 The objective of gene transfer 
The ability to manipulate microorganisms in vivo adds another dimension through which 
they can be studied. A number of powerful techniques including `gene knock out' 
mutagenesis, insertional mutagenesis, in vivo expression and promoter-reporter studies 
rely on the ability to introduce DNA into the cell. However, the strategy may not only 
be dependent on gene transfer, but on the efficiency with which the cells can be 
transformed. For instance, to generate gene knock outs by homologous recombination, 
this relatively inefficient process must be counteracted with the efficient delivery of the 
recombinant gene knock out cassette. Therefore, the organism must ideally be 
transformable at high frequency, with a range of `genetic tools'. 
In contrast to the genetic paradigms, such as E. cola and B. subtilis, members of the genus 
Clostridium are in general, poorly amenable to genetic- manipulation. Amongst the 
clostridia, the most significant advances have been made with C. perfringens, a medically 
important pathogen of both humans and animals, and with various strains of solvent 
producing saccharolytic clostridia such as C. acetobutylicum and C. befjerinckii (Minton 
et al., 1993). 
A degree of progress has been achieved with t%ie introduction of plasmid DNA (Zhou 
& Johnson, 1993) and conjugative transposons (Lin & Johnson, 1991) into a few 
proteolytic strains of C. botulinum. However, the plasmid employed (Zhou & Johnson, 
1993) propagates via the production of single stranded DNA intermediates and uses a 
rolling-circle mode of replication (Leenhouts et al., 1991). Such plasmids are 
intrinsically unstable (Janniere et al, 1990; Kiewiet et al., 1993), and thus, demonstration 
of plasmid replication in C. botrilinum with a vector which was considered to be 
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relatively stable would be a significant advantage; particularly for applications such as 
promoter-reporter gene fusion technology for regulatory studies. 
The aims of the studies detailed in this chapter were to initially demonstrate plasmid- 
based gene transfer into a group I, type A C. botulinum strain, to demonstrate gene 
transfer with a derivative of pCB 102, which does appear to be stable (section 5.4) and 
to attempt to optimise the frequency with which these strains were transformed. 
6.2 Electrotransformation of C botulinum NCTC 2916 
6.2.1 Electrotransformation 
Initial attempts to introduce a plasmid into a type A C. botulinum strain were based on 
the report of Zhou & Johnson, (1993) who used a `Hall A' strain. As there are several 
type A strains under this classification, the "Hall strain" NCTC 2916 was the initial 
choice as it was 
'also the focus for other genetic investigations in this study. 
The conditions of electroporation determined as optimal by Zhou & Johnson (1993) 
were also used. Cells (0.8 ml of cell suspension was used per cuvette, equivalent to 
4x108 CFU/ml) were harvested from a TPGY broth culture (OD660 0.8), washed and 
resuspended in chilled 10 % (w/v) PEG before electroporation in 0.4 cm gap cuvettes at 
25 µF and 2.5 kV. Freshly transformed cells whrd recovered and plated according to the 
same protocol. The plasmid used by Zhou & Johnson, pGK12 (see table 2.1), was 
prepared by the CsC1 density gradient method (section 2.2.2.3) and used at I µg/0.8 ml 
of cell resuspension. The conditions described by Zhou & Johnson, (1993) were 
successful, but the total number of transformants was low. Typically, between 0 and 10 
erythromycin resistant transformants were obtained per 0.8 ml of cell resuspension. 
Frequently no transformants were detected. 
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6.2.2 Validation of putative transformant4,. 
Transformants were selected on TPGY agar plates (Appendix II) supplemented with 5 
µg/m1 of erythromycin at 35°C in an anaerobic environment. After 48 h incubation 
colonies were observed which continued to `swarm' laterally, engulfing the entire agar 
plate. These colonies represented true transformants in comparison to colonies which 
took a minimum of a week to become visible, were considerably smaller and had a less 
aggressive swarming phenotype.. Although both types of erythromycin resistant 
colonies were able to grow on TPGY-agar plates supplemented with erythromycin (>50 
µg/ml), growth of the smaller colonies was significantly slower in comparison to the 
larger colonies and did not result in `plate engulfment'. Only large colonies could grow in 
TPGY broth supplemented with erythromycin (>20 p g/ml). 
The cell morphology and Gram status of putative transformants were determined by 
Gram staining. Trhsformants were also shown to harbour the type A neurotoxin gene 
by PCR, using oligonucleotides designed to amplify a DNA fragment between 
nucleotides 180-783 of the type A neurotoxin's gene coding sequence (Dr S. M. Whelan, 
Ph. D thesis, p181). 
6.2.3 Isolation of plasmid DNA from putativeetransformant colonies 
To verify the authenticity of C. botulinum transformants, plasmid DNA was isolated 
from TPGY broth cultures supplemented with erythromycin. Initial attempts at 
plasmid isolation using a published method (Strom et al., 1984) were unsatisfactory due 
to the presence of partially degraded chromosomal DNA, and the material obtained 
could not be used to successfully reintroduce plasmid pGK12 into E. coli strains. An 
alternative method, based on the alkaline lysis procedure (Ish-Horowicz & Burke, 1981; 
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section 2.2.2.7), did enable small quantities of plasmid to be isolated, which were 
reintroduced into E coli and subsequently isolated and inspected by restriction 
endonuclease mapping. These plasmids were shown to be identical to pGK12 control 
digests (data not presented). 
6.2.4 Large scale plasmid isolation from putative transformant colonies 
To isolate larger quantities of plasmid DNA, the procedure of Ish-Horowicz & Burke 
(1981) was adapted to process the larger cell mass. All solutions were increased in 
proportion to the culture volume. In addition the sample was subjected to a further 
isopycnic centrifugation step (section 2.2.2.4) to remove any contaminating traces of 
chromosomal DNA, RNA and protein. 
Inspection of the plasmid sample separated in a 0.8 % (w/v) agarose gel indicated that 
at least 5 species pf plasmid existed. This type of distribution is not unusual for a single 
plasmid, due to the presence of different molecular forms, such as multimeric, relaxed 
and supercoiled plasmid conformations. Restriction endonuclease analysis of the 
plasmid sample with enzymes cutting in pGK12, including Hpall and Sac IL 
demonstrated that a specific population of the plasmid DNA did conform to the pattern 
expected for pGK12. In addition, a quantitatively larger amount of digested DNA 
fragments migrated in an agarose gel at alternative molecular weights. Such an 
observation could either have been due to the presence of derivatives of pGK12, or 
from a novel plasmid(s) indigenous to this strain of C. botuliinini. As there were 
restriction endonuclease sites present in the unknown DNA which were not present in 
pGK 12 (including /; coRl, HindIIl and Bgl II), and the alternative DNA could be 
resolved to it single 60 kb fragment (figure 6 1), it was concluded that the DNA 
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complement of this transformed strain atethis point consisted of a small indigenous 
plasmid (, e6.0 kb) and the recombinant plasmid vector pGK12 (4.4 kb). 
6.2.5 Optimisation of gene transfer in C botulinum NCTC 2916 
6.2.5.1 Oxygen contamination 
Before an investigation of `biological' parameters was conducted, the electroporation 
method was assessed. As C. botulinum is an obligate anaerobe, contamination of cells by 
any solution containing oxygen was undesirable. To assess the steps of the 
electroporation protocol which were conducted outside of the anaerobic environment, 
e. g., centrifugation and electroporation, anaerobic indicator solutions (Don Whitely 
Scientific Ltd) were aliquoted into both the 250 ml Sorval Dry SpinTM centrifuge tubes 
and electroporation cuvettes. The centrifuge tubes appeared to eliminate aerobic 
contamination 4, ring a simulation of their use, however, obvious contamination of the 
electroporation cuvettes was detected even with the addition of sealing caps. In 
consequence, the entire electroporation apparatus was placed within the anaerobic 
cabinet for further use. 
Oxygen contamination of media and the electroporation buffer was evaluated by the 
addition of Resazurin, a redox indicator. All spbstances tested appeared free of oxygen 
after 48 h within the anaerobic cabinet. Thus, in the following experiments a period of 
48 h was the duration used to equilibriate buffers and media prior to electroporation. 
6.2.5.2 Estimation of cell viability 
The report of Zhou & Johnson (1993) demonstrated that 4x 108 CFU/ml of C. hotulinum 
cells were required in the electroporation to obtain 10; transformants /µg of DNA. No 
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Plasmid DNA was isolated from an erythromycin resistant clone of C. botuliruuºn NC'l'C 
2916 which was transformed with the recombinant vector pGK 12 (Kok et al., 1984). 
Restriction endonuclease analysis of pGK 12 plasmid DNA isolated from E. c( di (pGK 12") 
or C. butulinum NCTC 2916 (pGK 12`R) demonstrated that in addition to pGK 12, a second 
plasmid of approximately 6.0 kb is present in the clostridial extract. 
(1) 1 kb ladder 
(2) pGK 121'x'/uncut 
(3) pGK 12c'ß/u11cut 
(4) pGK 12E'ß /Hpu II 
(5) pGK 12c'R/Hpa II 
(6) pGK 12''x'/Sur II 
(7) pGK 12CR/Suc 11 
(K) pGK 12K'ß'/EcoR 1 
(9) pGK 12c ß/EcoR I 
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(11) pGK 12"VHinc1 III 
(12) pGK 12' 1Bgl II 
(13) pGK12c'VVRgI II 
(14) 1 kb lackier 
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details of culture volumes were given. To correlate the transformability of C. botulinum 
NCTC 2916 with the number of viable cells, electroporation was repeated as described 
in section 6.2.1, except that cell samples were diluted in electroporation buffer. CFU's 
were estimated from the original cell resuspension prior to electroporation by generating 
serial dilutions which were plated onto non-selective media. 
Dilation number Dilution 
cell: buf er 
Estimated CFU/mI 
experiment 1 
Number of 
transformants 
(Eva) 
experiment 2 
Estimated CFU/ml 
experiment 1 
Number of 
transfonnants 
(Em') 
experiment 2 
1 - 6.5x10' - 1.19x108 - 
2 - 6.5x107 12 1.19x108 24 
3 ' 1: 1 3.3x10' 24 6.0x107 24 
4 1: 3 1.6x107 12 3.0x107 18 
5 1: 7 8.1x106 0 1.5x107 12 
6 1: 15 4.1x106 0 7.4x106 4 
7 1: 31 2x106 0 3.7x106 0 
8 1: 63 1x106 0 1.9x106 0 
9 1: 127 5.1x105 0 9.3x105 0 
Table 6.1 Correlation of cell viability and transformation efficiency 
Electroporated samples were resuspended in 10 ml of diluent TPGY broth 
supplemented with 25 mM MgC12 and serially diluted 1: 100 four times using aliquots of 
100 µl. From these cultures, a further 100 tl of broth was plated on non-selective 
TPGY agar from which the original number of colonies were extrapolated (CFU/ml). 
190 
The results indicate that the number of CF'U's is lower than 4.8x108 by this procedure 
and variable between experiments. It was evident that there was no dramatic increase in 
the number of transformants as the total number of cells increased. Indeed, in proportion 
to the number of cells present, the efficiency was reduced at higher cell concentrations. 
Overall the efficiency was still lower than that reported by Zhou & Johnson (1993) 
with the equivalent CFU's. 
!: 
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6.2.5.3 Effect of field strength on transformation efficiency in C botulinum NCTC 
2916 
The electroporation method described in section 6.2.1 was repeated using the same 
method but the transformation was done at a variety of field strengths (kV/cm). 
Sample kV 
Field Strength 
(kV/an) 
Number of 
transformants 
A) 
CFU/ml 
(3rd dilution) 
% Survival 
(3rd dilution) 
CFU/ml 
(4th dilution) 
% Survival 
(4th dilution) 
1 - - - 2.5x10 - 3.8x10 - 
2 2.5 6.25 10 2.3x10 0.9 0 0 
3 2.25 5.625 14 3.8x10 15.0 3.8x10 10.0 
4 2.0 5.0 11 3.3x10 13.0 IX109 26.0 
5 1.75 4.375 23 7.3x10 29.0 8.8x10 23.0 
6 11.5 3.75 10 7.5x10 30.0 IX109 26.0 
7 1.25 3.125 0 IX109 40.0 1.4x10 36.0 
8 1.0 2.5 0 8.3x10 33.0 2x10 53.3 
9 0.75 1.875 0 1.5x10 60.0 8.1x10 >100 
10 0.5 1.25 0 UX109 50.0 6.9x10 >100 
11 0.25 0.625 0 confluent - 1.8XI09 46.6 
Table 6.2 Effect of electric field strength on transformation efficiency in 
botulinum NCTC 2916. Experiment 1 
Electroporated samples were resuspended in 10 ml of diluent TPGY broth supplemented 
with 25 mM MgC12 and serially diluted 1: 100 four times using aliquots of 100 µl. From 
these cultures, a further 100 µl of broth was plated on non-selective TPGY agar from 
which the original number of colonies were extrapolated. 
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4 
%I 
Sample kV 
Field 
Strength 
(kV/cm) 
Number of 
transformants 
(EmR) 
1 - - - 
2 2.5 6.25 12 
3 2.25 5.625 10 
4 2.0 5.0 16 
5 1.75 4.375 3 
6 1.5 3.75 0 
7 1.25 3.125 0 
8 1.0 2.5 0 
9 0.75 1.875 0 
10 0.5 1.25 0 
11 0.25 0.625 0 
Table 6.3 Effect of electric field strength on transformation efficiency in C 
botulinum NCTC 2916. Experiment 2 
The results suggest that electroporation in q. botulinum NCTC 2916 is not successful 
with an electric field strength below approximately 3.0 kV/cm. A significant increase in 
transformation frequency was not detected at higher field strengths. 
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6.2.5.4 Effect of DNA concentratioir on the transformation efficiency of C 
botulinum NCTC 2916 
The electroporation method described in section 6.2.1 was used with the addition of 
varying amounts plasmid DNA. The plasmid used was pGK12 (150 µg/ml in 1xTE 
buffer) prepared from E. coli HB101 by the CsC1 method (section 2.2.2.3). 
 
iF 
Sample DNA 
(volume) 
DNA 
(µg) 
Number of 
transformants 
(EmR) 
1 40.0 µl 6.000 1 
2 10.0 µl 1.500 1 
3 6.0 µ1 0.900 2 
4 3.0 µ1 0.450 0 
5, 1.5 µl 0.225 0 
6 1.0 µl 0.150 0 
7 0.50 0.075 0 
Table 6.4 Effect of DNA concentration on transformation efficiency in C 
botulinum NCTC 2916 1 
The number of erythromycin resistant colonies was particularly low in this experiment 
which may therefore be difficult to interpret. The results also reflect the inconsistent 
nature and poor gene transfer efficiency experienced with this strain and with these 
methods. 
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6.2.5.5 Other parameters 'Al 
Stationary growth phase (O. D600= 1.2) and early exponential growth phase 
(O. D600=0.4) cells were electroporated under the conditions defined in section 6.2.1. 
Neither of these modifications increased the total number of transformants above 10. 
Likewise, the adjustment of resistance from between 100-800 fl failed to improve gene 
transfer efficiency. 
6.2.5.6 Electrotransformation of C botulinum NCTC 2916 with pMTL540E 
The plasmid pGK12 had indisputably been introduced into C. botulinum NCTC 2916, 
albeit at low efficiency. As the procedure clearly allowed plasmid DNA to enter the 
cells, the possibility existed that pMTL540E could be similarly introduced. However, 
during the course of over 10 attempts, not a single positive transformant was detected. 
To investigate this observation, alternative constructs based on the pCB 102 replicon 
were made. The inducible MLS resistance gene in the pGK12 construct (derived from 
pE194; Kok et al., 1984) was cloned as a PCR fragment and used to replace the 
constitutive MLS resistance gene present in pMTL540E (Brehm et al., 1987). The ß- 
lactamase gene from pMTL540E was also removed. The resultant plasmid functioned in 
C. beyerinckii NCIMB 8052, but again, nö erythromycin resistant colonies were 
detected in C. botulinum NCTC 2916. Failure to transform could be due to the fact that, 
that the pCB102 replicon did not function in this group of clostridia, which is some 
what phylogenetically distinct from its natural host C. butyricum (Collins et al., 1994), 
or a barrier to transformation associated with the DNA existed. 
The presence of a type 11 restriction endonuclease in C. hotulinuim NCTC 2916 was 
assessed by the method of Mermelstein, (1992). Plasmids pGK12 and pMTL540E, 
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which were isolated from E. coli FIB 101 and used in electroporation experiments, were 
used as substrates in combination with commercially available restriction endonuclease 
buffers from Boehringer Mannheim: A, B, L, M, H and Northumbria Biochemicals Ltd: 
1-13). No endonuclease activity was detected after a 16 h incubation at 37 °C. In 
contrast, a type II restriction endonuclease with a specificity analogous to. MspI was 
detected in a non-proteolytic C. botulinum type B strain (T. Davis, unpublished data). 
Although RNA from C. botulinum NCTC 2916 was released into the `cleared lysate' 
during the restriction endonuclease extraction procedure, light microscopy suggested 
that the method of Mermelstein did not efficiently lyse the group I C. botulinum cells. 
To avoid entering a protracted search for barriers which inhibited the use of pMTL540E 
in C. botulinum NCTC 2916, an alternative `shotgun' approach was employed in which 
other C. botulinum type A strains were speculatively challenged with pMTL540E using 
the electroporaiön technique. 
6.3 Electrotransformation of C botulinum ATCC 3502 
6.3.1 Electrotransformation 
This type A strain was also described as a `Hall strain'. Colonies were whitish-grey in 
appearance, mucoid and shiny. Although surrpunded by `feathery' growth, the lateral 
growth was not as pronounced in comparison to strain NCTC 2916. 
Electroporation was conducted according to the details in section 6.2.1. pMTL540E 
plasmid DNA was isolated from E. coli HB 101 by the CsCl density-gradient method 
(section 2.2.2.3) of which 4 tg were used in each cuvette. Using this methodology a 
total of 37 Em' resistant colonies appeared after approximately 48 h incubation at 37 °C 
in an anaerobic cabinet. 
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Sample Plasmid Field strength 
Erythromycin 
Resistant 
Colonies 
1 - 6.25 kV/cm 0 
2 pMTL540E 6.25 kV/cm 8 
3 pMTL540E 6.25 kV/cm 17 
"4 . pMTL540E 
6.25 kV/cm 12 
Table 6.5 Electroporation of C botulinum ATCC 3502 with pMTL540E 
6.3.2 Analysis of the putative transformants 
Em' resistant colonies were essentially morphologically identical to C. botulinum ATCC 
3502 grown oii'TPGY agar. Light microscopy of the Gram stained colony preparations 
demonstrated that the putative transformants were short Gram positive rods. The 
toxigenic potential of the transformants was confirmed by amplification of a 600 bp DNA 
fragment of the type A neurotoxin gene (section 6.2.2). Plasmid DNA was extracted 
from 10 ml TPGY cultures, supplemented with erythromycin (20 µg/m1) which were 
grown for 16 h (section 6.2.3). E. coif strain TG1 was transformed with the plasmid 
DNA which conferred both an ampicillin kid erythromycin resistant phenotype. In 
addition the colonies were blue in the presence of IPTG and X-GAL indicating that the 
lacZa gene was also functional. Restriction endonuclease analysis of plasmid DNA 
isolated from the E. coli transformants demonstrated that the restriction endonuclease 
profiles of plasmids isolated from C. botulinum ATCC 3502 were identical to the 
original vector pMTL540E. 
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6.3.3 Large scale plasmid isolation from C botulinum ATCC 3502 transformants 
Larger quantities of plasmid DNA were isolated from the C. botulinum ATCC 3502 
transformants using the method developed for C. botulinum NCTC 2916 (section 6.2.4). 
Electrophoretic analysis of the plasmid sample in a 0.8 % (w/v) agarose gel 
demonstrated the presence of two high molecular weight bands. Restriction analysis 
revealed that the entire sample. was composed of DNA fragments which corresponded 
to the restriction profile of pMTL540E. No visible evidence supported the existence of 
additional plasmids in this sample (figure 6.2). 
6.3.4 Electrotransformation of C botulinum ATCC 3502 with passaged DNA 
To determine if the modification of plasmid DNA was influential in the frequency with 
which C. botuli. um ATCC 3502 could be transformed, two sources of the plasmid 
were used. Preparations were made either from an E coil strain (HB101 or GM2163) 
prepared using the CsCI density gradient method (section 2.2.2.3) or from the recipient 
clostridial strain, C. botulinum ATCC 3502 (section 6.3.3) or C. botulinum NCTC 2916 
(section 6.2.4). The electroporation procedure was identical to that described earlier 
(section 6.2.1). 1 
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Figure 6.2 Restriction endonuclease mapping of plasmid DNA isolated from 
C. botulinum ATCC 3502 
Plasmid DNA isolated from an erythromycin resistant, putative transformant 
colony of C. botulinum ATCC 3502 (section 6.3.3) was digested with a 
number of restriction endonucleases. pMTL540E plasmid DNA (control) 
isolated from an E. coli strain was also digested and concomitantly the samples 
were separated in a 0.8 % (w/v) agarose gel. 
Lane 1) 1Kb DNA ladder, Lane 2) control: uncut 3) 3502: uncut 4) control: Xba 
I 5) 3502: Xba I 6) control: Hind III 7) 3502: Hind III 8) control: Pvu 11 9) 
3502: Pvu 11 10) control: EcoR 111) 3502: EcoR 112) control: Sca 113) 3502: 
Sea 114) 1 Kb DNA ladder. 
The DNA fragments demonstrate that the plasmid DNA isolated from C. 
botulinum ATCC 3502 is essentially indistinguishable from pMTL540E isolated 
from E. coli indicating that this clostridial strain is successfully transformed 
with plasmid. 
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Plasmid Source Recipient Experiment 1 Experiment 2 Experiment 3 
pMTL540E E. colt C. botulinum 5 7 8 
(HB101) ATCC 3502 
pMTL540E C. botulinum C. botulinum 6 11 3 
ATCC 3502 ATCC 3502 
pGK12 E. coli C. botulinum 0 3 6 
(GM2163) ATCC 3502 
pGK12 C. botulinum C. botulinum 0 0 0 
NCTC 2916 ATCC 3502 
Table 6.6 Electroporation of C botulinum ATCC 3502 with plasmid DNA from 
different sources 
`a 
The transformation results did not provide sufficient evidence to speculate whether DNA 
modification was an important factor in determining transformation efficiency. Each 
plasmid preparation was able to transform E. coli strains at high efficiency indicating that 
the DNA was of good quality. 
11 
6.3.5 Effect of a cell wall modification agent on transformation efficiency in C 
botulinum ATCC 3502 
The effect of glycine on transformation efficiency was established by first determining 
the concentration at which it exerted an inhibition of cell growth. Incremental 
concentrations of glycine (w/v) in TPGY broth were inoculated with a3% volume of 
fresh exponential culture of C. botulinrim ATCC 3502 and incubated at 37 °C. After 16 
h broths containing glycine up to a2% (w/v) concentration appeared turbid, whilst 
200 
.r those at 2.5 % (w/v) and 3.0 % (w/v) appeared weakly turbid after 48 h. A repetition of 
this experiment with 0.1 % (w/v) increments between 2.0 % (w/v) and 3.0 % (w/v) 
glycine indicated that 2.2 %-2.3 % (w/v) glycine concentration range was critical for 
growth inhibition. Electrotransformation was repeated as detailed in section 6.2.1 except 
that C. botulinum ATCC 3502 was cultured overnight in 30 nil TPGY broth 
supplemented with 2% glycine (w/v) and inoculated into 2x 300 ml TPGY broth 
supplemented with 2% (w/v) glycine for the preparation of electro-competent cells. 
Plasmid Source Recipient Experiment Experiment Experiment 
1 2 3 
pMTL540E E. coli C botulinum 276 49 72 , 
(HB101) ATCC 3502 
pMTL540E C. botulinum C. botulinum 6 12 ND 
ATCC 3502 ATCC 3502 
pGK12 E. coif C. botulinum 9 23 10 
(GM2163) ATCC 3502 
pGK12 C. botulinum C. botulinum 0 ND ND 
NCTC 2916 ATCC 3502 
Table 6.7 Effect of a cell wall modification agent on gene transfer frequency in C 
botulinum ATCC 3502 
The results indicate that the addition of sub-inhibitory concentrations of glycine are able 
to increase electrotransformation efficiency by a modest amount. When comparing DNA 
isolated from E. coli HB 101 this increase approached a one log increase. However the 
success of this procedure still remains inconsistent. 
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6.4 Characterisation of a plasmid from C botulinum NCTC 2916 
6.4.1 Justification for cloning a plasmid indigenous to a group I, C botulinum 
strain 
During the course of the gene transfer studies in C. botulinum NCTC 2916, the failure to 
obtain a transformant using pMTL540E suggested that the replicon of this plasmid was 
unsuitable for use in group I C. botulinum. The possibility of isolating an alternative 
replicon derived from this organism was perceived as a means of circumventing such a 
problem. The co-isolation of a putative indigenous plasmid with pGK12 facilitated this 
process (section 6.2.4). The rational characterisation of the plasmid isolated from C. 
botulinum NCTC 2916 was implemented. 
6.4.2 Restriction endonuclease mapping of the putative plasmid from C 
botulinum NCTC 2916 
Samples of plasmid DNA isolated from C. botulinum NCTC 2916 (section 6.2.4) were 
digested with a range of restriction endonucleases and analysed on agarose gels. These 
gels indicated that an extrachromosomal element, probably a plasmid of approximately 
6.0 kb, appeared to be linearised with either EcoRI, XbaI or BgIII without cutting 
pGK12. Another enzyme, Sad, could linearisj both pGK12 (4.4 kb) and the indigenous 
plasmid leaving a faint band which was refractory to digestion by any enzyme used. It 
was thought that this band consisted of single stranded DNA plasmid intermediates 
(figure 6.1). Digests with HindRI appeared to cut the indigenous plasmid into two 
fragments of approximately 3.1 kb and 2.7 kb, whilst a second enzyme, HpaII, 
produced bands of approximately 4.2 and 1.5 kb. 
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6.4.3 Cloning a cryptic plasmid from C'botulinum NCTC 2916 
The two HindHI fragments from the cryptic plasmid appeared to be the most suitable 
candidates for cloning, partly because the plasmid could be sequenced from four 
separate ends and the original plasmid could be easily reconstructed. An 80 µl sample 
of the plasmid preparation from C. botulinum NCTC 2916 (section 6.2.4) was digested 
with HindIII and purified by phenol extraction. Likewise, 10 µg of the E coli cloning 
vector pMTL20 was digested with HindIII and phenol extracted. The two preparations 
were ligated together and used to transform E coli DH5 a. Transformants were selected 
in the presence of IPTG and X-Gal. White colonies were selected and screened for 
plasmids containing inserts of approximately 3.1 kb or 2.7 kb. Two colonies were found 
to contain inserts of the expected size. The plasmids pBP19 and pBP2, were used for 
further analyses. 
6.4.4 Determination of the complete nucleotide sequence of the indigenous 
plasmid from C botulinum NCTC 2916 
6.4.4.1 Nucleotide sequence analysis 
Plasmid DNA of the clones pBP19 and pBP2 were purified using the Qiagen method. 
Approximately I µg of each plasmid was segdericed with universal or reverse universal 
oligonucleotide primers (Appendix V) using an ABI automated sequencer (section 
2.2.11.5). The entire nucleotide sequence of each clone was determined on both strands 
using an oligonucleotide primer `walking' method. To establish the orientation of the 
two DNA fragments and contiguity of the Hindill sites, four sequencing primers were 
used as PCR primers to amplify DNA fragments spanning both HindIll sites. The PCR 
products were cloned (section 2.2.12.4) and sequenced. Individual sequences were 
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assembled into a single contig using the DNASTAR software package 'Seqman'. The 
contig was then translated in all six reading frames using the DNASTAR software 
package `Mapdraw' (figure 6.3). Assembly of the DNA sequences yielded the putative 
C. botulinum plasmid pBP1, of 5927 nucleotides in length and with an A+T base 
composition of 74.34 % typical of mesophilic clostridial DNA. 
6.4.4.2 Analysis of putative 4RFs 
An analysis of the translated DNA sequence suggested that pBP 1 consisted of 8 ORFs 
which were encoded on either DNA strand (see table 6.9 and figure 6.4). Distinct 
operons appeared to be formed by ORFs 3 and 4 plus ORFs 6 and 7. ORF 2 assumed a 
divergent orientation to ORF 3, whilst a similar relationship was found between ORF 5 
and ORF 6 (figure 6.4). To assign functions to the putative proteins encoded by ORFs 
1-8, each transläted protein sequence was used to search the SwissProt data base using a 
low K-tuple and percentage threshhold value. In addition, the secondary structure for 
each putative protein was predicted using the DNASTAR program `Protean'. 
ORF 1 
This ORF does not possess an obvious ribosome binding site or translational initiation 
codon. Comparison of the entire ORF with the current DNASTAR EMBL database 
(issue 100) suggested that the product of this gene bears a high degree of similarity with 
a group of topoisomerases with replicative origin-specific activities. This class of 
proteins are implicated in initiating the replication of plasmids whose members are 
broadly represented by pC194, a plasmid which replicates via a RC mechanism 
(Novick, 1989). An alignment of several replication proteins most similar to ORF I 
(figure 6.5) 
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Hind III 
AAGCTTCAAATAATATTGATGAATATGCTGAAAAATTAAAAGTTAATTTATCATCTAATTCTAATGAAATGCCAATATCAAG; GCATATTCAC; G'PTAI'AA 
-_-_-_____-___-. -. -. -. -. ____-. _. -. -. -. -. -. ______-. _. ____-_-. __. 100 
TTCGAAGTTTATTATAACTACTTATACGACTTTTTAATTTTCAATTAAATAGTAGATTAAGATTACTTTACGGTTATAGTTCCCGTATAAGTCCAATGTT 
ASNNIDEYAEKLKVNLSSNSNEMPISRAYSGYN 
TAGTTCTGGTGCTGTAGCTTATGCCCATAAATGGGCTACCTCTTTTAATCCTAAGTATATGAGATTTTCTGCTGATTGTACAAATTTTGTATCTCAATGC 
-. -. -_-_____________-____________________. -. -. -__. -. -. -___-. __. 200 
ATCAAGACCACGACATCGAATACGGGTATTTACCCGATGGAGAAAATTAGGATTCATATACTCTAAAAGACGACTAACATGTTTAAAACATAGAGTTACG 
SSGAVAYAHKWATSFNPKYMRFSADCTNFVSQC 
EcoR I 
-Ay" 
GCTTTTGAAGGTGGAACAA CAAACCATAATATTTCACCAGTTTGGATACCAGCACTACAAGAAAAAGGAGCTCCAAAATATTCAAAATCATGGACTT 
________-_-. -. -. -___-_-. -. -. ________-_-. -. -. -. -. -__. _. -. -. -__.. 300 
CGAAAACTTCCACCT TCTTAAGGTTTGGTATTATAAAGTGGTCAAACCTATGGTCGTGATGTTCTTTTTCCTCGAGGTTTTATAAGTTTTAGTACCTGAA 
AFEGGRIPNHNISPVWIPALQEKGAPKYSKSWTC 
GCGTAAAAGATTTTTATAACTTTATGCTTCAAGCAGGCTATGCTTCAGCTCCAGAAGGCGGTTGTAAACAAGCTAGATTGGGTGATGTTTGCAGCTTTAT 
--------------------------------------------------------------- 400 
CGýATTTTCCTAAAAAATATTGA AT CGAAGGTTCCGTCCGATACCGAAGTCCGAG TCCTTCC CCAACATTTTGGTTCCGATTCTAAACCCACCTACAACCGTCGAAAATA 
AATGTACCTAAAAATGATTGGACTCATGCAATGATTGTAACTAAAATTGATAGTAAAGGACGTGTGTATTATTCAGCACATACTGACCCTAAATTGGATG 
-_-_-. -. -. -. -. -. -. -. -_-_-"---. -. -_-. -. -. -. -_-. -. -_-_-"-_-. -. -.. 500 
TTACATGGATTTTTACTAACCTGAGTACGTTACTAACATTGATTTTAACTATCATTTCCTGCACACATAATAAGTCGTGTATGACTGGGATTTAACCTAC 
MYLKMIGLMQM. IVTKIDSKGRVYYSAHTDPKLDV 
of 4' 
TTCCTGTTTGGTACGCTTTAGATGGTAAAACTTATGGGAACATAAGATTAATAAAATTTTGGCATTAAAATAATTTAAATTACTCTTGTACTTAAAAGAA 
-_-_-----------------_-"-_-_-----_-----_-_-_-"---_-----. -. ---_. 600 
AAGGACAAACCATGCGAAATCTACCATTTTGAATACCCTTGTATTCTAATTATTTTAAAACCGTAATTTTATTAAATTTAATGAGAACATGAATTTTCTT 
PVWYALDGKTYGNIRLIKFWH. 
(Transcriptional terminator) 
BR/ II 
AGGGTAAAA TTCCATTCTTTATTATAAAGTTAAGTTTAAAATTATAATATGTTTTT=TAAATGAGTTAAATGTTAAAAAACGA 
_. _. _. _. _. _. _. _. _______. _. _. _. _. _. _. _. _. _. _. _. _. _. _____. _. _. _-"700 
TCCTTGAACATTTTCAAGGAAAGAAAATAAGAAATAATATTTCAATTCAAATTTTAATATTATACAAAATCTAGATTTACTCAATTTACAATTTTTTGCT 
Bel 11 
AAAATAATATAGGTTTAATAAAATTAGTCATTAAAATAGCTTTTTTATTTATATAAAAAGTTTATAGCA7SG'7CTCTTCAAGAATTTCAGATG000TTGTAT 
_. _. _. _. ___________________________. _. _. _________. _. _. _____. _.. 800 
TTTTATTATATCCAAATTATTTTAATCAGTAATT TTATCGAAAAAATAAATATATTTTTCAAATATCGTTCTAGAAGTTCTTAAAGTCTACGCCAACATA 
.KYLFNIALDELIESATT 
GTTCTTTTATACTTTTTATTCTTAAATCCGTCCAAACATCATCATCC»AATTACTGTATGCTTACTGCTCTTATTGTTTTTTTTGGGTCTGCCGACTTT 
-----------------. -_-_-_-_-. -. -_-_-"-----------. -. -----_-. -. -.. 900 
CAAGAAAATATGAAAAATAAGAATTTAGGCAGGTTTGTAGTAGTAGCTTTTAATGACATACGAATGACGAGAATAACAAAAAAAACCCAGACGGCTGAAA 
HEKISK1RLDTWVDDDFIVTHKSSKNNKKPRGVK 
TATTTCATCTTTACATATTTCTTTAGGCTCTATGGTTTTAAATT CATTATTTTTTAGTATATATCCATATCTTTTAAACTTAGATGTTATGCCCCTTGAT 
_____. _. _. _. _. _. _. _. _. _. _. _. _. _____. _. _. _. _. _. ___. ___. _. _. _. _.. 1000 
ATAAAGTAGAAATGTATAAAGAAATCCGAGATACCAAAATTTAAGTAATAAAAAATCATATATAGGTATAGAAAATTTGAATCTACAATACGGGGAACTA 
IEDKCIEKPEITKFENNKLIYGYRKFKSTIGRS 
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ATGCCTAAATTTTTAGATATTTTGCTTATTGATTTCCCGTTCATCAATTCAGAATTAAAAAACTCTATCTGCT TATCAATAGTTAAATTTAAAAATTCTT 
-_-_-___-_-. -. -. -__. _____. ___. _______. -. -_-. -. -. -. -___-. -. ____. 1100 
TACGGATTTAAAAATCTATAAAACGAATAACTAAAGGGCAAGTAGTTAAGTCTTAATTTTTTGAGATAGACGAATAGTTATCAATTTAAATTTTTAAGAA 
IGLNKSIKSISKGNMLESNPFE10KDITLNLFE 
CTCTATCCATACATAAAACCTCCTATATAGTTTTAAATCTGCATATATTATATTAACATATTTACAAAAATATGGAAATTAAATATTAGTATATGTCTAT 
_. _. _. _. _. _. _. _. -____. ___. ___. ___. ________---________. _. ______. 1200 
GAGATAGGTATGTATTTTC. AGGATATATCAAAATTTAGACGTATATAATATAATTGTATAAATGTTTTTATACCTTTAATTTATAATCATATACAGATA 
ERDM . +® orf5 RBS 
-o + CTTTTTTTATGTTTAGTAGTTATAGAAATCCTAAATTAATGGCACATATAAGAAGTAAATTTTACAAAGTTGCCTTATTTTATATATAAAAAAAATTTTT 
-. -. -. _____. -__. -_-_-____. -. -. -. -. -. -_____-_-. __-. -. -__. ______. 1300 
GAAAAAAATACAAATCATCAATATCTTTAGGATTTAATTACCGTGTATATTCTTCATTTAAAATGTTTCAACGGAATAAAATATATATTTTTTTTAAAAA 
--º _-- TTTTATTTCTTGTTATTTTTTTTTAATAACTTGTATATAAGAAAAAAAACAAAAAAAAATAAItGAt üAAAACTATTATGAAGAAAAATAAGAAAAACAAA 
-. -----------. ---------. -------------------------------------- 1400 
AAAATAAAGAACAATAAAAAAAAATTATTGAACATATATTCTTTTTTTTGTTTTTTTTTATTCCTCCTTTTGATAATACTTCTTTTTATTCTTTTTGTTT 
RPS o f6 rY MKKNKKNK 
TTAAAGAAAAATTTATTAAAGAAGATAGAAATTTTTTTACCTGTTGCACTTTTTATTAATTGTGTTTTTAATATTTTAAAAAATTTTAAAGATATATTTT 
--_------------. _. _. _. _. _____. ___. ___. _. _. -. _. -____. _. _. _. ___.. 1500 
ýAT'TCJTTN AAATALATTTCTTCTATCTTTAAAAA LATGGACýAACGT(ýAAAAATAAVPLrCAAAAATTATAAAAT'irTVAAAATTTCTATAT" 
LR IC IEIFFAFPCVFNLH IC D Ip 
f7I 
TTTAATGAAGTATATATTATACTTTATAATTTTTATGCTCTGTTTTAACTCTATCTATGCTCTATTTTTACTCTGTTTTAACTCCATTTTTACTCTATTA 
-. -. -. -. -. -. -. -_-. -. -. -_-. -. -_-----_-. -. -. -. -. -. -. -_-. -. -. -. -.. 1600 
AAATTACTTCATATATAATATGAAATATTAAAAATACGAGACAAAATTGAGATAGATACGAGATAAAAATGAGACAAAATTGAGGTAAAAATGAGATAAT 
.MKYILYFIIFMLCFNSIYALFLLCFNSIFTLL 
TTTTTGATTGAAATGGAGTCAATGTGGAGATTTTAAAAATTTTTAT TAGGTAGGAATAAAAAATTTTAAAATAC'I'Al'A'I'Tr. ATGGAATGGAAATCATC 
---_-__. ___. ___. _. _. _. _. _. _. _. _. _. _. -. ___. _. _. ___. ___"___. _. __. 1700 
AAAAACTAACTTTACCTCAGTTACACCTCTAAAATTTTTAAAAATACATCCATGCCTTATTTTTTAAAATTTTATGATGTAACTACCTTACCTTTAGTAG 
FLIEMESMWRF. 
ACACTGGA AAG AACATACAATGTTGCTCCCCGCGCCTAACGGCAAGTGATTATGGGT GT TGCTGTCGGGCAACC 
-_-___-----_-_-_-_-_-_______---_-----_-_----_-_______-_. -_--__. 1800 
TGTGACCT TTC TTGTATGTTACAACGAGGGGCGCGGATTGCCGTTCACTAATACCCA CA Ac GA1 Gr-rr(, T Ti ; c; 
35 
CCCC AGAGCATAGGACGGAGTCCTATA AAl' AAAGCCTCGCAGAGCATATTTA TTT ,G 
---------------------------------------------. ---------------- 1900 
GGGG TCTCGTATCCTGCCTCAGGATAT TT; TTTCGGAGCGTCTCGTATAAATGAAATCCGTATTTCA'I'A'I"1'ATACGATA 
-10 
CTTAAAAGTATTTAAAAAACTGTAGTAGTAAAAAA(+; F, c; TTTTGATGTGAGTTATTTAGTTTGCACAATGAAGAAAATGAAAAAAGATAATTTA 
-. ---------------------------------. -----------. ----------. 2000 
TGAAATGAATTTTCATAAATTTTTTGACATCATCATTTTTTCCTCAAAACTACACTCAATAAATCAAACGTGTTACTTCTTTTACTTTTTTCTATTAAAT 
(Pre recombine) RRS orf 8 4w VSYLVCTMKKMKKDNL 
TTTGGTTTGCAAAAACATAATCAACGAGAATCTGAAAATCATAATAACAAAGATATTGATAAAAATAAAAGTGATTTGAATTATGATTTAGTAAATGAAA 
--------------------------------------------------------------- 2100 
AAACCAAACGTTTTTGTATTAGTTGCTCTTAGACTTTTAGTATTATTGTTTCTATAACTATTTTTATTTTCACTAAACTTAATACTAAATCATTTACTTT 
FGLQKHNQRESENHNNKDIDKNKSDLNYDLVNEN 
ATAAAATTAATCTCT CAGAAAAGGTATTTGATTTGATTGAAAAAATAAGAGAAAGTGAAAAAGCTATCCGTAAGGATGCTGTTTTACTAGATGAATTTAT 
___. _. _. _. _. _. _. _. _. _. _. _. _. _.. __. _. _. _. _. _. _. _. _. _. _. _. _. _. _.. 2200 
TATT 
K 
TIAATTAGAGSGTCCTTTTTC`ATAAAACCTAAACIAACTE T TTTIATTTCTCCTTTCACCTTTTTTCCGAIAGG ATTTCCCTACCGACAAAATGATCCTACTTAAAAIA 
TATAAGCAGCGATAGAGATTTTTTTAAAAATATGAATGAAAATGAAATTAAAAAGTTCTTTGAAACTTCAAAACAGTTTTTTGCAGAGCGTTATGGGGAA 
---"-"-"-"---_-_- --------_ ----- -------------------_----- -- _. 2300 
AIATSCGSCGDTAT TDTAAAAFAAKTTNTAMACNTAETTTR TAETT 
IAATTT 
TCF GAFAACTTTGASGTKTTGTCAFAAAAACGTETCGCAYTAGCCCTT 
Nde 
GAAAATATAATTAGTGCTAATGTCCATTTAGATGAAACTACCCCTCATATGCACCTAGATGTGTGTCCGTTACGCAATGGGAGACTGCAAAGTAAAAATA 
_. _. ___. _. ___. _. _. _. __-______. ___. ___. _. _. _. _______. _. _. _. _. __. 2600 
CTTTTATATTAATCACGATTACAGGTAAATCTACTTTGATGGGGAGTATACGTGGATCTACACACAGGCAATGCGTTACCCTCTGACGTTTCATTTTTAT 
ENIISANVHLDETTPH 14 HLDVCPLRNGRLQSKNI 
TTTTTACTAGAAATGAACTTAGAAATATTCAAGAAGAATTACCTAAAACTTTAAAAAATAATGGATTTGAAATTGAGAGAGGTGTTAAAGGATCTACTCA 
--_. --------------------------. ---------------------------- 2500 
AAAAATGATCTTTACTTGAATCTTTATAAGTTCTTCTTAATGGATTTTGAAATTTTTTATTACCTAAACTTTAACTCTCTCCACAATTTCCTAGATGAGT 
FTRNELRN10EEL? KTLKNNGFEIERGVKGST0 
AAAACATATAGACATACAAACTTTAAAAGCACGAGAAGAAAAAAAACTTAAAGAGTTAAAGGAAAAAAATAAAGAGATAGAATTAAAGATTGCCAGTAGA 
------------------------. --------------_. _. -----------------0 2600 
TTTTGTATATCTGIATGTTTGAAAATTTTC TGCTCTTCTTTTTT TTGAATTTCTCAAATTTCCTTTTTTTATTTCTCTATCTTAAATTTCTAAC GTCATCT 
AAAGAAAAATTAGAAGAAGTTAAAGATTTAGATTTTCAAATTAAATCAAAAAAAACTGTTTTAAATAACTTAAATCAAGGGAATGACTGTCTCGATGAAG 
-------_-_-___-_-----_-------_-----. -_-------_-_-. -. -. -. -. -___. 2700 
JTTJTTTTTAATJTTJTTCVAATTTSTAtATCTAAAAGTTTAAJTTPGTJTTJTTIGACAA ATTTAýTGAAATTTAGTTCCCýTASTGACAeGSTAJTTE 
Hind III 
ATATTAAATATAAGCTTGATGGTTTTGACGTCAAAATGGATTACGTTGAATTTAGAAAATTTCAAACTCAAAT TGCAAGTATTAAAAAAGTAAAAAAAGA 
-_____-. -_-. -. -. -. _. -___-. __-_-. -. -. -. -. -. -_-. -. ___. -. -. -__. -.. 2800 
TATAATTTATATTCGAACTACCAAAACTGCAGTTTTACCTAATGCAACTTAAATCTTTTAAAGTTTGAGTTTAACGTTCATAATTTTTTCATTTTTTTCT 
IKYKLDGFDVKMDYVEFRK10T01ASIKKVKKE 
AAATGAAGATTTAAAAAATGAAAATAGTATAGTTCATAAAAAATGTTCTGACCTTAGAAAATCTCAAGAAGAAGTATCTAGTAGGTTTACAAATTGGATA 
--------------------------------------------------------------- 2900 
TNTACE 
D 
AALATTRTTTTACCTTTTATSCH 
IATCýAA HTA 
ýTTTTTACASGACDTGLAATTCTTTTT 
SGAGQTTCCTTCCTTVAT SGATSCATCCAAArGT 
NTAWCCIAT 
N& XboI/TagI 
GATAATACTTACAAGCATATGTCTTTGGACTCGAGAGAGCAGTTCAAACGAAGAGGTTCTGAATCCTTAGCTAATGGTTCAACAGGTAACTATGACGAAG 
_. _. _. _. _. _. _. _. _. _... _. _. _. _... _. _. _. _. _. _. _. -. -. -. _. _. _. _. _.. 3000 
CTATTATGAATGTTCGTATACAGAAACCTGAGCTCTCTCGTCAAGTTTGCTTCTCCAAGACTTAGGAATCGATTACCAAGTTGTCCATTGATACTGCTTC 
DNTYKHMSLD9REQFKRRGSESLANGSTGNYDED 
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ATAGCACCCTGGATAAGTCTGTAATGGATTCTAAGGCATTTAATGAAGACGTGTATATAAAATGTGCTAATGAAAAAGAAAATGCGTTAAAAGAGCCTAA 
_. _. _. _. _. _. _____. _. _. _. _. _. _. _. _. _____. _. _. ___"-. _____. ___. _. _ 3100 
TATCGTGGGACCTATTCAGACATTACCTAAGATTCCGTAAATTACTTCTGCACATATATTTTACACGATTACTTTTTCTTTTACGCAATTTTCTCGGATT 
STLDKSVMDSKAFNEDVYIKCANEKENALKEPK 
TI 
AATGAGTTCAAATGGTTTTGAAATTGATTGGTAGTTTAATTTAATATATTTTTTCTATTGGCTATCTMATACCTATAGAATCTTCTGTTCACTTTTGTT 
-_-_-. -_-_-. -. -. -. _-___. __-__-_-_-_-_---_-____-. -. _. -. -. -___-.. 3200 
TTACTCAAGTTTACCAAAACTTTAACTAACCATCAAATTAAATTATATAAAAAAGATAACCGATAGAGCTATGGATATCTTAGAAGACAAGTGAAAACAA 
MSSNGFEIDW. 
ýý uIIs.. ýýlus Origin) T- 
TTTGAAATAT TTTTAGCCCCTTTTTTTTAAAACT MAGGAGTTTCTTCATT '^13ATACTATACGTAACTATTTTCGATTTGACTTC 
-----_-_-_-_-_-_-_-_-----_-_-_-_-_-_-_-_-. -. -_-_-. -. -_-_-_-. -__3300 
AAACTTTATATTTTTCCCCGAAAAATCGGGGAAAAAAAATTTTGAGGCCTCCTCAAAGAAGTAAGAACTATGATATGCATTGATAAAAGCTAAACTGAAG 
TI 
ATTGTCAATTAAGCTAGTAAAATCAATGGTTAAAAAACAAAAAACTTGCATTTTTCTACCTAGTAATTTATAATTTTAAGTGTCGAGTTTAAAAGTATAA 
_. _. _. _. _. _. _. _. _. _____. _. _. _. _. _. _. ___. ___. ___. _. _. _. _. _. _. __. 3400 
TAACAGTTAATTCGATCATTTTAGTTACCAATTTTTTGTTTTTTGAACGTAAAAAGATGGATCATTAAATATTAAAATTCACAGCTCAAATTTTCATATT 
TTTACCAGGAAAGGAGCAAGTTTTTTAATAAGGAAAAATTTTTCCTTTTAAAATTCTATTTCGTTATATGACTAATTATAATCAAAAAAATGAAAATAAA 
-----------------_-_-_-_-"-"-_-_-_-. -. -. -. -. -. -. -. -_---"-"-_-. _ 3500 
AAATGGTCCTTTCCTCGTTCAAAAAATTATTCCTTTTTAAAAAGGAAAATTTTAAGATAAAGCAATATACTGATTAATATTAGTTTTTTTACTTTTATTT 
CAAGAGGTAAAAACTGCTTTAGAGAAATGTACTGATAAAAAAAGAAAAAATCCTAGATTTACGTCATACATAGCACCTTTAACTACTAAGAAAAATATTG 
-. ------. -. _. _. _. -_-. _. _. -. _----- . -. _. _. _. -. _. _. -. -------. -.. 3600 
GTTCTCCATTTTTGACGAAATCTCTTTACATGACTATTTTTTTCTTTTTTAGGATCTAAATGCAGTATGTATCGTGGAAATTGATGATTCTTTTTATAAC 
(Rep) RpS fl LEKCTDKKRKNPRFTSYIAPLTTKKNIE 
AAAGGACTTCCACTTGTGGAGATTATTTGTTTATGTTGAGTGATGCAGACTTAGAACATTTTAAATTACATAAAGGTAATTTTTGCGGTAATAGATTTTG 
_. -. -. _. _. -. -. __-. ____-. _. -. -. _____. _. _. _. _. _. _. _. _. _. _. _. _. _. 3700 
TTTCCTGAAGGTGAACACCTCTAATAAACAAATACAACTCACTACGTCTGAATCTTGTAAAATTTAATGTATTTCCATTAAAAACGCCATTAT CTAAAAC 
RTSTCGDYLFMLSDADLEHFKLHKGNFCGNRFC 
TCCAATGTGTAGTTGGCGACTTGCTTGTAAGGATAGTTTAGAAATATCTATTCTTATGGAGCATTTAAGAAAAGAAGAAAATAAAGAGTTTATATTTTTA 
--------------------------------------------------------------- 3800 
AGGTTACACATCAACCGCTGAACGAACATTCCTATCAAATCTTTATAGATAAGAATACCTCGTAAATTCTTTTCTTCTTTTATTTCTCAAATATAAAAAT 
PMCSWRLACKDSLEISILMEHLRKEENKEFIFL 
ACTCTTACAACTCCAAATGTAAAAAGTTATGATCTTAATTATTCTATTAAACAATATAATAAATCTTTTAAAAAATTAATGGAGCGTAAGGAAGTTAAGG 
-. ---------------------------. ---------------------------.. 3900 
TGAGAATGTTGAGGTTTACATTTTTCAATACTAGAATTAATAAGATAATTTGTTATATTATTTAGAAAATTTTTTAATTACCTCGCATTCCTTCAATTCC 
TLTTPNVKSYDL9YSIKQYNKSFKKLMERKEVKD 
ATATAACTAAAGGTTATATAAGAAAATTAGAAGTAACTTACCAAAAGGAAAAATACATAACAAAGGATTTATGGAAAATAAAAAAAGATTATTATCAAAA 
-_-_-________-__-___-_______-_-_-______-__-____. __-____. -__ 4000 
TATATTGATTTCCAATATATTCTTTTAATCTTCATTGAATGGTTTTCCTTTTTATGTATTGTTTCCTAAATACCTTTTATTTTTTTCTAATAATAGTTTT 
ITKGYIRKLEVTY0KEKYITKDLWKIKKDYYQK 
20R 
AAAAGGACTTGAAATTGGTGATTTAGAACCTAATTTTGATACTTATAATCCTCATTTTCATGTAGTTATTGCAGTTAATAAAAGTTATTTTACAGATAAA 
___________. _____. _. _. _. _________________. ___. _. _. ___. _. ___. _.. 6100 
TTTTCCTGAACTTTAACCACTAAATCTTGGATTAAAACTATGAATATTAGGAGTAAAAGTACATCAATAACGTCAATTATTTTCAATAAAATGTCTATTT 
KGLEIGDLEPNFDTYNPHFHVVIAVNKSYFTDK 
Taal 
AATTATTATATAAATCGAGAAAGATGGTTGGAATTATGGAAGTTTGCTACTAAGGATGATTCTATAACTCAAGTTGATGTTAGAAAAGCAAAAATTAATG 
-. ---------------. -. -------. ---------------. -------------. ----. 4200 
TTAATAATATATTTAGCTCTTTCTACCAACCTTAATACCTTCAAACGATGATTCCTACTAAGATATTGAGTTCAACTACAATCTTTTCGTTTTTAATTAC 
NYYINRERWLELWKFATKDDSIT0VDVRKAKIND 
Tag 
.1 
Hie III 
AT TATAAAGAGGTTTACGAACTTGCGAAATATTCAGCTAAAGACACTGATTATT TAATATCGAC, 'GCCAGTATT TGAAATTTPT TATAAAGCAT TAAAAGG 
-"-_-. -. -. -. -. -. -_-. -_-. -. -. -_-. -. -_-. -. -. ---. ---"---. -. -"----"4300 
TAATATTTCTCCAAATGCTTGAACGCTTTATAAGTCGATTTCTGTGACTAATAAATTATAGCTCCGGTCATAAACTTTAAAAAATATTTCGTAATTTTCC 
YKEVYELAKY5AKDTDYLI5RPVFEIFYKALKG 
CAAGCAGGTATTAGTTTTTAGTGGATTTTTTAAAGATGCACACAAATTGTACAAGCAAGGAAAACTTGATGTTTATAAAAAGAAAGATGAAATTAAATAT 
-----. ---. -_-. --__-. -. --__----__-------------. ---______"-___--- 4400 
GTTTCGQTCVAT. 
IATCAAAAA SCA 
G TAAAFFAATTT CTACCGTHTGTKTTALACATG K CGTT 
GCTTTTGAACTACAAATAKTTTTCT 
TTtCýTACETT 
IAATTTYTA K 
GTCTATATAGTTTATTATAATTGGTGCAAAAAACAATATGAAAAAACTAGAATAAGGGAACTTACGGAAGATGAAAAAGAAGAATTAAATCAAGATTTAA 
-. -"-_-_-. -_-_-. -. -. -_-----_-. -. -. -. -. -. -_-. -_-_-_-. -. -. ----- " 4500 
CAGATATATCAAATAATATTAACCACGTTTTTTGTTATACTTTTTTGATCTTATTCCCTTGAATGCCTTCTACTTTTTCTTCTTAATTTAGTT CTAAATT 
VYIVYYNWCKKQYEKTRIRELTEDEKEELNQDLI 
TAGATGAAATAGAAATAGATTAAAGTGTAACTATACTTTATATATATATGATTAAAAAAATAAAAAACAACAGCATTýTTGTTGTTTTTTATTTTC 
-. -------_-. -_-_-_-_-. -. -. -. -. -_-_-. -_-_---_-. -. -. -. -. -. -. -. -.. 6600 
ATCTACTTTATCTTTATCTAATTTCACATTGATATGAAATATATATATACTAATTTTTTTATTTTTTGTTGTCGGATAATCCAACAACAAAAAATAAAAG 
DEIEID. 
TTTATTAATTTTTTTAATTTTTAGTTTTTAGTTCTTTTTTAAAATAAGTTTCAGCCTCTTTTTCAATATTTTTTAAAGAAGGAGTATTTGCATGAATTGC 
---------------------------------------"---------"------------" 4700 
AAATAATTAAAAAAATTAAAAATCAAAAATCAAGAAAAAATTTTATTCAAAGTCGGAGAAAAAGTTATAAAAAATTTCTTCCTCATAAACGTACTTAACG 
.NKTKLEKKFYTEAEKSINKLSPTNAHIA 
Hae III 
CTTTTTTCTAACAGACTTAGGAAATATTTTAACAGTATCTTCTTGCGCCGGTGATTTTGGAACTTCATAACTTACTAATTTATAATTATTATTTTCTTTT 
--------------------------------------------------------------" 4800 
GAAAAAAGATTGTCTGAAT CCTTTATAAAATTGTCATAGAAGAACGCGGCCACTAAAACCTTGAAGTATTGAATGATTAAATATTAATAATAAAAGAAAA 
KKRVSKPFIKVTDE0APSKPVEYSVLKYNNNEK 
TTAATTGTAACAGTTGCAAAAGAAGCTGAACCTGTTCCTTCAACTAGTTTATCATCTTCAATATAATATTCTTGACCTATATAGTATAAATATATTTTTA 
--------------------------------------------------------------- 4900 
AATTAACATTGTCAACGTTTTCTTCGACTTGGACAAGGAAGTTGATCAAATAGTAGAAGTTATATTATAAGAACTGGATATATCATATTTATATAAAAAT 
KITVTAFSASGTGEVLKDDEIYYE0GIYYLYIK 
TTATATTTTTACTTTTTTCTGAATCTATTATTTTATAATCATAAAAAGTTTTACCACCAAAAGAAGGTTGTACTCCTTCTGGTCCAACATATTTTTTTAC 
__-. _. _. _. ___"-____. _. ___. _. _______. _. ___. _. _. _. -. _. _. _. -. _. _.. 5000 
AATATAAAAATGAAAAAAGACTTAGATAATAAAATATTAGTATTTTTCAAAATGGTGGTTTTCTTCCAACATGAGGAAGACCAGGTTGTATAAAAAAATG 
IINKSKESDIIKYDYFTKGGFSP0VGEPGVYKKV 
209 
TATATTATCTAAATAATTTTTGGGAACTGGTGTTGTAATTTGATTAATCGAACAACCAGTTATACTTAAAGGAATTATAACTATAAAAATATATAGGATT 
---------_-_-------_-_-_-. -. -------------_-_---. -_-_-----__---- 5100 
ATATAATAGATTTATTAAAAACCCTTGACCACAACATTAAACTAATTAGCTTGTTGGTCAATATGAATTTCCTTAATATTGATATTTTTATATATCCTAA 
INDLYNKPVPTT10NISCGTISLPIIVIFIYLI 
Hae III-ý 
ATCTTTTTAAATTTCATTATTGGCCTCCTTTTTATTAAATTTATGTTACCATAAAAAGGACA'1'AACC'A3CGAATATGTAGAATAT TTTTAATGTAGACAAAA 
-. ----- .-----_. _. _. -. -. _. _. _. _. _. _. _. _. _. _. __-. _. _. _----. -----5200 
TAGAAAAATTTAAAGTAATAACC; _: cC: AAAAATAATTTAAATACAATGGTATTTTTCCTGTATTGCCCTTATACATCTTATAAAAATTACATCTGTTTT 
IKKFKM 4w orf2 RBS 
1 -01. LaLl TTTTACATAAATATAAAGAAAGGAAGTGTTTGTT TAAATTTTATAG "AAACTAT': AAAAATT A'I'AAAAATTTATGAAAAAAAGGTTTTCGATGT 
__"_"_______------. _. _. _. ____. _____"-__. _______. _. _. ____-_-_-_- 5300 
AAAATGTATTTATATTTCTTTCCTTCACAAACAAATTTAAAATATCGTTTGATAGTTTTTAAT""'SCI'TATTTT AAATACTTTTTTTCCAAAAGCTACA 
M!! -f3 
UP 
MKKRFSML 
-'. 5 repeat 
TATTTTTATGTTTAACTTTAATAGTTTGTGGTTTATTTACAAATTCTAGAGTTTTTGCAAATGAATCAATTAAATCTATAAA'I I ?J C`l"", 
_. ___. ___________________. _. _. _. _. _. _. _________. _. _________. _. _5600 
ATAAAAATACAAATTGAAATTATCAAACACCAAATAAATGTTTAAGATCTCAAAAACGTTTACTTAGTTAATTTAGATATTTAC"I'AAATG(; TGTTTGACT 
FLCLTLIVCGLFTNSRVFANESIKSINDLPQTD 
iteron 
.. TA^TA^J TT',, TTTAATTAAAATTAATAACTCTATTGATAAAGTATTATCTTCAGATTTTGAAATTATGAAAACGTGGAAATTCACTAGTTGTAAG 
--------------------------------. ----. -. -------. ------- 5500 
AAATGGTGTTTGACTAAATTAATTTTAATTATTGAGATAACTATTTCATAATAGAAGTCTAAAACTTTAATACTTTTGCACCT TTAAGTGATCAACATTC 
LPQTDLIKINNSIDKVLSSDFEIHKTWKFTSCK 
GATGTAATTAAAGATCCAAAGTTATTACAATTAATTGATAAATCTAATAAATTTAATGTTGAATGGTATAAAAAAGGTGATTTAAAAATCAATAATTATA 
_. _. _. __-_-__________. _. _. _. _. _. _. _. _. _. _. _. _. -. _. -. _. _. _. -. _. _ 5600 
CTACATTAATTTCTAGGTTTCAATAATGTTAATTAACTATTTAGATTATTTAAATTACAACTTACCATATTTTTTCCACTAAATTTTTAGTTATTAATAT 
DVIKDPKLLQLIDKSNKFNVENYKKGDLKINNYT 
CATCAAAATTAAATATAGTTGATTTAATTAAAGAATCTAATAATAAATATATAGCTAATGTGACACATGATGTTAAATTTAAAGTAATTGGTAATGATTT 
------------------__-------------------_-----------. __-_-___-_- 5700 
GTAGTTTTAATTTATATCAACTAAATTAATTTCTTAGATTATTATTTATATATCGATTACACTGTGTACTACAATTTAAATTTCATTAACCATTACTAAA 
SKLNIVDLIKESNNKYIANVTHDVKFKVIGNDF 
TTTATTTGAATCAACTGGTAAAAGATATAGAATTGAGTTAATGTGTGGAAATAATAAATGGTATATTACTAAATTATTAGATT TAGCTACAGATTTAGAT 
-------. ---. -------------. -------------------------. -. ------- 5800 
AALATAFAACCTT 
SGTTGAGCATTTTTCTYTATRCT IAACCTCALAT 
tACCCAGCTNTANTAKTTACW CYTA 
IAATGAKTT LLAT. 
AAATCCTAAAATAGATGTCCTAAATCCTA 
ACAGATAATGTAAAT CCAATAGAAAATGAAAAAAATTCAATAACTAGGTCATTTAGGTCATTAAATAAAAATAATCAATTTCCTAATTATGACAATATGA 
-. -. -_-. -. -. -_-. -. -_-. -_-____"-_-_-_-___-_-_-______. _____. -. __- 5900 
TGTCTATTACATTTAGGTTATCTTTTACTTTTTTTAAGTTATTGATCCAGTAAATCCAGTAATTTATTTTTATTAGTTAAAGGATTAATACTGTTATACT 
TDNVNPIENEKNSITRSFRSLNKNN0PPNYDNMI 
awd" 
TTAATTCAAAGATATTATCAATTAGTGAAGCTT 
_. _. _. _.. _. _......... 5927 
AATTAAGTTTCTATAATAGTTAATCACTTCGAA 
NSKILSISEAS 
Figure 6.3 Complete annotated nucleotide sequence of pBPI 
Both DNA strands are shown and the Hind III site is duplicated at either end. Reading frames which use 
the upper strand as sense strand are shown in purple whilst reading frames which correspond to the 
lower strand are shown in blue. Possible secondary structures are represented as converging arrows and 
those thought to form the dso (minus origin) are in tan. Putative ribosome binding sites (RBS) are 
shaded in red and termination codons are represented with a single dot. Other features are labeled 
accordingly. 
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Figure 6.4 Schematic Map of pBPl 
Plasmid pBPI was isolated from C. botulinum NCTC 2916. The features represented above are 
derived from analysing the nucleotide sequence alone. Arrows represent ORF's deduced from 
combinations of translational signals, f represents dyad repeats typical of Rho-independent 
transcriptional terminators, S2 represent dyad repeats occuring in possible mRNA leader sequences 
which may function in transcriptional control, alone represent dyad repeats which could form a 
putative minus/single stranded origin of replication (sso). and together represents a sequence 
resembling the double stranded origin of replication from the pC 194 group of rolling circle 
plasmids (Seery et al., 1993). 
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10 20 30 40 
1LEKCTDKKRKNPRFTSYIAPLTTKKNI EE RTSTCGDYLFML ORF1 
1MEKYKDKKLKNQVLARFIKKF LS 
aSSWEY ýV Q ID CNTFMMMV ORF3 
MEKYTEKKQRNQVFQKFIKRHIGENQMDLVEDCNTFLSFV Rep 
50 60 70 80 
41 SDADLEHFKLHKGNFCGNRFCPMCSWRLACKDSLEISILM ORFI 
41 ADETLENKKQHKGNTCKNRFCPICSWKKARKEALALAIQM ORF3 
41 ADKTLEKQKLYKANSCKNRFCPVCAWRKARKDALGLSLMM Rep 
Region 1 
90 100 110 120 
81 EHLRKEENKEFIFLTLTTPNVKSYDLNYSIKQYNKSFKKL ORF1 
81 EYIKDTYNKQFIFLTLTTPNVKAEELHDEIREYNHAFQKL ORF3 
81 F Rep 
00 Region 2 IN- 
130 140 150 160 
121 MERKEVKDITKGYIRKLPVTYQKEKYITKDLWKIKKDYYQ ORF 1 
121 VKRKEVQSIVKGYIRKLHVTYNQ DM --------------- ORF3 
121 1KRKKVGSVIKGYVRKLEITYNKKR --------------- Rep 
00 Region 3 
170 180 190 200 
1 
161 KKGLEIGDLEPNFDTYNPHFHVVIAVNKSYFTDKYYINR ORF1 
146 -------------DDYNPHFHVLIAVNKSYFTDKRYYISQ ORF3 
146 -------------DDYNPHFHVLIAVNKSYFTDKRYYIS Rep 
Region 3 
212 
210 220 230 240 
201 ERWLELWKFATKDDSITQVDVRKAKINDYKEVYLAKYSA ORF1 
VQKVRTNSKKEVALAK': SA ORF 3 173 SRWLELWQQVTKNPLIT NQ VH II 
- 
173 QEWLDLWRDVTGISEITVQVKIRQNNNKELYMAKSG Rep 
Region 3_ Region 4 
250 260 270 280 
11 
241 KDTYLISRPVFEIFYKALKGKQVLVFSGFFKDAHKLYKQ ORF1 
213 KDSYLAEKVFDAFYKGLKGKQLIVYSGI. FKESNKLFKD ORF3 
213 KDSI; PLINKS ------ KSLKGKVLVYSGLFKEAK K---- Rep 
Region 5 
290 300 310 320 
1 
281 GKLDVY KKK D- EIKYV YY IVYYN WW C 
r' KQ YY EKTRIRELTEDE ORF1 
253 GELDYYKEQDPTE-YIY ALLY HWGKGNYVEDEKRLLTETE ORF3 
243 L -------- ETKRVFS Rep 
330 
320 KE EH LQDLID 
ýE I 
292 HKEINKDLIHEM 
EýI D ORF1 
DIEEE ORF 3 
Figure 6.5 Comparative alignment of the pBP1 ORF 1 with pC194 type replication proteins 
ORF 1 is the putative replication protein from pBPI (this study), ORF 3 is a putative replication 
protein from the bacterium Marinococcus halophilus (Louis & Galinski, 1996) and Rep is the 
replication protein from the Staphylococcus aureus plasmid pC 194 (Horinuchi & Weisblum, 1982) 
which represents this family. Amino acids are boxed when two or more residues are identical. 
Homologous regions of the three proteins suggest that they may all be members of the pC 194 
group of plasmid replication proteins. Regions I-V of the pC194 group are depicted by arrows with 
are beneath the sequences (adapted from Noirot-Gros et al., 1994). Residues which appear to be 
equivalent to the catalytic residues predicted in the active site of pC 194 are in red (Noirot-Gros et 
al., 1994). 
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demonstrated that the primary sequence of ORF I essentially conforms to the five 
conserved regions described for this class of replication proteins (Noirot-Gros et a1., 
1994). 
When ORF I of pPB I is compared with the Rep protein of pC 194 (the representative of 
this class of replication proteins) a number of features can be found in common, 
including two glutamate residues at positions 142 and 210 and a tyrosine residue at 
position 214 (residue numbering with respect to pC194 Rep). These residues are thought 
to be essential for the catalytic properties of this class of proteins (Noirot-Gross et al., 
1994). However among the five conserved motifs in this class of protein, region 3 of 
ORF 1 appears to be bisected by an insertion of 28 amino acids. The alignment also 
suggests that the initiation codon of ORF 1 from pBP 1 is UUA, an unusual initiation 
codon. This putative initiation codon is preceeded by 11 bases with the sequence 5'- 
AAGAGG-3' which could form a ribosome binding site. Very few alternative 
translational signals exist in this region. 
ORF 
LENGTH 
AMINO ACIDS MASS CHARGE PI 
BASE COMPOSITION 
(A+T) 
1 334 40.37 kDa +13.71 9.01 74.65% 
2 166 18.99 kDa +8.04 9.32 76.31% 
3 358 40.87 kDa +10.14 8.83 75.76 % 
4 45 5.30 kDa +3.24 9.51 68.15% 
5 122 14.29 kDa +3.23 8.87 73.50% 
6 47 5.09 kDa +8.87 10.25 87.94% 
7 43 5.39 kDa -0.15 6.26 75.97 % 
8 392 46.2 kDa +2.15 7.70 72.36% 
Table 6.8 Putative ORFs of pBPI 
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ORF'S 2,3 and 4 
Both ORF's 2 and 3 have putative methionine initiation codons preceded by sequences 
resembling ribosome binding sites (figure 6.3). The two genes are divergently arranged 
and their respective RBS are separated by 133 nucleotides. Recent evidence has 
indicated that transcripts are not thought to be functional if they start very close to the 
RBS (Vellanoweth, 1993); the full lengths of the promoters for these genes must be 
close if not overlapping. Analysis of the secondary structure of ORF's 2 and 3 using the 
Protean program of DNASTAR predicts that both putative proteins are largely 
hydrophilic in character. Their N-termini are strongly hydrophobic and on closer 
examination, these sequences appear to bear features typical of signal peptides (Izard & 
Kendall, 1994) suggesting an extra-cytoplasmic function for these peptides (figure 6.6). 
ORF 3 contains 2 additional features. Close to its 5' end is a 15 bp motif [5'- 
GATTTACCACAAACT-3'] which occurs as a tandem repeat, followed by a partial 
repeat and results in a amino acid motif DLPQT-DLPQT-DL. Whether this iteron is an 
important DNA or protein feature is unknown. However, the same amino acid motif 
could have been achieved with a range of codons. At the C-terminus is a hydrophobic 
region which could possibly function as a membrane anchor. 
ORF 4 is located downstream of ORF 3, and its initiation codon overlaps with the stop 
codon of ORF 3 (figure 6.3). The secondary structure for this putative peptide predicts 
four ß-pleated regions which are interspersed with turns; the hydropathicity profile 
suggests two hydrophilic regions alternating with three hydrophobic regions. Unlike 
ORF's 2 and 3, there is no evidence to suggest that ORF 4 possesses a signal sequence. 
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-3 -1 Y xi.:., zSTS NQ TT i i3 -1 S TT I TNSR 
Positively 
charged N- 
terminus (5- 
6 amino 
acids long) 
hydrophobic core of 
approximately 12 residues with 
no charged residues 
C-terminus of 
approximately 6 
residues with small side 
chain amino acids at -1 
and -3 positions often 
including proline or 
glycine 
Figure 6.6 Putative signal peptides of ORF 2 and ORF 3 from pBPI 
The N-terminus of ORFs 2 (top) and ORF 3 are annotated to highlight features 
which commonly occur in signal peptide sequences (Izard & Kendall, 1994). 
Positively charged amino acids are shaded in blue, negatively charged amino 
acids are shaded in red, neutral polar amino acids are shaded in purple whilst 
uncharged hydrophobic residues are shown yellow. Possible proteolyic cleavage 
sites are depicted by a green arrow and small amino acids (typically Alanine, 
Glycine, Serine or Threonine) at positions -1 and -3 to the cleavage site are also 
shown. These sequences contain N-terminal basic residues typical of signal 
peptides followed by a hydrophobic region which may extend slightly longer 
than 12 residues. The occurrence of some neutral polar residues within the 
proposed hydrophobic region is not inconsistent with this model as signal 
sequences are often `sub-optimal' (Izard & Kendall, 1994). 
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ORF 5 
This ORF has a methionine initiation codon preceded by a ribosome binding site, 5'- 
AGGAGG-3'. No similar proteins could be identified in a Swiss-Prot database search. 
Secondary structure analysis using the DNASTAR program `Protean' predicted three 
a-helical regions, each separated by turns and coils. A hydropathicity prediction 
suggested that the majority of the protein would possess a weak hydrophobic character 
bisected with a hydrophilic region of approximately 10 amino acids. 
ORF 6 and ORF 7 
In the reverse orientation to ORF 5 are two short contiguous ORF's with overlapping 
termination and start codons. ORF 6 is predicted to contain an N-terminal hydrophilic 
domain and a C-terminal hydrophobic domain. ORF 7 is predicted to be strongly 
hydrophobic and has negligible charge at physiological pH. These features may suggest 
that these putative proteins are co-expressed and may be located in the membrane. 
ORF 8 
A comparison of the translated sequence for ORF 8 with the entire Swiss-Prot protein 
database revealed that this putative protein has a relatively large number of homologs, 
which are distributed principally among the various groups of RC plasmids (van der 
Lelie et al., 1989). Whilst the majority of these have a methionine initiation codon, ORF 
8 is predicted to start with a valine residue, specified by the alternative initiation codon 
GUG (figure 6.7). These proteins, which have been implicated in plasmid mobilisation 
(Priebe & Lacks, 1989), encode site-specific recombinases whose target sequence occurs 
within the plasmid, 5' to the recombinase gene (Pre). Overlapping this recombination 
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. site, known as RSA, are the promoter elements of the Pre protein. Comparison of the 
sequences in front of ORF 8 with characterised RSA regions (van der Lelie et al., 1989; 
Josson et a!., 1990) allowed the identification of a putative RSA site and Pre promoter 
elements which are akin to the pUB110/pMV158 Pre group, but not with the pE194 
group (figure 6.7). This sequence identity grouping was also reflected in the sequence 
similarity between the Pre proteins. 
6.4.4.3 Non-coding sequences 
Analysis of the plasmid sequence using the `Squiggle' secondary structure prediction 
software (GCG package, Zuker, 1989) revealed a number of potential secondary 
structures. Inverted repeats typical of. rho-independent transcriptional terminators were 
found between the converging ORF's 1 and 2 and between ORFs 4 and 5 (figure 6.3). A 
third region of dyad symmetry is found in between ORF 5 and 6 in a region which is 
presumed to encode the promoters for these genes. The A+T rich nature of these two 
structures, and their locations, are more likely to make them candidates for some aspect 
of transcriptional control or fortuitous features in the high A+T DNA content of this 
intergenic region (A+T=85.3 %). A further 2 inverted repeats are found 5' to the 
putative replication protein. One of these occurs 28 bp before a heptameric motif 
described as a double-stranded origin nick site (dso), characteristic of the pC194 group 
of plasmids (Seery et al., 1993). Indeed, the occurrence of the combination of an inverted 
repeat, dso and pC194 type replication protein are indicative features that this 
extrachromosomal element is a plasmid which replicates via a RC mechanism. A second 
region of dyad symmetry is found between the dso and replication protein. Such 
features are found in 
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1 VS LVCT KR MKKDN FLKHNQR SENN ORF8pBP1 
1 MS AV RMQKVKSAGKM FHNQ RKSR Pre pTB19 
1 MS LANMQKLKADNVLGNHDQRTQHH Mob pLC88 
1ARSAGKM[j] Mob pBC16 
31 N KDIDKNK DLNYD VN NKI LSEK FNORF8pBP1 
31 TNDDIDHERRENYDLKNNK Pre pTB19 
3 
31 T DDI HDRSRENYD K[ 
I] 
G NG 
NKI 
EW 
MoMob 
pLC88 
b pBC16 
61 LIE KLRES EKAI RKDAVLLDEFI I SSDRDF ORF8pBP1 
61 IE SQKTGTRKTRKDAVLVNELLVTSDRDF Pro pTB19 
61 Y EHKTSQRAVR'KDAVLVNEWI I SSD®F Mob pLC88 
61 SQGTKTRL Mob pBC16 
91 FK MNEN IKKFFETUKQFFAERYGEENI I ORF8pBP1 
91 FEQL PG QKRFFEE YKLFSERYGKQNIA Pre pTB19 
91 FADLTAA MR. KYFETAKDYFAEKFGEENI R Mob pLC88 
91 EDYKLZSS ERYGKONIA Mob pBC16 
121 SANVHLD TTPHMHLDVC PLRN - RL - SKNORF8pBP1 
121 YATVHNDQTPHMHLGVVPMD- KLQGK Pre pTB19 
121 Y AI VHLD STPHMH®GI VPFDDEHKLSAKR Mob pLC88 
121 TNQM- JLL QG Mob pBC16 
149 IFTRN-FLRNEELPK-LKNNGFFLERVK ORF8 pBP1 
150 VFNRELWLQDKFPEHMKCFELKRE Pre pTB19 
151 VFNRTALRDVQDQLPAYLPQH G®N IQRV Mob pLC88 
150 VEWKFEH M©K GK EW Mob pBC16 
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176 GF T- KHIDIQILKARAEEKKIKE 
a- K ONA ORF8 pBP1 
180 GSDRKH I ETAKF K KQTLEKEI DFLEKPre pTB19 
181 ESGR KES LAVPGYKA------- -- MRE Mob pLC88 
180 GSDRKHIETAKFKKQTLEKEQDLQES Mob pBC16 
204NKNKE ELKIARSKEKLE ----- Y D[LDFQ ORF8pBP1 
210 KKDEWTAYSDKVKS DLEVPAKRHMKS VEVP Pre pTB19 
202 SQQKLAAVENETK- ---- -- QRQAKLKTYQ Mob pLC88 
210QK SELAILSEEVSGEF KI PVKREKK SV P Mob pBC16 
229 I KSKKTVLNNLNQGNDCLDEDI KYKLDGFD ORF8pBP1 
240 TGEKSM----FGLGKEIMKTEKKPTKNVVI Pre pTB19 
225 AT K- ------FDVNSVKTKESRFHKRYVLV Mob pLC88 
240 TG K®N L--- ---L1 
QE 0KTV M©S TGNVIL Mob pBC16 
259 VKMDYVEFRKFQTQIAS II KKVKK 
NE 
-- NE 
ýD L ORFB pBP1 
266 SERDYKNLVTAARDNDRLKQHVRLMSTDM Pre pTBl9 
248 DRFDFDKLKQGAS----------------- Mob pLC88 
264 KDEVF Q DLKQ KV KAGAVQQTRVD®LLNT[DY Mob pBC16 
8 
296 AREYK KLSKEHGQVK EKYSGLVERFNENVN Pre pTB19 
261 ----- ---------- ------------- LT Mob pLC88 
294 A KN 0 S 
[L K[ EVKELR STNKS QL SE ------- Mob pBCl6 
317 NTYKHMSLDSREQFaRRGSESLANGSTCN- ORF8 pBP1 
326 D- YNEL-LEENKSLKSKIS D- LKRDVSL I- Pre pTB19 
263 DTYFTETLSQRSDMDIQKDLIKAESKAME Mob pLC88 
317 ---------ENGR LEIS TVEH-LTNEIES L- Mob pBC16 
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346 YDEDSTLDKSVMDS - KAFNE- - DVYIKCAN ORF8pBP1 
352ERTDGLKA 
aF 
KVFKGFVDKVK Pre pTB19 
293 L Mob pLC88 
336 YVLTKDFLKAR TQN DLE S[EKQE LFGVFV 
IG 
KVK Mob pBC16 
373 
JEK 
-------- ENALKEPKMSSNGF ------ ORF8pBP1 
382 DKTAQ--FQEKHDL- EPKKNEFELT ---- H Pre pTB19 
323 GVGLPSEWLERAGLKEPSKKAP ------ QR Mob pLC88 
366 EKAPRGLFVRQHERSEEKKNTFSLQDVLQR Mob pBC16 
389 ----------------- 
1I IDW ORF8 pBP1 
405 NRVKKERS ----- RDQGMSL Pre pTB19 
347 PQERSEGP RDKLDGPTLE FGL Mob pLC88 
396 DRLREQRKAKRK, -KSHDLER Mob pBC16 
Figure 6.7 Comparative alignment of ORF 8 from pBP1 with Pre/Mob proteins 
ORF 8 encoded on plasmid pBP1 from C. botulinum NCTC 2916 is compared with 
plasmid recombination (Pre) and mobilisation (Mob) proteins found on rolling circle 
plasmids from Gram-positive bacteria; pTB19 isolated from Bacillus 
stearothermophilus (van der Lelie et al., 1989), pLC88 isolated from Lactobacillus 
casei (Bates & Gilbert, 1989) and pBC16 from Bacillus cereus (Tang & Wilson, 
unpublished data, EMBL-GenBank submission PPU32369) 
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other examples of this class of plasmid (Josson et al., 1990; Devine et al., 1989) and 
may also serve some function in plasmid maintenancetreplication (figure 6.3). 
The intergenic region between ORF 7 and the putative Pre gene contains a tract of DNA 
with a particularly high G+C base bias (47.3 % in 237 bp) in comparison to the 
remainder of the plasmid (25.66 % G+C). Inspection of this sequence revealed a 
proliferation of short inverted repeats which typically contained a high proportion of 
guanine and cytosine residues. This type . of 
feature is found throughout the rolling circle 
group of plasmids and may function to initiate the synthesis of a second DNA strand 
(lagging strand) from a single stranded replicative intermediate (Dempsey et al., 1995; 
Kramer et a!., 1997). Such motifs are commonly termed the single stranded origin (sso). 
A further inverted repeat is found spanning the 3' end of ORF 7; this could be a 
transcriptional termination signal associated with ORF 7 or participate in the proposed 
minus origin (figure 6.5). 
6.5 Discussion 
6.5.1 Transformation of group IC botulinum type A strains 
6.5.1.1 Evaluation of gene transfer in C botulinum type A 
Attempts to develop a gene transfer procedure for group I C. botulinum strains did not 
realise their potential as not all the criteria outlined in section 6.1.1 were achieved. 
Specifically, transformation frequency was not optimised to a point where gene knock 
out mutagenesis could be attempted with a suicide vector. The possible reasons for this 
are discussed. 
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6.5.1.2 Electroporation parameters 
Attempts to optimise electrotransformation of Gram-positive bacteria have generally 
succeeded through the methodical alteration of parameters such as electrical field 
strength, resistance, plasmid concentration, cell density and time constants (Dunny et 
al., 1991). Variations in these parameters are often accompanied by a concomitant 
fluctuation in transformants which may increase by the order of three to four logs. This 
increase was not observed with C. botulinum NCTC 2916, possibly because the 
appropriate parameters were not tried. Nevertheless, similar parameters have proved 
relatively successful for a number of other clostridia (Chen et al., 1996; Phillips-Jones, 
1995) including a type A C. botulinum strain (Zhou & Johnson, 1993). With these 
considerations in mind, it is unlikely that the electroporation parameters tested were 
entirely responsible for the poor transformation frequencies observed . Furthermore, 
they could not logically explain why one vector established in C. bolulinum NCTC 2916 
whilst a second vector did not. A similar argument for C. botulinum ATCC 3502 cannot 
be equally substantiated as less variables were tested. 
6.5.1.3 Host encoded factors 
Gram-positive organisms are in general, only poorly amenable to transformation, and 
one factor which may be significant is the production of extracellular non-specific 
nucleases. The inhibition of such nucleases has been implicated in the successful 
application of both protoplast transformation (Lin & Blasheck, 1984) and 
electrotransformation (Chen et al., 1996) of some clostridial species. Indeed, both strains 
of type A C. bolulinum used in this study as well as several non-proteolytic group If 
type B C. boiu/nnun strains and C. heiieri, lckr,, all exhibited DNase activity on DNase 
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agar (T. Davis unpublished observation). The results of Chen (1996) suggest that this 
type of factor could severely reduce transformation efficiency. 
Restriction endonucleases are widespread amongst bacteria and have proven a 
considerable barrier to gene transfer, not least in a number of clostridia (Mermelstein & 
Papoutsakis, 1993; Azeddoug et al., 1989; Azeddoug & Reysset, 1991; Chen et al., 
1996). Although restriction activity was not detected in group I C. botulinum in this 
study, the method may have been unsuitable, and. for instance, disruption of the cells may 
have released endogenous proteases from these proteolytic clostridial species which 
could potentially inactivate a restriction endonuclease. Alternatively they could possess 
type I or type III restriction enzymes which have more specific substrate requirements 
than type II systems (Bickle et al., 1987). Evidence of a restriction system has been 
demonstrated in a C. sporogenes strain (Dr M. Mauchline, pers. comm. ) and 
characterised in a non-proteolytic type B C. botulinum strain (T. Davis, unpublished 
data). In these examples, the unprotected vector pGK12 could be introduced by 
electrotransformation, albeit at very low frequency (T. Davis, unpublished data). 
However, other plasmids such as pMTL540E could not. Two possible explanations 
could account for these findings. Firstly pGK12 has a low G+C DNA bias and hence 
contains few restriction sites in comparison with pMTL540E. Thus pGK12 may avoid 
restriction by virtue of its sequence. This may be the case in the non-proteolytic C. 
botulinum strain where pGK12 has a single target sequence [5'-CCGG-3'] whilst 
pMTL540E contained 14. Secondly, the möde of replication may be responsible. 
Plasmids such as pGK12 replicate via single stranded intermediates in both E. coli and 
Gram-positive hosts and it may be these single stranded intermediates which are 
inefficient substrates for type II restriction enzymes that are successfully introduced. 
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The fact that C. botulinum NCTC 2916 can only be transformed with pGK12 suggests 
that a restriction barrier may exist. This could also be true for C. botulinum ATCC 3502 
if the restriction system recognised a low number of sites. As plasmid DNA can be 
purified from both strains, the methylation profile could be probed using a chemical 
modification method (Olek et al., 1996). 
An apparent increase in electrotransformation frequency by the addition of glycine to 
the growth media of C. botulinum ATCC 3502 suggests that the cell wall may also pose 
a barrier to the efficiency of the gene transfer process. Whether this is a physical barrier 
to the creation of `pores', a disposition to rupture the whole cell, or an inability to 
arrest the chemical imbalances caused by pore formation causing lysis (Weaver & 
Chizmadzhev, 1996), is difficult to assess. The observation that very high kill rates are 
possible would suggest that the latter two hypotheses are more likely. Sub-inhibitory 
concentrations of glycine are thought to interfere with cell wall synthesis (Miller, 
1994), so alterations to the electroporation protocol including the use of alternative cell 
wall modification agents and osmotic stabilizers, may be advantageous for these 
organisms. 
Neurotoxigenic clostridia have been associated with an autolytic phenomenon and an 
autolytic enzyme has been characterised (Kawata & Takumi, 1971). The lytic enzyme 
was isolated from a type A strain during logarithmic growth which contained both endo- 
ß-N-acetylglucosaminidase and N-acetylmuramyl-L-alanine amidase activities. In theory 
this enzyme would be present in the concentrated cell suspensions prepared for 
electrotransformation and would be liberated after electroporation when a large 
proportion of cells are damaged. It is conceivable that the autolysin would reduce the 
number of viable cells and, therefore, reduce the number of transformants. 
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6.5.1.4 Incompatibility 
A possibility exists that plasmids indigenous to the strains used in this study already 
possess elements which are incompatible with the recombinant vectors. This situation 
typically arises when attempts are made to force plasmids with a similar replicon to 
coexist. As `large scale' plasmid preparations were not conducted before gene transfer, 
the actual extra-chromosomal complement of these strains are unknown. 
6.5.1.5 Conclusions 
Gene transfer by electroporation has proved to be successful, albeit inefficient. Several 
possible barriers to this process have been postulated which could alone severely reduce 
transformation efficiency. In combination, these factors could pose a formidable barrier 
to the introduction of DNA to group I C. botulinum and must be individually addressed 
before an empirical assessment of physical parameters can be made. The introduction of 
a novel plasmid replicon into group I C. botulinum is an improvement on existing genetic 
systems which are currently limited to the use of `single stranded' replicons and 
conjugative transposons (Zhou & Johnson, 1993; Lin, 1992; Lin & Johnson, 1991). 
6.5.2 Theoretical characterisation of pBP1 
6.5.2.1 Method of replication 
The plasmid pBPI contains several functional elements which enable its classification. 
The presence of a putative Rep protein and nick site which are homologous with 
members of the pC194 `rolling circle' (RC) plasmids (Seery et al., 1993) strongly 
indicate that this is also a plasmid which replicates via this mechanism. Members of the 
RC plasinid family have been encountered as co-integrants with other plasmids 
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(Gennaro et al., 1987). However, no evidence was found to support the existence of a 
second replicon in pBP I. 
In addition to the requirement of initiating plasmid replication via the generation of a site 
specific `nick' at the plus origin, ss intermediate forms of the plasmid must also be 
converted back to the ds form. DNA elements described as minus origins support this 
conversion but are less conserved than the plus origins. Different RC plasmids utilise 
independent types of minus origins which may be host specific (Seery et al., 1993). 
Indeed, some plasmids, such as pMV158, may contain two or more separate types of 
minus origin (Khan, 1996). A region of complex dyad symmetry typical of minus 
origins has been detected in pBP1 which does not resemble ssoA or ssoU characterised 
in other plasmids (Kramer et al., 1997). A recombinant version of pBP 19 not containing 
this sequence was able to replicate autonomously in C. beyerinckii NCIIvIB 8052 (Dr 
M. Mauchline pers. comm. ). The replication of plasmids without a functional minus 
origin has previously been described and suggests that host factors responsible for 
lagging strand synthesis from the minus origin may also be able to initiate from other 
sites within plasmids, albeit at a cost to plasmid stability and copy number (Dempsey 
et al., 1995). 
Plasmid replication control in the RC plasmids is thought to be proportional to the 
quantities of the initiator protein (Rep) synthesised. Thus, mechanisms which modulate 
Rep synthesis exert control on copy number. Many Rep proteins, including that of 
pC194, have antisense RNA transcripts which are able to negatively regulate Rep 
transcription by attenuating Rep mRNA synthesis, or regulate Rep translation by 
sequestering the ribosome binding site of the Rep transcript (Rasooly & Rasooly, 1997). 
On the basis of the similarity between ORF 1 of pBP 1 and the Rep protein of pC 194, 
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these two mechanisms would appear to be likely candidates in the regulation of pBP I 
plasmid copy number. In addition, an unfavourable initiation codon (WA) for the 
pBP1 Rep could also reduce the translational efficiency of this gene. 
Members of other RC plasmid families may also have a further level of Rep protein 
regulation. Plasmids such as pMV158 and some other members of the pE194 family 
encode a trans-acting repressor termed `Cop' which in the case of pMV158, negatively 
regulates Rep synthesis at the transcriptional level. At the current time, analogous Cop 
proteins have not been found in the pC194 family and may consequently be unlikely to 
exist in pBP 1. 
6.5.2.2 Pre protein function 
A homologous group of proteins, termed Pre (plasmid recombination) or Mob proteins 
(mobilisation), commonly occur in RC plasmids. As their names suggest, they are 
thought to participate in plasmid recombination and mobilisation. Both activities are 
mediated via excision at a site specific sequence (RSA), and can result in the formation of 
co-integrants with other plasmids with the appropriate RSA site (Gennaro et al., 1987), 
or in plasmid mobilisatiön in the presence of the appropriate transfer functions from 
conjugal plasmids (Priebe & Lacks, 1989). Unlike a number of unrelated site specific 
recombinases, Pre proteins do not appear to participate in the resolution of plasmid 
multimers (Gennaro et al., 1987). The biological function of Pre in pBPI and other 
plasmids is not completely clear, but its continued selection may result from its ability 
to form heterologous cointegrants which could enable concomitant transfer of the RC 
plasmid into other hosts, or to entrap other genes into the plasmid Alternatively, it may 
function as an aid to assisted mobilisation. 
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6.5.2.3 Cassette structure 
A number of medically important RC plasmids commonly found in organisms such as 
staphylococci also have closely related counterparts in other Gram-positive bacteria 
such as B. subtilis and E. faecalis (Novick, 1989). Genomic sequence analysis has 
revealed that certain common features, such as antibiotic resistance determinants, 
replicons and Pre recombinase genes, occur in a number of distinct plasmids. In essence, 
RC plasmids are composed of a mosaic structure of "cassettes" which can be divided 
into essential replicative structures (Rep, dso, sso, cop), mobilisation and 
recombinogenic structures (Pre, mob) and antibiotic resistance determinants. The abrupt 
nature with which these elements join suggests that precise `cassette exchange' between 
plasmids has been responsible for plasmid evolution. In this light, examination of pBP I 
also reveals a number of "cassettes", including common features such as a replicon, Pre 
recombinase and minus origin. However, instead of encoding antibiotic resistance genes 
which would be of little use to the clostridium, this plasmid encodes six genes whose 
organisation resembles two regulons. Although their function remains cryptic, it is likely 
that ORFs 2 and 3 have an extracytoplasmic function whilst ORFs 4 and 5 may have a 
membrane location. 
Comparison of pBPI with two RC plasmids from other clostridia (Delver et al., 1996; 
Brehm et al., 1992) revealed that they contain replicons similar to the pC 194 family and 
also possess ORFs encoding cryptic proteins. In addition, the secondary structure 
motifs presented as minus origins do not resemble the minus origins of staphylococcal 
and related plasmids. In conclusion, the structure of pBPI would also appear to be a 
mosaic of structures with which we are already familiar, such as the type of replicon and 
recombinase gene. However, there are additional features which are not familiar. This is 
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perhaps not suprising when one considers, for instance, that the minus origin is thought 
to be host specific whilst the cryptic genes are likely to be pertinent to the environment 
in which the clostridium survive. 
6.5.2.4 Natural distribution of pBP1 
At least four investigations have documented the existence of plasmids indigenous to 
group _IC. 
botulinum strains and their closely related non-toxigenic counterpart C. 
sporogenes (Scott & Duncan, 1978; Strom et al., 1984; Weickert et al., 1986; Ferriera et 
al., 1987). The most comprehensive study of type A strains was conducted by 
Weickert and co-workers who reported the presence of 5 individual plasmids which 
were apparently distributed to different degrees in 12 distinct type A isolates, and in 
some cases, in C. sporogenes. These results are somewhat difficult to interpret as they 
are of ccc forms which generally migrate faster than linear or oc forms. 
An earlier study examined type A organisms and also found that distinct plasmid 
species appeared to occur in a number of isolates (Strom et al., 1984). The size of the 
ccc forms were corroborated with restriction digests using ? /Hind III fragments as 
molecular weight markers. Plasmids of approximately 5.0 kb, 9.7 kb, 18.4 kb and 38 kb 
were encountered, but none of the sizes reported appeared to correlate closely with the 
size of pBPl. The size of these plasmids roughly equated with the findings of Weickert 
(1986), Ferreira (1987) and with one of the plasmids described by Scott and Duncan 
(1978), which may indicate that certain plasmids are widely distributed in this organism 
which may be clonal. However, when all the current toxigenic members of group I C. 
bolulinum are considered, a range of plasmid species are present, suggesting that the 
extrachromosomal complements of this group are not clonal. Furthermore, 16S rRNA 
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gene sequencing (Collins et al., 1994) has demonstrated that the group I C. botulinum 
and C. sporogenes are not identical, whilst genomic fingerprinting has shown that C. 
botulinum type A strains are also not clonal (Lin & Johnson, 1995). 
In conclusion, there is no firm evidence to suggest pBP1 is widely distributed among the 
type A C. botulinum strains or their close relatives. 
6.5.2.5 Potential uses 
To date no other plasmids have been cloned from group I Clostridium botulinum strains, 
a factor which has previously made heterologous plasmids the vector of choice for 
studies in these organisms (Zhou & Johnson, 1993). Sequence analysis of pBPI will now 
allow a rational approach to the construction of a shuttle vector using the pBPI replicon. 
However, the similarity of the putative pBP 1 replicon with the pC194 family of plasmids 
strongly implies that this plasmid replicates via a RC mechanism, which are considered 
intrinsically unstable (Kiewiet et al., 1993; Janniere et al., 1990). Nonetheless, an 
indigenous plasmid may prove useful for cloning relatively small DNA inserts, 
particularly if the plasmid design sympathetically considers the natural order of pBP I. 
Relatively few genes have been cloned and studied from C. bolulinum strains. Thus, 
pBPI may also be an interesting source of transcriptional and translational signals. The 
prediction of two signal peptide sequences for ORFs 2 and 3 could be useful for the 
design of recombinant proteins that require export across the cytoplasmic membr; ne, 
such as ß- lactamases, which would increase the repertoire of resistance determinants for 
these organisms. 
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CHAPTER 7 
GENERAL DISCUSSION 
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7.1 Introduction 
Genetic analysis of botulinal neurotoxin operons has received a substantial amount of 
attention from the scientific community, partly because they continue to pose a threat to 
human health, particularly with the constant consumer pressure to reduce the 
processing/preservatives of the foods we eat. The neurotoxins (in the form of a 
neurotoxin complex) have also demonstrated their value as a tool in health care for the 
treatment of movement disorders. Both of these areas have considerable economic 
importance. The specific properties of the neurotoxin complex, particularly in host cell 
targeting are likely to continue this trend. 
The data generated in this study should contribute to the understanding of neurotoxin 
complex production and pave the way for a comprehensive study of factors which 
regulate neurotoxin production. Knowledge in both of these areas will be directly useful 
in the attainment of high neurotoxin titres for pharmaceutical applications and combat 
the production of neurotoxins in foods. 
7.2 The type B neurotoxin gene in C botulinum NCTC 2916 type A 
Genetic characterisation of the type B neurotoxin gene in this strain revealed a number of 
anomalies which are capable of completely disrupting productive translation. However, 
it appeared that the pseudogene was still actively transcribed. Although these studies 
reveal how this has occurred, they do not answer why. 
Clues which may resolve this question are found in the observation that the incidence of 
silent type B neurotoxin genes in type A C. botulinum strains is approximately 50 %, 
which is much higher than the incidence of dual neurotoxin producing strains (Franciosa 
et al., 1994). This could be interpreted as a selective advantage. 
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Secondly the conclusion that the nontoxic/haemagglutinin genes found adjacent to the 
silent type B pseudogene are unique in this strain, and that no haemagglutinin genes are 
to be found 5' to the type A neurotoxin gene, suggests an active role for the type B 
nontoxic/haemagglutinin proteins. 
Finally a survey of recent literature on the composition of the regulons accompanying 
neurotoxin genes suggests a bifurcation of genes and respective proteins which constitute 
neurotoxin complexes (Kubota et al., 1998; Hutson et al., 1996). 
The basis of this classification is whether a haemagglutinin operon is present. `Infant' 
type A2, type E and F strains do not possess haemagglutinin operons but have a gene 
termed p47. In contrast, classical type AI strains and type B, C, D and G strains do 
(Kubota et al., 1998; Bhandari et al., 1997). The comparisons are not completely direct 
as there is sequence divergence between the genes, rearrangments (i. e, position and 
orientation of ORF 3 homologues) and deletionsrinsertions (i. e, type G has no HA 33 
gene). In summary strains such as NCTC 2916 appear to possess a type B pseudogene in 
combination with a NTNH gene and haemagglutinin operon. In addition they 
accommodate a type Al neurotoxin gene with a NTNH gene and a `p47' gene which 
closely resembles the situation in `infant' type A2 strains, although these latter strains 
have a type A2 neurotoxin gene and no silent type B/haemagglutinin regulon. 
The reason for this could be that the strains with haemagglutinins are more proficient 
pathogens as the haemagglutinins facilitate the intestinal absorption of toxin (for 
example, L and LL forms produced by Al, B, C and D strains are considerably more 
toxic than M complexes produced by A2, E and F strains (Fujinaga et al., 1997). 
Thus, type A strains with the type B pseudogene and haemagglutinins located only at 
the type B regulon will have the advantage of having a type A progenitor complex 
containing haemagglutinins in addition to what ever advantage is conferred by p47. 
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7.3 Recombination in Clostridium botulinum 
The discovery that very similar neurotoxin genes are linked to disparate genes and 
operons that encode other components of the neurotoxin complex (i. e., NTNH and 
haemagglutinin genes), and as yet uncharacterised genes of cryptic function (i. e. p47 
genes), presents a very strong case for recombination. Indeed, the discovery of certain 
hybrid NTNH genes and hybrid neurotoxin genes indicates that interspecies gene transfer 
events must be occurring between unrelated species (Kubota et al., 1996; East et al., 
1996; Moriishi et al., 1996). Presumably there are more combinations of neurotoxin 
regulons to be discovered which may possibly be found in a wider spectrum of species 
than are already recognised as being neurotoxigenic. It is interesting to note that 
neurotoxigenic strains of C. baratii are quite closely related to C. perfringens! (Collins et 
al., 1994). Strains represented by C. botulinum NCTC 2916 would seem to represent a 
stable transition between the two common examples of type A strains. One could 
speculate that the p47-containing operon found adjacent to the type A neurotoxin gene 
was involved in a recombinational event with the silent type B locus resulting in the 
subsequent loss of the silent type B pseudogene locus and exchange of the 
haemagglutinin components to the type A gene. Such an event would result in a 
neurotoxin complex regulon which is virtually indistinguishable from the classical type Al 
strains. 
7.4 Regulation of neurotoxin complex production in Clostridium botulinum 
The association of the silent type B neurotoxin gene with a contiguous NTNH gene and 
opposing haemagglutinin genes is an organisation which appears to be reflected in all 
known haemagglutinin positive strains of C. botulinum (summarised in Kubota et a!., 
1998). The closely situated genes with a common function bear the hall marks of a co- 
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ordinately expressed regulon. The combination of both conserved promoter elements and 
putative transcription factor which occurs in various strains of C. botulinum (Henderson 
et al., 1995), C. tetani and other Clostridium, support this conclusion. However, little 
light has been shed on what type of transcriptional factor ORF 3 is (i. e, alternative sigma 
factor/phosphorylated response regulatorltranscriptional activator). Moreover, even less 
is known about what factors might interact with ORF 3 at the transcriptional or post 
translational level, and how these may correlate with the availability of exogenous carbon 
and nitrogen sources (Patterson-Curtis & Johnson, 1989; Leyer & Johnson, 1990). 
The presence of the p47 protein, in what appears to be an operon contiguous with the 
NTNH gene and neurotoxin gene in type A1/B`, A2, E and F strains, is a mystery as it 
does not appear to be associated with the neurotoxin complexes (Sugiyama, 1980). 
These operons do however possess a homologue of ORF 3 and a similarly conserved 
promoter element, suggesting that they may also be co-ordinately regulated. 
7.5 Development of a genetic system - critical evaluation 
During the course of this study a series of novel plasmid vectors based on the replicon of 
pCB 102 were constructed and subsequently shown to function in several diverse 
clostridial species. These included a representative of group I C. botulinum, C. 
perfringens and several species of solventogenic clostridia. These findings indicate that 
vectors based on the replicon of pCB102 may be generally useful for use in `cluster one' 
of the clostridia (Collins ei al., 1994). Preliminary data would indicate that the pCB 102- 
derived vectors tested were both structurally and segregationally stable. Furthermore, 
sequence analysis of the minimal replicon implied that pCB 102 did not belong to the 
commonly encountered classes of single-stranded replicating plasmids, but had some 
characteristics which were generally seen in other types of plasmids, e. g, the potential for 
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a `kissing complex' which is seen in ColE1 or pAMßl-like plasmid replicons. However, 
a study of the nucleic acid and protein replicative apparatus would be necessary to 
support this hypothesis. The availability of a structurally stable plasmid vector for use in 
C. bolulinum type A is an improvement on the existing class of single-stranded 
replicating plasmid vector currently in use (Zhou & Johnson, 1993; Janniere et al., 
1990). This should facilitate the implementation of in vivo reporter expression and 
complementation studies. Nevertheless, unless a conditionally selective replicon can be 
constructed (for instance a temperature sensitive replicon of a pCB 102 derived vector) a 
significant improvement in gene transfer frequency is required to generate chromosomal 
`knockout' mutants via a suicide vector approach. Improvements in gene transfer 
frequency by electroporation are likely to involve a more thorough assessment of factors, 
including the contribution of the cell wall, buffer composition, non-specific nucleases and 
restriction endonucleases. The presence of a restriction system in NCTC 2916 seems 
likely due to the successful transformation of one plasmid and not another. However, 
these could be more complex than type II restriction systems and, therefore, more 
difficult to detect. Efficient gene transfer may be impeded by poor recognition of the 
heterologous plasmid replicAtive signals, in this case plasmid pBP 1, isolated and 
characterised in this study may prove useful. Nucleotide sequence analysis of pBP1 
would strongly suggest that it replicates via a `single stranded' mechanism. As previously 
mentioned, this type of plasmid is not ideal for use as a recombinant vector. In hindsight, 
characterisation of a larger indigenous plasmid (>10 kb) may have yielded a more 
generally useful plasmid replicon. 
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BUFFERS AND STOCK SOLUTIONS 
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Where appropriate solutions were diluted to working concentration with sterile deionised 
water. Autoclaving was at 121 °C, 15 lb/sq. in. for 20 min. 
Acrylamide stock (40 %) 
Acrylamide 380 g 
Bis-acrylamide 20 g 
Made up to 1 litre with deionised H2O and deionised with amberlite MB-1 
resin and filtered. 
Acrylamide gel mix A (0.5xTBE) 
40 % acrylamide stock 150 ml 
l Ox TBE buffer 50 ml 
Urea (Ultra pure) 460 g 
Made up to 1 litre with deionised H20. 
Acrylamide gel mix B (5. Ox TBE) 
40 % acrylamide stock 150 ml 
IOx TBE buffer 500 ml 
Urea (Ultra pure) 460 g 
Bromophenol blue 0.05 g 
Made up to 1 litre with deionised 1120. 
Brij/DOC (pH 8.0) 
Tris-HC1 50 mm 
Brij-58 1.0 % (w/v) 
Na deoxycholate 0.4 % (w/v) 
EDTA 25 mM 
Chase solution 
dATP 2.5 mM 
dTTP 2.5 mM 
dGTP 2.5 mM 
dCTP 2.5 mM 
Made from 50 mM stock solutions with 1xTE. 
AE buffer(lx)(pH8.0) 
Tris-HCI 
EDTA 
50 mm 
10 mm 
PEB buffer (3x) 
PIPES 30 mM 
EDTA 1.5 mM 
NaCl 1.2 M 
285 
DNase I buffer 
Sodium acetate 100 mm 
MgSO4 5 mm 
pH 5.0 
DNA tracking dye 
Bromophenol blue 0.25 g/100 ml 
Sucrose 40 g/100 ml 
Formaldehyde gel-loading buffer (pH 8.0) 
Glycerol 50% (v/v) 
EDTA 1 mm 
Bromophenol blue 0.25 % (w/v) 
Xylene cyanol FF 0.25 % (w/v) 
GOOP prehybridisation buffer (pH 6.5) 
SDS '70.0 g/L 
EDTA 1.86 g/L 
NaH2PO4 , 41.0 g/L Na2HP04 41.0 g/L 
GTEL buffer (pH8.0) 
Glucose 50 mm 
Tris 25 mM 
EDTA 10 mm 
Lysis solution 
SDS 1% (w/v) 
NaOH 0.2 M 
Ligation buffer (10x) (pH 7.5) 
Tris-HC1 300 mM 
NaC1 300 mM 
MgC12 75 mM 
Spermidine 10 mm 
ATP 2.5 mM 
DTT 20 mM 
Na2EDTA 20 mM 
Kinase buffer(10x) (pH 7.4) 
Tris-HC1 500 mM 
MgC12 100 mm 
DTT 50 mm 
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S. E. B electroporation buffer (pH 7.4) 
Sucrose 270 mM 
Na2HPO4/NaH2PO4 7 mM 
MgC12 I mm 
SSC buffer (20x) (pH 7.0) 
NaCl 3.0 M 
Na3citrate. 2H20 0.3 M 
Strip neutralisation buffer (pH 7.5) 
NaCl 1.5 mm 
Tris-HCI 0.5 M 
S. T. E. T buffer (pH 8.0) 
Sucrose 8 g/100 ml 
Triton X-100 5 mI1 00 ml 
Na2EDTA 0.005 M 
Tris-Hcl 0.05 M 
TE buffer (lx) (pH 8.0) 
Tris HCl 10 mm 
Na2EDTA 0.1 mM 
TBE buffer (10x) (pH 8.3) 
Tris-borate 0.9 M 
Boric acid 0.9 M 
Na2EDTA 0.03 M 
TM buffer (lx) (pH 8.5) 
Tris-HC1 100 mm 
MgC12 50 mM 
AMV reverse transcriptase buffer (x5) (pH 8.5) 
Tris-HC1 250 mM 
MgC12 40 mM 
KCl 150 mm 
Dithiothreitol 5 mm 
Calf intestinal alkaline phosphatase buffer (x10)( pH 8.5) 
Tris-HCl 0.5 M 
EDTA 1.0 mm 
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Amplitaq DNA polymerase buffer (x10)( pH 8.3) 
MgC12 15 mm 
KCl 500 mm 
Tris-HC1 100 mm 
Gelatin 0.1 % 
T4 polynucleotide kinase buffer (x5)( pH 7.6) 
Tris-HCI 350 mM 
KC1 500 mm 
2-Mercaptoethanol 5 mm 
MgC12 50 mM 
Tris-Sucrose solution (pH 8.0) 
Tris-HC1 50 mM 
Sucrose 25 % w/v 
DNA sequencing reaction mixes 
Labeling mix 
dCTP 37.5 µM 
dGTP 37.5 µM 
dTTP 37.5 µM 
Stock solutions diluted in sterile deionised H2O. 
Labeling mixture for 1 reaction 
1xTE 2.0 µL 
DTT(100 mM) 1.0 pL 
H2O 1.6 µL 
T7 polymerase 0.5 pL 
[a 3SS]dATP 0.5 µL 
Dideoxy termination mixtures 
`A' ddATP(4 µM/L), dWTPs(160 µM/L), dSTPs(80 pM/L), 50 mM NaCL 
`T' ddTTP(4 iM/L), dWTPs(160 tM/L), dSTPs(80 jM/L), 50 mM NaCL 
`C' ddCTP(8 µM/L), dWTPs(160 µM/L), dSTPs(80 µM/L), . 50 mM NaCL 
`G' ddGTP(8 WAIL), dWTPs(160 pM/L), dSTPs(80 µM/L), 50 mM NaCL 
Antibiotic supplements 
Ampicillin stock solution 
100 mg of ampicillin sodium salt dissolved per 1 ml of 
deionised H2O and sterilised by filtration using a Sartorius 0.22 
µm disposable filter. 
Working concentration: 50-100 µg/ml- 
Storage -20 °C. 
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Erythromycin stock solution (E. coli) 
100 mg of erythromycin dissolved per I ml of 70 % ethanol 
and sterilised by filtration using a Sartorius 0.22 pm 
disposable filter. 
Working concentration: 500 µg/ml. 
Storage -20 °C. 
Erythromycin stock solution (Clostridium) 
10 mg of erythromycin dissolved per 1 ml of 70 % ethanol 
and sterilised by filtration using a Sartorius 0.22 µm 
disposable filter. 
Working concentration: 5-50 gg/ml. 
Storage -20 °C. 
Kanamycin stock solution 
10 mg of kanamycin sulphate disolved per 1 ml of deionised 
H2O and sterilised by filtration using a Sartorius 0.22 µm 
disposable filter. 
Working concentration: 50 pg/ml. 
Storage -20 °C. 
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F. coli MEDIA 
Luria-Bertani medium (pH 7.4) 
Tryptone 
Yeast extract 
NaCl 
Agar (solid media) 
2xYT(pH7.4) 
Tryptone 
Yeast extract 
NaCl 
Agar (solid media) 
SOC medium (pH 7.5) 
Tryptone 
Yeast extract 
NaCl 
KCI 
MgC12 
MgSO4 
Glucose 
H-Top Agar 
NaCl 
Agar 
M9 media (xlO)(pH 7.4) 
M9 Salts 
Na2BPO4.7H20 
KH2PO4 
NaCl 
NH4C1 
Non-autoclaved requirements. 
IM MgSO4 
0.1 M CaCl2 
20 % glucose 
Amino-acids 
9/1 10.0 
5.0 
5.0 
20.0 
9/1 16.0 
10.0 
5.0 
20.0 
9/1 20.0 
5.0 
20.0 mM 
2.5 mM 
10.0 mM 
10.0 mM 
20.0 mM 
9/1 8.0 
8.0 
9/1 128.0 
30.0 
5.0 
10.0 
MIA 
2.0 
0.2 
5.0 
2.0 
M9 agar plates were made by initially autoclaving a2% (w/v) agar solution. This was 
cooled to @ 50 °C and 100 ml of IN M9 salts added. Sterile solutions of MgSO4, CaCI2 , 
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glucose and specific requirements, typically amino acids were then added using an aseptic 
technique. 
CLOSTRIDIAL MEDIA 
USA II (pH 7.3) 
9/1 
Proteose peptone 20.0 
Yeast extract 10.0 
N. Z. Amine A 10.0 
Sodium thioglycollate 0.5 
Agar (solid media) 20.0 
YTG Media (pH 7.4) 
9/1 
Tryptone 16.0 
Yeast extract 10.0 
NaCI 5.0 
Glucose 5.0 
Agar (solid media) 20.0 
TPGY media 
9/1 
Tryptone 20.0 
Peptone 5.0 
Glucose 1.0 
Yeast Extract 5.0 
L-Cysteine HCl 1.0 
Agar (solid media) 20.0 
CMC broth 
Trypicase peptone 25 g 
Yeast extract 5.0 g 
Neutralised liver digest 5.0 g 
L-Cysteine HCI 0.5 g 
Sodium formaldhehyde- 
sulphoxylate 0.3 g 
K2HPO4(anhydrous) 5.0 g 
Vitamin K1 solution 1.0 ml 
Haemin solution 10 ml 
Glucose 4.0 g 
Soluble starch 1.0 g 
Cellobiose 1.0 g 
Maltose 1.0 g 
Resazurin 1.0 mg/ml 
Millipore H2O 1000 ml 
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APPENDIX III 
Annotated nucleotide sequence of neurotoxin complex operons 
5' to the silent type B neurotoxin in C. botulinum NCTC 2916 
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Hind III 
AAGCTTACATTATCAGATAAGTATTTTTTTACAATTTCTAATTTTAATTCAGTTGAATATATTTTTTTTGCCACAAAAATGCACCTCCAA 
------------_. _. _. -----------------"_. _. _. ---------------. -. -. -"-"-. -. -"-. 
90 
TTCGAATGTAATAGTCTATTCATAAAAAAATGTTAAAGATTAAAATTAAGTCAACTTATATAAAAAAAACGGTGTTTTTACGTGGAGGTT 
AAATTTAGATTTTTGTCTAAACTTTGGGGTGCACTTCATAAGCTGGTGGACTCTTATTTAATAATAAATCGTAATATATTAATTAGTAAT 
-----------------. ------------------___---_-_-_-_-_------. _. _-_----------- 180 
TTTAAATCTAAAAACAGATTTGAAACCCCACGTGAAGTATTCGACCACCTGAGAATAAATTATTATTTAGCATTATATAATTAATCATTA 
N Ti 
ATCTATATGCAATCTTATATTATAGTTATTTAATTCTGTAACTTCTACTTTTAATATATAAATTGCACCATTTAATAAACGTATTGAATT 
-. _. _. _. _. -. _. _. _. _. _. _. _. _. _. _. _. _. _. _. -. _. _. _. _. _"_. _. _. _. _. -"-. -"-. -"-. 270 
TAGATATACGTTAGAATATAATATCAATAAATTAAGACATTGAAGATGAAAATTATATATTTAACGTGGTAAATTATTTGCATAACTTAA 
DIHLRINYNNLETVEVKLIYIAGNLLRISN 
GGTATTATTTAAGAGGTGTAAATTTTGTCGTATACCAATTAACTTATAGCCGTCAATAGTTTCAATAACTCTAAATAAAGTACCTATTCC 
-----------------------------------------------------"--------- -------- 360 
CCATAATAAATTCTCCACATTTAAAACAGCATATGGTTAATTGAATATCGGCAGTTATCAAAGTTATTGAGATTTATTTCATGGATAAGG 
NNLLHLNQRIGILKYGDITFIVRFLGIG 
TTGATTATTACTAGTATAAAGCCTAATGTTAGATGTATCTTTATTATTAAAGTTACCAGGCACTGTAAATTCATATGAAATATAGTTACC 
-. -----. -. ---. -----------. -. -. -. -. -. ---. -----. -. -------. ---. -. ---. ----- -- 450 
AACTAATAATGATCATATTTCGGATTACAATCTACATAGAAATAATAATTTCAATGGTCCGTGACATTTAAGTATACTTTATATCAATGG 
ßNNSTYLRINSTDKNNFNGPVTF9YSIYN 
FcoR I 
AACATCAGGGCTTTGTCTTGTATAGTAATGTGCACCTGTTGAATTAAGATTATCTATTATATTAACTGAAGAA1T ATTAAATTTCGGAG 
------------------------------------------------------------ --- --m. -. 540 
TTGTAGTCCCGAAACAGAACATATCATTACACGTGGACAACTTAATTCTAATAGATAATATAATTGACTTCTTAAGTAATTTAAAGCCTC 
VDPSQRTYYHAGTSNLN F) IINVS5NMLNRL 
ATCCCCTTCTTCTCTCTTGAACTTTATTTGATTTTCTATATTAGGAGAAGTTTGTGGTACTCTAATGTAGTAATTTTTATCCTTATTAAG 
---. -------. -. -. -. -----. -----------------------"-------"----- - -"-------- 630 
TAGGGGAAGAAGAGAGAACTTGAAATAAACTAAAAGATATAATCCTCTTCAAACACCATGAGATTACATCATTAAAAATAGGAATAATTC 
DGEERKFKIQNEINPSTQPVRIYYNKPKNL 
CAAAACAACTAAATAACTTTTAGTATTAGGGTCGTCAACCCCAGTAATATAATTTATTGCTTTAATATTATTATTACATAAATTGCCAGC 
.......... ---------------------------- ------------------------------------ 720 
GTTTTGTTGATTTATTGAAAATCATAATCCCAGCAGTTGGGGTCATTATATTAAATAACGAAATTATAATAATAATGTATTTAACGGTCG 
LVVLYSKTNPPPVGTIYNIAKINNNCLNGA 
TTGCAAATTTCTATTACCCGAACCTATCGCTTCATATATTTTTAATGGTGGTAGATTATTTTGAGTATTAATTTTATAAATTCCTGTAGT 
-. _. _. -"_. _. -. _. _. _. _-_. _. _. _. _. _. -. _. -. _. _"_. _. _ __m .m --------------- 810 AACGTTTAAAGATAATGGGCTTGGATAGCGAAGTATATAAAAATTACCACCATCTAATAAAACTCATAATTAAAATATTTAAGGACATCA 
QLNRNGSGIAEYIKLPPLNNQTNIKYIGTT 
ATTTACTGTAAATAATATATAAAATGGATTATTATTTACAATACCTGGAATGTTATATGTGTAATTATCTGAAATAGCACTATTTATTTC 
------------------------------------------ - ------------------ 900 TAAATGACATTTATTATATATTTTACCTAATAATAAATGTTATGGACCTTACAATATACACATTAATAGACTTTATCGTCATAAATAAAG 
NVTFLIYFPNNNVIGPINYTYNPSIATNIE 
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TTGTATATTTTCAGATGGGTCTATGACACCTACTACAATTTCTTCCTCGGGACCATTTTGTATAAATCCATCTTCAGCCACTTGCATTTT- 
990 
AACATATAAAAGTCTACCCAGATACTGTGGATGATGTTAAAGAAGGAGCCCTGGTAAAACATATTTAGGTAGAAGTCGGTGAACGTAAAA 
QINES2DIVGVVIEEEPGNQIFGDEAVQMK 
AACTACTTCAGATTCAGGTGAAGGAGCATTAGTTACTTCACAATATCCTAAGGAAGGAAGATAATACTCAGCTTTATTAACAATACTTCC 
---------------------------------------"-------------------. -. -. -. -. -. -. -. - 1080 
TTTGATGAAGTCTAAGTCCACTTFCTCGTAAATCAATGAAGTGTTATAGGATTJCTTCCTTCTATTATGAGTCGAAATAATTGTTATGAAGG 
ATTTTGATAGTCTATTAATTCATATTTTTCATAGGTATTATAAGCCTTTATGCATATATTTTTATCTGAAGGAGCTTCTTCTACAAATTT. 
1170 
TflAAA6=ATCAGATAAITAýGTVA GTATC ATýATATT GGPMTACGTA'AT§AA, ATAGA5TT CTRGAýGAýGATGT'TAAA 
AAA TAACGATGTTGATGTATTAAATAATTGTACATTGAAAGCGTCTTTAAGTCCTTTCTTCAGTATATTGTTGTGAGAATTTTGTATCATT 
-----"--------------------------------------- -"-"-------"-"--- --- -- 1260 
TTE, TALTGS ATAAJTACT.. ATAATTTAITAAACATGTrAAC'TTGAGCAGAAAATTCAGAAEGAFA, GTCfiATATAAACAAACACTC'TAWFTAGTýA 
ACTTGTGGTGAATAATGGTCTAGTTGTATTTCTTAATCGAGGTTGTATAATACTTCCTGATGAACCTGCTTCGATTAATAATGTACCfAT. 
1350 
TGAACACCACTTATTACCAGATCAACATAAAGAATTAGCTCCAACATATTATGAAGGACTACTTGGACGAAGCTAATTATTACATGGATA 
STTFLFRTTNP. LRPQIISGSGGAEILTG 
CAAATCTTTATCATTTGTTCTTATATATCCATCACCCTTATTAATAACATATAGTCCATTACTATAAGGCAATACTCGTTGTGTGCTACT 
1440 
GTTTGGAAAATAGTAAACAAGAATATATAGGTAGTGGGAATAATTATTGTATATCAGGTANATGATATTeCGTTATGAGCAQCACACGATGA 
AACTTTAGAATTAAAAATATTGTTAGTTGGTATATTTTTAGTAGTTTCTAAAATTTTTTTATATAGGAATTGTTCATTTAAAATGCACTT 
1530 
TVGAKATCTTAATTTTJATANACAATCAAPCATATNAAAATCCATCAAAGALTT. AAKAAAKATýTALCCTTAA0CAAAGTeAAITTIACTG A 
ATCATTAGTTAGAAAGTAAAAATCTTTATTTATTTTTTCCCCTGGATTAAATTCTATAGACTTAACATATCCAAGAGATGGAACATATAA 
1620 
TAGTAAATCCAA 
LCT FTCATY 
T 
ETTAGAAKATAAA 
AAAAA 
PGGGGG 
A PCT 
rAAT 
TTAAGA TAT 
GTGAAT 
TGT ATAGGT 
LCTCTS 
A 
eCTTGTATATT 
AACTGCTCTCTCTATAATTTCATGTTGTAAGACTTTTATTATTTCATATCTAATGTAGGTATATTGTAAATACATATATAAGTTTTTATT- 
1710 
TTGACAGAG GAGATATTAAAGTACAAACATTC. TGAkAATAATAAAGTATAGGATTACATCCATATAýCATTTATGTATATATTCAAAAATrAA 
TGAGGGAGCGGTTTTACTAAATTCAAATCCTATTGGAATTTGATTAGCTTCAGTAAAGTTAGTAAATACAGTTTGTATATTATTTTTTAT 
. _. _ ______ .__. ___. _. _ ____ 
1800 
ACTCCCTC CCAAAATGATTTAAGTTTAGGATAA CTIAAACTAAATCAGAAGTTATETCAATCATTTATGTcAAAACATATTAATANAAAAATA 
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ATATTCTTCATTGAAAGATGGTGTTGGATAATAATATGGTATCGCATTATCATTTACACGTAGGTCCCCAACTATTCCTGTTGATCCATT 
-------------------"---------------. -"-----------------"-----------------"- 1890 
TATAAGAAGTAACTTTCTACCACAACCTATTATTATACCATAGCGTAATAGTAAATGTGCATCCAGGGGTTGATAAGGACAACTAGGTAA 
YEENFSPTPYYYPIANDNVRLDGVIGTSGN 
Xba I 
ACTAATTACACTTCCACCTAATATTTGATTTTGTCTAGATAATATCCATCCATCCCCTCTTCTAACTACATAATTACCATCAGCTAAATC 
---------. -"-. -. -----"-------"---"-------. -------------"-"---"-. -. -"-. -"--- 1980 
TGATTAATGTGAAGGTGGATTATAAACTAAAACAGATCTATTATAGGTAGGTAGGGGAGAAGATTGATGTATTAATGGTAGTCGATTTAG 
3IVSGGLIQNQRSLINGDGRRVVYNGDAL fi 
RcoR I 
AATAGTATCACTATAGTTTATAACTTTTTCTTGTATATCATTATAAATTTTTTTTATAGATGAATTCATACACTTTTCTCCTTTATATTT 
-------------------"_------"-"---"-"-"---"-----"---------"---_-"-"-"-"-"-"- 2070 
TTATCATAGTGATATCAAATATTGAAAAAGAACATATAGTAATATTTAAAAAAAATATCTACTTAAGTATGTGAAAAGAGGAAATATAAA 
ITDSYNIVKEQIDNY1KKISSNM f- IIA70 I Y. 
TTTCAAGTTTGAACATTTGATTTGAATTGTATATATCAAAATTCGGTAATAGGAGTAGTGGTTGGCTTAAAATATTTTCATTAGTATCAT 
-_-"-------"-------"----------_----------"----_"-"----_--"-_---"-"-"-"-"-"- 2160 
AAAGTTCAAACTTGTAAACTAAACTTAACATATATAGTTTTAAGCCATTATCCTCATCACCAACCGAATTTTATAAAAGTAATCATAGTA 
ELKFMQNSNYIDFNPLLLLPQSLINENTDY 
AAATGTCCCAGGCATAATCTAATTCATTCACTTTATTTAAACTTAACATAATATAAGTATTTACAGCAATTTTAATAGGAAACCAGTAGC 
-------"-"---------------------------------------------------------"-"--- - 2250 
TTTACAGGGTCCGTATTAGATTAAGTAAGTGAAATAAATTTGAATTGTATTATATTCATAAATGTCGTTAAAATTATCCTTTGGTCATCG 
IDWAYDLENVKNLSLMIYTNVAIKIPEW 'i C 
ATCTATTGGATAATGAATCTAAAGAAATAAATCCAAAGTTATCGTAACTTAAATACTTATTTGGTTCTGCTACATTAGAGATTTTAAAGC 
-----"---------------------------------------------------"---------"- ----- 2340 
TAGATAACCTATTACTTAGATTTCTTTATTTAGGTTTCAATAGCATTGAATTTATGAATAAACCAAGACGATGTAATCTCTAAAATTTCG 
R 11 SLSDLSIFGFNDYSLYKNPEAVNSIKF. 
T 
ATCTATTTTCAGCCATATATTCTACATTCCATTTTTGATTATTTGCAGAAGATTCATTTGAAAATGTTAATGATTTCGATACAGGATTTA 
---------------"-------"-------------------------------------"------- --"- 2430 
TAGATAAAAGTCGGTATATAAGATGTAAGGTAAAAACTAATAAACGTCTTCTAAGTAAACTTTTACAATTACTAAAGCTATGTCCTAAAT 
P% NEAMYEVNWKQNNA, SENSFTLSKSVENL 
AATATAAAGAACCAGAAAAGATAGATTTTATATTGTAATTACCATTAGGTAGAAAAGTTCTTTCAACTGACATATAATTCACCTCTTTAT 
-----------------------------------------"-"-----------"-"-----" - -- "- -- 2520 
TTATATTTCTTGGTCTTTTCTATCTAAAATATAACATTAATGGTAATCCATCTTTTCAAGAAAGTTGACTGTATATTAAGTGGAGAAATA 
YLSGFlSKINYNGNPLFT REV SM -4-- IIA17 
S. cal 
AAATTAGATGATAGTACTCATATTAAATCTTTGTTGATATTAATTTTATGGGTTACGAATATTCCATTTCTGATTATCATCTCCATGATA 
2610 
TTTAATCTACTATCATGAGTATAATTTAGAAACAACTATAATTAAAATACCCAATGCTTATAAGGTAAAGACTAATAGTAGAGGTACTAT 
PNRI 14 WKQNDD(HY 
XbaI 
ATTAAATACTTGAATAGCAGTTCCGTTTGCTGTTTGGCTGTTATATAAATCTAGAGCTTTAGTTGTATCGCGTAGATTAGTAATTGTATA 
_---. -. -. - _-. - --- -. ---_-. -. ---. ---. ---. __- --- "-"- -. -. - 2700 
TAATTTATGAACTTATCGTCAAGGCAAACGACAAACCGACAATATATTTAGATCTCGAAATCAACATAGCGCATCTAATCATTAACATAT 
NFVQIATGNATQ3NYLPLAKTTnRLNTITY 
296 
'GTTTCATCAGTATCTGAAACAGGATTTATAAGCCAATATTGGGCGTCATTATTTTGATCATTAGAAGAAGAAACCCTTACAGTATTACC 
--------_-_-----------------------_-----_-------------_-------------_----_- -790 
CAAAGTAGTCATAGACTTTGTCCTAAATATTCGGTTATAACCCGCAGTAATAAAACTAGTAATCTTCTTCTTTGGGAATGTCATAA'I'GG 
ýTTTGAAAAAATCCATGTTAGAACTCCGTTTGAAAGTATTGTATTAAAAAACTGGTATGCTGCTTTTTCTTCATTATATCTAATTGTCCA 
--------------------------------------------------------------------------- 2880 
'AAACTTTTTTAGGTACAATCTTGAGGCAAACTTTCATAACATAATTTTTTGACCATACGACGAAAAAGAAGTAATATAGATTAACAGGT 
TTTTTGATTGCGACCATAGTCCCAAGTATATAAATTAACATTTAGATTTGTCATATCCACTTGTTGTACGACTTTATTACGATCTAATAT 
AAAAACTAACGCTGGTATCAGGGTTCATATATT'PAATTGTAAATCTAAACAGTATAGGTGAACAACATGCTGAAA'I'fV1'1'(ý("1'AGA'I''1'A'I'i, 
&'1 II 
TGGACTTATTTTACATGTGAAATTGTTAAGATCTGATATTATATAATCTTCTATGATAAATTTTATATAATTTGAA'PTATTAAG'I'G'1'(, CT 
------_"_"_--. _. _. _. _. _. _. _. _. _. _. _. _. _. _. _. _. _. _. _. _. -. _. _. _. _. _. _. _. _. _. - _iir, i. 
ACCTGAATAAAATGTACACTTTAACAATTCTAGACTATAATATATTAGAAGATACTATTTAAAATATATTAAACTTAATAATTCACACGA 
1-lind ITI 
AAGCTTCAAATTACGAGCTACGGTATCAGCATATAATACTAAGTTAGGGTTTTTATAACTTGCAATAATAAATGAATTGTTACCAATGTC 
--------------------------------------------------------------------------- 3150 
TTCGAAGTTTAATGCTCGATGCCATAGTCGTATATTATGATTCAATCCCAAAAATATTGAACGTTATTATTTACTTAACAATGGTTACAG 
TTTTAATAATAACCAATATTGATTATCTGCATTTGAATCTTGTTGCGTTGATATATTATGTGTTGGTGCATTCCATGTTAAAACTAAATT 
-----------------"--------------------_----------. _----. --------_. _---_. _. _ 3240 
AAAATTATTATTGGTTATAACTAATAGACGTAAACTTAGAACAACGCAACTATATAATACACAACCACGTAAGGTACAATTTTGATTTAA 
EcoR V 
AGTATTATGGATATCCATACTTTTTATTTTATAAGCAGCTTTATTAGAATCATATATAAGTCTCCATCTTTCAAGGTAATTTCTAGTTTG 
---------- ------------------------------------------------------------ 3330 
TCATAATACCTATAGGTATGAAAAATAAAATATTCGTCGAAATAATCTTAGTATATATTCAGAGGTAGAAAGTTCCATTAAAGATCAAAC 
Hae III 
TTGAAATAAGCTAACGTTACCGGCAACTTGATAAAAAAATAAATTAGTATCGGCCTTACAGGAGATGGTAACAATTTTGTCATTTAATGA 
---------------------------------------------------------"----------------- 3420 
AACTTTATTCGATTGCAATGGCCGTTGAACTATTTTTTTATTTAATCATAGCCGGAATGTCCTCTACCATTGTTAAAACAGTAAATTACT 
ATTTTGGATTACTGAATAGTGTTCCATTATGATTCCTCCTTTATTTAAGAATTAATCTTACATATAACATATAACATAATCAAGTTATTT 
TAAAACCTAATGACTTATCACAAGGTAATACTAAGGAGGAAATAAATTCTTAATTAGAATGTATATTGTATATTGTATTAGTTCAATAAA 
HA34 
TTTGTAAACCTAAAATTTAAATATATCAAATTTTTATTAGTATGTTTACATAATTGATTATGGATATTTCGTAAAAATGGCTTATTAAAA 
--------------------------------------------------------------------------- 3600 
AAACAT TT GGATT T TAAA'I' T TATATAGTTTAAAAA TAA TC'a T. A CATIA T GTAT T AALT AATACCTATAAAGCAT TT T'I' ACCGAATAA'P T TT 
HA Promoter 
297 
ATTTAAAGGCAATTAGTTTATTTATAGTATAATAAAACAATAATATGTATATTATGGAGGGATAGTGGTAAATATGAATAAGTTGTT7": '' 
--------------------------------------------------------------------------- 
TAAATTTCCGTTAATCAAATAAATATCATATTATTTTGTTATTATACATATAATACCTCCCTATCACCATTTATACTTATTCAACAA. ." 
prf3 -º MNKL. 
ACAAATTAAAATGTTAAAAAATGACAACGAGGAGTTTCAAGAAATTTTTAAGCATTTTGAAAAAACTATAAATATATTTACTAGAAAA'I'ii 
--------------------------------------------- . -----------. -. -. -. -. -----. --- 
TGTTTAATTTTACAATTTTTTACTGTTGCTCCTCAAAGTTCTTTAAAAATTCGTAAAACTTTTTTGATATTTATATAAATGATCTTTTAT 
QIKMLFN NN NEEFQF1FK, HFFF1N1FTRKY 
TAATATATATGATAATTACAATGATATTTTGTACCATTTATGGTATACACTTAAAAAAGTTGATTTGAGCAATTTCAATACACAAAATi; r. 
_-_----------------------------. _-_-_--------. --_-------------------------- 1870 
ATTATATATACTATTAATGTTACTATAAAACATGGTAAATACCATATGTGAATTTTTTCAACTAAACTCGTTAAAGT, rATGTGTTTTA( 
NI7 1) WYPHL 11 TI ,KP: ti T ýý 
TTTAGAGAGATATATTAGTAGGACTTTAAAAAGATATTGCTTAGATATTTGCAATAAAAGAAAGATTGATAAGAAAATAATATATAATTC 
--------------------------------------------------------------------------- 3960 
AAATCTCTCTATATAATCATCCTGAAATTTTTCTATAACGAATCTATAAACGTTATTTTCTTTCTAACTATTCTTTTATTATATATTAAG 
LERY_R 71 1 :. 1LKRLCICN t' F; h" _; . 
Hind iii 
AGAAATTGCAGATAAGAAAT', AA; ('TTAATAGCAAATAGTTATTCAAGTTATTCAGAATTTGAATTTAATGATTTAATATCCATATTAC" 
------------------------------------------------------------_-_-_. _"_-_. --_ 4050 
TCTTTAACGTCTATTCTTTAATTCGAATTATCGTTTATCAATAAGTTCAATAAGTCTTAAACTTAAATTACTAAATTATAGGTATAATGG 
EiAýKKI. LIANF, h' ['. ., 
TGACGATCAAAAGAAAATTATATATATGAAATTTGTTGAAGATATTAAGGAGATAGATATAGCTAAAAAACTTAATATAAGTCC, T('AA'I'(; 
___------------------------. _. _---------_-_. _-_-----------------_---------- 414( 
ACTGCTAGTTTTCTTTTAATATATATACTTTAAACAACTTCTATAATTCCTCTATCTATATCGA'I"I"I''I'T'I'(! AAT'I'%, 'I'A'T' i' 'h. ; '! % :: '' 
DDQKKIIYMKEVED7KEID 
TGTATATAAAAATAAAATAATGGCTTTAGAGAGATTAGAACCCATATTGAAAAAATTAAT'I'RATA'I'GTAG'PI"I'A'! 'A'1""': ": "'!.! "_-"_. 
--------------------------------------------------------------------------- 
ACATATATTTTTATTTTATTACCGAAATCTCTCTAATCTTGGGTATAACTTTTTTAATTAATTATACATCAAATATAAAAA'I"I"I'T'I'TAAA 
MALERLEPILKKLINM 
N'T'NI I/ßnNTif°Promoter 
TAGGT TAGTGTGGCTATGTTATATATAAATGATAAGAATATACTGAAAAATGTATCCAAAATTTAAG(; (; (, r, (: GTGTATAG 
--------------------------------------------------------------------_. _. _. _ 4320 
ATCCAAATGT'I'TTTTATCACACCGATACAATATATATTTACTATTCTTATATGACTTTTTACATAGGTT'I'TAAA'I"1'('I', "V(7'A('ATATC 
TAAATAATTAAAAGTATGTGCGTTGAAATAAATTTAGGAGAGTGGTTAGATATGAATATAAATGACAACTTAAGTATAAATTCCCCGGTA 
-----------------------------------------------------------------. --------- 4410 
ATTTATTAATTTTCATACACGCAACTTTATTTAAATCCTCTCACCAATCTATACTTATATTTACTGTTGAATTCATATTTAAGGGGC('AT' 
NTNH "NN1NN tN I. 
., E' V 
GATAATAAAAATGTTGTAGTAGTTAGAGCTAGAAAAACTGATACGGTTTTTAAGGCTTTTAAGGTTGCTCCCAATATTTGGGTGGC(; c'(7.. 
_-_---------------_. ---------. ----------------------_. _. ---. ---. _. _. _. _. -. - 4500 
CTATTATTTTTACAACATCATCAATCTCGATCTTTTTGACTATGCCAAAAATTCCGAAAATTCCAACGA(; GGT'I'A'I'AAA000AC('(; r'(; (. 1' 
DNY [I VVvVRAkKTp. FK :11 1- V5: WVA 
297 4 
GAGAGATATTATGGCGAATCTTTGAGTATAGATGAAGAATATAAAGTTGATGGGGGAATATATGATTCTAATTTTCTTTCACAAGATA';: 
--------------------------------------------------------------------------- 
CTCTCTATAATACCGCTTAGAAACTCATATCTACTTCTTATATTTCAACTACCCCCTTATATACTAAGATTAAAAGAAAGTGTTCTA': ''; " 
ERYYGESLSIDEEYKVIYDý; 
-. 
S= 
-L 
GAAAAAGATAAGTTCTTACAAGCCATTATTACTTTGTTAAAAAGAATTAATAGTACTAACGCTGGGGAAAAGT'I'ATTATCTTTGATTT('f 
4590 
- -------------------------------------------------------------------------- 4680 
CTTTTTCTATTCAAGAATGTTCGGTAATAATGAAACAATTTTTCTTAATTATCATGATTGCGACCCCTTTTCAATAATAGAAACTAAAGA 
EKDKFLQAIITI '- KRINTNA6i, KLLSL1S 
1 
'.. 
% 
ACAGCTATTCCATTTCCTTATGGATATATAGGTGGAGGGTATTATGCACCTAATATGATTACTTTTGGATCAGCACCAAAATCTAATAAA 
---------------------------------------------'-'-'-------------------'---'- 4770 
TGTCGATAAGGTAAAGGAATACCTATATATCCACCTCCCATAATACGTGGATTATACTAATGAAAACCTAGTCGTGGTTTTAGATTATTT 
TA: FPGGAYYAFNMITPG3A f' PNh 
FrnR j Sca L 
AAATTGAATTCTTTAATTTCAAGTACTATTCCATTTCCTTATGCAGGATATAGAGAAACAAATTATCTTTCATCTGAAGATAATAAAAGT 
--------------------------------------------------------------------------- 4860 
TTTAACTTAAGAAATTAAAGTTCATGATAAGGTAAAGGAATACGTCCTATATCTCTTTGTTTAATAGAAAGTAGACTTCTATTATTTT« 
KLN,. LIS., TIFFF1A i7, YRF t1 Y_h: FN1h: 
TTCTATGCATCTAATATAGTTATTTTTGGTCCAGGAGCAAACATAGTAGAAAACAATACTGTTTTTTATAAAAAGGAAGATGCAGAAAAT 
-_----------------------------------------------------------_. _--. -. -. ----_ 4950 
AAGATACGTAGATTATATCAATAAAAACCAGGTCCTCGTTTGTATCATCTTTTGTTATGACAAAAAATATTTTTCCTTCTACGTCTTTTA 
FYAFNIFGPGANIVFNNTVFYKKFPA F' , 
GGAATGGGAACAATGACTGAAATATGGTTCCAACCATTTCTAACCTATAAATATGACGAATTTTATATTGATCCTGCAATAGAA'rTAATA 
-------------------------------------------------------------------------. - 5040 
CCTTACCCTTGTTACTGACTTTATACCAAGGTTGGTAAAGATTGGATATTTATACTGCTTAAAATATAACTAGGACGTTATCTTAATTAT 
GMGTMTEIWFQPFTYKYDEFYIGPAIP1, I 
AAATGTTTAATAAAATCTCTTTATTTCTTATATGGTATAAAACCGAGTGATGATTTAGTTATTCCATATAGATTAAGAAGTGAATTAGAG 
--------------------------------------------------------------------------_ 5130 
TTTACAAATTATTTTAGAGAAATAAAGAATATACCATATTTTGGCTCACTACTAAATCAATAAGGTATATCTAAT'1'C'I'T('ACTTAATC'TC 
KCLIKSLYFI, YGIKP5DDLVIPYP1, h F. I, K 
AATATAGAATACTCACAATTGAATATAGTTGATTTACTAGTATCTGGAGGCATTGATCCTAAATTTATAAATACAGATCCATATTGGTTI' 
--------------------------------------------------------------------------- 
TTATATCTTATGAGTGTTAACTTATATCAACTAAATGATCATAGACCTCCGTAACTAGGATTTAAATATTTATGTCTAGGTATAAGCAAA 
T! TE[ tI I, vGGiD i' h; F' PTYWF 
ATAGATAATTATTTCTCAAATGCAAAAAAAGTGTTTGAAGATCATAGGAATATTTATGAAACAGAAATTGAAGGAAATAATG('GATT(; (; "' 
------------------------------------------------------------_. _. _. _. _. _---- 
a10 
TATCTATTAATAAAGAGTTTACGTTTTTTTCACAAACTTCTAGTATCCTTATAAATACTTTGTCTTTAACTTCCTTTATTACGGTAA''ý'A 
IDNYFSMAKKVFEDHRNIYE 'P KIE ri A 
AATGATATAAAATTGAGATTAAAACAAAAGTTTCGAATCAATATCAATGATATATGGGAATTAAATTTAAATTATTTCTCTAAAGAGTTT 
--------------------------------------------------------------- -------- . _. _ ', 400 
TTACTATATTTTAACTCTAATTTTGTTTTCAAAGCTTAGTTATAGTTACTATATACCCTTAATTTAAATTTAATAAAGAGATTTCT('AAA 
NDIKLRLKQKFFIN4 PJ K 
298 
AGCATTATGATGCCAGATAGATTTAATAATGCACTTAAACATTTTTATAGAAAACAATACTACAAAATAGATTATCCAGAAAATTATAGT 
---------------------------------------------------------------------. -. -. - 5490 
T CGTAATACTACGGTCTATCTAAATTATTACGTGAATTTGTAAAAATATCTTTTGTTATGATGTTTTATCTAATAGGTCTTTTAATATCA 
SIMMPD IF FNFANKHIRKQ 'i YKIDF. F 
ATAAATGGTTTTGTTAATGGTCAAATTAATGCTCAATTATCTTTATCAGATAGAAATCAAGATATTATAAATAAACCTGAAGAAATAAT^. ' 
TATTTACCAAAACAATTACCAGTTTAATTACGAGTTAATAGAAATAGTCTATCTTTAGTTCTATAATATTTATTTGGACTTc: TTTATTAA 
INGFVNFQINAQLSLS [D RNQD1INEF. 
AATTTATTAAATGGAAATAATGTTTCATTAATGAGAAGTAATATTTATGGTGATGGATTAAAAAGCACTGTAGATGATTTTTACAGTAAT 
-----------"-----------"-----------------------------"-"-----"-"-----"---"- gib 10 
TTAAATAATTTACCTTTATTACAAAGTAATTACTCTTCATTATAAATACCACTACCTAATTTTTCGTGACATCTACTAAAAATGTCAT'1'F. 
NLLP: LRNFV 
TATAAAATCCCATATAATAGAGCCTATGAATATCATTTTAATAATTCAAATGATTCTTCTTTAGATAATGTTAACATTGGAGTAATAGAC 
-------------------------------------------------------------------------. _ 5760 
ATATTTTAGGGTATATTATCTCGGATACTTATAGTAAAATTATTAAGTTTACTAAGAAGAAATCTATTACAATTGTAACCTCATTATCTG 
YK_PINRAYEYHFNNSND. 1P il vF: ý'.. , 
AATATTCCAGAGATTATAGATGTAAATCCTTATAAGGAAAATTGTGATAAGTTTTCACCGGTACAGAAAATTACAAGTACTA!; hk; AAATT 
--------------------------------------------------------------------------- 5850 
TTATAAGGTCTCTAATATCTACATTTAGGAATATTCCTTTTAACACTATTCAAAAGTGGCCATGTCTTTTAATGTTCATGATCTCTTTAA 
NIPFI !'N L' IKENCPKF I' VQK, I !' 
Hae lI1 
AA TACAAATATACCATGGCCTATAAATTATTTACAAGCTCAAAATACTAACAATGAAAAATTTAGTTTATCCTCAGATTTTGTAGAAGTA 
-----------------------------------------------------------------------. -. - 5940 
TTATGTTTATATGGTACCGGATATTTAATAAATGTTCGAGTTTTATGATTGTTACTTTTTAAATCAAATAGGAGTCTAAAACATCTT('A'I' 
I1 TNIPWFNYLQAQNTNNF, KF1. S5 11 V. 
GTTTCTTCTAAAGATAAATCTTTAGTGTATTCTTTCTTATCTAATGTAATGTTTTATTTAGATTCCATAAAGGATAATAGT('(TATTGA'1' 
---------------------------------------------------------------------. _. -. - 0030 
CAAAGAAGATTTCTATTTAGAAATCACATAAGAAAGAATAGATTACATTACAAAATAAATCTAAGGTATTTCCTATTATCAGGATAACTA 
VSSKDKLVY9FLNVMFYLDSIK 1) N _H 1 
ACAGATAAAAAATATTATTTATGGTTAAGAGAGATTTTTAGAAATTATTCTTTTGATATTACTGCAACTCAAGAAA'I'TAA'I'Ac, 'I'GA'1'TGC 
-_-----------------------------------------------------------------------. - 6120 
TGTCTATTTTTTATAATAAATACCAATTCTCTCTAAAAATCTTTAATAAGAAAACTATAATGACGTTGAGTTCTTI'AAT'I'AT(, AC, TAA('(; 
TDKHYLWLREIFRNYSFDITATQ:.. : 
GGTATTAATAAAGTAGTAACTTGGTTTGGAAAAGCATTAAATATTTTAAATACATCCGATTCTTTTGTAGAAGAATTTCAAAATTTAGGA 
-------------------------------------------------------------------------. _ 6210 
CCATAATTATTTCATCATTGAACCAAACCTTTTCGTAATTTATAAAATTTATGTAGGCTAAGAAAACATCT'I'CTTAAAGTTTTAAATCCT 
IH FC VVWFKALNIi. NiVFQNI. 
I/Ta I C1 g 9. 
CCAATTTCACTTATTAATAAAAAAGAAAATTTAAGTATGCCTAAAATAGAAATCGATGAAATACCTAATAGTATGTTc; AA'1'('TTTCATTT 
--------------------------------------------------------------------------- 6300 
GGTTAAAGTGAATAATTATTTTTTCTTTTAAATTCATACGGATTTTATCTTTAGCTACTTTATGGATTATCATACAACTTA(GAAAGTAAA 
PISLI,! KKF, ,NLM_KIE1PFiN_, -:., 
sue: 
yý. 
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AAAGATTTAAGTGAAAATTTATTTAATATATTCTCTAAAAACAACTCTTATTTTGAAAAAATCTACTATGATTTCTTAGATCAA': ';: 
---------------------------------------------------------------. -. -. ------ 390 
TTTCTAAATTCACTTTTAAATAAATTATATAAGAGATTTTTGTTGAGAATAAAACTTTTTTAGATGATACTAAAGAATCTAGTTACCACC 
!! DLSENLFNFSKNNSYFFKIYYPFLP (+ WW 
ACACAATATTATAGTCAATATTTTGATTTAATTTGTATGGCTAAAAGATCAGTGTTAGCTCAAGAAAGTTTAATAAAAAAAATAATACAI. 
__-------------. -----------------------. -. -. -------------. _. ---. _. _. _. _... 0480 
TGTGTTATAATATCAGTTATAAAACTAAATTAAACATACCGATTTTCTAGTCACAATCGAGTTCTTTCAAATTATTTTTTTTATTATGTT 
TQYYSQYFDLICMAKRSVLAQFLKII, 
AAAAAATTGAGTTATTTAATAGGAAATTCTAATATATCATCTGATAACTTAGCATTGATGAATCTGACAACAACAAATACATTAAGAGAT 
---. -. -. -. -. -. -. -. ---. -. -. -. -. -. -----------------------. -. -. -. -. -. -. -. -. _. 6570 
TTTTTTAACTCAATAAATTATCCTTTAAGATTATATAGTAGACTATTGAATCGTAACTACTTAGACTGTTGTTGTTTATGTAATTCTCTA 
KKLSYLI C7' NNý5DNPAI. M Ii PT!: :'h 
ATTTCAAACGAATCACAAATAGCAATGAACAATGTAAACAATTTTTTAAACAATGTTGCTATATGTGTTTTTCAAACTAATATATAT('(' 
-------------------------------------------------------------------------- o060 
TAAAGTTTGCTTAGTGTTTATCGTTACTTGTTACATTTGTTAAAAAATTTGTTACAACGATATACACAAAAAGTTTGATTATATATAGI; iA 
ISNESQIAMNNVNNFLNNVAIVQTNI 
AAGTTTATTTCTTTTATGGAACAATGTATTAATAATATAAATAAGAATACAAGAGAATTTATACAAAAATGTACCAATATTACTGAAAAT 
-----------------------------------------------------------------------. _. 6750 
TTCAAATAAAGAAAATACCTTGTTACATAATTATTATATTTATTCTTATGTTCTCTTAAATATGTTTTTACA'I"1'T. ": '; ". ': 7"_-'". ' ":: I'A KFFMFQ_INNNNF. FO. 
11 
h d I in U 
GAAAAATTACAATTGATTAACCAAAATATTTTTAGTAGCTTAGATTTTGATTTTTTAAACATTGAAAATTTGAAAAN"I"1'A'I°: ';.; ". ':: "; ". 
-------------------------------------------------------------------------. 6840 
CTTTTTAATGTTAACTAATTGGTTTTATAAAAATCATCGAATCTAAAACTAAAAAATTTGTAACTTTTAAAC'I'TT'I', '1; L, ',. i'AAATTAAGT 
EKLQL7NNIESSLDF f) FLNTENI, FN. 
GAGACAGGATTACTTATAAAGGAGGAAACTTCACCCTATGAACTAGTGTTATATGCTTTTCAGGAACCAGGTAATAATGCTATCGGA(, AT 
-----------------------------------------------------------"-----. _. _. _. _. 1)936 
CTCTGTCCTAATGAATATTTCCTCCTTTGAAGTGGGATACTTGATCACAATATACGAAAAGTCCTTGGTCCATTATTACGATAGCCTCTA 
ETGLLIKEETSPYELVLYAFQEPGNNAIrD 
GCATCTGGTAAAAATACATCAATAGAATATTCTAAGGACATAGGTTTAGTTTATGGAATAAATAGTGATGCATTATATTTAAATGGAT(', " 
--_---_-_. -. -------------. _-_-_. _-_-_---_---_. ----_. _. _. _. _-_. _. _. _. _. -. _. 'uS0 CGTAGACCATTTTTATGTAGTTATCTTATAAGATTCCTGTATCCAAATCAAATACCTTATTTATCACTACGTAATATAAAT'1'TACý'TAi'. F. 
A. SGK ;1TS1LCK T) FLVY(, N I) ALY1. N .' 
AATCAAAGTATAAGTTTTTCTAATGATTTCTTTGAAAATGGATTAACTAATAGTTTTTCAATTTATTTTTGGTTGAGAAATTTGGGCAIV, 
---------------------------------------------------------------. _. _. _. _. _. 11 
TTAGTTTCATATTCAAAAAGATTACTAAAGAAACTTTTACCTAATTGATTATCAAAAAGTTAAATAAAAACCAACTCTTTAAAF'CCGTTT 
NQSSF_NPFFF. NGI, TNFWVNN:. V 
GATACTATTAAATCTAAGCTAATAGGTAGTAAGGAAGATAATTGTGGTTGGGAAATTTATTTTCAAGATACTGGGTTGGTTTTTAATATG 
___. _---_------------. ----------------------------_------------------. _. - 
CTATGATAATTTAGATTCGATTATCCATCATTCCTTCTATTAACACCAACCCTTTAAATAAAAGTTCTATGACCCAACCAAAAATTATAv' 
DTIKSKL11KFP? NGWEIYhVF: '. " 
. ':, 
ýý 
3 00 
ý` 
,ro: 
'ä wiý, 'ýýýb"t 
ATAGATTCTAATGGAAACGAGAAGAATATATATCTATCTGATGTTTCTAATAATAGTTGGCACTATATAACTATATCTGTAGATCGTTTA 
-------------------------------------------------------------------------- 7290 
TATCTAAGATTACCTTTGCTCTTCTTATATATAGATAGACTACAAAGATTATTATCAACCGTGATATATTGATATAGACATCTAGCAAAT 
ID.. NGNEKNIYLSDVNNNS PI 11 Y1.. vNN,. 
AAAGAACAATTATTAATATTTATTGATGATAATTTAGTGGCTAATGAAAGTATTAAAGAAATTTTAAATATCTATTCAAGTAATACAATT 
-------------------------------------------------------------------------- 7380 
TTTCTTGTTAATAATTATAAATAACTACTATTAAATCACCGATTACTTTCATAATTTCTTTAAAATTTATAGATAAGTTCATTATGTTAA 
KEQLLTFIDDN_, ANES -1 F NN', itJIYNT? 
-&L 
IL 
TCTTTAGTTAATGAAAATAATCCAATATATGTTGAAGGATTATCTATTTTGAATAGATCTATTACAAGTGAAGAAGTTGTAAATAATTAT 
---------------------------------------------------------------. -----. ---- 7470 
AGAAATCAATTACTTTTATTAGGTTATATACAACTTCCTAATAGATAAAACTTATCTAGATAATGTTCACTTCTTCAACATTTATTAATA 
SLVNENNPIYVE: G I, P, LNRSITF. FVV td NY 
TTTACTTATTTAAATAATTCATATATAAGGGATATTTCTGGAGAAAGATTAGAATACAATAAAACCTATGAACTATACAATTATGTATTC 
-------------------------------------------------------------------------- 7560 
AAATGAATAAATTTATTAAGTATATATTCCCTATAAAGACCTCTTTCTAATCTTATGTTATTTTGGATACTTGATATGTTAATACATAAG 
FTYLNNSYIRDIS 
ý3 F; 
1, ýT F'. ., 1NVF 
CCAGAAAGCTCGTTATATGAAGTTACTGAAAACAATAATATATATTTGTCAATTAAAAATACAAATAACCTTAATATTCAAGGTGCTAAG 
-------------------------------------------------------------------------- 7650 
GGTCTTTCGAGCAATATACTTCAATGACTTTTGTTATTATATATAAACAGTTAATTTTTATGTTTATTGGAATTATAAGTTCCACGATTC 
PESSLYEVTENNNSYLS1KN 'P NN,, NIQGAN 
TTTAAATTAATAAATATTGACGCAAACAAGCAATATGTTCAAAAGTGGGATGAAGGAGTAGTTTGTTTATTAGGAGATGAAGAAAAATAT 
_-_---------------------------_--------. _---------------_------------. _. _. 7740 
AAATTTAATTATTTATAACTGCGTTTGTTCGTTATACAAGTTTTCACCCTACTTCCTCATCAAACAAATAATCCTCTACTTCTTTTTATA 
FKLINIDA 11 KQYVQKW001, VVC1, L (, f) 0E F' 
Stu I/ 
GTAGATATATCCTCTGAAAATAATAGAATCCAATTAGTTAGCTCTAAAGATACTGCAAAGAGAATAATATTTAATAACGATATATTTA(-, G 
-----------------------------------------------------------------------"-- 
7830 
CATCTATATAGGAGACTTTTATTATCTTAGGTTAATCAATCGAGATTTCTATGACGTTTCTCTTATTATAAATTATTGCTATATAAAT(IC 
V I) 100NNR1 C) LVK f% :'AKF. I 
He III 
CCTAATTGCCTTACATTTGCTTATAATAATAAATATTTATCTTTATCCTTAAGAGATAGAAATTATAATTGGATGA'I'A'I'GTAA'I'AATAAT 
-------------------------------"------------------------------------------ 7920 
GGATTAACGGAATGTAAACGAATATTATTATTTATAAATAGAAATAGGAATTCTCTATCTTTAATATTAACCTACTATACATTATTATTA 
PNCLTFAYNNKYLSLSLRDN Nl 14 WMICNNN 
GACAATATACCTAAGGCTGCACATTTATGGGCATTAAAAGGGATATAAACTTAAAA'1'Ph. AGAATATTTATGCCAGTTACAATAAF. 
------------------- ........ . --------------------------- . ------------------ 8010 
CTGTTATATGGATTCCGACGTGTAAATACCCGTAATTTTCCCTATATTTGAATTTTAI"I'(: ý"I',:, 'TCTTATAAATACGGTCAATGTTATTT 
DNIPKAAHLWALKG1 BUNT/Bo -*> M I' T1N 
APPENDIX III Annotated nucleotide sequence of neurotoxin complex operons 5' to the silent type 
B neurotoxin in C. botulinum NCTC 2916 
Open reading frames are translated below the corresponding sequence, Red font indicates translation from 
the sense strand whilst blue indicates translation from the reverse strand. Putative ribosome binding sites 
are shown in red, selected restriction sites; = and Promoter sequences of the Haemagglutinin operon 
and NTNHBoNTB° ; 
301 
APPENDIX IV 
COMPARATIVE ALIGNMENT OF THE NTNH GENE 
FROM THE TYPE B NEUROTOXIN LOCUS IN C. 
BOTULINUM TYPE A, STRAIN NCTC 2916, WITH NTNH 
GENES FROM OTHER SEROTYPES 
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NMm co NC') co NN)to QQtnmUW4. QQQN[DUWIL ý QQQV)mUWL. : QaaNCDUWLA- 
a F- a º- c9 c7 LO c9c uuC-1 F- F- º- I-- i- º- aaaa as 
hF-º-º-F-1-f- c9 c7 0 c9 C9c7c9 Qaaadaa QaaaaQa 
C90[3o aaa F-F-F-F- I- I-I- co U®C71.0U UUUUUUL 
«4 h-º-F-º-I-I-® r-h-f-f-º-h-º- aaaaa c7 c9 
F-f-©ýº-º-© HF-NHHF-I- H1- F-1-H u I- HI. - H- 
00 LD C7 c9 c9 c7 adadaQa C3 LD 0U º- 1-1 F- F- -- º- ý- º- º- 
ý- º-® ý- i- f-® E- F-- f- ý- º- f- aaaa u º- 
-f-ýý-h-º-h- aaaaQaa Qd 4« I- I-F-I-I-I- 
0 9c7c7c7co CD aaaaaaa aa-: c -cc -F-º-----ý-"º- 
1-F-f-F-º-r-F- uu[5 UUý ý-- ! --h®ý-E- as ouscA ý-- ua 
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M13 Forward (-20) Primer 
5'-GTAAAACGACGGCCAG-3' 
M13 Reverse Primer 
5'-CAGGAAACAGCTATGAC-3' 
B2676 
5'-GTAAATAATTATTTTTCTTATT-3' 
B2677 
5'-CTCTCGCAAATGGAGGCTCCATC-3' 
B2708 
5'-TTTTTTAGATCAATGGTGGAC-3' 
B2709 
5'-ATTCTCCGGTGGATAATAAGAATG-3' 
3237 
5'-TCGAAATATTATAGAGGGG-3' 
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